File Nos. 333-174627
811-22564
AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION
ON SEPTEMBER 15, 2011
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-1A
|
|
|
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
|
|
o
|
Pre-Effective Amendment No. 2
|
|
þ
|
Post-Effective Amendment No. __
|
|
o
|
|
|
|
and
|
|
|
|
REGISTRATION STATEMENT UNDER THE INVESTMENT COMPANY ACT OF 1940
|
|
o
|
Amendment No. 2
|
|
þ
|
GMO SERIES T
RUST
(Exact Name of Registrant as Specified in Charter)
40 Rowes Wharf, Boston, Massachusetts 02110
(Address of principal executive offices)
617-330-7500
(Registrants telephone number, including area code)
with a copy to:
|
|
|
J.B. Kittredge, Esq.
GMO Trust
40 Rowes Wharf
Boston, Massachusetts 02110
|
|
Thomas R. Hiller, Esq.
Ropes & Gray LLP
Prudential Tower
800 Boylston Street
Boston, Massachusetts 02199
|
(Name and address of agents for service)
Approximate date of proposed public offering: As soon as practicable after the effective date of
this registration statement.
It is proposed that this filing will become effective:
o
immediately upon filing pursuant to paragraph (b)
o
on (date), pursuant to paragraph (b)
o
60 days after filing pursuant to paragraph (a)(1)
o
on (date), pursuant to paragraph (a)(1)
o
75 days after filing pursuant to paragraph (a)(2)
o
on (date) pursuant to paragraph (a)(2) of Rule 485
If appropriate, check the following box:
o
This post-effective amendment designates a new effective date for a previously filed
post-effective amendment.
Pursuant to the provisions of Rule 24f-2 under the Investment Company Act of 1940, Registrant
declares that an indefinite number of its shares of common stock are being registered under the
Securities Act of 1933 by this registration statement.
THE REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ON SUCH
DATE OR DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANT SHALL FILE A
FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS REGISTRATION STATEMENT SHALL THEREAFTER
BECOME EFFECTIVE IN ACCORDANCE WITH THE PROVISIONS OF SECTION 8(a) OF THE SECURITIES ACT OF 1933 OR
UNTIL THE REGISTRATION STATEMENT SHALL BECOME EFFECTIVE ON SUCH DATE AS THE COMMISSION, ACTING
PURSUANT TO SECTION 8(a), MAY DETERMINE.
GMO Series Trust
Prospectus
October 1, 2011
§
GMO U.S. Core Equity Series Fund
Class R1:
§
Shares of the Fund described in
this Prospectus may not be available
for purchase in all states. This
Prospectus does not offer shares in
any state where they may not lawfully
be offered.
Grantham, Mayo, Van Otterloo & Co. LLC
40 Rowes Wharf
Boston, Massachusetts 02110
The Securities and Exchange Commission has not approved or disapproved these securities or
passed upon the adequacy of this Prospectus. Any representation to the contrary is a criminal
offense.
TABLE OF CONTENTS
|
|
|
|
|
|
|
Page
|
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
7
|
|
|
|
|
|
|
|
|
|
8
|
|
|
|
|
|
|
|
|
|
14
|
|
|
|
|
|
|
|
|
|
16
|
|
|
|
|
|
|
|
|
|
18
|
|
|
|
|
|
|
|
|
|
18
|
|
|
|
|
|
|
|
|
|
19
|
|
|
|
|
|
|
|
|
|
21
|
|
|
|
|
|
|
|
|
|
22
|
|
|
|
|
|
|
|
|
|
22
|
|
|
|
|
|
|
|
|
back cover
|
|
|
|
|
|
|
|
|
back cover
|
|
|
|
|
|
|
|
|
back cover
|
|
i
GMO U.S. Core Equity Series Fund
FUND SUMMARY
Investment Objective
High total return (including both capital appreciation and income).
Fees and Expenses
The table below describes the fees and expenses that you may pay if you buy and hold shares of
GMO U.S. Core Equity Series Fund (the Fund).
Annual Fund Operating Expenses
1
(expenses that you pay each year as a percentage of the value of your investment)
|
|
|
|
|
|
|
Class R1
|
Management fee
|
|
|
0.31
|
%
2
|
Distribution (12b-1) fee
|
|
None
|
Other expenses
|
|
|
|
|
Administration fee
|
|
|
0.05
|
%
|
Other expenses
|
|
|
0.82
|
%
|
Total other expenses
|
|
|
0.87
|
%
|
Total annual fund operating expenses
|
|
|
1.23
|
%
|
Expense reimbursement
|
|
|
(0.62
|
%)
3
|
Total annual operating expenses after reimbursement
|
|
|
0.61
|
%
|
|
|
|
1
|
|
The amounts represent an annualized estimate of the Funds operating expenses for
its initial fiscal year. The information in this table and in the Example below reflect the
expenses of both the Fund and GMO U.S. Core Equity Fund (USCEF), the underlying fund in which the
Fund invests.
|
|
2
|
|
The amount reflects the management fee paid by USCEF. The Fund does not charge a
management fee, but indirectly bears the management fee paid by USCEF.
|
|
|
3
|
|
Subject to certain exclusions (Excluded Fund Fees and Expenses), Grantham, Mayo, Van
Otterloo & Co. LLC (the Manager or GMO) has contractually agreed to reimburse the Fund to the
extent the Funds total annual operating expenses exceed 0.00% of the Funds average daily net
assets. Excluded Fund Fees and Expenses include administration fees, expenses incurred indirectly
by investment in USCEF and any other underlying funds, independent Trustee expenses, certain legal
costs, investment-related costs (e.g., brokerage commissions, securities lending fees, interest
expense), hedging transaction fees, and extraordinary expenses, as described under Expenses in
this Prospectus. This expense limitation will continue through at least October 1, 2012, and may
not be terminated prior to this date without the consent of the Funds Board of Trustees.
|
|
Example
This example is intended to help you compare the cost of investing in the Fund with the cost
of investing in other mutual funds. The example assumes that you invest $10,000 in the Fund for the
time periods indicated, regardless of whether or not you redeem your shares at the end of such
periods. The example also assumes that your investment has a 5% return each year and that the
Funds operating expenses remain the same as those shown in the table. The one year amounts shown
reflect expense reimbursements and both amounts shown include the expenses of both USCEF and the
Fund.
-2-
Although your actual costs may be higher or lower, based on these assumptions your costs would
be:
|
|
|
|
|
|
|
|
|
|
|
1 Year*
|
|
3 Years
|
Class R1
|
|
$
|
62
|
|
|
$
|
329
|
|
Portfolio Turnover
The Fund pays transaction costs when it buys and sells securities. A higher portfolio turnover
rate may indicate higher transaction costs. These costs, which are not reflected in Annual Fund
Operating Expenses or in the Example, affect the Funds performance. Because the Fund commenced
operations on or following the date of this Prospectus, the Funds portfolio turnover rate is not
available.
Principal Investment Strategies
The Fund invests substantially all of its assets in GMO U.S. Core Equity Fund (USCEF), which
invests directly in securities and other instruments. The Funds investment objective and
principal investment strategies, therefore, are substantially similar to those of USCEF.
References to the Fund may refer to actions undertaken by the Fund or USCEF. The Funds investment
adviser, GMO, is also the investment adviser to USCEF.
The Manager seeks to achieve the Funds investment objective by investing in equities or
groups of equities that the Manager believes will provide higher returns than the S&P 500 Index.
The Manager uses active investment management methods, which means that equities are bought
and sold according to the Managers evaluation of companies published financial information,
securities prices, equity and bond markets, and the overall economy.
In selecting equities for the Fund, the Manager may use a combination of quantitative and
qualitative investment methods to identify equities that the Manager believes present positive
return potential relative to other equities. Some of these methods evaluate individual equities or
groups of equities (e.g. equities of companies in a particular industry) based on the ratio of
their price to historical financial information, including book value, cash flow and earnings, and
forecasted financial information provided by industry analysts. The Manager may compare these
ratios to industry or market averages in assessing the relative attractiveness of an equity or
group of equities. Other methods used by the Manager focus on evaluating patterns of price movement
or volatility of an equity or group of equities relative to the Funds investment universe. The
Manager also may adjust the Funds portfolio for factors such as position size, industry and sector
exposure, and market capitalization. The Manager may invest in companies of any market
capitalization.
As a substitute for direct investments in equities, the Manager may use exchange-traded and
over-the-counter (OTC) derivatives. The Manager also may use derivatives: (i) in an attempt to
reduce investment exposures (which may result in a reduction below zero); (ii) in an attempt to
adjust elements of the Funds investment exposure; and (iii) to effect transactions intended as
substitutes for securities lending. Derivatives used may include futures, options and swap
contracts. In addition, the Fund may lend its portfolio securities.
Under normal circumstances, the Fund invests directly and indirectly (e.g., through underlying
funds or derivatives) at least 80% of its assets in equity investments tied economically to the
U.S. The
-3-
terms equities and equity investments refer to direct and indirect investments in common
stocks and other stock-related securities, such as preferred stocks, convertible securities and
depositary receipts.
For cash management purposes, the Fund may invest in GMO U.S. Treasury Fund, another fund
managed by GMO and offered through a separate prospectus, and unaffiliated money market funds.
The Fund may hold cash, cash equivalents, and/or U.S. government securities to manage cash
inflows and outflows as a result of shareholder purchases and redemptions.
Principal Risks of Investing in the Fund
The value of the Funds shares changes with the value of the Funds investments,
principally in USCEF shares. Many factors can affect this value, and you may lose money by
investing in the Fund. Because the Fund invests substantially all of its assets in USCEF, the most
significant risks of investing in the Fund are the risks to which the Fund is exposed through
USCEF, which include those outlined in the following brief summary of principal risks. In addition
to the risks the Fund is exposed to through its investment in USCEF, the Fund is subject to the
risk that cash flows in or out of the Fund will cause its performance to differ from that of USCEF.
|
|
Market Risk Equity Securities
The market value of equity investments may decline due
to factors affecting the issuing companies, their industries, or the economy and equity
markets generally. If the Fund purchases equity investments at a discount from their value as
determined by the Manager, the Fund runs the risk that the market prices of these investments
will not increase to that value for a variety of reasons, one of which may be the Managers
overestimation of the value of those investments. The Fund also may purchase equity
investments that typically trade at higher multiples of current earnings than other
securities, and the market values of these investments often are more sensitive to changes in
future earnings expectations than those other securities. Because the Fund normally does not
take temporary defensive positions, declines in stock market prices generally are likely to
reduce the net asset value of the Funds shares.
|
|
|
Management and Operational Risk
The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior market
data can fail to predict future market events. Further, the data used in models may be
inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or another
service providers internal systems or controls will cause losses for the Fund or impair
operations.
|
|
|
Derivatives Risk
The use of derivatives involves the risk that their value may not move
as expected relative to the value of the relevant underlying assets, rates or indices.
Derivatives also present other Fund risks, including market risk, liquidity risk and
counterparty risk.
|
|
|
Counterparty Risk
The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations.
|
|
|
Leveraging Risk
The Funds use of derivatives and securities lending may cause its
portfolio to be leveraged. Leverage increases the Funds portfolio losses when the value of
its investments decline.
|
-4-
|
|
Smaller Company Risk
Smaller companies may have limited product lines, markets, or
financial resources, may lack the competitive strength of larger companies, or may lack
managers with experience or depend on a few key employees. The securities of small- and
mid-cap companies often are less widely held and trade less frequently and in lesser
quantities, and their market prices often fluctuate more, than the securities of companies
with larger market capitalizations.
|
|
|
Focused Investment Risk
Focusing investments in sectors or companies or in industries
with high positive correlations to one another creates additional risk.
|
|
|
Market Disruption and Geopolitical Risk
Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well as
other changes in foreign and domestic economic and political conditions could adversely affect
the value of the Funds investments.
|
|
|
Large Shareholder Risk
To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, financial intermediaries, asset allocation funds,
or other funds managed by GMO (GMO Funds)), the Fund is subject to the risk that these
shareholders will disrupt operations by purchasing or redeeming shares in large amounts and/or
on a frequent basis.
|
|
|
Fund of Funds Risk
The Fund is indirectly exposed to all of the risks of an investment
in USCEF, including the risk that USCEF will not perform as expected.
|
Performance
The bar chart and table below provide some indication of the risks of investing in
the Fund by showing changes in USCEFs annual total returns from year to year for the periods
indicated and by comparing USCEFs average annual total returns for different calendar periods with
those of a broad-based index. After-tax returns are calculated using the historical highest
individual federal marginal income tax rates and do not reflect the impact of state and local
taxes. Actual after-tax returns depend on your tax situation and may differ from those shown.
After-tax returns shown are not relevant if you are tax-exempt or if you hold your Fund shares
through tax-deferred arrangements (such as a 401(k) plan or individual retirement account). Past
performance (before and after taxes) is not an indication of future performance.
Annual Total Returns/Class III Shares
*
Years Ending December 31
Highest Quarter: 16.38% (2Q2003)
Lowest Quarter: -17.31% (3Q2002)
Year-to-Date (as of 08/15/2011): -0.25%
-5-
Average Annual Total Returns*
Periods Ending December 31, 2010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 Year
|
|
5 Years
|
|
10 Years
|
|
Inception
|
Class III
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9/18/85
|
|
Return Before Taxes
|
|
|
7.99
|
%
|
|
|
-0.31
|
%
|
|
|
0.11
|
%
|
|
|
10.19
|
%
|
Return After Taxes on
Distributions
|
|
|
7.72
|
%
|
|
|
-1.07
|
%
|
|
|
-0.48
|
%
|
|
|
7.39
|
%
|
Return After Taxes on
Distributions and Sale of
Fund Shares
|
|
|
5.22
|
%
|
|
|
-0.46
|
%
|
|
|
-0.15
|
%
|
|
|
7.57
|
%
|
S&P 500 Index (reflects
no deduction for fees,
expenses, or taxes)
|
|
|
15.06
|
%
|
|
|
2.29
|
%
|
|
|
1.41
|
%
|
|
|
10.52
|
%
|
|
|
|
|
*
|
|
The Fund invests substantially all of its assets in USCEF, a series of
GMO Trust that has an investment objective and policies and restrictions
substantially identical to those of the Fund. Performance of the Fund is that
of USCEF (Class III shares) and its predecessor fund, adjusted to reflect the
gross expenses (on a percentage basis) that are expected to be borne by
shareholders of Class R1 shares of the Fund, as reflected in the Annual Fund
Operating Expenses table.
|
|
Management of the Fund
Investment Adviser: Grantham, Mayo, Van Otterloo & Co. LLC
Investment Division and Senior Members of GMO responsible for day-to-day management of the Fund:
|
|
|
|
|
|
|
Senior Members
|
|
|
Investment Division
|
|
(Length of Service)
|
|
Title
|
Quantitative Equity
|
|
Thomas Hancock
(since the Funds inception)
|
|
Co-Director,
Quantitative Equity
Division, GMO.
|
|
|
|
|
|
Quantitative Equity
|
|
Sam Wilderman
(since the Funds inception)
|
|
Co-Director,
Quantitative Equity
Division, GMO.
|
Purchase and Sale of Fund Shares
Class R1 shares of the Fund may be purchased by eligible retirement plans. There are no
minimum initial or subsequent investment requirements for Class R1 shares of the Fund.
In general, retirement plan participants may redeem shares of the Fund on any day when the New
York Stock Exchange (NYSE) is open for business by contacting the retirement plan administrator.
Tax Information
The Fund normally distributes net investment income and net realized capital gains, if any, to
shareholders. By investing in the Fund through a tax-advantaged retirement account, you will not
be subject to tax on these Fund distributions if your Fund shares remain in a tax-advantaged
account. Depending on the type of retirement account, you may be taxed upon withdrawals from that
account. You should consult with your tax advisor or the plan administrator or other financial
intermediary through
-6-
which your investment in the Fund is made regarding the U.S. federal income tax consequences
of your investment.
Financial Intermediary Compensation
If you purchase shares of the Fund through a broker-dealer, agent or other financial
intermediary (such as a bank), the Fund and its related companies may pay that party for the sale
of Fund shares and related services. These payments may create a conflict of interest by
influencing the broker-dealer or other intermediary and your salesperson to recommend the Fund over
another investment. Ask your salesperson or visit your financial intermediarys website for more
information.
ADDITIONAL INFORMATION ABOUT THE FUNDS
INVESTMENT STRATEGIES, RISKS, AND EXPENSES
Fund Summary.
The preceding section contains a summary of the investment
objective, fees and expenses, principal investment strategies, principal risks, management, and
other important information for the Fund. The summary is not all-inclusive, and the Fund may make
investments, employ strategies, and be exposed to risks that are not described in the summary.
More information about the Funds investments and strategies is contained in the Statement of
Additional Information (SAI). See the back cover of this Prospectus for information about how to
receive the SAI. Information about USCEF is contained in a separate prospectus.
Fundamental Investment Objective/Policies.
The Board of Trustees (Trustees) of GMO Series
Trust (the Trust) may change the Funds investment objective or policies without shareholder
approval or prior notice unless an objective or policy is identified in this Prospectus or in the
SAI as fundamental. Because the Fund invests substantially all of its assets in USCEF, its
investment objective and policies will change to reflect any changes to USCEFs investment
objectives and policies. There is no guarantee that the Fund will be able to achieve its
investment objective.
Portfolio Turnover.
Portfolio turnover is not a principal consideration when GMO makes
investment decisions for the Fund, and the Fund has not placed any limit on the rate of portfolio
turnover and portfolio securities may be sold without regard to the time they have been held.
Based on its assessment of market conditions and purchase or redemption requests, GMO may cause the
Fund to trade more frequently at some times than at others. High turnover rates may adversely
affect the Funds performance by generating higher transaction costs.
Certain Definitions.
When used in this Prospectus, the term invest includes both direct
investing and indirect investing and the term investments includes both direct investments and
indirect investments. For example, the Fund may invest indirectly by investing in another Fund or
by investing in derivatives and synthetic instruments. When used in this Prospectus, (i) the terms
equity investments and equities refer to investments (as defined above) in common stocks and
other stock-related securities, such as preferred stocks, convertible securities, and depositary
receipts, and (ii) the term total return includes capital appreciation and income.
Benchmark.
The Funds benchmark, the S&P 500 Index, is an independently maintained and widely
published index comprised of U.S. large capitalization stocks.
Fee and Expense Information.
The following paragraphs contain additional information about the
fee and expense information included in the Fund Summary.
-7-
Annual Fund Operating Expenses Other Expenses.
The amount listed under Other expenses in
the Annual Fund Operating Expenses table included in the Fund Summary reflects an annualized
estimate of direct expenses associated with an investment in the Fund and USCEF for the Funds
initial fiscal year. USCEF may invest in certain other funds of GMO Trust and certain other pooled
investment vehicles (underlying funds), and the indirect net expenses associated with USCEFs
investment in underlying funds are reflected in Other expenses. Actual indirect expenses will
vary depending on the particular underlying funds in which USCEF invests.
Fee and Expense Example.
The expense example under Example included in the Fund Summary
assumes that all dividends and distributions, if any, are reinvested.
Temporary Defensive Positions.
The Fund normally does not take temporary defensive positions.
To the extent the Fund takes a temporary defensive position, it may not achieve its investment
objective.
Fund Codes.
See Fund Codes on the inside back cover of this Prospectus for information
regarding the Funds ticker, news-media symbol, and CUSIP number.
This Prospectus does not offer shares in any state where they may not lawfully be offered.
DESCRIPTION OF PRINCIPAL RISKS
Investing in mutual funds involves many risks, and factors that may affect the Funds
portfolio as a whole, called principal risks, are discussed briefly in the Fund Summary and are
discussed in additional detail in this section. The risks of investing in the Fund depend on the
types of investments in its portfolio and the investment strategies the Manager employs on its
behalf. This section describes the nature of these principal risks and some related risks, but
does not describe every potential risk of investing in the Fund. The Fund could be subject to
additional risks because of the types of investments it makes and market conditions, which may
change over time. The SAI includes more information about the Fund and its investments.
Because the Fund invests substantially all of its assets in USCEF, the most significant risks
of investing in the Fund are the risks to which the Fund is exposed through USCEF, which include
the principal risks summarized below. In addition to the risks the Fund is exposed to through its
investment in USCEF, the Fund is subject to the risk that cash flows in or out of the Fund will
cause its performance to differ from that USCEF. As indicated in the Fund Summary and in the
Additional Information About the Funds Investment Strategies, Risks, and Expenses section of
this Prospectus, references in this section to investments made by the Fund include those made by
USCEF.
The Fund, by itself, generally is not a complete investment program, but rather is intended to
serve as part of a diversified portfolio of investments. An investment in the Fund is not a bank
deposit and, therefore, is not insured or guaranteed by the Federal Deposit Insurance Corporation
or any other government agency.
|
|
|
MARKET RISKEQUITY SECURITIES
|
The Fund runs the risk that the market value of its equity investments will decline. The
market value of an equity investment may decline for reasons that directly relate to the issuing
company, such as management performance, financial leverage and reduced demand for its goods or
services. It also may decline due to factors that affect a particular industry, such as a decline
in demand, labor or raw material shortages, increased production costs, regulation, or competitive
industry conditions. In addition, market
-8-
value may decline as a result of general market conditions that are not specifically related
to a company or industry, such as real or perceived adverse economic conditions, changes in the
general outlook for corporate earnings, changes in interest or currency rates, or adverse investor
sentiment generally. Equity investments generally have greater price volatility than fixed-income
and other investments with a scheduled stream of payments, and the market price of equity
investments is more susceptible to moving up or down in a rapid or unpredictable manner.
The Fund invests a substantial portion of its assets in equities and, as described under
Additional Information About the Funds Investment Strategies, Risks, and Expenses Temporary
Defensive Positions, generally does not take temporary defensive positions. As a result, declines
in stock market prices generally are likely to reduce the net asset value of the Funds shares.
If the Fund purchases equity investments at a discount from their value as determined by the
Manager, the Fund runs the risk that the market prices of these investments will not increase to
that value for a variety of reasons, one of which may be the Managers overestimation of the value
of those investments.
Equity investments trading at higher multiples of current earnings than other securities have
market values that often are more sensitive to changes in future earnings expectations than other
securities. At times when the market is concerned that these expectations may not be met, the
market values of those securities typically fall.
|
|
|
MANAGEMENT AND OPERATIONAL RISK
|
The Fund is subject to management risk because it relies on the Managers ability to achieve
their investment objectives. The Manager uses proprietary investment techniques in making
investment decisions for the Fund, but that does not assure that the Manager will achieve the
desired results and the Fund may incur significant losses. The Manager, for example, may fail to
use derivatives effectively, choosing to hedge or not to hedge positions at disadvantageous times.
As described in the Fund Summary, the Manager uses quantitative analyses and/or models. Any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior market data
can fail to predict future market events. Further, the data used in models may be inaccurate and/or
it may not include the most recent information about a company or a security. There also can be no
assurance that all of the Managers personnel will continue to be associated with the Manager for
any length of time. The loss of the services of one or more employees of the Manager could have an
adverse impact on the Funds ability to achieve its investment objectives.
The Fund generally does not take temporary defensive positions. Instead it usually is fully
invested in the asset class in which it is permitted to invest (e.g., equity investments tied
economically to the U.S.). The Fund may buy securities not included in its benchmark, hold
securities in very different proportions than its benchmark, and/or engage in other strategies that
cause its performance to differ from (and/or be uncorrelated with or negatively correlated with)
that of its benchmark. In those cases, the Funds performance will depend on the ability of the
Manager to choose securities that perform better than securities that are included in the benchmark
and/or to utilize those other strategies in a way that adds value relative to the benchmark.
The Fund is also subject to the risk of loss and impairment of operations from operational
risk as a result of the Managers and other service providers provision of investment management,
administrative, accounting, tax, legal, shareholder, and other services to the Fund. Operational
risk can result from inadequate procedures and controls, human error, and system failures by a
service provider. For example,
-9-
trading delays or errors (both human and systematic) could prevent the Fund from purchasing or
selling a security that the Manager expects will appreciate or decline in value, as the case may
be, thus preventing the Fund from benefiting from potential investment gains or avoiding losses on
the security. The Manager is not contractually liable to the Fund for losses associated with
operational risk absent the Managers willful misfeasance, bad faith, gross negligence, or reckless
disregard of its contractual obligations to provide services to the Fund. Other Fund service
providers also have limitations on their liability to the Fund for losses resulting from their
errors.
The Fund may invest in derivatives, which are financial contracts whose value depends on, or
is derived from, the value of underlying assets, reference rates, or indices. Derivatives include
futures, foreign currency contracts, swap contracts, reverse repurchase agreements, and other OTC
contracts. Derivatives may relate to securities, interest rates, currencies or currency exchange
rates, inflation rates, commodities, and indices. The SAI contains a description of the various
types and uses of derivatives in the Funds investment strategies.
The use of derivatives involves risks that are in addition to, and potentially greater than,
the risks associated with investing directly in securities and other more traditional assets. In
particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a
derivatives contract will be unable or unwilling to make timely settlement payments or otherwise
honor its obligations. OTC derivatives contracts typically can be closed only with the other party
to the contract. If the counterparty defaults, the Fund will have contractual remedies but may not
be able to enforce them. Because the contract for each OTC derivative is individually negotiated,
the counterparty may interpret contractual terms (e.g., the definition of default) differently than
the Fund, and if that occurs, the Fund may decide not to pursue its claims against the counterparty
in order to avoid incurring the cost and unpredictability of legal proceedings. The Fund,
therefore, may be unable to obtain payments the Manager believes are owed under OTC derivatives
contracts or those payments may be delayed or made only after the Fund has incurred the costs of
litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral
(e.g., foreign currency forwards), that require collateral but that do not provide for the Funds
security interest in it to be perfected, that require a significant upfront deposit by the Fund
unrelated to the derivatives intrinsic value, or that do not require the collateral to be
regularly marked-to-market (e.g., certain OTC derivatives). Even when obligations are required by
contract to be collateralized, there is usually a lag between the day the collateral is called for
and the day the Fund receives it. When a counterpartys obligations are not fully secured by
collateral, the Fund is exposed to the risk of having limited recourse if the counterparty
defaults. The Fund may invest in derivatives with a limited number of counterparties, and events
affecting the creditworthiness of any of those counterparties may have a pronounced effect on the
Fund. Derivatives risk is particularly acute in environments (like those experienced recently) in
which financial services firms are exposed to systemic risks of the type evidenced by the
insolvency of Lehman Brothers and subsequent market disruptions. During these periods of market
disruptions, the Fund may have a greater need for cash to provide collateral for large swings in
its mark-to-market obligations under the derivatives used by the Fund.
Derivatives also present risks described elsewhere in this Description of Principal Risks
section, including market risk and counterparty risk. Many derivatives, in particular OTC
derivatives, are complex and their valuation often requires modeling and judgment, which increases
the risk of mispricing or improper valuation. The pricing models used by the Fund or its pricing
agents may not produce valuations that are consistent with the values realized when OTC derivatives
are actually closed out or sold. This valuation risk is more pronounced when the Fund enters into
OTC derivatives with specialized
-10-
terms because the value of those derivatives in some cases is determined only by reference to
similar derivatives with more standardized terms. As a result, incorrect valuations may result in
increased cash payments to counterparties, undercollateralization and/or errors in the calculation
of the Funds net asset value.
The Funds use of derivatives may not be effective or have the desired results. Moreover,
suitable derivatives will not be available in all circumstances. For example, the economic costs of
taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is
deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that
counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise
reduce the Funds risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected
relative to the value of the assets, rates, or indices they are designed to track.
Swap contracts and other OTC derivatives are highly susceptible to counterparty risk (see
Counterparty Risk below), and are subject to documentation risks. Because many derivatives have
a leverage component (i.e., a notional value in excess of the assets needed to establish and/or
maintain the derivative position), adverse changes in the value or level of the underlying asset,
rate or index may result in a loss substantially greater than the amount invested in the derivative
itself.
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives market, including clearing, margin, reporting and registration requirements. Because
the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations
could, among other things, restrict the Funds ability to engage in derivatives transactions (for
example, by making certain types of derivatives transactions no longer available to the Fund)
and/or increase the costs of such derivatives transactions (for example, by increasing margin or
capital requirements), and the Fund may be unable to execute its investment strategy as a result.
It is unclear how the regulatory changes will affect counterparty risk.
This is the risk that the counterparty to a repurchase agreement or reverse repurchase
agreement or other OTC derivatives contract or a borrower of the Funds securities will be unable
or unwilling to make timely settlement payments or otherwise honor its obligations. If a
counterparty fails to meet its contractual obligations, goes bankrupt, or otherwise experiences a
business interruption, the Fund could miss investment opportunities or otherwise hold investments
it would prefer to sell, resulting in losses for the Fund. Counterparty risk is pronounced during
unusually adverse market conditions and is particularly acute in environments (like those
experienced recently) in which financial services firms are exposed to systemic risks of the type
evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions.
Participants in OTC derivatives markets typically are not subject to the same level of credit
evaluation and regulatory oversight as are members of exchange-based markets and, therefore, OTC
derivatives generally expose the Fund to greater counterparty risk than exchange-traded
derivatives. The Fund is subject to the risk that a counterparty will not settle a transaction in
accordance with its terms and conditions because of a dispute over the terms of the contract
(whether or not bona fide) or because of a credit or liquidity problem, thus causing the Fund to
suffer a loss. If a counterpartys obligation to the Fund is not collateralized, then the Fund is
essentially an unsecured creditor of the counterparty. If the counterparty defaults, the Fund will
have contractual remedies, but the Fund may be unable to enforce them. Counterparty risk is greater
for derivatives with longer maturities where events may intervene to
-11-
prevent settlement. Counterparty risk is also greater when the Fund has concentrated its
derivatives with a single or small group of counterparties as it sometimes does as a result of its
use of swaps and other OTC derivatives. To the extent the Fund has significant exposure to a single
counterparty, this risk will be particularly pronounced. The Fund is subject, in particular, to
the creditworthiness of the contracts counterparties because some types of swap contracts used by
the Fund have durations longer than six months (and, in some cases, a number of decades). The
creditworthiness of a counterparty may be adversely affected by greater than average volatility in
the markets, even if the counterpartys net market exposure is small relative to its capital.
Counterparty risk still exists even if a counterpartys obligations are secured by collateral
because the Funds interest in collateral may not be perfected or additional collateral may not be
promptly posted as required.
The Fund is also subject to counterparty risk because it executes its securities transactions
through brokers and dealers. If a broker or dealer fails to meet its contractual obligations, goes
bankrupt, or otherwise experiences a business interruption, the Fund could miss investment
opportunities or be unable to dispose of investments it would prefer to sell, resulting in losses
for the Fund.
Counterparty risk with respect to OTC derivatives may be further complicated by recently
enacted U.S. financial reform legislation. See Derivatives Risk above for more information.
The Funds use of reverse repurchase agreements and other derivatives and securities lending
may cause its portfolio to be leveraged (i.e., the Funds exposure to underlying securities, assets
or currencies exceeds its net asset value). Leverage increases the Funds portfolio losses when the
value of its investments declines. Because many derivatives have a leverage component (i.e., a
notional value in excess of the assets needed to establish and/or maintain the derivative
position), adverse changes in the value or level of the underlying asset, rate or index may result
in a loss substantially greater than the amount invested in the derivative itself. In the case of
swaps, the risk of loss generally is related to a notional principal amount, even if the parties
have not made any initial investment. Some derivatives have the potential for unlimited loss,
regardless of the size of the initial investment. The Funds use of reverse repurchase agreements
also subjects the Fund to interest costs based on the difference between the sale and repurchase
price of a security involved in such a transaction. The Funds portfolio also will be leveraged if
it borrows money to meet redemption requests or settle investment transactions or if it avails
itself of the right to delay payment on a redemption.
The Fund may manage some of its derivative positions by offsetting derivative positions
against one another or against other assets. To the extent offsetting positions do not behave in
relation to one another as expected, the Fund may perform as if it were leveraged.
Market risk and liquidity risk are particularly pronounced for securities of companies with
smaller market capitalizations, including small- and mid-cap companies. These companies may have
limited product lines, markets, or financial resources, may lack the competitive strength of larger
companies, or may lack managers with experience or depend on a few key employees. In addition,
their securities often are less widely held and trade less frequently and in lesser quantities, and
their market prices often fluctuate more, than the securities of companies with larger market
capitalizations.
-12-
|
|
|
FOCUSED INVESTMENT RISK
|
A fund whose investments are focused in particular countries, regions, sectors or companies or
in industries with high positive correlations to one another (e.g., different industries within
broad sectors, such as technology or financial services) is subject to greater overall risk than a
fund whose investments are more diversified. A fund that invests in the securities of a limited
number of issuers is particularly exposed to adverse developments affecting those issuers, and a
decline in the market value of a particular security held by a Fund may affect a Funds performance
more than if the Fund invested in the securities of a larger number of issuers.
Because the Fund typically invests a significant portion of its assets in equity investments
tied economically to the U.S., it is vulnerable to events affecting those equity investments.
Investments that share common characteristics are often subject to similar business risks and
regulatory burdens, and often react similarly to specific economic, market, political or other
developments.
|
|
|
MARKET DISRUPTION AND GEOPOLITICAL RISK
|
The Fund is subject to the risk that geopolitical and other events will disrupt securities
markets and adversely affect global economies and markets. The wars in Iraq and Afghanistan have
had a substantial effect on the economies and securities markets of the U.S. and other countries.
Terrorism in the U.S. and around the world has had a similar global impact and has increased
geopolitical risk. The terrorist attacks on September 11, 2001 resulted in the closure of some U.S.
securities markets for four days, and similar attacks are possible in the future. War, terrorism,
and related geopolitical events have led, and in the future may lead, to increased short-term
market volatility and may have adverse long-term effects on U.S. and world economies and markets
generally. Likewise, natural and environmental disasters, such as the earthquake and tsunami in
Japan in early 2011, and systemic market dislocations of the kind surrounding the insolvency of
Lehman Brothers in 2008, if repeated, would be highly disruptive to economies and markets. Those
events as well as other changes in foreign and domestic economic and political conditions also
could adversely affect individual issuers or related groups of issuers, securities markets,
interest rates, credit ratings, inflation, investor sentiment and other factors affecting the value
of the Funds investments. During such market disruptions, the Funds exposure to the risks
described elsewhere in this Description of Principal Risks section, including market risk and
counterparty risk likely will increase. Market disruptions can also prevent the Fund from
implementing its investment program for a period of time and achieving its investment objective.
For example, a disruption may cause the Funds derivatives counterparties to discontinue offering
derivatives on some underlying commodities, securities, reference rates or indices, or to offer
such products on a more limited basis, or the current global economic crisis may strain the U.S.
Treasurys ability to satisfy its obligations.
To the extent that shares of the Fund are held by large shareholders (e.g., institutional
investors, financial intermediaries or other GMO Funds), the Fund is subject to the risk that these
shareholders will purchase or redeem shares in large amounts and/or on a frequent basis. In
addition, GMO Funds and other accounts over which GMO has investment discretion that invest in the
Fund are not subject to restrictions on the frequency of trading of shares. These transactions
could adversely affect the Fund if the Fund sells portfolio securities to raise the cash to satisfy
shareholder redemption requests or purchase portfolio securities to invest cash. This risk is
particularly pronounced when one shareholder owns a substantial portion of the Fund. A substantial
percentage of the Fund may be held by other GMO Funds and/or separate accounts managed by the
Manager for its clients. Asset allocation decisions by the Manager may
result in substantial redemptions from (or investments into) the Fund. These transactions may
adversely affect the Funds performance to the extent that the Fund is required to sell investments
(or invest cash) at
-13-
times when it would not otherwise do so. These transactions also may increase
transaction costs. In addition, to the extent the Fund invests in other GMO Funds having large
shareholders, the Fund is indirectly subject to this risk.
Because the Fund invest in substantially all of its assets in USCEF, which may invest in
shares of other investment companies, including other GMO Funds and money market funds (for
purposes of this risk disclosure, underlying Funds), the Fund is exposed to the risk that USCEF
or the underlying Funds do not perform as expected.
Because the Fund bears the fees and expenses of USCEF, and USCEF bears the fees and expense of
the underlying Funds in which it invests (absent reimbursement of those expenses), the Fund and
USCEF will incur additional expenses when investing in underlying Funds. In addition, total Fund
expenses will increase if USCEF or its successor increases its fees or incurs additional expenses,
or when USCEF makes a new investment in underlying Funds with higher fees or expenses than those of
the underlying Funds in which USCEF has already invested. The fees and expenses associated with an
investment in these underlying Funds can be less predictable and potentially higher than fees of
other funds with similar investment programs.
The Fund is also indirectly exposed to all of the risks applicable to an investment in the
underlying Funds. In addition, since the Fund and USCEF invest in shares of other GMO Funds, they
are also likely subject to Large Shareholder Risk because underlying GMO Funds are more likely to
have large shareholders (e.g., other GMO Funds). See Large Shareholder Risk above.
MANAGEMENT OF THE FUND
GMO, 40 Rowes Wharf, Boston, Massachusetts 02110, provides investment management and
shareholder services to the Fund, USCEF and other GMO Funds. GMO is a private company, founded in
1977. As of December 31, 2011, GMO managed on a worldwide basis more than $100 billion of assets
for the GMO Funds and other investors, such as pension plans, endowments, and foundations.
Subject to the approval of the Trustees, the Manager establishes and modifies when it deems
appropriate the investment strategies of the Fund. In addition to its management of the Funds
investment portfolio and the shareholder services it provides to the Fund, the Manager administers
the Funds business affairs.
The Fund invests substantially all of its assets in an underlying fund, USCEF. The Trustees
may unanimously determine to change the underlying fund in which the Fund invests, and will provide
the Funds shareholders at least 60 days notice prior to implementing such a change.
The Fund does not pay the management a fee for investment management services, but, as a
shareholder of USCEF, it bears a pro rata portion of USCEFs expenses. USCEF paid the Manager, as
compensation for investment management services, an annual fee equal to 0.28% of USCEFs average
daily net assets for each class of shares during its fiscal year ended February 28, 2011.
Class R1 shares of the Fund pay the Manager an administration fee, which is used by the
Manager to defray its expenses (or the expenses of a third party) in providing administration and
record keeping services to investors purchasing Class R1 shares of the Fund through eligible
retirement plans.
-14-
A discussion of the basis for the Trustees approval of the Funds initial investment
management contract will be included in the Funds first shareholder report.
GMOs Quantitative Equity Division is responsible for day-to-day investment management of the
Fund and USCEF. The Divisions investment professionals work collaboratively to manage the Funds
and USCEFs portfolio, and no one person is primarily responsible for day-to-day management of the
Fund and USCEF.
The following table identifies the senior members of GMOs Quantitative Equity
Division who are responsible for providing investment management services to the Fund and USCEF and
each senior members length of service as a senior member, title, and business experience during
the past five years. The senior members manage or allocate responsibility for portions of the
portfolios to members of their Division, oversee the implementation of trades, review the overall
composition of the portfolios, including compliance with stated investment objectives and
strategies, and monitor cash.
|
|
|
|
|
|
|
Senior Members
|
|
Title;
|
Investment Division
|
|
(Length of Service)
|
|
Business Experience During Past 5 Years
|
Quantitative Equity
|
|
Thomas Hancock
(since the Funds
inception)
|
|
Co-Director, Quantitative Equity
Division, GMO. Dr. Hancock has been
responsible for overseeing the
portfolio management of GMOs
international developed market and
global quantitative equity portfolios
since 1998.
|
|
|
|
|
|
Quantitative Equity
|
|
Sam Wilderman
(since the Funds
inception)
|
|
Co-Director, Quantitative Equity
Division, GMO. Mr. Wilderman has been
responsible for overseeing the
portfolio management of GMOs U.S.
quantitative equity portfolios since
2005. Previously, Mr. Wilderman was
responsible for portfolio management
of and research for GMOs emerging
equity portfolios since 1996.
|
The SAI contains information about how GMO determines the compensation of the senior members,
other accounts they manage and related conflicts, and their ownership of the Fund and other GMO
Funds for which they have responsibility.
Custodian and Fund Accounting Agent
State Street Bank and Trust Company (State Street Bank), One Lincoln Street, Boston,
Massachusetts 02111, serves as the Trusts custodian and fund accounting agent on behalf of the
Fund.
Transfer Agent
State Street Bank serves as the Trusts transfer agent on behalf of the Fund.
Expenses
There are two types of expenses related to mutual funds expenses that a shareholder pays
directly (called a sales charge) and expenses that are deducted from Fund assets.
Class R1 shareholders do not pay any expenses directly as Class R1 shares of the Fund are sold
without an initial sales charge or a contingent deferred sales charge upon redemption.
-15-
The costs of managing, administering, and operating the Fund are spread among each class of
shares, including Class R1 shares. These costs cover such things as the Funds pro rata share of
the expenses of USCEF, shareholder servicing, custody, auditing, administrative and transfer agency
expenses, and fees and expenses of the Trustees and are reflected in the Funds Annual Fund
Operating Expenses table under the caption Fees and Expenses in the Fund Summary.
As more fully described in the Funds fee table, the Manager has contractually agreed to
reimburse the Fund for the portion of the Funds total annual operating expenses that exceed 0.00%
of the Funds average daily net assets (the Expense Reimbursement Amount) exclusive of Excluded
Fund Fees and Expenses. As used in this Prospectus, Excluded Fund Fees and Expenses means
administration fees, expenses incurred indirectly by investment in USCEF and any other GMO Funds,
fees and expenses of the independent Trustees of the Trust and their independent counsel, fees and
expenses for legal services the Manager for the Trust has not undertaken to pay, compensation and
expenses of Trust officers and agents who are not affiliated with GMO, brokerage commissions,
securities lending fees and expenses, interest expense, transfer taxes, and other
investment-related costs (including expenses associated with investments in any company that is an
investment company (including an exchange-traded fund) or would be an investment company under the
1940 Act, but for the exceptions to the definition of investment company provided in Sections
3(c)(1) and 3(c)(7) of the 1940 Act), hedging transaction fees, extraordinary, non-recurring and
certain other unusual expenses (including taxes).
The Funds contractual expense limitations will continue through at least October 1, 2012,
and may not be terminated prior to this date without the consent of the Funds Board of Trustees.
DETERMINATION OF NET ASSET VALUE
The net asset value or NAV of the Fund is determined as of the close of regular trading on
the NYSE, generally at 4:00 p.m. Boston time. The NAV per share of Class R1 shares of the Fund is
determined by dividing the total value of the Funds portfolio investments and other assets, less
any liabilities, allocated to that share class by the total number of outstanding shares of that
class. NAV is not determined on any days when the NYSE is closed for business. The Fund also may
elect not to determine NAV on days during which no share is tendered for redemption and no order to
purchase or sell a share is received by the Fund. U.S. generally accepted accounting principles
(GAAP) may require the Fund to accrue for certain taxes that may or may not ultimately be paid.
The amounts of such accruals will be determined by the Manager in its sole discretion.
Because the Fund invests substantially all of its assets in USCEF, the Funds net asset value
is calculated based upon the net asset value of USCEF. Like the Fund, USCEFs NAV is determined as
of the close of regular trading on the NYSE. Following is a description of how the value of
USCEFs investments and any investments by the Fund in addition to its investments in USCEF are
generally determined:
Exchange-listed securities (other than Exchange-listed options)
|
|
|
Last sale price or
|
|
|
|
|
Official closing price or
|
|
|
|
|
Most recent quoted price published by the exchange (if no reported last sale or
official closing price) or
|
-16-
|
|
|
Quoted price provided by a pricing source (if the private market is more
reliable in determining market value than the exchange)
|
|
|
(Also, see discussion in Fair Value Pricing below regarding foreign equity securities.)
|
Exchange-listed options
|
|
|
Exchange-listed options are valued at the last sale price, provided that price
is between the closing bid and ask prices. If the last sale price is not within this
range, then they will be valued at the closing bid price for long positions and the
closing ask price for short positions
|
Unlisted securities
(if market quotations are readily available)
|
|
|
Most recent quoted price
|
Note: There can be no assurance that quoted prices will be available. If reliable quotes
are not available, the Fund or USCEF may seek alternative valuation methodologies (e.g.,
valuing the relevant assets at fair value as described below).
Non-emerging market debt obligations
(having sixty days or less to final maturity)
|
|
|
Amortized cost (unless circumstances dictate otherwise; for example, if the
issuers creditworthiness has become impaired)
|
All other fixed income securities
(includes bonds, asset-backed securities, loans, structured
notes)
|
|
|
Most recent quoted price supplied by a single pricing source chosen by the
Manager
|
Shares of other GMO Funds and other open-end registered investment companies
Fair Value Pricing
For all other assets and securities, including derivatives, and in cases where market prices
are not readily available or circumstances make an existing methodology or procedure unreliable,
the Funds and USCEFs investments are valued at fair value, as determined in good faith by the
Trustees or pursuant to procedures approved by the Trustees.
The value of assets that are fair valued is determined by the Trustees or persons acting at
their direction pursuant to procedures approved by the Trustees. Factors that may be considered in
determining fair value include, among others, the value of other financial instruments traded on
other markets, trading volumes, changes in interest rates, observations from financial
institutions, significant events (which may be considered to include changes in the value of U.S.
securities or securities indices) that occur after the close of the relevant market and before the
Funds or USCEFs net asset value is calculated, other news events, and significant unobservable
inputs (including the Funds or USCEFs own assumptions in determining the fair value of
investments). Although the goal of fair valuation is to determine the amount the owner of the
securities might reasonably expect to receive upon their current sale, because of the uncertainty
inherent in fair value pricing, the fair value determined for a particular security may be
materially different from the value realized upon its sale.
-17-
Quoted prices are typically the bid price for securities held long and the ask price for
securities sold short. If the pricing convention for the applicable security does not involve a bid
or an ask, the quoted price is the quotation provided by a third party pricing source in accordance
with the convention for that security.
The Manager evaluates pricing sources on an ongoing basis and may change a pricing source at
any time. The Manager normally does not evaluate the prices supplied by pricing sources on a
day-to-day basis. The Manager monitors erratic or unusual movements (including unusual inactivity)
in the prices supplied for a security and has discretion to override a price supplied by a source
(e.g., by taking a price supplied by another) when it believes that the price supplied is not
reliable. In addition, although alternative prices often are available for many securities held by
the Fund or USCEF, the existence of those alternative sources does not necessarily provide greater
certainty about the prices used by the Fund or USCEF. In addition, because the Fund or USCEF may
hold portfolio securities listed on foreign exchanges that trade on days on which the NYSE or the
U.S. bond markets are closed, the net asset value of the Funds or USCEFs shares may change
significantly on days when shares cannot be redeemed.
NAME POLICY
To comply with Securities and Exchange Commission (SEC) rules regarding the use of
descriptive words in a funds name, the Fund has adopted a policy of investing at least
80% of its assets, through USCEF, in equity investments tied economically to the U.S. (the Name
Policy). The Name Policy is described in the Principal investment strategies section of the Fund
Summary.
The Fund will not change its Name Policy without providing its shareholders at least 60 days
prior written notice. When used in connection with the Funds Name Policy, assets include the
Funds net assets plus any borrowings made for investment purposes. For purposes of this
Prospectus, an investment is tied economically to the U.S. if: (i) it is an investment in an
issuer that is organized under the laws of the U.S. or in an issuer that maintains its principal
place of business in the U.S.; (ii) it is traded principally in the U.S.; or (iii) it is an
investment in an issuer that derived at least 50% of its revenues or profits from goods produced or
sold, investments made, or services performed in the U.S., or has at least 50% of its assets in the
U.S. USCEF may invest directly in securities of companies in the U.S. or indirectly, for example,
through investments in another GMO Fund, derivatives, or synthetic instruments with underlying
assets that have economic characteristics similar to investments tied economically to the U.S.
DISCLOSURE OF PORTFOLIO HOLDINGS
The Fund has established a policy with respect to disclosure of its portfolio holdings. That
policy is described in the SAI. The largest fifteen portfolio holdings of the Fund and USCEF are
posted monthly on GMOs website. In addition, from time to time, position attribution information
regarding the Fund and USCEF may be posted to GMOs website (e.g., best/worst performing positions
in the Fund over a specified time period). Such information is available without a confidentiality
agreement to registered users on GMOs website. Additional information regarding the Funds and
USCEFs portfolio holdings as of each months end is made available to shareholders of the Trust,
qualified potential shareholders as determined by GMO (potential shareholders), and their
consultants or agents through a secured link on GMOs website approximately five days after month
end. Periodically, in response to heightened market interest in specific issuers, the Funds and
USCEFs holdings in one or more issuers may be made available on a more frequent basis to
shareholders of the Trust, potential shareholders, and their consultants or agents through a
secured link on GMOs website. This information may be posted as soon as the business day following
the date to which the information relates.
-18-
To access this information on GMOs website (http://www.gmo.com/america/strategies),
shareholders, potential shareholders, and their consultants and agents (permitted recipients)
must contact GMO to obtain a password and user name (to the extent they do not already have them)
and generally must enter into a confidentiality agreement with GMO and the Trust. GMO also may
provide permitted recipients with information regarding underlying direct holdings of the Fund, and
a confidentiality agreement is not required to view this information. GMO may make portfolio
holdings information available in alternate formats and under additional circumstances under the
conditions described in the SAI. Beneficial owners of shares of the Fund who have invested in the
Fund through a broker or agent should contact that broker or agent for information on how to obtain
access to information on the website regarding the Funds portfolio holdings.
The Fund, USCEF, or GMO may suspend the posting of portfolio holdings, and the Fund may modify
the disclosure policy, without notice to shareholders. Once posted, the Funds and USCEFs
portfolio holdings will remain available on the website at least until the Fund files a Form N-CSR
(annual/semiannual report) or Form N-Q (quarterly schedule of portfolio holdings) for the period
that includes the date of those holdings.
HOW TO PURCHASE SHARES
Class R1 shares of the Fund may be purchased by eligible retirement plans (e.g., 401(k) plans,
457 plans, employer-sponsored 403(b) plans, profit-sharing and money purchase pension plans, and
qualified deferred compensation plans) whose accounts are maintained by the Fund at an omnibus
level.
Under ordinary circumstances, you may purchase the Funds shares on days when the NYSE is open
for business. Retirement plan participants may establish an account and add shares to an account
by contacting the plan administrator (or another financial intermediary designated by the Fund or
the plan administrator). The plan administrator or designated financial intermediary will conduct
the transaction, or provide plan participants with the means to conduct the transaction themselves.
Retirement plan participants should contact the plan administrator or designated financial
intermediary for instructions on purchasing shares.
There are no minimum initial or subsequent investment requirements for Class R1 shares of the
fund. The plan administrator or other financial intermediary may impose transaction fees and/or
other restrictions (in addition to those described in this Prospectus) for purchasing Fund shares
through them.
Funding Your Investment.
You may purchase shares:
|
4
|
|
By wire.
Instruct your bank to wire the amount of your investment to:
|
State Street Bank and Trust Company, Boston, Massachusetts
ABA#: 011000028
Attn: Transfer Agent
Credit: GMO Series Fund Deposit Account 10111003
Further credit: GMO U.S. Core Equity Series Fund
Purchase Policies.
The plan administrator or other financial intermediary is responsible for
transmitting a purchase request in good order to the Trust or its designated agent to avoid having
it rejected by the Trust or its designated agent. If the purchase request is received in good
order by the Trust or its designated agent, together with the U.S. dollar amount of the shares to
be purchased (when federal funds, a wire, a check or Automated Clearing House (ACH) transaction are
received), prior to the close of regular trading on the NYSE (generally 4:00 p.m. Boston time), the
purchase price for the Fund
-19-
shares to be purchased is the net asset value per share determined on that day. If the
request and payment are received after the close of regular trading on the NYSE, the purchase price
for the Fund shares to be purchased is the net asset value per share determined on the next
business day that the NYSE is open. The specific requirements for good order depend on the type
of account and transaction and the method of purchase; contact your financial intermediary. The
Fund and its agents reserve the right to reject any purchase request.
To help the U.S. government fight the funding of terrorism and money laundering activities,
federal law requires the Trust to verify identifying information provided by each investor that
opens an account. Additional identifying documentation also may be required. If the Trust is
unable to verify the information shortly after your account is opened, the account may be closed
and your shares redeemed at their net asset value at the time of the redemption.
The Fund in its sole discretion and without notice may temporarily or permanently suspend
sales of its shares to new investors and/or existing shareholders, change the categories of
investors eligible to purchase Class R1 shares of the Fund, and change the minimum initial or
subsequent investment requirements for Class R1 shares of the Fund.
Frequent Trading Activity.
As a matter of policy, the Trust will not honor requests for
purchases or exchanges by shareholders identified as engaging in frequent trading strategies,
including market timing, that GMO determines could be harmful to the Fund and its shareholders.
Frequent trading strategies are generally strategies that involve repeated exchanges and/or
purchases and redemptions (or redemptions and purchases) within a short period of time. Frequent
trading strategies may be disruptive to the efficient management of the Fund, materially increase
portfolio transaction costs and taxes, dilute the value of shares held by long-term investors, or
otherwise be harmful to the Fund and its shareholders.
The Trustees have adopted procedures designed to detect and prevent frequent trading activity
that is harmful to the Fund and its shareholders (the Procedures). The Procedures include the
fair valuation of foreign securities, periodic surveillance of trading in shareholder accounts and
inquiry as to the nature of trading activity. If GMO determines that an account is engaging in
frequent trading that has the potential to be harmful to the Fund or its shareholders, the
Procedures permit GMO to adopt various prevention measures, including suspension of the accounts
exchange and purchase privileges. There is no assurance that the Procedures will be effective in
all instances. The Fund will not automatically redeem shares that are the subject of a rejected
exchange request. The Fund reserves the right to reject any order or terminate the sale of Fund
shares at any time.
Class R1 shares of the Fund are distributed through financial intermediaries that submit
aggregate or net purchase and redemption orders through omnibus accounts. These omnibus accounts
often by nature engage in frequent transactions due to the daily trading activity of their
underlying investors. Because transactions by omnibus accounts often take place on a net basis,
GMOs ability to detect and prevent frequent trading strategies within those accounts is limited.
GMO ordinarily seeks the agreement of a financial intermediary to monitor for and/or restrict
frequent trading in accordance with the Procedures. In addition, the Fund may rely on a financial
intermediary to monitor for and/or restrict frequent trading in accordance with the intermediarys
policies and procedures in lieu of the Procedures if GMO believes that the financial intermediarys
policies and procedures are reasonably designed to detect and prevent frequent trading activity
that GMO considers to be potentially harmful to the Fund and its shareholders. Shareholders who own
Fund shares through an intermediary should consult with that intermediary regarding its frequent
trading policies.
-20-
HOW TO REDEEM SHARES
Under ordinary circumstances, you may redeem the Funds shares on days when the NYSE is open
for business. Retirement plan participants may sell shares of the Fund by contacting the plan
administrator (or another financial intermediary designated by the Fund or the plan administrator).
The plan administrator or designated financial intermediary will conduct the transaction for
retirement plan participants, or provide retirement plan participants with the means to conduct the
transaction themselves. Financial intermediaries, including your plan administrator, may impose
transaction fees and/or other restrictions (in addition to those described in this Prospectus) for
redeeming Fund shares through them.
Redemption Policies.
The plan administrator or other financial intermediary is responsible for
submitting a redemption request in good order to avoid having it rejected by the Trust or its
designated agent. If the redemption request is received in good order by the Trust or its
designated agent prior to the close of regular trading on the NYSE (generally 4:00 p.m. Boston
time), the redemption price for the Fund shares to be redeemed is the net asset value per share
determined on that day. If the request is received after the close of regular trading on the NYSE,
the redemption price for the Fund shares to be redeemed is the net asset value per share determined
on the next business day that the NYSE is open. The specific requirements for good order depend
on the type of account and transaction and the method of redemption; contact your financial
intermediary. In the event of a disaster affecting Boston, Massachusetts, plan administrators and
other financial intermediaries should contact GMO to confirm that your redemption request was
received and is in good order.
Failure to provide the Trust with a properly authorized redemption request or otherwise
satisfy the Trust as to the validity of any change to the wire instructions or registration address may result in a delay in processing a redemption request, delay in remittance
of redemption proceeds, or a rejection of the redemption request.
In its sole discretion, GMO may determine to have the Fund pay redemption proceeds wholly or
partly in securities (selected by GMO) instead of cash. In particular, if market conditions
deteriorate and the Manager believes the Funds redemption fee (if any) is not fair compensation
for transaction costs, the Fund may limit cash redemptions (honoring redemptions with portfolio
securities) to protect the interests of all Fund shareholders. In the event that the Fund makes a
redemption in kind, you should expect to incur brokerage and other transaction charges when
converting the securities to cash, and the securities will likely increase or decrease in value
before you sell them.
Redemption proceeds for investors who invest through eligible retirement plans or other
financial intermediaries will be sent directly to the plan administrator or other financial
intermediary. The Fund may take up to seven days to remit proceeds to the plan administrator or
other financial intermediary.
The Fund may suspend the right of redemption and may postpone payment for more than seven
days:
|
|
|
if the NYSE and/or the Federal Reserve Bank are closed on days other than
weekends or holidays
|
|
|
|
|
during periods when trading on the NYSE is restricted
|
|
|
|
|
during an emergency that makes it impracticable for the Fund to dispose of
its securities or to fairly determine the net asset value of the Fund
|
|
|
|
|
during any other period permitted by the SEC for your protection.
|
-21-
Pursuant to the Trusts Agreement and Declaration of Trust, the Trust has the unilateral right
to redeem Fund shares held by a shareholder at any time.
DISTRIBUTIONS AND TAXES
The Funds policy is to declare and pay distributions of its net investment income, if any, at
least annually. The Fund also intends to distribute net realized capital gains, whether from the
sale of securities held by the Fund for not more than one year (net short-term capital gains) or
from the sale of securities held by the Fund for more than one year (net long-term capital gains),
if any, at least annually. In addition, the Fund may, from time to time and at its discretion,
make unscheduled distributions in advance of large redemptions by shareholders or as otherwise
deemed appropriate by the Fund. From time to time, distributions by the Fund could constitute, for
U.S. federal income tax purposes, a return of capital to shareholders. Shareholders should read
the description below for information regarding the tax character of distributions from the Fund to
shareholders.
All dividends and capital gain distributions paid to shareholders will be reinvested
automatically, unless a shareholder elects to receive cash.
The Fund is treated as a separate taxable entity for U.S. federal income tax purposes and
intends to qualify each year as a regulated investment company (RIC) under Subchapter M of the
Internal Revenue Code of 1986, as amended (the Code). A RIC generally is not subject to tax at
the fund level on income and gains from investments that are timely distributed to shareholders.
However, the Funds failure to qualify as a RIC would result in Fund-level taxation, and
consequently, a reduction in the value of the Fund, as well as in the income available for
distribution to its shareholders.
Shares of the Fund are offered primarily to certain eligible retirement
plans, as well as through certain other tax-advantaged accounts (see How to Purchase Shares
above). Shareholders that are retirement plans that qualify for tax-exempt treatment under U.S.
federal income tax laws generally are not subject to U.S. federal income tax on distributions from
the Fund or on redemptions of Fund shares. Special tax rules apply to investments through such
plans. Plan participants whose retirement plan invests in the Fund generally are not subject to
U.S. federal income tax on Fund distributions received by the plan or on redemptions of Fund shares
by the plan. However, distributions to plan participants from a retirement plan generally are
taxable to plan participants as ordinary income, with certain exceptions (for example,
distributions to participants from a Roth 401(k) plan generally are not taxable to those
participants).
This prospectus does not address tax considerations that may be relevant to participants
in nonqualified retirement plans, or to other investors. You should consult with your own
tax advisor or the plan administrator or other financial intermediary through which your investment
in the Fund is made to determine the suitability of the Fund as an investment through your
retirement plan or other tax-advantaged account and the specific U.S. federal income, as well as
any possible state, local, foreign or other, tax consequences to you of investing in the Fund
through your plan or other account. See Taxes in the SAI for more information.
FUND CODES
The following chart identifies the ticker, news-media symbol, and CUSIP number for each share class
of the Fund currently being offered (if any).
|
|
|
|
|
|
|
|
|
Ticker
|
|
Symbol
|
|
CUSIP
|
Class R1
|
|
|
|
|
|
|
-22-
GMO SERIES TRUST
ADDITIONAL INFORMATION
The Funds annual and semiannual reports to shareholders (when available) will contain
additional information about the Funds investments. The Funds annual report (when available)
will contain a discussion of the market conditions and investment strategies that significantly
affected the Funds performance during its initial fiscal year. The Funds annual and semiannual
reports (when available) will be, and the Funds SAI is, available free of charge by writing to
Shareholder Services at GMO, 40 Rowes Wharf, Boston, Massachusetts 02110 or by calling collect at
1-617-346-7646. The SAI contains more detailed information about the Fund and is incorporated by
reference into this Prospectus, which means that it is legally considered to be part of this
Prospectus.
You can review and copy the Prospectus, SAI, and reports (when available) at the SECs Public
Reference Room in Washington, D.C. Information regarding the operation of the Public Reference
Room may be obtained by calling the SEC at 1-202-551-8090. Reports and other information about the
Fund are available on the EDGAR database on the SECs Internet site at http://www.sec.gov. Copies
of this information may be obtained, upon payment of a duplicating fee, by electronic request at
the following e-mail address: publicinfo@sec.gov, or by writing the Public Reference Section of the
SEC, Washington, D.C. 20549-1520.
Shareholders who wish to communicate with the Trustees must do so by mailing a written
communication, addressed as follows: To the Attention of the Board of Trustees, c/o GMO Trust Chief
Compliance Officer, 40 Rowes Wharf, Boston, MA 02110. The shareholder communication must (i) be in
writing and be signed by the shareholder, (ii) identify the Fund, and (iii) identify the class and
number of shares held beneficially or of record by the shareholder.
SHAREHOLDER INQUIRIES
Plan administrators and financial
intermediaries may request additional
information from and direct inquiries to:
Shareholder Services at
Grantham, Mayo, Van Otterloo & Co. LLC
40 Rowes Wharf, Boston, MA 02110
1-617-346-7646 (call collect)
1-617-439-4192 (fax)
SHS@GMO.com
website: http://www.gmo.com
Plan participants should contact their plan administrator
or other financial intermediary for information.
DISTRIBUTOR
Funds Distributor, LLC
10 High Street
Suite 302
Boston, Massachusetts 02110
Investment Company Act File No. 811-22564
GMO SERIES TRUST
STATEMENT OF ADDITIONAL INFORMATION
October 1, 2011
GMO U.S. Core Equity Series Fund
Class R1:
This Statement of Additional Information is not a prospectus. It relates to the Prospectus for GMO
U.S. Core Equity Series Fund (the Fund) dated October 1, 2011, as amended and revised from
time to time thereafter (the Prospectus), and should be read in conjunction therewith.
Information from the Prospectus is, and (when available) information from the annual report to
shareholders of the Fund will be, incorporated by reference into this Statement of Additional
Information. The Prospectus and the annual report to shareholders (when available) of the Fund may
be obtained free of charge from GMO Series Trust (the Trust), 40 Rowes Wharf, Boston,
Massachusetts 02110, or by calling the Trust collect at 1-617-346-7646.
Table of Contents
|
|
|
|
|
|
|
Page
|
|
|
|
|
2
|
|
|
|
|
2
|
|
|
|
|
3
|
|
|
|
|
31
|
|
|
|
|
33
|
|
|
|
|
36
|
|
|
|
|
37
|
|
|
|
|
37
|
|
|
|
|
45
|
|
|
|
|
53
|
|
|
|
|
56
|
|
|
|
|
58
|
|
|
|
|
59
|
|
|
|
|
62
|
|
|
|
|
63
|
|
|
|
|
63
|
|
|
|
|
64
|
|
|
|
|
64
|
|
|
|
|
A-1
|
|
|
|
|
B-1
|
|
-i-
INVESTMENT OBJECTIVES AND POLICIES
The investment objective and principal strategies of,
and risks of investing in, the Fund are
described in the Prospectus. The Fund invests substantially all of its assets
in GMO U.S. Core Equity Fund (USCEF), which invests
directly in securities and other instruments. References to the Fund in
this Statement of Additional Information may refer to actions
undertaken by the Fund or USCEF. Unless
otherwise indicated in the Prospectus or this Statement of Additional Information, the investment
objective and policies of the Fund may be changed without shareholder approval.
FUND INVESTMENTS
The following list indicates the types of investments that the Fund (through USCEF) is generally
permitted (but not required) to make. The Fund may, however, make other types of investments,
provided the investments are consistent with the Funds investment objective and policies and the
Funds investment restrictions do not expressly prohibit it from so doing.
Investors should note that, when used in this Statement of Additional Information, the term
invest includes both direct investing and indirect investing and the term investments includes
both direct investments and indirect investments. For instance, the Fund may invest indirectly or
make indirect investments by investing in another investment company or in derivatives and
synthetic instruments with economic characteristics similar to the underlying asset. Accordingly,
the following list indicates the types of investments that the Fund (through USCEF) is directly or
indirectly permitted to make.
|
|
U.S. Equity Securities
1
|
|
|
|
|
Foreign InvestmentsForeign Issuers
2
|
|
|
|
|
Foreign InvestmentsForeign Issuers (Traded on U.S. Exchanges)
2
|
|
|
|
Securities Lending
|
|
|
|
Depositary Receipts
|
|
|
|
Convertible Securities
|
|
|
|
Preferred Stocks
|
|
|
|
Warrants and Rights
|
|
|
|
Options and Futures
|
|
|
|
Swap Contracts and Other Two-Party Contracts
|
|
|
|
|
Foreign Currency Transactions
|
|
|
|
Repurchase Agreements
|
|
|
|
Debt and Other Fixed Income Securities
|
|
|
|
Debt and Other Fixed Income SecuritiesLong and Medium Term Corporate &
Government Bonds
3
|
|
|
|
Debt and Other Fixed Income SecuritiesShort-Term Corporate &
Government Bonds
3
|
|
|
|
Cash and Other High Quality Investments
|
|
|
|
U.S. Government Securities and Foreign Government Securities
|
|
|
|
Real Estate Investment Trusts and other Real Estate-Related Investments
|
2
|
|
Reverse Repurchase Agreements and Dollar Roll Agreements
|
|
|
|
Illiquid Securities, Private Placements, Restricted Securities, and IPOs
and Other Limited Opportunities
|
|
|
|
Investments in Other Investment Companies or Other Pooled Investments
|
|
|
|
Investments in Other Investment CompaniesShares of Other GMO Trust
Funds
|
Footnotes to Fund Investments List
|
|
|
|
1
|
|
For more information, see, among other sections, Description of Principal
RisksMarket RiskEquity Securities Risk in the Prospectus.
|
|
|
2
|
|
For more information, see, among other sections, Descriptions and Risks of Fund
InvestmentsRisks of Foreign Investments herein.
|
|
3
|
|
For more information, see, among other sections, Descriptions and Risks of Fund
InvestmentsU.S. Government Securities and Foreign Government Securities herein.
|
(
Note
: Some of the footnotes to the above list refer investors to various risks
described in the Description of Principal Risks section of the Prospectus for more information
relating to a particular type of investment listed in the charts. The presence of such a risk
cross reference for a particular Fund investment is not intended to indicate that such risk is a
principal risk of the Fund, and instead is intended to provide more information regarding the risks
associated with the particular investment. Please refer to the Fund Summary and Description of
Principal Risks sections of the Prospectus for a description of the Funds principal risks.)
DESCRIPTIONS AND RISKS OF FUND INVESTMENTS
The following is a description of investment practices in which the Fund (through USCEF) may engage
and the risks associated with their use. Because the Fund invests substantially all of its assets
in USCEF, the Fund is exposed to the investment practices of USCEF. USCEF, and therefore the Fund,
is also indirectly exposed to the investment practices of the GMO Funds or other investment
companies in which USCEF invests (the underlying funds), and USCEF and the Fund are therefore
subject to all risks associated with the practices of the underlying funds.
UNLESS OTHERWISE NOTED
HEREIN, THE INVESTMENT PRACTICES AND ASSOCIATED RISKS DETAILED BELOW ALSO INCLUDE THOSE TO WHICH
USCEF AND THE FUND MAY BE EXPOSED THROUGH USCEFS INVESTMENT IN UNDERLYING FUNDS. ANY REFERENCES
TO INVESTMENTS MADE BY THE FUND INCLUDE THOSE THAT MAY BE MADE BOTH DIRECTLY BY THE FUND AND USCEF,
AND INDIRECTLY BY USCEF (E.G., THROUGH USCEFS INVESTMENTS IN UNDERLYING FUNDS OR THROUGH
INVESTMENTS IN DERIVATIVES OR SYNTHETIC INSTRUMENTS).
Portfolio Turnover
Based on the Managers assessment of market conditions, it may trade the Funds investments more
frequently at some times than at others, resulting in a higher portfolio turnover rate. Increased
portfolio turnover involves correspondingly greater brokerage commissions and other transaction
costs, which will be borne directly by the Fund, and which may adversely affect the Funds
performance. It also may give rise to additional taxable income for its shareholders,
including through the realization of capital gains or other types of income that are taxable to
Fund shareholders when distributed by the Fund to them, unless those shareholders are
3
themselves
exempt from taxation or otherwise investing in the Fund through a tax-advantaged account. If
portfolio turnover results in the recognition of short-term capital gains, those gains, when
distributed to shareholders, typically are taxed to shareholders at ordinary income tax rates. The
after-tax impact of portfolio turnover is not considered when making investment decisions for the
Fund. See Distributions and Taxes in the Prospectus and Distributions and Taxes in this
Statement of Additional Information for more information.
Diversified Portfolios
The Fund is a diversified fund required to satisfy the diversified fund requirements under the
Investment Company Act of 1940, as amended (the 1940 Act). At least 75% of the value of a
diversified funds total assets must be represented by cash and cash items (including receivables),
government securities, securities of other investment companies, and other securities that for the
purposes of this calculation are limited in respect of any one issuer to not greater than 5% of the
value of the funds total assets and not more than 10% of the outstanding voting securities of any
single issuer.
The Fund also must meet diversification standards to qualify as a regulated investment company
under the Internal Revenue Code of 1986, as amended (the Code). See Taxes below for a
description of these diversification standards.
Accelerated Transactions
For the Fund to take advantage of certain available investment opportunities, the Manager may need
to make investment decisions on an expedited basis. In such cases, the information available to
the Manager at the time of an investment decision may be limited. The Manager may not, therefore,
have access to the detailed information necessary for a full analysis and evaluation of the
investment opportunity.
Risks of Foreign Investments
General.
Investment in foreign issuers or securities principally traded outside the United States
may involve special risks due to foreign economic, political, and legal developments, including
favorable or unfavorable changes in currency exchange rates, exchange control regulations
(including currency blockage), expropriation, nationalization or confiscatory taxation of assets,
and possible difficulty in obtaining and enforcing judgments against foreign entities. The Fund
may be subject to foreign taxation on realized capital gains, dividends or interest payable on
foreign securities, on transactions in those securities and on the repatriation of proceeds
generated from those securities. Transaction-based charges are generally calculated as a
percentage of the transaction amount and are paid upon the sale or transfer of portfolio securities
subject to such taxes. Any taxes or other charges paid or incurred by the Fund in respect of its
foreign securities will reduce its yield. See Taxes below for more information about these and
other special tax considerations applicable to investments in securities of foreign issuers and
securities principally traded outside the United States.
In addition, the tax laws of some foreign jurisdictions in which the Fund may invest are unclear
and interpretations of such laws can change over time. As a result, in order to comply with
guidance related to the accounting and disclosure of uncertain tax positions under U.S. generally
4
accepted accounting principles (GAAP), the Fund may be required to accrue for book purposes
certain foreign taxes in respect of its foreign securities or other foreign investments that it may
or may not ultimately pay. Such tax accruals will reduce the Funds net asset value at the time
accrued, even though, in some cases, the Fund ultimately will not pay the related tax liabilities.
Conversely, the Funds net asset value will be increased by any tax accruals that are ultimately
reversed.
Issuers of foreign securities are subject to different, often less comprehensive, accounting,
custody, reporting, and disclosure requirements than U.S. issuers. The securities of some foreign
governments, companies, and securities markets are less liquid, and at times more volatile, than
comparable U.S. securities and securities markets. Foreign brokerage commissions and related fees
also are generally higher than in the United States. The Fund also may be affected by different
custody and/or settlement practices or delayed settlements in some foreign markets. The laws of
some foreign countries may limit the Funds ability to invest in securities of certain issuers
located in those countries.
Foreign countries may have reporting requirements with respect to the ownership of securities, and
those reporting requirements may be subject to interpretation or change without prior notice to
investors. While the Fund makes reasonable efforts to stay informed of foreign reporting
requirements relating to the Funds foreign portfolio securities (
e.g.
, through the Funds
brokerage contacts, publications of the Investment Company Institute, which is the national
association of U.S. investment companies, the Funds custodial network, and, to the extent deemed
appropriate by the Fund under the circumstances, local counsel in the relevant foreign country), no
assurance can be given that the Fund will satisfy applicable foreign reporting requirements at all
times.
Securities Lending
The Fund may make secured loans of its portfolio securities amounting to not more than one-third of
its total assets. For these purposes, total assets include the proceeds of such loans. The risks
in lending portfolio securities, as with other extensions of credit, consist of possible delay in
recovery of the securities or possible loss of rights in the collateral should the borrower fail
financially, including possible impairment of the Funds ability to vote the securities. However,
securities loans will be made to broker-dealers that the Manager believes to be of relatively high
credit standing pursuant to agreements requiring that the loans be collateralized by cash, liquid
securities, or shares of other investment companies with a value at least equal to the market value
of the loaned securities (marked to market daily). If a loan is collateralized by U.S. government
or other securities, the Fund receives a fee from the borrower. If a loan is collateralized by
cash, the Fund typically invests the cash collateral for its own account in one or more money
market funds (in which case the Fund will bear its pro rata share of such money market funds fees
and expenses), or directly in interest-bearing, short-term securities, and typically pays a fee to
the borrower that normally represents a portion of the Funds earnings on the collateral. As with
other extensions of credit, the Fund bears the risk of delay in the recovery of loaned securities
and of loss of rights in the collateral should the borrower fail financially. The Fund also bears
the risk that the value of investments made with collateral may decline. The Fund bears the risk
of total loss with respect to the investment of collateral.
5
Voting rights or rights to consent with respect to the loaned securities pass to the borrower. The
Fund has the right to call loans at any time on reasonable notice and will do so if both (i) the
Manager receives adequate notice of a proposal upon which shareholders are being asked to vote, and
(ii) the Manager believes that the benefits to the Fund of voting on such proposal outweigh the
benefits to the Fund of having the security remain out on loan. However, the Fund bears the risk
of delay in the return of the security, impairing the Funds ability to vote on such matters. The
Manager has retained lending agents on behalf of the Fund that are compensated based on a
percentage of the Funds return on its securities lending. The Fund may also pay various fees in
connection with securities loans, including shipping fees and custodian fees.
Depositary Receipts
The Fund may invest in American Depositary Receipts (ADRs), Global Depositary Receipts (GDRs),
and European Depositary Receipts (EDRs) or other similar securities representing ownership of
foreign securities (collectively, Depositary Receipts) if issues of such Depositary Receipts are
available that are consistent with the Funds investment objective. Depositary Receipts generally
evidence an ownership interest in a corresponding foreign security on deposit with a financial
institution. Transactions in Depositary Receipts usually do not settle in the same currency as the
underlying foreign securities are denominated or traded. Generally, ADRs are designed for use in
the U.S. securities markets and EDRs are designed for use in European securities markets. GDRs may
be traded in any public or private securities market and may represent securities held by
institutions located anywhere in the world. GDRs and other types of Depositary Receipts are
typically issued by foreign banks or trust companies, although they may be issued by U.S. financial
institutions, and evidence ownership interests in a security or pool of securities issued by either
a foreign or a domestic corporation.
Because the value of a Depositary Receipt is dependent upon the market price of an underlying
foreign security, Depositary Receipts are subject to most of the risks associated with investing in
foreign securities directly. Depositary Receipts may be issued as sponsored or unsponsored
programs. See Descriptions and Risks of Fund InvestmentsRisks of Foreign Investments.
Depositary Receipts also may be subject to liquidity risk.
Convertible Securities
A convertible security is a security (a bond or preferred stock) that may be converted at a stated
price within a specified period into a specified number of shares of common stock of the same or a
different issuer. Convertible securities are senior to common stock in a corporations capital
structure, but are usually subordinated to senior debt obligations of the issuer. Convertible
securities provide holders, through their conversion feature, an opportunity to participate in
increases in the market price of their underlying securities. The price of a convertible security
is influenced by the market price of the underlying security, and tends to increase as the market
price rises and decrease as the market price declines. The Manager regards convertible securities
as a form of equity security.
The value of a convertible security is a function of its investment value (determined by its
yield in comparison with the yields of other securities of comparable maturity and quality that do
not have a conversion privilege) and its conversion value (the securitys worth, at market
6
value,
if converted into the underlying common stock). The investment value of a convertible security is
influenced by changes in interest rates, with investment value declining as interest rates increase
and increasing as interest rates decline. The credit standing of the issuer and other factors may
also have an effect on the convertible securitys investment value. The conversion value of a
convertible security is determined by the market price of the underlying common stock. If the
conversion value is low relative to the investment value, as in the case of broken or busted
convertibles, the price of the convertible security is governed principally by its investment
value. To the extent the market price of the underlying common stock approaches or exceeds the
conversion price, the price of the convertible security will be increasingly influenced by its
conversion value. A convertible security generally will sell at a premium over its conversion
value by the extent to which investors place value on the right to acquire the underlying common
stock while holding a fixed income security. Generally, the amount of the premium decreases as the
convertible security approaches maturity.
A convertible security may be subject to redemption at the option of the issuer at a price
established in the convertible securitys governing instrument. If a convertible security held by
the Fund is called for redemption, the Fund will be required to permit the issuer to redeem the
security, convert it into the underlying common stock or sell it to a third-party.
Preferred Stocks
Preferred stocks include convertible and non-convertible preferred and preference stocks that are
senior to common stock. Preferred stocks are equity securities that are senior to common stock
with respect to the right to receive dividends and a fixed share of the proceeds resulting from the
issuers liquidation. Some preferred stocks also entitle their holders to receive additional
liquidation proceeds on the same basis as holders of the issuers common stock, and thus represent
an ownership interest in the issuer. Depending on the features of the particular security, holders
of preferred stock may bear the risks disclosed in the Prospectus or this Statement of Additional
Information regarding equity or fixed income securities.
Investment in preferred stocks involves certain risks. Certain preferred stocks contain provisions
that allow an issuer under certain conditions to skip or defer distributions. If the Fund owns a
preferred stock that is deferring its distribution, it may be required to report income for tax
purposes despite the fact that it is not receiving current income on this position. Preferred
stocks often are subject to legal provisions that allow for redemption in the event of certain tax
or legal changes or at the issuers call. In the event of redemption, the Fund may not be able to
reinvest the proceeds at comparable rates of return. Preferred stocks are subordinated to bonds
and other debt securities in an issuers capital structure in terms of priority for corporate
income and liquidation payments, and therefore will be subject to greater credit risk than those
debt securities. Preferred stocks may trade less frequently and in a more limited volume and may be
subject to more abrupt or erratic price movements than many other securities, such as common
stocks, corporate debt securities and U.S. government securities.
Warrants and Rights
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give
the holder the right to receive, upon exercise, a security of the issuer at a stated price. The
7
Fund typically uses warrants and rights in a manner similar to its use of options on securities, as
described in Options and Futures below. Risks associated with the use of warrants and rights are
generally similar to risks associated with the use of options. Unlike most options, however,
warrants and rights are issued in specific amounts, and warrants generally have longer terms than
options. Warrants and rights are not likely to be as liquid as exchange-traded options backed by a
recognized clearing agency. In addition, the terms of warrants or rights may limit the Funds
ability to exercise the warrants or rights at such time, or in such quantities, as the Fund would
otherwise wish.
Options and Futures
The Fund uses options and futures for various purposes, including for investment purposes and as a
means to hedge other investments. (See Uses of Derivatives below for more information regarding
the various derivatives strategies the Fund may employ using options and futures.) The use of
options contracts, futures contracts, and options on futures contracts involves risk. Thus, while
the Fund may benefit from the use of options, futures, and options on futures, unanticipated
changes in interest rates, securities prices, currency exchange rates, or other underlying assets
or reference rates may adversely affect the Funds performance.
Options on Securities and Indices.
The Fund may purchase and sell put and call options on equity,
fixed income or other securities or indices in standardized exchange-traded contracts. An option
on a security or index is a contract that gives the holder of the option, in return for a premium,
the right (but not the obligation) to buy from (in the case of a call) or sell to (in the case of a
put) the writer of the option the security underlying the option (or the cash value of the index
underlying the option) at a specified price. Upon exercise, the writer of an option on a security
has the obligation to deliver the underlying security upon payment of the exercise price or to pay
the exercise price upon delivery of the underlying security. Upon exercise, the writer of an
option on an index is required to pay the difference between the cash value of the index and the
exercise price multiplied by the specified multiplier for the index option.
Purchasing Options on Securities and Indices.
Among other reasons, the Fund may purchase a put
option to hedge against a decline in the value of a portfolio security. If such a decline occurs,
the put option will permit the Fund to sell the security at the higher exercise price or to close
out the option at a profit. By using put options in this manner, the Fund will reduce any profit
it might otherwise have realized in the underlying security by the amount of the premium paid for
the put option and by its transaction costs. In order for a put option purchased by the Fund to be
profitable, the market price of the underlying security must decline sufficiently below the
exercise price to cover the premium paid by the Fund and transaction costs.
Among other reasons, the Fund may purchase call options to hedge against an increase in the price
of securities the Fund anticipates purchasing in the future. If such a price increase occurs, a
call option will permit the Fund to purchase the securities at the exercise price or to close out
the option at a profit. The premium paid for the call option, plus any transaction costs, will
reduce
the benefit, if any, that the Fund realizes upon exercise of the option and, unless the price of
the underlying security rises sufficiently, the option may expire worthless to the Fund. Thus, for
a call option purchased by the Fund to be profitable, the market price of the underlying security
8
must rise sufficiently above the exercise price to cover the premium paid by the Fund to the writer
and transaction costs.
In the case of both call and put options, the purchaser of an option risks losing the premium paid
for the option plus related transaction costs if the option expires worthless.
Writing Options on Securities and Indices.
Because the Fund receives a premium for writing a put
or call option, the Fund may seek to increase its return by writing call or put options on
securities or indices. The premium the Fund receives for writing an option will increase the
Funds return in the event the option expires unexercised or is closed out at a profit. The size
of the premium the Fund receives reflects, among other things, the relationship of the market price
and volatility of the underlying security or index to the exercise price of the option, the
remaining term of the option, supply and demand, and interest rates.
The Fund may write a call option on a security or other instrument held by the Fund (commonly known
as writing a covered call option). In such case, the Fund limits its opportunity to profit from
an increase in the market price of the underlying security above the exercise price of the option.
Alternatively, the Fund may write a call option on securities in which it may invest but that are
not currently held by the Fund (commonly known as writing a naked call option). During periods
of declining securities prices or when prices are stable, writing these types of call options can
be a profitable strategy to increase the Funds income with minimal capital risk. However, when
securities prices increase, the Fund is exposed to an increased risk of loss, because if the price
of the underlying security or instrument exceeds the options exercise price, the Fund will suffer
a loss equal to the amount by which the market price exceeds the exercise price at the time the
call option is exercised, minus the premium received. Calls written on securities that the Fund
does not own are riskier than calls written on securities owned by the Fund because there is no
underlying security held by the Fund that can act as a partial hedge. When such a call is
exercised, the Fund must purchase the underlying security to meet its call obligation or make a
payment equal to the value of its obligation in order to close out the option. Calls written on
securities that the Fund does not own have speculative characteristics and the potential for loss
is unlimited. There is also a risk, especially with less liquid preferred and debt securities,
that the securities may not be available for purchase.
The Fund also may write a put option on a security. In so doing, the Fund assumes the risk that it
may be required to purchase the underlying security for an exercise price higher than its
then-current market price, resulting in a loss on exercise equal to the amount by which the market
price of the security is below the exercise price minus the premium received.
OTC Options
. The Fund may also invest in over-the-counter (OTC) options. OTC options differ
from exchange-traded options in that they are two-party contracts, with price and other terms
negotiated between the buyer and seller, and generally do not have as much market liquidity as
exchange-traded options.
Closing Options Transactions
.
The holder of an option may terminate its position in a put or call
option it has purchased by allowing it to expire or by exercising the option. If an option is
9
American style, it may be exercised on any day up to its expiration date. In contrast, a European
style option may be exercised only on its expiration date.
In addition, a holder of an option may terminate its obligation prior to the options expiration by
effecting an offsetting closing transaction. In the case of exchange-traded options, the Fund, as
a holder of an option, may effect an offsetting closing sale transaction by selling an option of
the same series as the option previously purchased. The Fund realizes a loss from a closing sale
transaction if the premium received from the sale of the option is less than the premium paid to
purchase the option (plus transaction costs). Similarly, if the Fund has written an option, it may
effect an offsetting closing purchase transaction by buying an option of the same series as the
option previously written. The Fund realizes a loss from a closing purchase transaction if the
cost of the closing purchase transaction (option premium plus transaction costs) is greater than
the premium received from writing the option. If the Fund desires to sell a security on which it
has written a call option, it will effect a closing purchase prior to or concurrently with the sale
of the security. There can be no assurance, however, that a closing purchase or sale can be
effected when the Fund desires to do so.
An OTC option may be closed only with the counterparty, although either party may engage in an
offsetting transaction that puts that party in the same economic position as if it had closed out
the option with the counterparty.
No guarantee exists that the Fund will be able to effect a closing purchase or a closing sale with
respect to a specific option at any particular time.
Risk Factors in Options Transactions.
There are various risks associated with transactions in
exchange-traded and OTC options. The value of options written by the Fund will be affected by many
factors, including changes in the value of underlying securities or indices, changes in the
dividend rates of underlying securities (or in the case of indices, the securities comprising such
indices), changes in interest rates, changes in the actual or perceived volatility of the stock
market and underlying securities, and the remaining time to an options expiration. The value of
an option also may be adversely affected if the market for the option is reduced or becomes less
liquid. In addition, since an American style option allows the holder to exercise its rights any
time prior to expiration of the option, the writer of an American style option has no control over
the time when it may be required to fulfill its obligations as a writer of the option. This risk
is not present when writing a European style option since the holder may only exercise the option
on its expiration date.
The Funds ability to use options as part of its investment programs depends on the liquidity of
the markets in those instruments. In addition, there can be no assurance that a liquid market will
exist when the Fund seeks to close out an option position. If the Fund were unable to close out an
option that it had purchased on a security, it would have to exercise the option in order to
realize any profit or the option may expire worthless. As the writer of a call option on a
portfolio security, during the options life, the Fund foregoes the opportunity to profit from
increases in the market value of the security underlying the call option above the sum of the
premium and the
strike price of the call, but retains the risk of loss (net of premiums received) should the price
of the underlying security decline. Similarly, as the writer of a call option on a securities
index, the
10
Fund foregoes the opportunity to profit from increases in the index over the strike
price of the option, though it retains the risk of loss (net of premiums received) should the price
of the Funds portfolio securities decline. If the Fund writes a call option and does not hold the
underlying security or instrument, the amount of the Funds potential loss is theoretically
unlimited.
An exchange-traded option may be closed out by means of an offsetting transaction only on a
national securities exchange (Exchange), which provides a secondary market for an option of the
same series. If a liquid secondary market for an exchange-traded option does not exist, the Fund
might not be able to effect an offsetting closing transaction for a particular option. Reasons for
the absence of a liquid secondary market on an Exchange include the following: (i) insufficient
trading interest in some options; (ii) restrictions by an Exchange on opening or closing
transactions, or both; (iii) trading halts, suspensions, or other restrictions on particular
classes or series of options or underlying securities; (iv) unusual or unforeseen interruptions in
normal operations on an Exchange; (v) inability to handle current trading volume; or (vi)
discontinuance of options trading (or trading in a particular class or series of options) (although
outstanding options on an Exchange that were issued by the Options Clearing Corporation should
continue to be exercisable in accordance with their terms). In addition, the hours of trading for
options on an Exchange may not conform to the hours during which the securities held by the Fund
are traded. To the extent that the options markets close before the markets for the underlying
securities, significant price and rate movements can take place in the underlying markets that may
not be reflected in the options markets.
The Exchanges generally have established limits on the maximum number of options an investor or
group of investors acting in concert may write. The Fund, the Manager, and other clients of the
Manager may constitute such a group. These limits could restrict the Funds ability to purchase or
sell options on a particular security.
An OTC option may be closed only with the counterparty, although either party may engage in an
offsetting transaction that puts that party in the same economic position as if it had closed out
the option with the counterparty; however, the exposure to counterparty risk may differ. See Swap
Contracts and Other Two-Party ContractsRisk Factors in Swap Contracts, OTC Options, and Other
Two-Party Contracts below for a discussion of counterparty risk and other risks associated with
investing in OTC options.
The Funds ability to engage in options transactions may be limited by tax considerations.
Currency Options.
The Fund may purchase and sell options on currencies. Options on currencies
possess many of the same characteristics as options on securities and generally operate in a
similar manner.
Futures.
To the extent consistent with applicable law and its investment restrictions, the Fund
may invest in futures contracts on, among other things, financial instruments (such as a U.S.
government security or other fixed income security), individual equity securities (single stock
futures), securities indices, interest rates, and currencies. Futures contracts on securities
indices
are referred to herein as Index Futures. The purchase of futures contracts can serve as a long
11
hedge, and the sale of futures contracts can serve as a limited short hedge. The purchase and sale
of futures contracts also may be used for speculative purposes.
Certain futures contracts are physically settled
(i.e.
, involve the making and taking of delivery
of a specified amount of an underlying security or other asset). For instance, the sale of futures
contracts on foreign currencies or financial instruments creates an obligation of the seller to
deliver a specified quantity of an underlying foreign currency or financial instrument called for
in the contract for a stated price at a specified time. Conversely, the purchase of such futures
contracts creates an obligation of the purchaser to pay for and take delivery of the underlying
foreign currency or financial instrument called for in the contract for a stated price at a
specified time. In some cases, the specific instruments delivered or taken, respectively, on the
settlement date are not determined until on or near that date. That determination is made in
accordance with the rules of the exchange on which the sale or purchase was made. Some futures
contracts are cash settled (rather than physically settled), which means that the purchase price is
subtracted from the current market value of the instrument and the net amount, if positive, is paid
to the purchaser by the seller of the futures contract and, if negative, is paid by the purchaser
to the seller of the futures contract. In particular, Index Futures are agreements pursuant to
which two parties agree to take or make delivery of an amount of cash equal to the difference
between the value of a securities index at the close of the last trading day of the contract and
the price at which the index contract was originally written. Although the value of a securities
index might be a function of the value of certain specified securities, no physical delivery of
these securities is made.
The purchase or sale of a futures contract differs from the purchase or sale of a security or
option in that no price or premium is paid or received. Instead, an amount of cash, U.S.
government securities, or other liquid assets equal in value to a percentage of the face amount of
the futures contract must be deposited with the broker. This amount is known as initial margin.
The amount of the initial margin is generally set by the market on which the contract is traded
(margin requirements on foreign exchanges may be different than those on U.S. exchanges).
Subsequent payments to and from the broker, known as variation margin, are made on a daily basis as
the price of the underlying futures contract fluctuates, making the long and short positions in the
futures contract more or less valuable, a process known as marking to the market. For futures
contracts which are cash settled, the Fund may designate or segregate liquid assets in an amount
equal to the Funds daily marked-to-market value of such contract. Prior to the settlement date of
the futures contract, the position may be closed by taking an opposite position. A final
determination of variation margin is then made, additional cash is required to be paid to or
released by the broker, and the purchaser realizes a loss or gain. In addition, a commission is
paid to the broker on each completed purchase and sale.
Although some futures contracts call for making or taking delivery of the underlying securities,
currencies or other underlying instrument, in most cases, futures contracts are closed before the
settlement date without the making or taking of delivery by offsetting purchases or sales of
matching futures contracts (i.e., with the same exchange, underlying financial instrument,
currency, or index, and delivery month). If the price of the initial sale exceeds the price of the
offsetting purchase, the seller is paid the difference and realizes a gain. Conversely, if the
price
of the offsetting purchase exceeds the price of the initial sale, the seller realizes a loss.
Similarly,
12
a purchase of a futures contract is closed out by selling a corresponding futures
contract. If the offsetting sale price exceeds the original purchase price, the purchaser realizes
a gain, and, if the original purchase price exceeds the offsetting sale price, the purchaser
realizes a loss. Any transaction costs must also be included in these calculations.
In the United States, futures contracts are traded only on commodity exchanges or boards of trade
known as contract markets approved by the Commodity Futures Trading Commission (CFTC),
and must be executed through a futures commission merchant or brokerage firm that is a member of
the relevant market. The Fund may also purchase futures contracts on foreign exchanges or similar
entities, which are not regulated by the CFTC and may not be subject to the same degree of
regulation as the U.S. contract markets. (See Additional Risks of Options on Securities, Futures
Contracts, and Options on Futures Contracts Traded on Foreign Exchanges below.)
Index Futures.
The Funds purchase and sale of Index Futures is limited to contracts and exchanges
approved by the CFTC. The Fund may close open positions on an exchange on which Index Futures are
traded at any time up to and including the expiration day. In general, all positions that remain
open at the close of business on that day must be settled on the next business day (based on the
value of the relevant index on the expiration day). Additional or different margin requirements as
well as settlement procedures may apply to foreign stock Index Futures.
Interest Rate Futures.
The Fund may engage in transactions involving the use of futures on
interest rates. These transactions may be in connection with investments in U.S. government
securities and other fixed income securities.
Currency Futures.
The Fund may buy and sell futures contracts on currencies.
Options on Futures Contracts.
Options on futures contracts give the purchaser the right in return
for the premium paid to assume a long position (in the case of a call option) or a short position
(in the case of a put option) in a futures contract at the option exercise price at any time during
the period of the option (in the case of an American style option) or on the expiration date (in
the case of European style option). Upon exercise of a call option, the holder acquires a long
position in the futures contract and the writer is assigned the opposite short position. In the
case of a put option, the holder acquires a short position and the writer is assigned the opposite
long position in the futures contract. Accordingly, in the event that an option is exercised, the
parties will be subject to all the risks associated with the trading of futures contracts, such as
payment of initial and variation margin deposits.
The Fund may use options on futures contracts in lieu of writing or buying options directly on the
underlying securities or purchasing and selling the underlying futures contracts. For example, to
hedge against a possible decrease in the value of its portfolio securities, the Fund may purchase
put options or write call options on futures contracts rather than selling futures contracts.
Similarly, the Fund may hedge against a possible increase in the price of securities the Fund
expects to purchase by purchasing call options or writing put options on futures contracts
rather than purchasing futures contracts. In addition, the Fund may purchase and sell interest
13
rate options on U.S. Treasury or Eurodollar futures to take a long or short position on interest
rate fluctuations. Options on futures contracts generally operate in the same manner as options
purchased or written directly on the underlying investments.
The Fund also is required to deposit and maintain margin with respect to put and call options on
futures contracts written by it. Such margin deposits may vary depending on the nature of the
underlying futures contract (and the related initial margin requirements), the current market value
of the option, and other futures positions held by the Fund.
A position in an option on a futures contract may be terminated by the purchaser or seller prior to
expiration by effecting a closing purchase or sale transaction, subject to the availability of a
liquid secondary market, which is the purchase or sale of an option of the same type (i.e., the
same exercise price and expiration date) as the option previously purchased or sold. The
difference between the premiums paid and received represents the Funds profit or loss on the
transaction.
Risk Factors in Futures and Futures Options Transactions
. Investment in futures contracts involves
risk. A purchase or sale of futures contracts may result in losses in excess of the amount
invested in the futures contract. If a futures contract is used for hedging, an imperfect
correlation between movements in the price of the futures contract and the price of the security,
currency, or other investment being hedged creates risk. Correlation is higher when the investment
being hedged underlies the futures contract. Correlation is lower when the investment being hedged
is different than the security, currency, or other investment underlying the futures contract, such
as when a futures contract on an index of securities is used to hedge a single security, a futures
contract on one security (e.g., U.S. Treasury bonds) is used to hedge a different security, or when
a futures contract in one currency is used to hedge a security denominated in another currency. In
the case of Index Futures and futures on commodity indices, changes in the price of those futures
contracts may not correlate perfectly with price movements in the relevant index due to market
distortions. In the event of an imperfect correlation between a futures position and the portfolio
position (or anticipated position) intended to be hedged, the Fund may realize a loss on the
futures contract at the same time the Fund is realizing a loss on the portfolio position intended
to be hedged. To compensate for imperfect correlations, the Fund may purchase or sell futures
contracts in a greater amount than the hedged investments if the volatility of the price of the
hedged investments is historically greater than the volatility of the futures contracts.
Conversely, the Fund may purchase or sell fewer futures contracts if the volatility of the price of
the hedged investments is historically less than that of the futures contract. The successful use
of transactions in futures and related options for hedging also depends on the direction and extent
of exchange rate, interest rate and asset price movements within a given time frame. For example,
to the extent equity prices remain stable during the period in which a futures contract or option
is held by the Fund investing in equity securities (or such prices move in a direction opposite to
that anticipated), the Fund may realize a loss on the futures transaction, which is not fully or
partially offset by an increase in the value of its portfolio securities. As a result, the
Funds total return for such period may be less than if it had not engaged in the hedging
transaction.
14
All participants in the futures market are subject to margin deposit and maintenance requirements.
Instead of meeting margin calls, investors may close futures contracts through offsetting
transactions, which could distort normal correlations. The margin deposit requirements in the
futures market are less onerous than margin requirements in the securities market, allowing for
more speculators who may cause temporary price distortions. Trading hours for foreign stock Index
Futures may not correspond perfectly to the trading hours of the foreign exchange to which a
particular foreign stock Index Future relates. As a result, the lack of continuous arbitrage may
cause a disparity between the price of foreign stock Index Futures and the value of the relevant
index.
The Fund may purchase futures contracts (or options on them) as an anticipatory hedge against a
possible increase in the price of a currency in which securities the Fund anticipates purchasing is
denominated. In such instances, the currency may instead decline. If the Fund does not then
invest in those securities, the Fund may realize a loss on the futures contract that is not offset
by a reduction in the price of the securities purchased.
The Funds ability to engage in the futures and options on futures strategies described above
depends on the liquidity of the markets in those instruments. Trading interest in various types of
futures and options on futures cannot be predicted. Therefore, no assurance can be given that the
Fund will be able to utilize these instruments at all or that their use will be effective. In
addition, there can be no assurance that a liquid market will exist at a time when the Fund seeks
to close out a futures or option on a futures contract position, and that Fund would remain
obligated to meet margin requirements until the position is closed. The liquidity of a secondary
market in a futures contract may be adversely affected by daily price fluctuation limits
established by commodity exchanges to limit the amount of fluctuation in a futures contract price
during a single trading day. Once the daily limit has been reached, no trades of the contract may
be entered at a price beyond the limit, thus preventing the liquidation of open futures positions.
In the past, prices have exceeded the daily limit on several consecutive trading days. Short (and
long) positions in Index Futures may be closed only by purchasing (or selling) a futures contract
on the exchange on which the Index Futures are traded.
As discussed above, if the Fund purchases or sells a futures contract, it is only required to
deposit initial and variation margin as required by relevant CFTC regulations and the rules of the
contract market. The Funds net asset value will generally fluctuate with the value of the
security or other instrument underlying a futures contract as if it were already in the Funds
portfolio. Futures transactions can have the effect of investment leverage. Furthermore, if the
Fund combines short and long positions, in addition to possible declines in the values of its
investment securities, the Fund will incur losses if the index underlying the long futures position
underperforms the index underlying the short futures position.
In addition, if the Funds futures brokers become bankrupt or insolvent, or otherwise default on
their obligations to the Fund, the Fund may not receive all amounts owing to it in respect of its
trading, despite the futures clearinghouse fully discharging all of its obligations. Furthermore,
in the event of the bankruptcy of a futures broker, the Fund could be limited to recovering only a
pro rata share of all available funds segregated on behalf of the futures brokers combined
customer accounts, even though certain property specifically traceable to the Fund was held by
15
the futures broker.
The Funds ability to engage in futures and options on futures transactions may be limited by tax
considerations.
Additional Risks of Options on Securities, Futures Contracts, and Options on Futures Contracts
Traded on Foreign Exchanges.
Options on securities, futures contracts, options on futures
contracts, and options on currencies may be traded on foreign exchanges. Such transactions may not
be regulated as effectively as similar transactions in the United States (which are regulated by
the CFTC) and may be subject to greater risks than trading on domestic exchanges. For example,
some foreign exchanges may be principal markets so that no common clearing facility exists and a
trader may look only to the broker for performance of the contract. The lack of a common clearing
facility creates counterparty risk. If a counterparty defaults, the Fund normally will have
contractual remedies against that counterparty, but may be unsuccessful in enforcing those
remedies. When seeking to enforce a contractual remedy, the Fund also is subject to the risk that
the parties may interpret contractual terms (e.g., the definition of default) differently.
Counterparty risk is greater for derivatives with longer maturities where events may intervene to
prevent settlement. Counterparty risk is also greater when the Fund has concentrated its
derivatives with a single or small group of counterparties as it sometimes does as a result of its
use of swaps and other OTC derivatives. To the extent the Fund has significant exposure to a
single counterparty, this risk will be particularly pronounced for the Fund. If a dispute occurs,
the cost and unpredictability of the legal proceedings required for the Fund to enforce its
contractual rights may lead the Fund to decide not to pursue its claims against the counterparty.
The Fund thus assumes the risk that it may be unable to obtain payments owed under foreign futures
contracts or that those payments may be delayed or made only after the Fund has incurred the costs
of litigation. In addition, unless the Fund hedges against fluctuations in the exchange rate
between the currencies in which trading is done on foreign exchanges and other currencies, any
profits that the Fund might realize in trading could be offset (or worse) by adverse changes in the
exchange rate. The value of foreign options and futures may also be adversely affected by other
factors unique to foreign investing (see Risks of Foreign Investments above).
Swap Contracts and Other Two-Party Contracts
The Fund uses swap contracts (or swaps) and other two-party contracts for the same or similar
purposes as options and futures. (See Uses of Derivatives below for more information regarding
the various derivatives strategies the Fund may employ using swap contracts and other two-party
contracts.)
Swap Contracts.
The Fund may directly or indirectly use various different types of swaps, such as
swaps on securities and securities indices, total return swaps, interest rate swaps, currency
swaps, credit default swaps, variance swaps, inflation swaps, and other types of available swap
agreements. Swap contracts are two-party contracts entered into primarily by institutional
investors for periods ranging from a few weeks to a number of years. Under a typical swap, one
party may agree to pay a fixed rate or a floating rate determined by reference to a specified
instrument, rate, or index, multiplied in each case by a specified amount (notional amount),
16
while the other party agrees to pay an amount equal to a different floating rate multiplied by the
same notional amount. On each payment date, the parties obligations are netted, with only the net
amount paid by one party to the other.
Swap contracts are typically individually negotiated and structured to provide exposure to a
variety of different types of investments or market factors. Swap contracts may be entered into
for hedging or non-hedging purposes and therefore may increase or decrease the Funds exposure to
the underlying instrument, rate, asset or index. Swaps can take many different forms and are known
by a variety of names. The Fund is not limited to any particular form or variety of swap agreement
if the Manager determines it is consistent with the Funds investment objective and policies.
The Fund may enter into swaps on securities, baskets of securities or securities indices. For
example, the parties to a swap contract may agree to exchange returns calculated on a notional
amount of a security, basket of securities, or securities index (e.g., S&P 500 Index).
Additionally, the Fund may use total return swaps, which typically involve commitments to pay
amounts computed in the same manner as interest in exchange for a market-linked return, both based
on notional amounts. The Fund may use such swaps to gain investment exposure to the underlying
security or securities where direct ownership is either not legally possible or is economically
unattractive. To the extent the total return of the security, basket of securities, or index
underlying the transaction exceeds or falls short of the offsetting interest rate obligation, the
Fund will receive a payment from or make a payment to the counterparty, respectively.
In addition, the Fund may enter into an interest rate swap in order to protect against declines in
the value of fixed income securities held by the Fund. In such an instance, the Fund may agree
with a counterparty to pay a fixed rate (multiplied by a notional amount) and the counterparty pay
a floating rate multiplied by the same notional amount. If interest rates rise, resulting in a
diminution in the value of the Funds portfolio, the Fund would receive payments under the swap
that would offset, in whole or in part, such diminution in value. The Fund may also enter into
swaps to modify its exposure to particular currencies using currency swaps. For instance, the Fund
may enter into a currency swap between the U.S. dollar and the Japanese Yen in order to increase or
decrease its exposure to each such currency.
The Fund may use inflation swaps, which involve commitments to pay a regular stream of inflation
indexed cash payments in exchange for receiving a stream of nominal interest payments (or vice
versa), where both payment streams are based on a notional amount. The nominal interest payments
may be based on either a fixed interest rate or variable interest rate, such as LIBOR. Inflation
swaps may be used to hedge the inflation risk in nominal bonds (i.e., non-inflation indexed bonds),
thereby creating synthetic inflation indexed bonds, or combined with U.S. Treasury futures
contracts to create synthetic inflation indexed bonds issued by the U.S. Treasury.
In addition, the Fund may directly or indirectly use credit default swaps to take an active long or
short position with respect to the likelihood of default by a corporate or sovereign issuer of
fixed income securities (including asset-backed securities). In a credit default swap, one party
pays, in effect, an insurance premium through a stream of payments to another party in exchange for
the
17
right to receive a specified return in the event of default (or similar events) by one or more
third parties on their obligations. For example, in purchasing a credit default swap, the Fund may
pay a premium in return for the right to put specified bonds or loans to the counterparty, such as
a U.S. or foreign issuer or basket of such issuers, upon issuer default (or similar events) at
their par (or other agreed-upon) value. The Fund, as the purchaser in a credit default swap, bears
the risk that the investment might expire worthless. It also would be subject to counterparty risk
the risk that the counterparty may fail to satisfy its payment obligations to the Fund in the
event of a default (or similar event) (see Risk Factors in Swap Contracts, OTC Options, and Other
Two-Party Contracts below). In addition, as a purchaser in a credit default swap, the Funds
investment would only generate income in the event of an actual default (or similar event) by the
issuer of the underlying obligation. The Fund may also invest in credit default indices, which are
indices that reflect the performance of a basket of credit default swaps.
The Fund also may use credit default swaps for investment purposes by selling a credit default
swap, in which case the Fund will receive a premium from its counterparty in return for the Funds
taking on the obligation to pay the par (or other agreed-upon) value to the counterparty upon
issuer default (or similar events). As the seller in a credit default swap, the Fund effectively
adds economic leverage to its portfolio because, in addition to its total net assets, the Fund is
subject to investment exposure on the notional amount of the swap. If no event of default (or
similar event) occurs, the Fund would keep the premium received from the counterparty and would
have no payment obligations. For credit default swap agreements on asset-backed securities, an
event of default may result from various events, which may include an issuers failure to pay
interest or principal, a breach of a material representation or covenant, an agreement by the
holders of an asset-backed security to a maturity extension, or a write-down on the collateral
underlying the security. For credit default swap agreements on corporate or sovereign issuers, an
event of default may result from such events as the issuers bankruptcy, failure to pay interest or
principal, repudiation/moratorium or restructuring.
The Fund may use variance swap agreements, which involve an agreement by two parties to exchange
cash flows based on the measured variance (or square of volatility) of a specified underlying
asset. One party agrees to exchange a fixed rate or strike price payment for the floating rate
or realized price variance on the underlying asset with respect to the notional amount. At
inception, the strike price chosen is generally fixed at a level such that the fair value of the
swap is zero. As a result, no money changes hands at the initiation of the contract. At the
expiration date, the amount paid by one party to the other is the difference between the realized
price variance of the underlying asset and the strike price multiplied by the notional amount. A
receiver of the realized price variance would receive a payment when the realized price variance of
the underlying asset is greater than the strike price and would make a payment when that variance
is less than the strike price. A payer of the realized price variance would make a payment when the
realized price variance of the underlying asset is greater than the strike price and would receive
a payment when that variance is less than the strike price. This type of agreement is essentially a
forward contract on the future realized price variance of the underlying asset.
Contracts for Differences.
Contracts for differences are swap arrangements in which the parties
agree that their return (or loss) will be based on the relative performance of two different groups
18
or baskets of securities. Often, one or both baskets will be an established securities index. The
Funds return will be based on changes in value of theoretical long futures positions in the
securities comprising one basket (with an aggregate face value equal to the notional amount of the
contract for differences) and theoretical short futures positions in the securities comprising the
other basket. The Fund also may use actual long and short futures positions and achieve similar
market exposure by netting the payment obligations of the two contracts. The Fund will only enter
into contracts for differences (and analogous futures positions) when the Manager believes that the
basket of securities constituting the long position will outperform the basket constituting the
short position. If the short basket outperforms the long basket, the Fund will realize a loss
even in circumstances when the securities in both the long and short baskets appreciate in value.
Interest Rate Caps, Floors, and Collars.
The Fund uses interest rate caps, floors, and collars for
the same or similar purposes as it uses interest rate futures contracts and related options and, as
a result, will be subject to similar risks. See Options and FuturesRisk Factors in Options
Transactions and Risk Factors in Futures and Futures Options Transactions above. Like
interest rate swap contracts, interest rate caps, floors, and collars are two-party agreements in
which the parties agree to pay or receive interest on a notional principal amount and are generally
individually negotiated with a specific counterparty. The purchaser of an interest rate cap
receives interest payments from the seller to the extent that the return on a specified index
exceeds a specified interest rate. The purchaser of an interest rate floor receives interest
payments from the seller to the extent that the return on a specified index falls below a specified
interest rate. The purchaser of an interest rate collar receives interest payments from the seller
to the extent that the return on a specified index falls outside the range of two specified
interest rates.
Swaptions
.
An option on a swap agreement, also called a swaption, is an OTC option that gives
the buyer the right, but not the obligation, to enter into a swap on a specified future date in
exchange for paying a market-based premium. A receiver swaption gives the owner the right to
receive the total return of a specified asset, reference rate, or index (such as a call option on a
bond). A payer swaption gives the owner the right to pay the total return of a specified asset,
reference rate, or index (such as a put option on a bond). Swaptions also include options that
allow one of the counterparties to terminate or extend an existing swap.
Risk Factors in Swap Contracts, OTC Options, and Other Two-Party Contracts
.
The Fund may only
close out a swap, contract for differences, cap, floor, collar, or OTC option (including swaption)
with its particular counterparty, and may only transfer a position with the consent of that
counterparty. If a counterparty fails to meet its contractual obligations, goes bankrupt, or
otherwise experiences a business interruption, the Fund could miss investment opportunities or
otherwise hold investments it would prefer to sell, resulting in losses for the Fund. If the
counterparty defaults, the Fund will have contractual remedies, but there can be no assurance that
the counterparty will be able to meet its contractual obligations or that the Fund will be able to
enforce its rights. For example, because the contract for each OTC derivatives transaction is
individually negotiated with a specific counterparty, the Fund is subject to the risk that a
counterparty may interpret contractual terms (e.g., the definition of default) differently than the
Fund. The cost and unpredictability of the legal proceedings required for the Fund to enforce its
19
contractual rights may lead it to decide not to pursue its claims against the counterparty.
Counterparty risk is greater with longer maturities where events may intervene to prevent
settlement. Counterparty risk is also greater when the Fund has concentrated its derivatives with
a single or small group of counterparties as it sometimes does as a result of its use of swaps and
other OTC derivatives. To the extent the Fund has significant exposure to a single counterparty,
this risk will be particularly pronounced for the Fund. The Fund, therefore, assumes the risk that
it may be unable to obtain payments the Manager believes are owed under an OTC derivatives contract
or that those payments may be delayed or made only after the Fund has incurred the costs of
litigation. In addition, counterparty risk is pronounced during unusually adverse market
conditions and is particularly acute in environments (like those experienced recently) in which
financial services firms are exposed to systemic risks of the type evidenced by the insolvency of
Lehman Brothers in 2008 and subsequent market disruptions.
The credit rating of a counterparty may be adversely affected by greater-than-average volatility in
the markets, even if the counterpartys net market exposure is small relative to its capital.
Counterparty risk with respect to OTC derivatives may be further complicated by recently enacted
U.S. financial reform legislation. See Legal and Regulatory Risk below for more information.
The Funds ability to enter into these transactions may be affected by tax considerations.
Additional Risk Factors in OTC Derivatives Transactions.
Participants in OTC derivatives markets
typically are not subject to the same level of credit evaluation and regulatory oversight as are
members of exchange-based markets and, therefore, OTC derivatives generally expose the Fund to
greater counterparty risk than exchange-traded derivatives.
Among other trading agreements, the Fund is party to International Swaps and Derivatives
Association, Inc. Master Agreements (ISDA Agreements) or other similar types of agreements with
select counterparties that generally govern over-the-counter derivative transactions entered into
by the Fund. The ISDA Agreements typically include representations and warranties as well as
contractual terms related to collateral, events of default, termination events, and other
provisions. Termination events may include the decline in the net assets of the Fund below a
certain level over a specified period of time and entitle a counterparty to elect to terminate
early with respect to some or all the transactions under the ISDA Agreement with that counterparty.
Such an election by one or more of the counterparties could have a material adverse impact on the
Funds operations.
Use of Futures and Related Options, Interest Rate Floors, Caps and Collars, Certain Types of Swap
Contracts and Related InstrumentsCommodity Pool Operator Status
.
The Fund has claimed an
exclusion from the definition of commodity pool operator under the Commodity Exchange Act and,
therefore, is not subject to registration or regulation as a commodity pool operator under that
Act.
20
Foreign Currency Transactions
Currency exchange rates may fluctuate significantly over short periods of time. They generally are
determined by the forces of supply and demand in the currency exchange markets, trade balances, the
relative merits of investments in different countries, actual or perceived changes in interest
rates, differences in relative values of similar assets in different currencies, long-term
opportunities for investment and capital appreciation, and other complex factors. Currency
exchange rates also can be affected unpredictably as a result of intervention (or the failure to
intervene) by the U.S. or foreign governments, central banks, or supranational agencies such as the
International Monetary Fund, or by currency or exchange controls or political and economic
developments in the U.S. or abroad. Currencies in which the Funds assets are denominated, or in
which the Fund has taken a long position, may be devalued against other currencies, resulting in a
loss to the Fund. Similarly, currencies in which the Fund has taken a short position may increase
in value relative to other currencies, resulting in a loss to the Fund.
In addition, some currencies are illiquid (e.g., emerging country currencies), and the Fund may not
be able to covert these currencies into U.S. dollars, in which case the Manager may decide to
purchase U.S. dollars in a parallel market where the exchange rate is materially and adversely
different. Exchange rates for many currencies (e.g., emerging country currencies) are particularly
affected by exchange control regulations.
The Fund may buy or sell foreign currencies or deal in forward foreign currency contracts, currency
futures contracts and related options, and options on currencies. The Fund may use such currency
instruments for hedging, investment, and/or currency risk management. Currency risk management may
include taking overweighted or underweighted currency positions relative to both the securities
portfolio of the Fund and the Funds performance benchmark or index. The Fund also may purchase
forward foreign exchange contracts in conjunction with U.S. dollar-denominated securities in order
to create a synthetic foreign currency-denominated security that approximates desired risk and
return characteristics when the non-synthetic securities either are not available in foreign
markets or possess undesirable characteristics.
Forward foreign currency contracts are contracts between two parties to purchase and sell a
specified quantity of a particular currency at a specified price, with delivery and settlement to
take place on a specified future date. A forward foreign currency contract can reduce the Funds
exposure to changes in the value of the currency it will deliver and can increase its exposure to
changes in the value of the currency it will receive for the duration of the contract. The effect
on the value of the Fund is similar to the effect of selling securities denominated in one currency
and purchasing securities denominated in another currency. Contracts to sell a particular foreign
currency would limit any potential gain that might be realized by the Fund if the value of the
hedged currency increases. In addition, it is not always possible to hedge fully or perfectly
against currency fluctuations affecting the value of the securities denominated in foreign
currencies because the value of such securities also is likely to fluctuate because of independent
factors not related to currency fluctuations. If a forward foreign currency contract is used for
hedging, an imperfect correlation between movements in the price of the forward foreign currency
contract and the price of the currency or other investment being hedged creates risk.
21
Forward foreign currency contracts involve a number of the same characteristics and risks as
currency futures contracts (discussed below) but there also are several differences. Forward
foreign currency contracts are not market traded, and are not necessarily marked to market on a
daily basis. They settle only at the pre-determined settlement date. This can result in
deviations between forward foreign currency prices and currency futures prices, especially in
circumstances where interest rates and currency futures prices are positively correlated. Second,
in the absence of exchange trading and involvement of clearing houses, there are no standardized
terms for forward currency contracts. Accordingly, the parties are free to establish such
settlement times and underlying amounts of a currency as desirable, which may vary from the
standardized provisions available through any currency futures contract. Finally, forward foreign
currency contracts, as two party obligations for which there is no secondary market, involve
counterparty risk not present with currency futures contracts, discussed below.
The Fund also may purchase or sell currency futures contracts and related options. Currency
futures contracts are contracts to buy or sell a standard quantity of a particular currency at a
specified future date and price. However, currency futures can be and often are closed out prior
to delivery and settlement. In addition, the Fund may use options on currency futures contracts,
which give their holders the right, but not the obligation, to buy (in the case of a call option)
or sell (in the case of a put option) a specified currency futures contract at a fixed price during
a specified period. (See Options and FuturesFutures above for more information on futures
contracts and options on futures contracts.)
The Fund also may purchase or sell options on currencies. These give their holders the right, but
not the obligation, to buy (in the case of a call option) or sell (in the case of a put option) a
specified quantity of a particular currency at a fixed price during a specified period. Options on
currencies possess many of the same characteristics as options on securities and generally operate
in a similar manner. They may be traded on an exchange or in the OTC markets. Options on
currencies traded on U.S. or other exchanges may be subject to position limits, which may limit the
ability of the Fund to reduce foreign currency risk using options. (See Options and
FuturesCurrency Options above for more information on currency options.)
Repurchase Agreements
The Fund may enter into repurchase agreements with banks and broker-dealers. A repurchase
agreement is a contract under which the Fund acquires a security (usually an obligation of the
government in the jurisdiction where the transaction is initiated or in whose currency the
agreement is denominated) for a relatively short period (usually less than a week) for cash and
subject to the commitment of the seller to repurchase the security for an agreed-upon price on a
specified date. The repurchase price exceeds the acquisition price and reflects an agreed-upon
market rate unrelated to the coupon rate on the purchased security. Repurchase agreements afford
the Fund the opportunity to earn a return on temporarily available cash without market risk,
although the Fund bears the risk of a sellers failure to meet its obligation to pay the repurchase
price when it is required to do so. Such a default may subject the Fund to expenses, delays, and
risks of loss including: (i) possible declines in the value of the underlying security while the
Fund seeks to enforce its rights thereto, (ii) possible reduced levels of income and lack of access
to income during this period, and (iii) the inability to enforce its rights and the expenses
involved in attempted enforcement. Entering into repurchase agreements entails certain risks,
22
which include the risk that the counterparty to the repurchase agreement may not be able to fulfill
its obligations, as discussed above, that the parties may disagree as to the meaning or application
of contractual terms, or that the instrument may not perform as expected. See Description of
Principal RisksCounterparty Risk in the Prospectus.
Debt and Other Fixed Income Securities Generally
Debt and other fixed income securities include fixed and floating rate securities of any maturity.
Fixed rate securities pay a specified rate of interest or dividends. Floating rate securities pay
a rate that is adjusted periodically by reference to a specified index or market rate. Fixed and
floating rate securities include securities issued by federal, state, local, and foreign
governments and related agencies, and by a wide range of private issuers, and generally are
referred to in this Statement of Additional Information as fixed income securities. Indexed
bonds are a type of fixed income security whose principal value and/or interest rate is adjusted
periodically according to a specified instrument, index, or other statistic (e.g., another
security, inflation index or currency). In addition, the Fund may create synthetic bonds which
approximate desired risk and return profiles. This may be done where a non-synthetic security
having the desired risk/return profile either is unavailable (e.g., short-term securities of
certain foreign governments) or possesses undesirable characteristics (e.g., interest payments on
the security would be subject to foreign withholding taxes).
Holders of fixed income securities are exposed to both market and credit risk. Market risk (or
interest rate risk) relates to changes in a securitys value as a result of changes in interest
rates. In general, the values of fixed income securities increase when interest rates fall and
decrease when interest rates rise. Credit risk relates to the ability of an issuer to make
payments of principal and interest. Obligations of issuers are subject to bankruptcy, insolvency
and other laws that affect the rights and remedies of creditors. Fixed income securities
denominated in
foreign currencies also are subject to the risk of a decline in the value of the denominating
currency.
Because interest rates vary, the future income of the Fund cannot be predicted with certainty. To
the extent the Fund invests in indexed securities, the future income of the Fund also will be
affected by changes in those securities indices over time (e.g., changes in inflation rates or
currency rates).
Cash and Other High Quality Investments
The Fund may temporarily invest a portion of its assets in cash or cash items pending other
investments or to maintain liquid assets required in connection with some of the Funds
investments. These cash items and other high quality debt securities may include money market
instruments, such as securities issued by the United States Government and its agencies, bankers
acceptances, commercial paper, and bank certificates of deposit. If a custodian holds cash on
behalf of the Fund, the Fund may be an unsecured creditor in the event of the insolvency of the
custodian. In addition, the Fund will be subject to credit risk with respect to such a custodian,
which may be heightened to the extent the Fund takes a temporary defensive position.
23
U.S. Government Securities and Foreign Government Securities
U.S. government securities include securities issued or guaranteed by the U.S. government or its
authorities, agencies, or instrumentalities. Foreign government securities include securities
issued or guaranteed by foreign governments (including political subdivisions) or their
authorities, agencies, or instrumentalities or by supra-national agencies. Different kinds of U.S.
government securities and foreign government securities have different kinds of government support.
For example, some U.S. government securities (e.g., U.S. Treasury bonds) are supported by the full
faith and credit of the United States. Other U.S. government securities are issued or guaranteed
by federal agencies or government-chartered or -sponsored enterprises but are neither guaranteed
nor insured by the U.S. government (e.g., debt securities issued by the Federal Home Loan Mortgage
Corporation (Freddie Mac), Federal National Mortgage Association (Fannie Mae), and Federal Home
Loan Banks (FHLBs)). Similarly, some foreign government securities are supported by the full
faith and credit of a foreign national government or political subdivision and some are not.
Foreign government securities of some countries may involve varying degrees of credit risk as a
result of financial or political instability in those countries or the possible inability of the
Fund to enforce its rights against the foreign government. As with issuers of other fixed income
securities, sovereign issuers may be unable or unwilling to satisfy their obligations to pay
principal or interest payments.
Supra-national agencies are agencies whose member nations make capital contributions to support the
agencies activities. Examples include the International Bank for Reconstruction and Development
(the World Bank), the Asian Development Bank, and the Inter-American Development Bank.
As with other fixed income securities, U.S. government securities and foreign government securities
expose their holders to market risk because their values typically change as interest rates
fluctuate. For example, the value of U.S. government securities or foreign government securities
may fall during times of rising interest rates. Yields on U.S. government securities and foreign
government securities tend to be lower than those of corporate securities of comparable maturities.
Generally, when interest rates on short term U.S. Treasury obligations equal or approach zero, a
fund that invests a substantial portion of its assets in U.S. Treasury obligations will have a
negative return unless the Manager waives or reduces its management fees.
In addition to investing directly in U.S. government securities and foreign government securities,
the Fund may purchase certificates of accrual or similar instruments evidencing undivided ownership
interests in interest payments and/or principal payments of U.S. government securities and foreign
government securities. The Fund may also invest in Separately Traded Registered Interest and
Principal Securities (STRIPS), which are interests in separately traded interest and principal
component parts of U.S. Treasury obligations that represent future interest payments, principal
payments, or both, are direct obligations of the U.S. government, and are transferable through the
federal reserve book-entry system. Certificates of accrual and similar instruments may be more
volatile than other government securities.
24
Real Estate Investment Trusts and other Real Estate-Related Investments
The Fund may invest in pooled real estate investment vehicles (so-called real estate investment
trusts or REITs) and other real estate-related investments such as securities of companies
principally engaged in the real estate industry. In addition to REITs, companies in the real
estate industry and real estate-related investments may include, for example, entities that either
own properties or make construction or mortgage loans, real estate developers, and companies with
substantial real estate holdings. Each of these types of investments is subject to risks similar
to those associated with direct ownership of real estate. Factors affecting real estate values
include the supply of real property in particular markets, overbuilding, changes in zoning laws,
casualty or condemnation losses, delays in completion of construction, changes in real estate
values, changes in operations costs and property taxes, levels of occupancy, adequacy of rent to
cover operating expenses, possible environmental liabilities, regulatory limitations on rent,
fluctuations in rental income, increased competition and other risks related to local and regional
market conditions. The value of real-estate related investments also may be affected by changes in
interest rates, macroeconomic developments, and social and economic trends. For instance, during
periods of declining interest rates, certain mortgage REITs may hold mortgages that the mortgagors
elect to prepay, which prepayment may diminish the yield on securities issued by those REITs. Some
REITs have relatively small market capitalizations, which can tend to increase the volatility of
the market price of their securities.
REITs are pooled investment vehicles that invest in real estate or real estate-related companies.
The Fund may invest in different types of REITs, including equity REITs, which own real estate
directly; mortgage REITs, which make construction, development, or long-term mortgage loans; and
hybrid REITs, which share characteristics of equity REITs and mortgage REITs. In general, the
value of a REITs shares changes in light of factors affecting the real estate industry. REITs are
also subject to the risk of fluctuations in income from underlying real estate assets, poor
performance by the REITs manager and the managers inability to manage cash flows generated by the
REITs assets, prepayments and defaults by borrowers, self-liquidation, adverse changes in the tax
laws, and, with regard to U.S. REITs (as defined in Taxes below), the risk of failing to qualify
for tax-free pass-through of income under the Code and/or to maintain exempt status under the 1940
Act. See Taxes below for a discussion of special tax considerations relating to the Funds
investment in U.S. REITs.
By investing in REITs indirectly through a Fund, investors will bear not only their proportionate
share of the expenses of the Fund, but also, indirectly, similar expenses of REITs. In addition,
REITs depend generally on their ability to generate cash flow to make distributions to investors.
Investments in REITs are subject to risks associated with the direct ownership of real estate.
Reverse Repurchase Agreements and Dollar Roll Agreements
The Fund may enter into reverse repurchase agreements and dollar roll agreements with banks and
brokers to enhance return. Reverse repurchase agreements involve sales by the Fund of portfolio
securities concurrently with an agreement by the Fund to repurchase the same securities at a later
date at a fixed price. During the reverse repurchase agreement period, the Fund continues to
receive principal and interest payments on the securities and also has the
25
opportunity to earn a return on the collateral furnished by the counterparty to secure its
obligation to redeliver the securities.
Dollar rolls are transactions in which the Fund sells securities for delivery in the current month
and simultaneously contracts to repurchase substantially similar (same type and coupon) securities
on a specified future date. During the roll period, the Fund foregoes principal and interest paid
on the securities. The Fund is compensated by the difference between the current sales price and
the forward price for the future purchase (often referred to as the drop) as well as by the
interest earned on the cash proceeds of the initial sale.
If the Fund enters into reverse repurchase agreements and dollar roll agreements, it will maintain
cash, U.S. government securities, or other liquid assets equal in value to its obligations under
those agreements. If the buyer in a reverse repurchase agreement or dollar roll agreement files
for bankruptcy or becomes insolvent, the Funds use of proceeds from the sale of its securities may
be restricted while the other party or its trustee or receiver determines whether to honor the
Funds right to repurchase the securities. Furthermore, in that situation the Fund may be unable
to recover the securities it sold in connection with a reverse repurchase agreement and as a result
would realize a loss equal to the difference between the value of the securities and the payment it
received for them. This loss would be greater to the extent the buyer paid less than the value of
the securities the Fund sold to it (e.g., a buyer may only be willing to pay $95 for a bond with a
market value of $100). The Funds use of reverse repurchase agreements also subjects the Fund to
interest costs based on the difference between the sale and repurchase price of a security involved
in such a transaction. Additionally, reverse repurchase agreements entail the same risks as
over-the-counter derivatives. These include the risk that the counterparty to the reverse
repurchase agreement may not be able to fulfill its obligations, as discussed above, that the
parties may disagree as to the meaning or application of contractual terms, or that the instrument
may not perform as expected. See Description of Principal RisksDerivatives Risk and
Counterparty Risk in the Prospectus and Uses of Derivatives below. Reverse repurchase
agreements and dollar rolls are not considered borrowings by the Fund for purposes of the Funds
fundamental investment restriction on borrowings.
Illiquid Securities, Private Placements, Restricted Securities, and IPOs and Other Limited
Opportunities
The Fund may invest up to 15% of its net assets in illiquid securities. For this purpose,
illiquid securities are securities that the Fund may not sell or dispose of within seven days in
the ordinary course of business at approximately the amount at which the Fund has valued the
securities.
A repurchase agreement maturing in more than seven days is considered illiquid, unless it can be
terminated after a notice period of seven days or less.
The Manager also may deem certain securities to be illiquid as a result of the Managers receipt
from time to time of material, non-public information about an issuer, which may limit the
Managers ability to trade such securities for the account of any of its clients, including the
Fund. In some instances, these trading restrictions could continue in effect for a substantial
period of time.
26
Private Placements and Restricted Investments.
Illiquid securities include securities of private
issuers, securities traded in unregulated or shallow markets, securities issued by entities deemed
to be affiliates of the Fund, and securities that are purchased in private placements and are
subject to legal or contractual restrictions on resale. Because relatively few purchasers of these
securities may exist, especially in the event of adverse economic and liquidity conditions or
adverse changes in the issuers financial condition, the Fund may not be able to initiate a
transaction or liquidate a position in such investments at a desirable price. Disposing of
illiquid securities may involve time-consuming negotiation and legal expenses, and selling them
promptly at an acceptable price may be difficult or impossible.
While private placements may offer attractive opportunities not otherwise available in the open
market, the securities purchased are usually restricted securities or are not readily
marketable. Restricted securities cannot be sold without being registered under the Securities
Act of 1933, as amended (the 1933 Act), unless they are sold pursuant to an exemption from
registration (such as Rules 144 or 144A). Securities that are not readily marketable are subject
to other legal or contractual restrictions on resale. The Fund may have to bear the expense of
registering restricted securities for resale and the risk of substantial delay in effecting
registration. The Fund selling its securities in a registered offering may be deemed to be an
underwriter for purposes of Section 11 of the 1933 Act. In such event, the Fund may be liable to
purchasers of the securities under Section 11 if the registration statement prepared by the issuer,
or the prospectus forming a part of it, is materially inaccurate or misleading, although the Fund
may have a due diligence defense.
At times, the inability to sell illiquid securities can make it more difficult to determine their
fair value for purposes of computing the Funds net asset value. The judgment of the Manager
normally plays a greater role in valuing these securities than in valuing publicly traded
securities.
IPOs and Other Limited Opportunities
.
The Fund may purchase securities of companies that are
offered pursuant to an initial public offering (IPO) or other similar limited opportunities.
Although companies can be any age or size at the time of their IPO, they are often smaller and have
a limited operating history, which involves a greater potential for the value of their securities
to be impaired following the IPO. The price of a companys securities may be highly unstable at
the time of its IPO and for a period thereafter due to factors such as market psychology prevailing
at the time of the IPO, the absence of a prior public market, the small number of shares available,
and limited availability of investor information. Securities purchased in IPOs have a tendency to
fluctuate in value significantly shortly after the IPO relative to the price at which they were
purchased. These fluctuations could impact the net asset value and return earned on the Funds
shares. Investors in IPOs can be adversely affected by substantial dilution in the value of their
shares, by sales of additional shares, and by concentration of control in existing management and
principal shareholders. In addition, all of the factors that affect the performance of an economy
or equity markets may have a greater impact on the shares of IPO companies. IPO securities tend to
involve greater risk due, in part, to public perception and the lack of publicly available
information and trading history.
27
Investments in Other Investment Companies or Other Pooled Investments
Subject to applicable regulatory requirements, the Fund may invest in shares of both open- and
closed-end investment companies (including other GMO Funds, money market funds, and exchange-traded
funds (ETFs)). Investing in another investment company exposes the Fund to all the risks of that
investment company and, in general, subjects it to a pro rata portion of the other investment
companys fees and expenses. The Fund also may invest in private investment funds, vehicles, or
structures.
ETFs are hybrid investment companies that are registered as open-end investment companies or unit
investment trusts (UITs) but possess some of the characteristics of closed-end funds. ETFs in
which the Fund may invest typically hold a portfolio of common stocks that is intended to track the
price and dividend performance of a particular index. The Fund may also invest in actively managed
ETFs. Common examples of ETFs include S&P Depositary Receipts (SPDRs), Vanguard ETFs, and
iShares, which may be purchased from the UIT or investment company issuing the securities or in the
secondary market (SPDRs, Vanguard ETFs, and iShares are predominantly listed on the NYSE Arca).
The market price for ETF shares may be higher or lower than the ETFs net asset value. The sale
and redemption prices of ETF shares purchased from the issuer are based on the issuers net asset
value.
Because ETFs are investment companies, investments in ETFs would, absent exemptive relief, be
limited under applicable statutory limitations. Those limitations restrict the Funds investment
in the shares of an ETF or other investment company to up to 5% of the Funds assets (which may
represent no more than 3% of the securities of such ETF or other investment company) and limit
aggregate investments in all ETFs and other investment companies to 10% of the Funds assets.
Short Sales
The Fund may seek to hedge investments or realize additional gains through short sales. The Fund
may make short sales against the box, meaning the Fund may make short sales where the Fund owns,
or has the right to acquire at no added cost, securities or currencies identical to those sold
short. If the Fund makes a short sale against the box, the Fund will not immediately deliver the
securities or currencies sold and will not immediately receive the proceeds from the sale.
However, with respect to securities, the Fund is required to hold securities equivalent in kind and
amount to the securities sold short (or securities convertible or exchangeable into such
securities) while the short sale is outstanding. Once the Fund closes out its short position by
delivering the securities or currencies sold short, it will receive the proceeds of the sale. The
Fund will incur transaction costs, including interest, in connection with opening, maintaining, and
closing short sales against the box.
A Fund will incur a loss as a result of a short sale if the price of the security or index or
currency increases between the date of the short sale and the date on which the Fund replaces the
borrowed security or currency. A Fund will realize a gain if the price of the security or currency
declines between those dates. The amount of any gain will be decreased, and the amount of any loss
increased, by the amount of the premium, dividends or interest a Fund may be required to pay in
connection with a short sale. A Fund may also take short positions in securities through
28
various derivative products. These derivative products will typically expose the Fund to economic
risks similar to those associated with shorting securities directly.
Lack of Correlation Risk
There can be no assurance that the short positions that a Fund holds will act as an effective hedge
against its long positions. Any decrease in negative correlation or increase in positive
correlation between the positions the Manager anticipated would be offsetting (such as short and
long positions in securities or currencies held by a Fund) could result in significant losses for
the Fund.
Legal and Regulatory Risk
Legal, tax and regulatory changes could occur during the term of the Fund that may adversely affect
the Fund. New (or revised) laws or regulations may be imposed by the CFTC, the SEC, the U.S.
Federal Reserve or other banking regulators, other governmental regulatory authorities or
self-regulatory organizations that supervise the financial markets that could adversely affect the
Fund. In particular, these agencies are empowered to promulgate a variety of new rules pursuant to
recently enacted financial reform legislation in the United States. The Fund also may be adversely
affected by changes in the enforcement or interpretation of existing statutes and rules by these
governmental regulatory authorities or self-regulatory organizations. In addition, the securities
and futures markets are subject to comprehensive statutes, regulations and margin requirements.
The CFTC, the SEC, the Federal Deposit Insurance Corporation, other regulators and self-regulatory
organizations and exchanges are authorized to take extraordinary actions in the event of market
emergencies. The regulation of derivatives transactions and funds that engage in such transactions
is an evolving area of law and is subject to modification by government and judicial action.
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives market, including clearing, margin, reporting and registration requirements. Because
the legislation leaves much to rule making, its ultimate impact remains unclear. New regulations
could, among other things, restrict the Funds ability to engage in derivatives transactions (for
example, by making certain types of derivatives transactions no longer available to the Fund)
and/or increase the costs of such derivatives transactions (for example, by increasing margin or
capital requirements), and the Fund may be unable to execute its investment strategy as a result.
It is unclear how the regulatory changes will affect counterparty risk.
The CFTC and certain futures exchanges have established limits, referred to as position limits,
on the maximum net long or net short positions which any person may hold or control in particular
options and futures contracts. All positions owned or controlled by the same person or entity,
even if in different accounts, may be aggregated for purposes of determining whether the applicable
position limits have been exceeded. Thus, even if the Fund does not intend to exceed applicable
position limits, it is possible that different clients managed by the Manager and its affiliates
may be aggregated for this purpose. Although it is possible that the trading decisions of the
Manager may have to be modified and that positions held by the Fund may have to be liquidated in
order to avoid exceeding such limits, the Manager believes that this is unlikely.
29
The modification of investment decisions or the elimination of open positions, if it occurs, may
adversely affect the profitability of the Fund.
The SEC in the past has adopted interim rules requiring reporting of all short positions above a
certain de minimis threshold and is expected to adopt rules requiring monthly public disclosure in
the future. In addition, other non-U.S. jurisdictions where the Fund may trade have adopted
reporting requirements. If the Funds short positions or its strategy become generally known, it
could have a significant effect on the Managers ability to implement its investment strategy. In
particular, it would make it more likely that other investors could cause a short squeeze in the
securities held short by a Fund forcing the Fund to cover its positions at a loss. Such reporting
requirements may also limit the Managers ability to access management and other personnel at
certain companies where the Manager seeks to take a short position. In addition, if other
investors engage in copycat behavior by taking positions in the same issuers as the Fund, the cost
of borrowing securities to sell short could increase drastically and the availability of such
securities to the Fund could decrease drastically. Such events could make a Fund unable to execute
its investment strategy. In addition, the SEC recently proposed additional restrictions on short
sales. If the SEC were to adopt additional restrictions regarding short sales, they could restrict
a Funds ability to engage in short sales in certain circumstances, and the Fund may be unable to
execute its investment strategy as a result.
The SEC and regulatory authorities in other jurisdictions may adopt (and in certain cases, have
adopted) bans on short sales of certain securities in response to market events. Bans on short
selling may make it impossible for the Fund to execute certain investment strategies and may have a
material adverse effect on the Funds ability to generate returns.
Pending federal legislation would require the adoption of regulations that would require any
creditor that makes a loan and any securitizer of a loan to retain at least 5% of the credit risk
on any loan that is transferred, sold or conveyed by such creditor or securitizer. It is currently
unclear how these requirements would apply to loan participations, syndicated loans, and loan
assignments. Funds that invest in loans could be adversely affected by the regulation. The effect
of any future regulatory change on the Fund could be substantial and adverse.
Lack of Operating History
As of the date of this SAI, the Fund has no
operating history. The past performance of other investment funds
managed by the Manager cannot be relied upon as an indicator of the Funds success, in part because
of the unique nature of such Funds investment strategy. An investor in each Fund must rely upon
the ability of the Manager in identifying and implementing investments. There can be no assurance
that such personnel will be successful in identifying and implementing investment opportunities for
such Fund.
30
USES OF DERIVATIVES
Introduction and Overview
Derivatives are financial contracts whose value depends on, or is derived from, the value of
underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the
investment exposures of the Funds portfolio. Derivatives may relate to securities, interest
rates, currencies, currency exchange rates, inflation rates, and indices, and include foreign
currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and
OTC contracts.
This overview outlines various ways in which the Fund (through USCEF) may use different types of
exchange-traded and OTC derivatives in implementing its investment programs. It is intended to
supplement the information included in the Prospectus, including the risks associated with
derivatives described under Description of Principal Risks in the Prospectus, and the information
provided in the Fund Investments and Descriptions and Risks of Fund Investments sections of
this Statement of Additional Information. This overview, however, is not intended to be exhaustive
and the Fund may use types of derivatives and/or employ derivatives strategies not otherwise
described in this Statement of Additional Information or the Prospectus.
In addition, the Fund may decide not to employ any of the strategies described below, and no
assurance can be given that any strategy used will succeed. Also, suitable derivatives
transactions may not be available in all circumstances and there can be no assurance that the Fund
will be able to identify or employ a desirable derivatives transaction at any time or from time to
time, or that any such transactions will be successful.
The Fund may take advantage of instruments and any security or synthetic or derivative instruments
which are not presently contemplated for use by the Fund or which are not currently available, but
which may be developed, to the extent such opportunities are both consistent with the Funds
investment objective and legally permissible for the Fund. The Fund may become a party to various
other customized derivative instruments entitling the counterparty to certain payments on the gain
or loss on the value of an underlying or referenced instrument.
Note
: Unless otherwise noted below in this section, the uses of derivatives discussed
herein with respect to the Fund only refer to the Funds (through USCEFs) direct use of such
derivatives. As indicated in the Prospectus and in the Fund Investments section of this
Statement of Additional Information, the USCEF may invest in other Funds of the Trust, which, in
turn, may use types of derivatives and/or employ derivatives strategies that differ from those
described in this Statement of Additional Information or the Prospectus.
Function of Derivatives in the Fund.
The types of derivatives used and derivatives strategies
employed by the Fund and the extent the Fund uses derivatives may vary. In addition, specific
market conditions may influence the Managers choice of derivatives and derivatives strategies for
the Fund, in some cases to a significant extent.
31
Legal and Regulatory Risk Relating to Derivatives.
As described above under Descriptions and
Risks of Fund InvestmentsLegal and Regulatory Risk, the U.S. government recently enacted
legislation which includes provisions for new regulation of the derivatives market, including
clearing, margin, reporting and registration requirements. Because the legislation leaves much to
rule making, its ultimate impact remains unclear. The regulatory changes could, among other
things, restrict the Funds ability to engage in derivatives transactions (including because
certain types of derivatives transactions may no longer be available to the Fund) and/or increase
the costs of such derivatives transactions (including through increased margin or capital
requirements), and the Fund may be unable to execute its investment strategy as a result. It is
unclear how the regulatory changes will affect counterparty risk.
Use of Derivatives by the Fund
Types of Derivatives That May Be Used by the Fund
|
|
|
Options, futures contracts, and related options on securities indices
|
|
|
|
|
Long swap contracts in which the Fund pays a fixed rate plus the negative performance,
if any, and receives the positive performance, if any, of an index, a single equity
security, or a basket of equity securities
|
|
|
|
|
Short swap contracts in which the Fund receives a fixed rate plus the negative
performance, if any, and pays the positive performance of an index, a single equity
security, or a basket of equity securities
|
|
|
|
|
Contracts for differences,
i.e.
, swaps on an index, a single equity security, or a
basket of equity securities that contain both long and short equity components
|
|
|
|
|
Warrants and rights
|
|
|
|
|
Reverse repurchase agreements
|
Foreign Currency Derivative Transactions That May Be Employed by the Fund
|
|
|
Buying and selling spot currencies
|
Uses of Derivatives by the Fund
The Fund primarily uses derivatives as a substitute for direct investment in securities or other
assets. For example, the Fund may use derivatives instead of investing directly in equity
securities, including using equity derivatives to maintain equity exposure when it holds cash by
equitizing its cash balances using futures contracts or other types of derivatives.
The Fund also may use derivatives in an attempt to reduce its investment exposures (which may
result in a reduction below zero).
In addition, the Fund may use derivatives in an attempt to adjust elements of its investment
exposures to various securities, sectors and markets without actually having to sell existing
investments or make new direct investments. For example, if the Fund holds a large proportion of
stocks of companies in a particular sector and the Manager believes that stocks of companies
32
in another sector will outperform those stocks, the Fund might use a short futures contract on an
appropriate index (to synthetically sell a portion of the Funds portfolio) in combination with a
long futures contract on another index (to synthetically buy exposure to that index).
The Fund may use derivatives to effect transactions intended as substitutes for securities lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net
long exposure in excess of its net assets.
INVESTMENT RESTRICTIONS
Fundamental Restrictions:
The following are Fundamental Investment Restrictions of the Fund, which may
not
be changed
without shareholder approval. The Fund has adopted the same Fundamental Investment Restrictions as
USCEF.
(1) The Fund may not borrow money except under the following circumstances: (i) The Fund may
borrow money from banks so long as after such a transaction, the total assets (including the amount
borrowed) less liabilities other than debt obligations, represent at least 300% of outstanding debt
obligations; (ii) The Fund may also borrow amounts equal to an additional 5% of its total assets
without regard to the foregoing limitation for temporary purposes, such as for the clearance and
settlement of portfolio transactions and to meet shareholder redemption requests; and (iii) The
Fund may enter into transactions that are technically borrowings under the 1940 Act because they
involve the sale of a security coupled with an agreement to repurchase that security (e.g
.
, reverse
repurchase agreements, dollar rolls, and other similar investment techniques) without regard to the
asset coverage restriction described in (i) above, so long as and to the extent that the Funds
custodian earmarks and maintains cash and/or high-grade debt securities equal in value to its
obligations in respect of these transactions.
Under current pronouncements of the Securities and Exchange Commission (SEC) staff, the above
types of transactions are not treated as involving senior securities so long as and to the extent
that the Fund maintains liquid assets equal in value to its obligations in respect of these
transactions.
(2) The Fund may not purchase securities on margin, except such short-term credits as may be
necessary for the clearance of purchases and sales of securities. (For this purpose, the deposit or
payment of initial or variation margin in connection with futures contracts or related options
transactions is not considered the purchase of a security on margin.)
(3) The Fund may not make short sales of securities or maintain a short position for the Funds
account unless at all times when a short position is open the Fund owns an equal amount of such
securities or owns securities which, without payment of any further consideration, are convertible
into or exchangeable for securities of the same issue as, and equal in amount to, the securities
sold short.
33
This restriction does not prohibit the payment of an amount to exercise the right to acquire the
identical securities, provided that the Fund maintains segregated liquid assets in an amount
sufficient to exercise such right.
(4) The Fund may not underwrite securities issued by other persons except to the extent that, in
connection with the disposition of its portfolio investments, it may be deemed to be an underwriter
under federal securities laws.
(5) The Fund may not purchase or sell real estate, although it may purchase securities of issuers
which deal in real estate, including securities of real estate investment trusts, and may purchase
securities which are secured by interests in real estate.
(6) The Fund may not make loans, except by purchase of debt obligations or by entering into
repurchase agreements or through the lending of the Funds portfolio securities. Loans of
portfolio securities may be made with respect to up to 33 1/3% of the Funds total
assets.
(7) The Fund may not concentrate more than 25% of the value of its total assets in any one
industry.
For purposes of this Fundamental Restriction (7), an industry shall not be considered to include
the U.S. government or its agencies or instrumentalities.
(8) The Fund may not purchase or sell commodities or commodity contracts, except that the Fund may
purchase and sell financial futures contracts and options thereon.
(9) The Fund may not issue senior securities, as defined in the 1940 Act and as amplified by
rules, regulations and pronouncements of the SEC.
The SEC has concluded that even though reverse repurchase agreements, firm commitment agreements,
and standby commitment agreements fall within the functional meaning of the term evidence of
indebtedness, the issue of compliance with Section 18 of the 1940 Act will not be raised with the
SEC by the Division of Investment Management if the Fund covers such obligations or maintains
liquid assets equal in value to its obligations with respect to these transactions. Similarly, so
long as such assets are maintained, the issue of compliance with Section 18 will not be raised with
respect to any of the following: any swap contract or contract for differences; any pledge or
encumbrance of assets permitted by Non-Fundamental Restriction (4) below; any borrowing permitted
by Fundamental Restriction (1) above; any collateral arrangements with respect to initial and
variation margin permitted by Non-Fundamental Restriction (4) below; and the purchase or sale of
options, forward contracts, futures contracts or options on futures contracts.
34
(10) The Fund may not cause less than 75% of the value of the Funds total assets to be
represented by cash and cash items (including receivables), Government securities, securities of
other investment companies, and other securities for the purposes of this calculation limited in
respect of any one issuer to an amount not greater than 5% of the value of the Funds total assets
and to not more than 10% of the outstanding voting securities of any single issuer.
Non-Fundamental Restrictions:
The following are Non-Fundamental Investment Restrictions of the Fund, which may be changed by the
Trustees
without
shareholder approval:
(1) The Fund may not buy or sell oil, gas, or other mineral leases, rights or royalty contracts,
although it may purchase securities of issuers that deal in oil, gas, or other mineral leases,
rights or royalty contracts, including securities of royalty trusts, and may purchase securities
which are secured by, or otherwise hold or represent interests in, oil, gas, or other mineral
leases, rights or royalty contracts.
(2) The Fund may not make investments for the purpose of gaining control of a companys
management.
(3) The Fund may not invest more than 15% of its net assets in illiquid securities.
(4) The Fund may not pledge, hypothecate, mortgage, or otherwise encumber its assets in excess of
33 1/3% of the Funds total assets (taken at cost). (For the purposes of this restriction,
collateral arrangements with respect to swap agreements, the writing of options, stock index,
interest rate, currency or other futures, options on futures contracts and collateral arrangements
with respect to initial and variation margin are not deemed to be a pledge or other encumbrance of
assets. The deposit of securities or cash or cash equivalents in escrow in connection with the
writing of covered call or put options, respectively, is not deemed to be a pledge or encumbrance.)
(5) The Fund may not change its Name Policy as set forth under the Funds Principal investment
strategies in the Prospectus without providing the Funds shareholders with a notice meeting the
requirement of Rule 35d-1(c) at least 60 days prior to such change.
For purposes of the Name Policy, the Fund considers the term invest to include both direct
investing and indirect investing and the term investments to include both direct investments and
indirect investments (for instance, the Fund may invest indirectly or make indirect investments by
investing in another GMO Fund or in derivatives and synthetic instruments with economic
characteristics similar to the underlying asset), and the Fund may achieve exposure to a particular
investment, industry, country, or geographic region through direct investing or indirect investing
and/or direct investments or indirect investments. The terms equity investments and equities
refer to direct and indirect investments (described above) in common stocks and other stock-related
securities, such as preferred stocks, convertible securities and depositary receipts. These
investments also include exchange-traded equity REITs and equity income trusts.
35
When used in connection with the
Funds Name Policy, the Manager uses the terms assets and tied economically as defined in the Prospectus.
Except as indicated above in Fundamental Restriction (1), all percentage limitations on investments
set forth herein and in the Prospectus will apply at the time of the making of an investment and
shall not be considered violated unless an excess or deficiency occurs or exists immediately after
and as a result of such investment.
The phrase shareholder approval, as used in the Prospectus and in this Statement of Additional
Information, and the phrases vote of a majority of the outstanding voting securities and the
approval of shareholders, as used herein with respect to the Fund, mean the affirmative vote of
the lesser of (1) more than 50% of the outstanding shares of the Fund, or (2) 67% or more of the
shares of the Fund present at a meeting if more than 50% of the outstanding shares are represented
at the meeting in person or by proxy. Except for policies and restrictions that are explicitly
described as fundamental in the Prospectus or this Statement of Additional Information, the
investment policies and restrictions of the Fund may be changed by the Trusts Trustees without the
approval of shareholders of the Fund. Policies and restrictions of the Fund that are explicitly
described as fundamental in the Prospectus or this Statement of Additional Information cannot be
changed without the approval of shareholders of the Fund.
DETERMINATION OF NET ASSET VALUE
The net asset value or NAV of each class of shares of the Fund is determined as of the close of
regular trading on the New York Stock Exchange (NYSE), generally at 4:00 p.m. Boston time. The
NAV per share of a class of shares of the Fund is determined by dividing the total value of the
Funds portfolio investments and other assets, less any liabilities, allocated to that share class
by the total number of outstanding shares of that class. NAV is not determined on any days when the
NYSE is closed for business. The Fund also may elect not to determine NAV on days during which no
share is tendered for redemption and no order to purchase or sell a share is received by the Fund.
Because the Fund invests substantially all of its assets in USCEF, the Funds net asset value
is calculated based upon the net asset value of USCEF. Please refer to Determination of Net
Asset Value in the Prospectus for additional information.
The Manager evaluates pricing sources on an ongoing basis and may change a pricing source at any
time. The Manager normally does not evaluate the prices supplied by pricing sources on a
day-to-day basis. The Manager monitors erratic or unusual movements (including unusual inactivity)
in the prices supplied for a security and has discretion to override a price supplied by a source
(e.g., by taking a price supplied by another) when it believes that the price supplied is not
reliable. In addition, although alternative prices may be available for securities held by the
Fund, those alternative sources are not typically part of the valuation process and do not
necessarily provide greater certainty about the prices used by the Fund. In addition, because the
36
Fund may hold portfolio securities listed on foreign exchanges that trade on days on which the NYSE
or the U.S. bond markets are closed, the net asset value of the Funds shares may change
significantly on days when shares cannot be redeemed.
DISTRIBUTIONS
The Prospectus describes the distribution policies of the Fund under the heading Distributions and
Taxes. The Fund generally maintains a policy to pay its shareholders, as dividends, substantially
all net investment income, if any, and all net realized capital gains, if any, after offsetting any
available capital loss carryovers. The Fund, from time to time and at the Funds discretion, also
may make unscheduled distributions of net investment income, short-term capital gains, and/or
long-term capital gains prior to large redemptions by shareholders from the Fund or as otherwise
deemed appropriate by the Fund (see discussion in Taxes below).
TAXES
The following discussion of U.S. federal income tax consequences of investment in the Fund is based
on the Internal Revenue Code of 1986, as amended (the Code), U.S. Treasury regulations, and other
applicable authority, as of the date of this SAI. These authorities are subject to change by
legislative or administrative action, possibly with retroactive effect. This discussion does not
purport to be complete or to deal with all aspects of U.S. federal income taxation of an investment
in the Fund. Further, the discussion below is based on the assumption that the shares of the Fund
are held solely by certain eligible retirement plans, as well as through certain other
tax-advantaged accounts, and only certain tax aspects of an investment in the Fund relevant to such
shareholders are described herein. The discussion below does not address tax considerations that
may be relevant to participants in nonqualified retirement plans, or to other investors.
Prospective investors are urged to consult the plan sponsor or other intermediary through which
their investment is made, as well as their own tax advisors and financial planners, regarding the
U.S. federal income tax consequences to them of an investment in the Fund, the application of
state, local, or foreign laws, and the effect of any possible changes in applicable tax laws on an
investment in the Fund.
Tax Status and Taxation of the Fund
The Fund is treated as a separate taxable entity for U.S. federal income tax purposes. The Fund
intends to qualify each year as a regulated investment company (RIC) under Subchapter M of the
Code. In order to qualify for the special tax treatment accorded RICs and their shareholders, the
Fund must, among other things:
(a)
|
|
derive at least 90% of its gross income for each taxable year from (i) dividends, interest,
payments with respect to certain securities loans, and gains from the sale or other
disposition of stock, securities, or foreign currencies, or other income (including but not
limited to gains from options, futures, or forward contracts) derived with respect to its
business of investing in such stock, securities, or currencies and (ii) net income derived
from interests in qualified publicly traded partnerships (as defined below);
|
|
(b)
|
|
diversify its holdings so that, at the end of each quarter of the Funds taxable year, (i) at
least 50% of the market value of the Funds total assets consists of cash and cash items, U.S.
|
37
|
|
government securities, securities of other RICs, and other securities limited in respect of
any one issuer to a value not greater than 5% of the value of the Funds total assets and not
more than 10% of the outstanding voting securities of such issuer, and (ii) not more than 25%
of the value of the Funds total assets is invested in the securities (other than those of the
U.S. government or RICs) of any one issuer or of two or more issuers which the Fund controls
and which are engaged in the same, similar, or related trades or businesses, or in the
securities of one or more qualified publicly traded partnerships (as defined below); and
|
|
(c)
|
|
distribute with respect to each taxable year at least 90% of the sum of its investment
company taxable income (as that term is defined in the Code without regard to the deduction
for dividends paidgenerally, taxable ordinary income and the excess, if any, of net
short-term capital gains over net long-term capital losses) and any net tax-exempt interest
income for such year.
|
In general, for purposes of the 90% gross income requirement described in paragraph (a) above,
income derived from a partnership will be treated as qualifying income only to the extent such
income is attributable to items of income of the partnership which would be qualifying income if
realized directly by the RIC. However, 100% of the net income derived from an interest in a
qualified publicly traded partnership (defined generally as a partnership (i) the interests in
which are traded on an established securities market or are readily tradable on a secondary market
or the substantial equivalent thereof, (ii) that derives at least 90% of its income from passive
income sources defined in Section 7704(d) of the Code, and (iii) that derives less than 90% of its
income from the qualifying income described in paragraph (a)(i) above) will be treated as
qualifying income. In addition, although in general the passive loss rules of the Code do not
apply to RICs, such rules do apply to a RIC with respect to items attributable to an interest in a
qualified publicly traded partnership. Further, for the purposes of the diversification test in
paragraph (b) above: (i) the term outstanding voting securities of such issuer will include the
equity securities of a qualified publicly traded partnership, and (ii) identification of the issuer
(or, in some cases, issuers) of a particular Fund investment can depend on the terms and conditions
of that investment. In some cases, identification of the issuer (or issuers) is uncertain under
current law, and an adverse determination or future guidance by the Internal Revenue Service
(IRS) with respect to issuer identification for a particular type of investment may adversely
affect the Funds ability to meet the diversification test in (b) above.
If the Fund qualifies as a RIC that is accorded special tax treatment, the Fund will not be subject
to U.S. federal income tax on income distributed in a timely manner to its shareholders in the form
of dividends (including Capital Gain Dividends, as defined below).
As described above, the Fund intends generally to distribute at least annually to its shareholders
substantially all of its net investment income (including any net tax-exempt interest income) and
all of its net realized capital gains (including both net short-term and long-term capital gains).
Any net taxable investment income or net short-term capital gains (as reduced by any net long-term
capital losses) retained by the Fund will be subject to tax at the Fund level at regular corporate
rates. Although the Fund intends generally to distribute all of its net capital gain (i.e., the
excess of any net long-term capital gains over net short-term capital losses) each year, the
Fund reserves the right to retain for investment all or a portion of its net capital gain. If the
Fund
38
retains any net capital gain, it will be subject to tax at the Fund level at regular corporate
rates on the amount retained.
Amounts not distributed on a timely basis by RICs in accordance with a calendar-year distribution
requirement are subject to a nondeductible 4% excise tax at the Fund level. This excise tax,
however, is inapplicable to any RIC whose sole shareholders are certain qualified retirement or
pension plans, separate accounts of life insurance companies funding variable contracts, Section
529 qualified tuition programs or certain other permitted tax-exempt investors, or other RICs that
are also exempt from the excise tax. In determining whether these investors are the sole
shareholders of a RIC for purposes of this exception to the excise tax, shares attributable to an
investment in the RIC (not exceeding $250,000) made in connection with the organization of the RIC
are not taken into account.
If the Fund is subject to the excise tax and fails to distribute in a calendar year at least an
amount generally equal to the sum of 98% of its ordinary income for such year and 98.2% of its
capital gain net income for the one-year period ending October 31 within that year, plus any such
retained amounts from the prior year, the Fund would be subject to a nondeductible 4% excise tax on
the undistributed amounts. If the Fund is subject to the excise tax, the Fund intends generally to
make distributions sufficient to avoid imposition of the 4% excise tax, although the Fund reserves
the right to pay an excise tax rather than make an additional distribution when circumstances
warrant (e.g., the payment of the excise tax amount is deemed by the Fund to be
de minimis
). For
purposes of the required excise tax distribution, the Funds ordinary gains and losses from the
sale, exchange, or other taxable disposition of property that would otherwise be taken into account
after October 31 of a calendar year generally are treated as arising on January 1 of the following
calendar year.
Realized capital losses in excess of realized capital gains (Net Capital Losses) are not
permitted to be deducted against net investment income. Instead, potentially subject to the
limitations described below, the Fund will carry Net Capital Losses forward from any taxable year
to subsequent taxable years to offset capital gains, if any, realized during such subsequent
taxable year. Distributions from capital gains are generally made after applying any available
capital loss carryforwards. Capital loss carryforwards are reduced to the extent they offset
current-year net realized capital gains, whether the Fund retains or distributes such gains.
Any Net Capital Losses will be carried forward to one or more subsequent taxable years without
expiration. Any such carryforward losses will retain their character as short-term or long-term
and will be applied first against gains of the same character before offsetting gains of a
different character (e.g., Net Capital Losses that are long-term will first offset any long-term
capital gain with any remaining amounts available to offset any short-term capital gain). The
Funds available capital loss carryforwards, if any, will be set forth in its annual shareholder
report for each fiscal year.
In addition, the Funds ability to use Net Capital Losses may be limited following the occurrence
of certain (i) acquisitive reorganizations and (ii) shifts in the ownership of the Fund by a
shareholder owning or treated as owning 5% or more of the shares of the Fund (each, an
ownership change). The Code may similarly limit the Funds ability to use any of its other
39
capital losses, or ordinary losses, that have accrued but have not been recognized (i.e.,
built-in losses) at the time of an ownership change to the extent they are realized within the
five-year period following the ownership change.
Taxation of Fund Distributions and Redemptions
As noted above, shares of the Fund will be held solely by certain eligible retirement plans, as
well as through certain other tax-advantaged accounts. Shareholders that are retirement plans that
qualify for tax-exempt treatment under U.S. federal income tax laws generally are not subject to
U.S. federal income tax on distributions from the Fund or on redemptions of Fund shares. Special
tax rules apply to investments through such plans. Plan participants whose retirement plan invests
in the Fund generally are not subject to U.S. federal income tax on Fund distributions received by
the plan or on redemptions of Fund shares by the plan. However, distributions to plan participants
from a retirement plan generally are taxable to plan participants as ordinary income, with certain
exceptions (for example, distributions to participants from a Roth 401(k) plan generally are not
taxable to those participants).
As noted above, this discussion does not address tax considerations that may be relevant to
participants in nonqualified retirement plans, or to other investors. All investors should
consult with their own tax advisors or the plan administrator or other financial intermediary
through which their investment in the Fund is made to determine the suitability of the Fund as an
investment through their retirement plan or other tax-advantaged account and the specific U.S.
federal income, as well as any possible state, local, foreign, or other tax consequences to them of
investing in the Fund through their plan or other account.
Backup Withholding
The Fund (or in the case of shares held through an intermediary, the intermediary) generally is
required to withhold and remit to the U.S. Treasury a percentage of the taxable distributions and
redemption proceeds paid to any individual shareholder who fails to properly furnish the Fund (or
the intermediary) with a correct taxpayer identification number, who has under-reported dividend or
interest income, or who fails to certify that he or she is not subject to such withholding. The
backup withholding tax rate is 28% for amounts paid through 2012. This rate will expire and the
backup withholding rate will be 31% for amounts paid after December 31, 2012, unless Congress
enacts tax legislation providing otherwise. Any tax withheld as a result of backup withholding
does not constitute an additional tax imposed on the record owner of the account, and may be
claimed as a credit on the record owners U.S. federal income tax return, provided the appropriate
information is furnished to the IRS.
Shareholder Reporting Obligations With Respect to Foreign Bank and Financial Accounts and Other
Foreign Financial Assets
Certain individuals (and, if provided in future guidance, certain domestic entities) must disclose
annually their interests in specified foreign financial assets on IRS Form 8938, which must be
attached to their U.S. federal income tax returns for taxable years beginning after March 18,
2010 The IRS has not yet released a copy of the Form 8938 and has suspended the requirement to
attach Form 8938 for any taxable year for which an income tax return is filed before the release
40
of
Form 8938. Following Form 8938s release, individuals will be required to attach to their next
income tax return required to be filed with the IRS a Form 8938 for each taxable year for which the
filing of Form 8938 was suspended. Until the IRS provides more details regarding this reporting
requirement, including in Form 8938 itself and related Treasury regulations, it remains unclear
under what circumstances, if any, a shareholders (indirect) interest in the Funds specified
foreign financial assets, if any, will be required to be reported on this Form 8938. In addition,
shareholders that are U.S. persons and own, directly or indirectly, more than 50% of a Fund could
be required to report annually their financial interest in the Funds foreign financial
accounts, if any, on Treasury Department Form TD F 90-22.1, Report of Foreign Bank and Financial
Accounts (FBAR). Shareholders should consult their plan sponsor or other intermediary through
which a Fund investment is made (if applicable), as well as a tax advisor, regarding the
applicability to them of both of these reporting requirements.
Other Reporting and Withholding Requirements
Rules enacted in March 2010 under the HIRE Act require the reporting to the IRS of direct and
indirect ownership of foreign financial accounts and foreign entities by U.S. persons. Failure to
provide this required information can result in a 30% withholding tax on certain payments
(withholdable payments), beginning in 2014 or 2015, depending on the type of payment.
Specifically, withholdable payments subject to this 30% withholding tax include payments of
U.S.-source interest and dividends, including certain payments with respect to derivative
instruments that are treated as dividend equivalents, in each case made on or after January 1,
2014, and payments of gross proceeds from the sale or other disposal of property that can produce
U.S.-source interest or dividends made on or after January 1, 2015.
The IRS has issued only preliminary guidance with respect to these rules; their scope remains
unclear and potentially subject to material change. Very generally, it is possible that all or a
portion of distributions made by the Fund on or after the dates noted above (or such later dates as
may be provided in future guidance) to a shareholder will be subject to the 30% withholding
requirement. Payments to a foreign shareholder that is a foreign financial institution will
generally be subject to withholding, unless such shareholder enters into a timely agreement with
the IRS. Payments to shareholders that are U.S. persons or foreign individuals will generally not
be subject to withholding, so long as such shareholders provide the Fund with such certifications
or other documentation, including, to the extent required, with regard to their direct and indirect
owners, as the Fund requires to comply with these rules. Persons investing in the Fund through an
intermediary should contact their intermediary regarding the application of this reporting and
withholding regime to their investments in the Fund.
Shareholders are urged to consult a tax advisor regarding this reporting and withholding regime, in
light of their particular circumstances.
The Fund and its shareholders may be subject to certain other tax reporting requirements as a
result of the investment strategies and activities of the Fund. Certain U.S. federal, state, local
and foreign tax reporting requirements may require the Fund to provide certain information about
its shareholders to the IRS and other similar authorities responsible for tax matters in other
jurisdictions (e.g., foreign countries).
41
Tax Implications of Certain Investments
As discussed in the Funds Prospectus, the Fund invests substantially all of its assets in shares
of USCEF. Therefore, unless otherwise specified, the following section discusses certain U.S.
federal income tax consequences of investments made by USCEF.
USCEF may make extensive use of various types of derivative financial instruments to the extent
consistent with its investment policies and restrictions. The tax treatment of certain derivative
instruments may require USCEF to accrue and distribute income not yet received. To generate
sufficient cash to make the requisite distributions, USCEF may be required to sell securities in
its portfolio (including when it is not advantageous to do so) that it otherwise would have
continued to hold.
The tax rules applicable to derivative financial instruments are in some cases uncertain under
current law, including under Subchapter M of the Code. Accordingly, while USCEF intends to account
for such transactions in a manner it deems to be appropriate, an adverse determination or future
guidance by the IRS with respect to one or more of these rules (which determination or guidance
could be retroactive) may adversely affect USCEFs ability to meet one or more of the relevant
requirements to maintain its qualification as a RIC, as well as to avoid the Fund-level tax. See
Loss of RIC Status below.
Certain investments made and investment practices engaged in by USCEF can produce a difference
between its book income and its taxable income. These can include, but are not limited to, certain
hedging activities, as well as Section 1256 contracts, passive foreign investment companies (as
defined below), and debt obligations with discount or purchased at a premium.
Any investment by USCEF in equity securities of a real estate investment trust (as defined in
Section 856 of the Code) qualifying for special tax treatment under Subchapter M of the Code (U.S.
REIT) may result in the Funds receipt of cash in excess of the U.S. REITs earnings; if the Fund
distributes these amounts, these distributions could constitute a return of capital to Fund
shareholders for U.S. federal income tax purposes. Investments in U.S. REIT equity securities may
also require the Fund to accrue and distribute income not yet received. To generate sufficient
cash to make the requisite distributions, the Fund may be required to sell securities in its
portfolio (including when it is not advantageous to do so) that it otherwise would have continued
to hold.
Under a notice issued by the IRS in October 2006 and Treasury regulations that have not yet been
issued, but may apply retroactively, a portion of the Funds income (including income allocated to
the Fund from USCEF with respect to USCEFs investment in a U.S. REIT or other pass-through entity)
that is attributable to a residual interest in a real estate mortgage investment conduit (REMIC)
or an equity interest in a taxable mortgage pool (TMP) (referred to in the Code as an excess
inclusion) will be subject to U.S. federal income tax in all events. This notice also provides
and the regulations are expected to provide that excess inclusion income of RICs, such as USCEF and
the Fund, will be allocated to shareholders of RICs in proportion to the dividends received by such
shareholders, with the same consequences as if the shareholders held the related interest directly.
As a result, to the extent the Fund invests in any such interests
42
through USCEF, it may not be a suitable investment for certain tax-exempt investors, as noted
below.
In general, excess inclusion income allocated to shareholders (i) cannot be offset by net operating
losses (subject to a limited exception for certain thrift institutions), and (ii) will constitute
unrelated business taxable income (UBTI) to entities (including a qualified pension plan, an
individual retirement account, a 401(k) plan, a Keogh plan, or other tax-exempt entity) subject to
tax on UBTI, thereby potentially requiring such an entity that is allocated excess inclusion
income, and otherwise might not be required to file a tax return, to file a tax return and pay tax
on such income.
Under current law, income of the Fund that would be treated as UBTI if earned directly by a
tax-exempt entity generally will not be attributed and taxed as UBTI when distributed to tax-exempt
shareholders (that is, the Fund blocks this income with respect to such shareholders).
Notwithstanding this blocking effect, a tax-exempt shareholder could realize UBTI by virtue of
its investment in the Fund if shares in the Fund constitute debt-financed property in the hands of
the tax-exempt shareholder within the meaning of Section 514(b) of the Code. A tax-exempt
shareholder may also recognize UBTI if the Fund recognizes excess inclusion income derived from
direct or indirect investments in residual interests in REMICs or equity interests in TMPs as
described above, if the amount of such income recognized by the Fund exceeds the Funds investment
company taxable income (after taking into account deductions for dividends paid by the Fund).
Some debt obligations with a fixed maturity date of more than one year from the date of issuance
(and zero-coupon debt obligations with a fixed maturity date of more than one year from the date of
issuance) that are acquired by USCEF or the Fund will be treated as debt obligations that are
issued originally at a discount. Generally, the amount of the OID is treated as interest income
and is included in USCEFs or the Funds taxable income (and required to be distributed by USCEF or
the Fund) over the term of the debt security, even though payment of that amount is not received
until a later time, usually upon partial or full repayment or disposition of the debt security. In
addition, payment-in-kind securities will give rise to income which is required to be distributed
and is taxable even though USCEF or the Fund, as a holder of the security, receives no interest
payment in cash on the security during the year.
If USCEF or the Fund holds certain debt obligations that are treated as issued or purchased at a
discount, it may be required to pay out as an income distribution each year an amount which is
greater than the total amount of cash interest USCEF or the Fund actually received in respect of
such obligations. To generate a sufficient amount of cash to make the requisite distributions,
USCEF or the Fund may be required to sell securities in its portfolio (including when it is not
advantageous to do so) that it otherwise would have continued to hold.
USCEFs investments in foreign securities (if any) may be subject to foreign withholding and other
taxes on dividends, interest, or capital gains, which can decrease the Funds yield. USCEF may
otherwise be subject to foreign taxation on repatriation proceeds generated from those securities
or to other transaction-based foreign taxes on those securities, which can also decrease the Funds
yield. Such foreign withholding taxes and other taxes may be reduced or eliminated under income
tax treaties between the United States and certain foreign jurisdictions. Depending
43
on the number of foreign shareholders in USCEF, however, such reduced foreign withholding and other
tax rates may not be available for investments in certain jurisdictions.
In addition, any transactions by USCEF in foreign currencies, foreign currency-denominated debt
obligations, or certain foreign currency options, futures contracts, or forward contracts (or
similar instruments) may give rise to ordinary income or loss to the extent such income or loss
results from fluctuations in the value of the foreign currency concerned and can give rise to
differences in USCEFs book and taxable income. USCEF may be required to sell securities in its
portfolio (including when it is not advantageous to do so) in order to generate sufficient cash to
make the requisite distributions of such income. Any net ordinary losses so created cannot be
carried forward by USCEF to offset income or gains earned in subsequent taxable years.
USCEFs investments in certain passive foreign investment companies (PFICs), as defined below,
could subject USCEF to U.S. federal income tax (including interest charges) on distributions
received from a PFIC or on proceeds received from the disposition of shares in a PFIC, which tax
cannot be eliminated by making distributions to USCEF shareholders, including the Fund. However,
USCEF may make certain elections to avoid the imposition of that tax. For example, USCEF may elect
to treat a PFIC as a qualified electing fund (QEF) (i.e., make a QEF election), in which case
USCEF will be required to include its share of the PFICs income and net capital gain annually,
regardless of whether it receives any distribution from the PFIC. Alternately, USCEF may make an
election to mark the gains (and to a limited extent the losses) in such holdings to the market as
though it had sold (and, solely for purposes of this mark-to-market election, repurchased) its
holdings in those PFICs on the last day of USCEFs taxable year. Such gains and losses are treated
as ordinary income and loss. The QEF and mark-to-market elections may have the effect of
accelerating the recognition of income (without the receipt of cash) and increasing the amount
required to be distributed for USCEF to avoid taxation. Making either of these elections therefore
may require USCEF to liquidate other investments (including when it is not advantageous to do so)
to meet its distribution requirement, which also may affect the Funds total return. In addition,
there is a risk that USCEF may not realize that a foreign corporation in which it invests is a PFIC
for U.S. federal tax purposes and thus fail to timely make a QEF or mark-to-market election in
respect of that corporation, in which event USCEF could be subject to the U.S. federal income taxes
and interest charges described above.
A PFIC is any foreign corporation in which (i) 75% or more of the gross income for the taxable year
is passive income, or (ii) the average percentage of the assets (generally by value, but by
adjusted tax basis in certain cases) that produce, or are held for the production of, passive
income is at least 50%. Generally, passive income for this purpose means dividends, interest
(including income equivalent to interest), royalties, rents, annuities, the excess of gains over
losses from certain property transactions and commodities transactions, income from certain
notional principal contracts, and foreign currency gains. Passive income for this purpose does not
include rents and royalties received by the foreign corporation from active business and certain
income received from related persons.
44
Loss of RIC Status
If the Fund were to fail to meet the income or diversification test described in Tax Status and
Taxation of the Fund above, the Fund could in some cases cure such failure, including by paying a
Fund-level tax and, in the case of a diversification test failure, disposing of certain assets. If
the Fund were ineligible to or otherwise did not cure such failure for any year, or if the Fund
were otherwise to not qualify for taxation as a RIC for such year, the Fund would be taxed as an
ordinary corporation on its taxable income for that year without being able to deduct the
distributions it makes to its shareholders, thereby reducing the value of a shareholders
investment in the Fund, and depending on when the Fund discovered its qualification failure for a
particular taxable year, the Fund may be subject to penalties and interest on any late payments of
its Fund-level taxes for such year. In addition, in the event of any such loss of RIC status, all
distributions from the Funds earnings and profits, including any distributions of net tax-exempt
income and net long-term capital gains, would be taxable to Fund shareholders as ordinary income.
In order to re-qualify for taxation as a RIC that is accorded special tax treatment, the Fund may
be required to recognize unrealized gains, pay substantial taxes and interest on such gains, and
make certain substantial distributions.
Tax Shelter Reporting Regulations
Under Treasury regulations, if a shareholder recognizes a loss on disposition of the Funds shares
of $2 million or more for an individual shareholder or $10 million or more for a corporate
shareholder, the shareholder must file with the IRS a disclosure statement on Form 8886. Direct
shareholders of portfolio securities are in many cases excepted from this reporting requirement,
but under current guidance, shareholders of a RIC are not excepted. Future guidance may extend the
current exception from this reporting requirement to shareholders of most or all RICs. The fact
that a loss is reportable under these regulations does not affect the legal determination of
whether the taxpayers treatment of the loss is proper. Shareholders should consult their tax
advisors to determine the applicability of these regulations in light of their individual
circumstances.
MANAGEMENT OF THE TRUST
The following tables present information regarding each Trustee and officer of the Trust as of the
date of this Statement of Additional Information. Each Trustees and officers date of birth
(DOB) is set forth after his or her name. Unless otherwise noted, (i) each Trustee and officer
has engaged in the principal occupation(s) noted in the table for at least the most recent five
years, although not necessarily in the same capacity, and (ii) the address of each Trustee and
officer is c/o GMO Series Trust, 40 Rowes Wharf, Boston, MA 02110. Each Trustee serves in office for
a term of eight years or,
if sooner, until the Trustee dies, resigns or is removed or until the election and qualification of the Trustees successor. Each officer serves in office
until his or her successor is elected and determined to be qualified to carry out the duties and
responsibilities of the office, or until the officer resigns or is removed from office.
45
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
|
|
|
|
|
|
|
|
Portfolios in
|
|
|
|
|
Position(s)
|
|
|
|
|
|
Fund
|
|
Other
|
Name and Date
|
|
Held
|
|
Length of
|
|
Principal Occupation(s)
|
|
Complex
1
|
|
Directorships
|
of Birth
|
|
with the Trust
|
|
Time Served
|
|
During Past 5 Years
|
|
Overseen
|
|
Held
|
INDEPENDENT TRUSTEE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Maria D. Furman
DOB: 02/03/1954
|
|
Trustee
|
|
Since August 2011.
|
|
Retired.
|
|
|
1
|
|
|
Trustee of MassMutual Premier Funds and MML Series Investment Fund II (32 portfolios).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INTERESTED TRUSTEE AND OFFICER
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Joseph B.
Kittredge, Jr.
2
DOB: 08/22/1954
|
|
Trustee;
President and
Chief Executive
Officer of the Trust
|
|
Since May 2011.
|
|
General Counsel, Grantham, Mayo, Van Otterloo & Co. LLC (October 2005-present); President and Chief Executive Officer of GMO Trust since March 2009.
|
|
|
67
|
|
|
None.
|
|
|
|
|
1
|
|
The Fund Complex consists of the funds of GMO Series Trust and GMO Trust.
|
|
|
|
2
|
|
Mr. Kittredge is an interested person of the Trust, as such term is used in the 1940
Act (an Interested Trustee), by virtue of his positions with GMO indicated in the table above.
|
|
46
Information About Each Trustees Experience, Qualifications, Attributes, or Skills for Board
Membership.
The Board of Trustees has determined that each Trustee should serve as such based on
identifying and evaluating the skill sets and qualifications of potential candidates. The Board of
Trustees generally considered the educational, business and professional experience of each Trustee
in determining his or her qualifications to serve as a Trustee of the Fund. The Board of Trustees
focuses on the complementary skills and experience of the Trustees as a group, as well as on those
of any particular Trustee. The Board of Trustees noted that both Trustees had considerable
experience in overseeing investment management activities and/or related operations and in serving
on the boards of other companies. In addition, the Board of Trustees also considered, among other
factors, the particular attributes described below with respect to the individual Trustees:
Maria D. Furman Ms. Furmans experience serving on the boards and committees of other
organizations, her professional training and her qualification as a chartered financial analyst, and
her experience in the management of a leading investment management firm.
Joseph B. Kittredge, Jr. Mr. Kittredges experience serving as President of GMO Trust and
General Counsel and a Member of GMO, his professional training and his experience as a lawyer
representing mutual funds and investment management firms, including as a partner at a leading law
firm, and his perspective on Board matters as a senior executive of GMO.
Information relating to the experience, qualifications, attributes and skills of the Trustees is
required by the registration form adopted by the SEC, does not constitute holding out the Board or
any Trustee as having any special expertise or experience, and does not impose any greater
responsibility or liability on any such person or on the Board as a whole than would otherwise be
the case.
Officers
|
|
|
|
|
|
|
|
|
Position(s)
|
|
|
|
|
Name and Date of
|
|
Held
|
|
Length
|
|
Principal Occupation(s)
|
Birth
|
|
with the Trust
|
|
of Time Served
|
|
During Past 5 Years
|
Joseph B.
Kittredge, Jr.
DOB: 08/22/1954
|
|
Trustee;
President and Chief
Executive Officer
|
|
Since May 2011.
|
|
General Counsel, Grantham, Mayo, Van
Otterloo & Co. LLC (October
2005-present); President and Chief
Executive Officer, GMO Trust (March
2009- present).
|
|
|
|
|
|
|
|
Sheppard N. Burnett
DOB: 10/24/1968
|
|
Treasurer and Chief
Financial Officer
|
|
Since May 2011
|
|
Head of Fund Administration (December
2006-present), Fund Administration
Staff (June 2004-November 2006),
Grantham, Mayo, Van Otterloo & Co.
LLC; Chief Financial Officer (March
2007-present), Treasurer (November
2006-March 2007), and Assistant
Treasurer (September 2004-
November 2006), GMO Trust.
1
|
47
|
|
|
|
|
|
|
|
|
Position(s)
|
|
|
|
|
Name and Date of
|
|
Held
|
|
Length
|
|
Principal Occupation(s)
|
Birth
|
|
with the Trust
|
|
of Time Served
|
|
During Past 5 Years
|
John McGinty
DOB: 08/11/1962
|
|
Chief Compliance
Officer
|
|
Since August 2011.
|
|
Chief Compliance Officer, Grantham,
Mayo, Van Otterloo & Co. LLC (July
2009-present); Chief Compliance
Officer, GMO Trust (February
2011-present); Senior Vice President
and Deputy General Counsel (January
2007-July 2009), Vice President and
Associate General Counsel (February
2006-December 2006), Fidelity
Investments.
|
|
|
|
|
|
|
|
Jason B. Harrison
DOB: 01/29/1977
|
|
Clerk and Chief Legal Officer
|
|
Clerk since May 2011; Chief
Legal Officer since September 2011.
|
|
Legal Counsel, Grantham, Mayo, Van
Otterloo & Co. LLC (since February
2006); Chief Legal Officer and Vice
President-Law (October 2010-present),
Vice President (November 2006-October
2010).
|
|
|
|
|
1
|
|
Mr. Burnett also serves as an officer of certain other pooled investment vehicles of
which GMO or an affiliate of GMO serves as the investment adviser.
|
|
Trustees Responsibilities.
Under the provisions of the GMO Series Trust Declaration of Trust, the Trustees manage the business of the Trust,
an open-end management investment company. The Trustees have all powers necessary or convenient to carry out that
responsibility, including the power to engage in transactions of all kinds on behalf of the Trust. Except as
provided in the Declaration of Trust, the exercise by the Trustees of their powers shall be valid if, but only if,
the exercise is approved by a majority of the Trustees then in office, so long as: (i) at least one Independent Trustee
votes for or abstains from such exercise, and (ii) at least one Interested Trustee votes for or abstains from such
exercise; and further provided that if there is only one Trustee, such Trustee is permitted to exercise any power on
his own. Without limiting the foregoing, the Trustees shall have the power to amend the Declaration of Trust; select
the investment companies, including series of GMO Trust, in which a series of the Trust shall invest; adopt, amend or
repeal By-Laws not inconsistent with the Declaration of Trust providing for the regulation and management of the affairs
of the Trust; elect and remove officers and appoint and terminate agents; fix the number of Trustees and, subject to the
provisions of the Declaration of Trust, fill any vacancies on the Board; remove a Trustee; extend a Trustees term for one
or more successive eight (or fewer)-year periods; designate one or more committees of the Trustees with such powers and
authority as the Trustees determine; employ one or more custodians of the assets of the Trust and to authorize such
custodians to employ subcustodians and to deposit all or any part of such assets in a system or systems for the central
handling of securities or with a Federal Reserve Bank; retain a transfer agent or a shareholder servicing agent, or both,
to provide for the distribution of shares by the Trust, through one or more principal underwriters or otherwise, and make
rules for the transfer of shares of each series and class and similar matters; establish or change a record date for
determining shareholders who are entitled to receive payment of any dividend or other distribution and close the
register or transfer books of a series or class of the Trust prior to the payment of a distribution; and they may
in general delegate such authority as they consider desirable to any officer of the Trust, to any committee of the
Trustees, and to any agent or employee of the Trust or to any such custodian or underwriter.
48
Board Leadership Structure and Risk Oversight.
The Board of Trustees is responsible for the
general oversight of the Funds affairs and for assuring that the Fund is managed in the best
interests of its shareholders. The Board regularly reviews the Funds investment performance as
well as the quality of services provided to the Fund and its shareholders by GMO and its
affiliates, including shareholder servicing. At least annually, the Board reviews and evaluates
the fees and operating expenses paid by the Fund for these services and negotiates changes that it
deems appropriate. In carrying out these responsibilities, the Board is assisted by the Funds
auditors, independent counsel to the Independent Trustees and other persons as appropriate, who are
selected by and responsible to the Board. In addition, the Funds Chief Compliance Officer reports
directly to the Board.
Currently, one of the Trustees is an Independent Trustee. The Independent Trustee must vote
separately to approve all financial arrangements and other agreements with the Funds investment
adviser, GMO, and other affiliated parties. The role of the Independent Trustee has been
characterized as that of a watchdog charged with oversight of protecting shareholders interests
against overreaching and abuse by those who are in a position to control or influence a fund.
The Board of Trustees focuses
on the oversight of risk as part of its broader oversight of the Funds affairs.
While risk management is primarily the responsibility of the Funds investment adviser, GMO, the
Board regularly receives reports, including reports from GMO and the Funds Chief Compliance
Officer, regarding investment risks, compliance risks, and certain other risks applicable to the
Fund. The Audit Committee, which is
discussed in more detail below, focuses on different aspects of these risks
within the scope of the committees authority and their potential impact on the Fund, and
discusses with GMO the ways in which GMO monitors and controls such risks.
The Board recognizes that not all risks that may affect the Fund can be identified, that it may not
be practical or cost-effective to eliminate or mitigate certain risks, that it may be necessary to
bear certain risks (such as investment-related risks) to achieve the Funds goals, that reports
received by the Trustees with respect to risk management matters are typically summaries of the
relevant information, and that the processes, procedures and controls employed to address risks may
be limited in their effectiveness. As a result of the foregoing and other factors, risk management
oversight by the Board and by the Committee is subject to substantial limitations.
Committees
The Board of Trustees has the authority to establish committees, which may exercise the power
49
and authority of the Trustees to the extent the Board determines. The committees assist the Board
of Trustees in performing its functions and duties under the 1940 Act and Massachusetts law.
The Board of Trustees currently has established one standing committee: the Audit Committee. As of
the date of this SAI, the Audit Committee has held 1 meeting.
Audit Committee.
The Audit Committee (i) oversees the Trusts accounting and financial reporting
policies and practices and internal controls over financial reporting; (ii) oversees the quality
and objectivity of the Trusts financial statements and the independent audit of those statements;
(iii) appoints, determines the independence and compensation of, and oversees the work performed by
the Trusts independent auditors in preparing or issuing an audit report or related work; (iv)
approves all audit and permissible non-audit services provided to the Trust, and certain other
persons by the Trusts independent auditors; and (v) acts as a liaison between the Trusts
independent auditors and the Board of Trustees. Ms. Furman is the sole member of the Audit
Committee.
The Audit Committee may utilize the resources of the
Funds counsel and auditors as well as other persons. The Committee meets from time to time, either in
conjunction with regular meetings of the Board or otherwise. The Board appoints the members of the Committee
and has appointed the sole Independent Trustee to the Committee.
Trustee Fund Ownership
The following table sets forth ranges of the current Trustees direct beneficial share ownership in
the Fund and the aggregate dollar ranges of their direct beneficial
share ownership in the funds of GMO
Series Trust and GMO Trust (the Family of Investment
Companies) as of December 31, 2010.
|
|
|
|
|
|
|
|
|
Aggregate Dollar Range of Shares
|
|
|
|
|
Directly Owned in all
|
|
|
|
|
Registered Investment Companies
|
|
|
Dollar Range of
|
|
(whether or not offered in the
|
|
|
Shares Directly Owned in
|
|
Prospectus) Overseen by Trustee in
|
Name
|
|
the Fund*
|
|
Family of Investment Companies
|
Maria D. Furman
|
|
None
|
|
None
|
|
|
|
|
|
Joseph B. Kittredge, Jr.
|
|
None
|
|
$50,001- $100,000
|
|
|
|
|
*
|
|
The Fund will commence operations on or following the date of this SAI, and, therefore, has not
yet offered any shares for sale as of this date.
|
|
The following table sets forth ranges of Mr. Kittredges indirect beneficial share ownership
in the Fund and the aggregate dollar range of his indirect beneficial
share ownership in the Family of Investment Companies as of December 31, 2010.
50
|
|
|
|
|
|
|
|
|
Aggregate Dollar Range of Shares
|
|
|
|
|
Indirectly Owned in all
|
|
|
|
|
Registered Investment Companies
|
|
|
Dollar Range of
|
|
(whether or not offered in the
|
|
|
Shares Directly Owned in
|
|
Prospectus) Overseen by Trustee in
|
Name
|
|
the Fund*
|
|
Family of Investment Companies
|
Joseph B. Kittredge, Jr.
|
|
None
|
|
$50,001 - $100,000
|
|
|
|
|
*
|
|
The Fund will commence operations on or following the date of this SAI, and, therefore, has not
yet offered any shares for sale as of this date.
|
|
Trustee Ownership of Securities Issued by the Manager or Principal Underwriter
None.
Trustee Ownership of Related Companies
There were no securities owned by the current Independent Trustee and her family members, as of
December 31, 2010, in the Manager, Funds Distributor, LLC, the Funds principal underwriter, or
entities directly or indirectly controlling, controlled by, or under common control with the
Manager or Funds Distributor, LLC.
Remuneration.
The Trust has adopted a compensation policy for its Trustees. Ms. Furman, the
Trusts Independent Trustee, receives an annual retainer from the Trust for her services. Ms.
Furman also is paid a fee for participating in in-person and telephone meetings of the Board of
Trustees and its committee, and a fee for consideration of actions proposed to be taken by written
consent. The Trust pays no additional compensation for travel time to meetings, attendance at
directors educational seminars or conferences, service on industry or association committees,
participation as speakers at directors conferences, or service on special director task forces or
subcommittees, although the Trust does reimburse Trustees for seminar or conference fees and for
travel expenses incurred in connection with attendance at seminars or conferences. The Trustees do
not receive any employee benefits such as pension or retirement benefits or health insurance.
Other than as set forth in the following table, no Trustee of the Trust received any direct
compensation from the Fund or the Fund Complex for the fiscal year ended April 30, 2011:
|
|
|
|
|
Name of Person,
|
|
Maria D. Furman,
|
|
Position:
|
|
Trustee
|
|
Compensation from the Fund:
|
|
$
|
59,000
|
*
|
Pension or Retirement Benefits Accrued as Part of Fund
Expenses:
|
|
|
N/A
|
|
Estimated Annual Benefits Upon Retirement:
|
|
|
N/A
|
|
Total Compensation from the Fund Complex:
|
|
$
|
59,000
|
*
|
51
|
|
|
|
*
|
|
Reflects an estimate of the direct compensation to be paid to the Trustee for the
Funds initial fiscal year ending April 30, 2012. Actual direct compensation paid to the Trustee
will vary depending on the net assets of the Fund throughout its initial fiscal year.
|
|
The Fund does not expect to pay any officer of the Trust aggregate compensation exceeding
$60,000 for the Funds initial fiscal year ending April 30, 2012.
Mr. Kittredge does not receive any compensation from the Trust, but as a member of the Manager will
benefit from management, shareholder servicing, administration, and any other fees paid to GMO and
its affiliates by the Fund and various other GMO Funds not offered through the Prospectus. The
officers of the Trust do not receive any employee benefits such as pension or retirement benefits
or health insurance from the Trust.
The Fund will commence operations on or following the date of this Statement of Additional
Information, and therefore, has not yet offered any shares for sale. Therefore, as of the date
hereof, the Trustees and Officers of the Trust as a group owned less than 1% of the outstanding
shares of each class of shares of the Fund.
Code of Ethics.
The Trust and the Manager have each adopted a Code of Ethics pursuant to the
requirements of the 1940 Act. Under each Code of Ethics, personnel are permitted to engage in
personal securities transactions only in accordance with specified conditions relating to their
position, the identity of the security, the timing of the transaction, and similar factors.
Transactions in securities that may be purchased or held by the Fund are permitted, subject to
compliance with each Code. Personal securities transactions must be reported quarterly and broker
confirmations must be provided for review.
The non-interested Trustees of the Trust are subject to a separate Code of Ethics for the
Independent Trustees pursuant to the requirements of the 1940 Act. Transactions by the Independent
Trustees in securities, including securities that may be purchased or held by the Fund, are
permitted, subject to compliance with the Code of Ethics. Pursuant to the Code of Ethics, an
Independent Trustee ordinarily is not required to report his or her personal securities
transactions or to identify his or her brokerage accounts to the Fund or its representatives,
subject to certain limited exceptions specified in the Code of Ethics.
The Funds principal underwriter, which is not affiliated with the Fund or the Manager, also has
adopted a Code of Ethics pursuant to the requirements of the 1940 Act. Transactions in securities
effected by the principal underwriters personnel who are designated as Access Persons under the
Code, including securities that may be purchased or held by the Fund, are permitted, subject to
compliance with the Code. Currently, there are no Access Persons of the Distributor as it relates
to the Fund.
52
INVESTMENT ADVISORY AND OTHER SERVICES
Management Contracts
As disclosed in the Prospectus under the heading Management of the Trust, under a Management
Contract (the Management Contract) between the Trust, on behalf of the Fund, and the Manager,
subject to such policies as the Trustees of the Trust may determine, the Manager furnishes
continuously an investment or asset allocation program, as applicable, for the Fund, and makes
investment decisions on behalf of the Fund and places all orders for the purchase and sale of
portfolio securities. Subject to the control of the Trustees, the Manager also manages,
supervises, and conducts the other affairs and business of the Trust, furnishes office space and
equipment, provides bookkeeping and certain clerical services, and pays all salaries, fees, and
expenses of officers and Trustees of the Trust who are affiliated with the Manager. As indicated
under Portfolio Transactions Brokerage and Research Services, the Trusts portfolio
transactions may be placed with broker-dealers who furnish the Manager, at no cost, research,
statistical and quotation services of value to the Manager in advising the Trust or its other
clients.
In addition, as disclosed in the Prospectus, the Manager has contractually agreed to waive and/or
reimburse the Fund for specified Fund expenses through at least October 1, 2012.
The Management Contract provides that the Manager shall not be subject to any liability in
connection with the performance of its services in the absence of willful misfeasance, bad faith,
gross negligence, or reckless disregard of its obligations and duties.
The Management Contract will be approved by the Trustees of the Trust (including a majority of the
Trustees who were not interested persons of the Manager) and by the Funds sole initial
shareholder in connection with the organization of the Trust and the establishment of the Fund.
Generally, the Management Contract continues in effect for a period of two years from the date of
its execution and continuously thereafter so long as its continuance is approved at least annually
by (i) the vote, cast in person at a meeting called for that purpose, of a majority of those
Trustees who are not interested persons of the Manager or the Trust, and by (ii) the majority
vote of either the full Board of Trustees or the vote of a majority of the outstanding shares of
the Fund. The Management Contract automatically terminates on assignment, and is terminable on not
more than 60 days notice by the Trust to the Manager. In addition, the Management Contract may be
terminated on not more than 60 days written notice by the Manager to the Trust.
The Manager does not charge the Fund a Management Fee. The Fund, as a result of its investment in
USCEF, indirectly bears the Management Fee paid by USCEF, which is calculated based on a fixed
percentage of the Funds average daily net assets.
In the event that the Manager ceases to be the manager of the Fund, the right of the Trust to use
the identifying name GMO may be withdrawn.
53
Portfolio Management
GMOs Quantitative Equity Division is responsible for day-to-day investment management of the Fund.
The divisions investment professionals work collaboratively to manage the Funds portfolio, and
no one person is primarily responsible for day-to-day management of the Fund.
The following table sets forth information about accounts overseen or managed by the senior members
of the Quantitative Equity Division as of June 30, 2011.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Registered investment companies
|
|
|
|
|
|
|
managed (including non-GMO
|
|
|
|
|
Senior
|
|
mutual fund subadvisory
|
|
Other pooled investment
|
|
Separate accounts managed
|
Member
|
|
relationships)
|
|
vehicles managed (world-wide)
|
|
(world-wide)
|
|
|
Number of
|
|
|
|
|
|
Number of
|
|
|
|
|
|
Number of
|
|
|
|
|
accounts
1
|
|
Total assets
1,2
|
|
accounts
|
|
Total assets
|
|
accounts
|
|
Total assets
|
Thomas Hancock
|
|
|
22
|
|
|
$
|
39,606,579,724.31
|
|
|
|
8
|
|
|
$
|
3,771,131,608.57
|
|
|
|
43
|
|
|
$
|
9,802,534,789.93
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sam Wilderman
|
|
|
22
|
|
|
$
|
39,606,579,724.31
|
|
|
|
8
|
|
|
$
|
3,771,131,608.57
|
|
|
|
43
|
|
|
$
|
9,802,534,789.93
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Registered investment companies
|
|
|
|
|
|
|
managed for which GMO receives
|
|
Other pooled investment
|
|
Separate accounts managed
|
|
|
a performance-based fee
|
|
vehicles managed (world-wide)
|
|
(world-wide) for which GMO
|
|
|
(including non-GMO mutual fund
|
|
for which GMO receives a
|
|
receives a performance-based
|
|
|
subadvisory relationships)
|
|
performance-based fee
|
|
fee
|
|
|
Number of
|
|
|
|
|
|
Number of
|
|
|
|
|
|
Number of
|
|
|
|
|
accounts
|
|
Total assets
|
|
accounts
|
|
Total assets
|
|
accounts
|
|
Total assets
|
Thomas Hancock
|
|
|
0
|
|
|
|
0
|
|
|
|
2
|
|
|
$
|
1,923,426,551.41
|
|
|
|
8
|
|
|
$
|
2,019,760,575.59
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sam Wilderman
|
|
|
0
|
|
|
|
0
|
|
|
|
2
|
|
|
$
|
1,923,426,551.41
|
|
|
|
8
|
|
|
$
|
2,019,760,575.59
|
|
|
|
|
|
1
|
|
Includes GMO Funds (including GMO Funds not offered through the Prospectus) that
had commenced operations on or before June 30, 2011.
|
|
|
2
|
|
For some senior members, Total assets includes assets invested by other GMO Funds.
|
Because the senior members manage other accounts, including accounts that pay higher fees or
accounts that pay performance-based fees, potential conflicts of interest exist, including
potential conflicts between the investment strategy of the Fund and the investment strategy of the
other accounts managed by the senior members and potential conflicts in the allocation of
investment opportunities between the Fund and the other accounts.
Senior members of the division are generally members (partners) of GMO. As of August 15, 2011, the
compensation of the senior members consisted of a fixed annual base salary, a partnership interest
in the firms profits and, possibly, an additional, discretionary, bonus related to the senior
members contribution to GMOs success. The compensation program does not disproportionately
reward outperformance by higher fee/performance fee products. Base salary is determined by taking
into account current industry norms and market data to ensure that GMO pays a competitive base
salary. The level of partnership interest is determined by taking into
54
account the individuals
contribution to GMO and its mission statement. A discretionary bonus may also be paid to recognize
specific business contributions and to ensure that the total level of compensation is competitive
with the market. Because each persons compensation is based on his or her individual performance,
GMO does not have a typical percentage split among base salary, bonus and other compensation. A
GMO membership interest is the primary incentive for persons to maintain employment with GMO. GMO
believes this is the best incentive to maintain stability of portfolio management personnel.
Senior Member Fund Ownership.
The Fund will commence operations on or following the date of this
Statement of Additional Information, and therefore, has not yet offered any shares for sale.
Therefore, as of the date hereof, neither Mr. Hancock nor Mr. Wilderman had any direct or indirect
ownership of the Fund.
Custodial Arrangements and Fund Accounting Agents
. As described in the Prospectus, State Street
Bank and Trust Company (State Street Bank), One Lincoln Street, Boston, Massachusetts 02111,
serves as the Trusts custodian and fund accounting agent on behalf of the Fund. As such, State
Street Bank holds in safekeeping certificated securities and cash belonging
to the Fund and, in such capacity, is the registered owner of securities in book-entry form
belonging to the Fund. Upon instruction, State Street Bank receives and delivers cash and
securities of the Fund in connection with Fund transactions and collects all dividends and other
distributions made with respect to Fund portfolio securities. State Street Bank also maintains
certain accounts and records of the Trust and calculates the total net asset value, total net
income and net asset value per share of the Fund on a daily basis.
Administration Arrangements
. As disclosed in the Prospectus, pursuant to the terms of an
Administration Agreement with the Fund, Class R1 shares of the Fund pay the Manager an
administration fee, which is used by the Manager to defray its expenses (or the expenses of a third
party) in providing administration and record keeping services to investors purchasing Class R1
shares of the Fund through eligible retirement plans. The Manager contracts with State Street Bank
in connection with the provision of certain administrative services and pays State Street Bank a
portion of its administration fee in connection therewith.
Independent Registered Public Accounting Firm
. The Trusts independent registered public
accounting firm is PricewaterhouseCoopers LLP, 125 High Street, Boston, Massachusetts 02110.
PricewaterhouseCoopers LLP conducts annual audits of the Trusts financial statements, assists in
the preparation of the Funds federal and state income tax returns, consults with the Trust as to
matters of accounting and federal and state income taxation, and provides assistance in connection
with the preparation of various SEC filings.
Distributor
. Funds Distributor, LLC, 10 High Street, Suite 302, Boston, Massachusetts 02110,
serves as the Trusts distributor on behalf of the Fund.
Counsel
. Ropes & Gray LLP, Prudential Tower, 800 Boylston Street, Boston, Massachusetts 02199,
serves as counsel to the Trust.
Transfer Agent.
State Street Bank serves as the Trusts transfer agent on behalf of the Fund.
55
PORTFOLIO TRANSACTIONS
Decisions to buy and sell portfolio securities for the Fund and for each of its other investment
advisory clients are made by the Manager with a view to achieving each clients investment
objectives taking into consideration other account-specific factors such as, without limitation,
cash flows into or out of the account, current holdings, the accounts benchmark(s), applicable
regulatory limitations, liquidity, cash restrictions, applicable transaction documentation
requirements, market registration requirements and/or time constraints limiting the Managers
ability to confirm adequate transaction documentation or seek interpretation of investment
guideline ambiguities. Therefore, a particular security may be bought or sold only for certain
clients of the Manager even though it could have been bought or sold for other clients at the same
time. Also, a particular security may be bought/sold for one or more clients when one or more
other clients are selling/buying the security or taking a short position in the security, including
clients invested in the same investment strategy.
To the extent permitted by applicable law, the Managers compliance policies and procedures and a
clients investment guidelines, the Manager may engage in cross trades where, as investment
manager to a client account, the Manager causes that client account to purchase a security directly
from (or sell a security directly to) another client account.
In certain cases, the Manager may identify investment opportunities that are suitable for the Fund
and one or more private investment companies for which the Manager or one of its affiliates serves
as investment manager, general partner and/or managing member (GMO Private Funds). In most
cases, the Manager receives greater compensation in respect of a GMO Private Fund (including
incentive-based compensation) than it receives in respect of the Fund. In addition, senior members
or other portfolio managers frequently have a personal investment in a GMO Private Fund that is
greater than such persons investment in the Fund (or, in some cases, may have no investment in the
Fund). The Manager itself also makes investments in GMO Private Funds. To help manage these
potential conflicts, the Manager has developed and reviewed with the Trusts Board of Trustees
trade allocation policies that establish a framework for allocating initial public offerings
(IPOs) and other limited opportunities that take into account the needs and objectives of each
Fund and the other GMO clients.
Transactions involving the issuance of Fund shares for securities or assets other than cash will be
limited to a bona fide reorganization or statutory merger and to other acquisitions of portfolio
securities that meet all of the following conditions: (i) such securities meet the investment
objective and policies of the Fund; (ii) such securities are acquired for investment and not for
resale; and (iii) such securities can be valued pursuant to the Trusts pricing policies.
Brokerage and Research Services
. In selecting brokers and dealers to effect portfolio transactions
for the Fund, the Manager seeks best execution. Best execution is not based solely on the explicit
commission charged by the broker/dealer and, consequently, a broker/dealer effecting a transaction
may be paid a commission higher than that charged by another broker/dealer for the same
transaction. Seeking best price and execution involves the weighing of qualitative as well as
quantitative factors, and evaluations of best execution are, to a large extent, possible, if at
all, only after multiple trades have been completed. The Manager does place trades with
broker/dealers that provide investment ideas and other research services, even
56
if the relevant broker has not yet demonstrated an ability to effect best price and execution;
however, trading with such a broker (as with any and all brokers) will typically be curtailed or
suspended, in due course, if the Manager is not reasonably satisfied with the quality of particular
trade executions, unless or until the broker has altered its execution capabilities in such a way
that the Manager can reasonably conclude that the broker is capable of achieving best price and
execution.
The determination of what may constitute best price and execution involves a number of
considerations, including, without limitation, the overall net economic result to the Fund; the
efficiency with which the transaction is effected; access to order flow; the ability of the
executing broker/dealer to effect the transaction where a large block is involved; reliability
(e.g., lack of failed trades); availability of the broker/dealer to stand ready to execute possibly
difficult transactions in the future; technological capabilities of the broker/dealer; the
broker/dealers inventory of securities sought; the financial strength and stability of the
broker/dealer; and the relative weighting of opportunity costs (i.e., timeliness of execution) by
different strategies. Additionally, regulations in certain markets, primarily emerging markets,
require the Manager to identify and trade with one or a limited number of brokers on behalf of
clients. In some instances, the Manager may utilize principal bids with consideration to such
factors as reported broker flow, past bids and a firms ability and willingness to commit capital.
Most of the foregoing are subjective considerations made in advance of the trade and are not always
borne out by the actual execution.
The Managers broker/dealer selection may, in addition to the factors listed above, also be based
on research services provided by the broker/dealer. In seeking best execution and in determining
the overall reasonableness of brokerage commissions, the Manager may consider research services
received by broker-dealers and therefore, may have an incentive to select or recommend a
broker-dealer based on the Managers interest in receiving the research or other products or
services, rather than on the lowest commission charged. The Manager may also direct trades to
broker/dealers based in part on the broker/dealers history of providing, and capability to
continue providing, pricing information for securities purchased. Best execution may be determined
for investment strategies without regard to client specific limitations.
Generally, the Manager determines the overall reasonableness of brokerage commissions paid upon
consideration of the relative merits of a number of factors, which may include: (i) the net
economic effect to the Fund; (ii) historical and current commission rates; (iii) the kind and
quality of the execution services rendered; (iv) the size and nature of the transactions effected;
and (v) research services received. These factors are considered mostly over multiple transactions
covering extended periods of time and are used to evaluate the relative performance of the brokers
and other institutions used to effect transactions for accounts. In some instances, the Manager
may evaluate best execution on principal bids based on the total commissions charged (the bid for
handling a trade as a principal trade) because the trades were filled at the price set at an agreed
upon time (e.g., previous nights close). In those cases, any additional impact or cost is
represented by the cents per share or basis points extra paid in addition to a typical commission
rate.
57
Because the Manager will frequently use broker/dealers that provide research in all markets and
that research is a factor in evaluating broker/dealers, the Manager relies on the statutory safe
harbor in Section 28(e) of the Securities Exchange Act of 1934, as amended (the 1934 Act).
However, the Manager does not participate in any formal soft dollar arrangements involving third
party research (i.e., research provided by someone other than the executing broker/dealer) or the
payment of any of the Managers out-of-pocket expenses. In all cases, the research services
received by the Manager are limited to the types of research contemplated by Section 28(e) of the
1934 Act. Research services provided by broker/dealers take various forms, including personal
interviews with analysts, written reports, pricing services in respect of securities, and meetings
arranged with various sources of information regarding particular issuers, industries, governmental
policies, specific information about local markets and applicable regulations, economic trends, and
other matters. To the extent that services of value are received by the Manager, the Manager may
avoid expenses which might otherwise be incurred. Such services furnished to the Manager may be
used in furnishing investment or other advice to all or some subset of the Managers clients,
including the Fund, and services received from a broker/dealer that executed transactions for the
Fund will not necessarily be used by the Manager specifically in servicing the Fund.
The Fund will commence operations on or following the date of this Statement of Additional
Information and, therefore, has not yet paid any amounts in brokerage commissions or acquired
securities of any brokers or dealers (as defined in the 1940 Act) or of their parents.
Due to restrictions under the 1940 Act, it is possible that, as the result of certain affiliations
between a broker/dealer or its affiliates and the Fund, the Manager or the Funds distributor, the
Fund may refrain, or be required to refrain, from engaging in principal trades with such
broker/dealer. Additionally, the Fund may be restricted in its ability to purchase securities
issued by affiliates of the Funds distributor.
PROXY VOTING POLICIES AND PROCEDURES
The Trust has adopted a proxy voting policy under which responsibility to vote proxies related to
its portfolio securities has been delegated to the Manager. Because the Fund
invests in USCEF in reliance on Section 12(d)(1)(E) of the 1940 Act, the Fund is obligated either
to seek instructions from its security holders with regard to the voting of all proxies with
respect to its interest in USCEF and to vote such proxies only in accordance with such
instructions, or to vote the shares of USCEF held by it in the same proportion as the vote of all
other holders of USCEF. The Board of Trustees of the Trust has reviewed and approved the proxy
voting policies and procedures the Manager follows when voting proxies on behalf of USCEF.
The Managers proxy voting policies on a particular issue may or may not reflect the views of
individual members of the Board of Trustees of the Trust, or a majority of the Board of Trustees.
Information regarding how the Fund voted proxies relating to portfolio securities during the most
recent 12-month period ended June 30 will be available on the Trusts website at www.gmo.com and on
the Securities and Exchange Commissions website at www.sec.gov no later than August
31 of each year.
58
DISCLOSURE OF PORTFOLIO HOLDINGS
The policy of the Trust is to protect the confidentiality of the Funds portfolio holdings and to
prevent inappropriate selective disclosure of those holdings. The Board of Trustees has approved
this policy and material amendments require its approval.
Registered investment companies that are sub-advised by GMO may be subject to different portfolio
holdings disclosure policies, and neither GMO nor the Board of Trustees exercises control over
those policies. In addition, separate account clients of GMO have access to their portfolio
holdings and are not subject to the Funds portfolio holdings disclosure policies. Some of the
funds that are sub-advised by GMO and some of the separate accounts managed by GMO have
substantially similar investment objectives and strategies and, therefore, potentially similar
portfolio holdings.
Neither GMO nor the Fund will receive any compensation or other consideration in connection with
its disclosure of the Funds portfolio holdings.
GMO may disclose the Funds portfolio holdings (together with any other information from which the
Funds portfolio holdings could reasonably be derived, as reasonably determined by GMO) (the
Portfolio Holdings Information) to shareholders, qualified potential shareholders as determined
by GMO, and their consultants and agents (collectively, Permitted Recipients) by means of the GMO
website. The Funds Prospectus describes the type of information disclosed on GMOs website, as
well as the frequency with which it is disclosed and the lag between the date of the information
and the date of its disclosure. The largest fifteen holdings of the Fund and USCEF are posted
monthly on GMOs website and typically are available to shareholders without a confidentiality
agreement. In addition, from time to time position attribution information regarding the Fund and
USCEF may be posted to GMOs website (e.g., best/worst performing positions in the Fund or USCEF
over a specified time period). In response to market interest in specific issuers, the Funds and
USCEFs holdings in one or more issuers may be made available on a more frequent basis as
circumstances warrant. Typically, no confidentiality agreement is needed to access this
information.
GMO also may make Portfolio Holdings Information available to Permitted Recipients by email, or by
any other means in such scope and form and with such frequency as GMO may reasonably determine, no
earlier than the day next following the day on which the Portfolio Holdings Information is posted
on the GMO website (provided that the Funds Prospectus describes the nature and scope of the
Portfolio Holdings Information that will be available on the GMO website, when the information will
be available and the period for which the information will remain available, and the location on
the Funds website where the information will be made available) or on the same day as a publicly
available, routine filing with the SEC that includes the Portfolio Holdings Information. A
confidentiality agreement is not required to access Portfolio Holdings Information filed with the
SEC as described in the preceding sentence.
GMO also may disclose portfolio holdings information to all shareholders of the Fund and USCEF and
their consultants and agents from time-to-time. Such disclosure may be made by email, written
notice or any other means in such scope and form as GMO may reasonably
59
determine, and generally
will not be subject to a confidentiality agreement and will not be required to be posted to GMOs
website in advance.
Except as otherwise noted, to receive Portfolio Holdings Information, Permitted Recipients must
enter into a confidentiality agreement with GMO and the Trust that requires that the Portfolio
Holdings Information be used solely for purposes determined by senior management of GMO to be in
the best interest of the shareholders of the Fund.
In some cases, GMO may disclose to a third party Portfolio Holdings Information that has not been
made available to Permitted Recipients on the GMO website or in a publicly available, routine
filing with the SEC. That disclosure may only be made if senior management of GMO determines that
it is in the best interests of the shareholders of the Fund. In addition, the third party
receiving the Portfolio Holdings Information must enter into a confidentiality agreement with GMO
and the Trust that requires that the Portfolio Holdings Information be used solely for purposes
determined by GMO senior management to be in the best interest of the Funds shareholders.
If GMO becomes aware that a recipient has or is likely to violate the terms of a confidentiality
agreement regarding Portfolio Holdings Information, GMO shall cease providing such information to
such recipient.
The procedures pursuant to which GMO may disclose to a third party Portfolio Holdings Information
that has not been made available to Permitted Recipients do not apply to Portfolio Holdings
Information provided to entities who provide on-going services to the Fund in connection with its
day-to-day operations and management, including GMO, GMOs affiliates, the Funds custodian and
auditors, the Funds pricing service vendors, broker-dealers when requesting bids for or price
quotations on securities, brokers in the normal course of trading on the Funds behalf, and persons
assisting the Fund in the voting of proxies. In addition, (i) when an investor indicates that it
wants to purchase shares of the Fund in exchange for securities acceptable to GMO, GMO may make
available a list of securities that it would be willing to accept for the Fund, and, from time to
time, the securities on the list may overlap with securities currently held by the Fund; and (ii)
when the Fund determines to pay redemption proceeds wholly or partly in-kind with securities, GMO
may make available a list of securities it intends to deliver from the Fund.
No provision of this policy is intended to restrict or prevent the disclosure of Portfolio Holdings
Information as may be required by applicable law, rules or regulations.
GMOs General Counsel or Chief Compliance Officer may authorize exceptions to these procedures.
Exceptions must be disclosed to the Chief Compliance Officer of the Trust.
If senior management of GMO identifies a potential conflict with respect to the disclosure of
Portfolio Holdings Information between the interest of the Funds shareholders, on the one hand,
and GMO or an affiliated person of GMO or the Fund, on the other, GMO is required to inform
the Trusts Chief Compliance Officer of the potential conflict, and the Trusts Chief Compliance
Officer has the power to decide whether, in light of the potential conflict, disclosure should be
permitted under the circumstances. The Trusts Chief Compliance Officer also is required to
60
report
his decision to the Board of Trustees.
GMO periodically reports the following information to the Board of Trustees:
|
|
|
Determinations made by senior management of GMO relating to the use of Portfolio
Holdings Information by Permitted Recipients and third parties;
|
|
|
|
|
The nature and scope of disclosure of Portfolio Holdings Information to third parties;
|
|
|
|
|
|
Exceptions to the disclosure policy authorized by GMOs General Counsel or Chief
Compliance Officer; and
|
|
|
|
|
|
Any other information the Trustees may request relating to the disclosure of Portfolio
Holdings Information.
|
Ongoing Arrangements To Make Portfolio Holdings Available
.
Senior management of GMO has authorized
disclosure of Portfolio Holdings Information on an on-going basis (generally, daily, except with
respect to PricewaterhouseCoopers LLP, which receives holdings semi-annually and as necessary in
connection with the services it provides to the Fund) to the following entities that provide
on-going services to the Fund in connection with its day-to-day operations and management, provided
that they agree or have a duty to maintain this information in confidence:
|
|
|
Name of Recipient
|
|
Purpose of Disclosure
|
State Street Bank and Trust Company
|
|
Custodial services and compliance testing
|
|
|
|
Brown Brothers Harriman & Co.
|
|
Compliance testing
|
|
|
|
Boston Global Advisors
|
|
Securities lending services
|
|
|
|
PricewaterhouseCoopers LLP
|
|
Independent registered public accounting firm
|
|
|
|
Institutional Shareholder Services
Inc.
(formerly known as
RiskMetrics Group, Inc.)
|
|
Corporate actions services
|
|
|
|
FactSet
|
|
Data service provider
|
Senior management of GMO has authorized disclosure of Portfolio Holdings Information on an on-going
basis (daily) to the following recipients, provided that they agree or have a duty to maintain this
information in confidence and are limited to using the information for the specific purpose for
which it was provided:
|
|
|
Name of Recipient
|
|
Purpose of Disclosure
|
Epstein & Associates, Inc.
|
|
Software provider for Code of Ethics monitoring system
|
|
|
|
Financial Models Company Inc.
|
|
Recordkeeping system
|
61
DESCRIPTION OF THE TRUST AND OWNERSHIP OF SHARES
The Trust, an open-end management investment company, is organized as a Massachusetts business
trust under the laws of Massachusetts by an Agreement and Declaration of Trust dated May 27, 2011, as amended and restated September 13, 2011, and as such Declaration of
Trust may be amended from time to time. A copy of the Declaration of Trust is on file with the
Secretary of The Commonwealth of Massachusetts. The Trust operates as a series investment
company that consists of separate series of investment portfolios, each of which is represented by
a separate series of shares of beneficial interest. The Fund is a series of the Trust. The fiscal
year for the Fund ends on the last day of April.
Pursuant to the Declaration of Trust, the Trustees have currently authorized the issuance of an
unlimited number of full and fractional shares of the Fund.
Interests in the Fund are represented by shares of the series. Each share of the series
represents an equal proportionate interest, together with each other share, in the Fund. Upon
liquidation of the Fund, shareholders of the series are entitled to share pro rata in the net
assets of the Fund available for distribution to shareholders. The Declaration of Trust also
permits the Trustees to charge shareholders directly for custodial, transfer agency, and servicing
expenses, but the Trustees have no present intention to make such charges.
The Declaration of Trust also permits the Trustees, without shareholder approval, to subdivide the
shares of any series into two or more classes of shares with such preferences and special or
relative rights and privileges (including conversion rights, if any) as the Trustees may designate.
This power is intended to allow the Trustees to provide for an equitable allocation of the effect
of any future regulatory requirements that might affect various classes of shareholders
differently. The Trustees have currently authorized the establishment and designation of one class
of shares for the series: Class R1 Shares.
The Trustees may also, without shareholder approval, establish one or more additional separate
portfolios for investments in the Trust or merge two or more existing portfolios (i.e., a new
fund). Shareholders investments in such a portfolio would be evidenced by a separate series of
shares.
The Declaration of Trust provides for the
perpetual existence of the Trust.
While the Declaration of Trust further provides that the Trustees, may
terminate the Trust at any time, the 1940 Act requires that the Trust
receive the authorization of a majority of its outstanding shares in order to change the nature of
its business so as to cease to be an investment company.
Shareholders should be aware that to the extent a shareholders investment in a Fund exceeds
certain threshold amounts or percentages, the investment may constitute a reportable acquisition
under the Hart-Scott-Rodino Act (HSR) and the shareholder may be required to make a corresponding
filing under HSR. HSR regulations are complex and shareholders should consult
their legal advisers about the precise HSR filing consequences of an investment in the Fund.
62
VOTING RIGHTS
The Shareholders shall have power to vote only on matters
that the Trustees consider necessary or desirable. Shareholders are entitled to one vote for each full share held
(with fractional votes for fractional shares held) as to any matter on which it is entitled to vote.
Normally the Trust does not hold meetings of shareholders
to elect Trustees except in accordance with the 1940 Act (i) the Trust will hold a shareholders meeting for the
election of Trustees at such time as less than a majority of the Trustees holding office have been elected by
shareholders, and (ii) if, as a result of a vacancy in the Board of Trustees, less than two-thirds of the
Trustees holding office have been elected by the shareholders, that vacancy may only be filled by a vote of
the shareholders.
The Trustees may modify the rights and preferences of any shares. Voting rights are not cumulative.
SHAREHOLDER AND TRUSTEE LIABILITY
Under Massachusetts law, shareholders could, under some circumstances, be held personally liable
for the obligations of the Trust. However, the Declaration of Trust disclaims shareholder
liability for acts or obligations of the Trust and requires that notice of that disclaimer be given
in each agreement, obligation, or instrument entered into or executed by the Trust or the Trustees.
The Declaration of Trust provides for indemnification out of all the property of the Fund for all
loss and expense of any shareholder of the Fund held personally liable for the obligations of the
Trust. Thus, the risk of a shareholder incurring financial loss on account of shareholder
liability is limited to circumstances in which the disclaimer is inoperative and the Fund is unable
to meet its obligations.
The Declaration of Trust further provides that the Trustees will not be liable for errors of
judgment or mistakes of fact or law. However, nothing in the Declaration of Trust protects a
Trustee against any liability to which the Trustee would otherwise be subject by reason of willful
misfeasance, bad faith, gross negligence, or reckless disregard of the duties involved in the
conduct of his office. The Declaration of Trust provides for indemnification by the Trust of the
Trustees and the officers of the Trust except for any matter as to which any such person did not
act in good faith in the reasonable belief that his action was in or not opposed to the best
interests
of the Trust. Trustees and officers may not be indemnified against any liability to the Trust or
the Trust shareholders to which they would otherwise be subject by reason of willful
63
misfeasance,
bad faith, gross negligence, or reckless disregard of the duties involved in the conduct of their
office.
BENEFICIAL OWNERS OF 5% OR MORE OF THE FUNDS SHARES
The Fund will commence operations on or following the date of this Statement of Additional
Information, and therefore, no shareholder owns beneficially more than 5% of the outstanding shares
of the Fund as of the date of this Statement of Additional Information.
FINANCIAL STATEMENTS
The Funds initial audited financial statements are attached as Appendix B.
64
Appendix A
COMMERCIAL PAPER AND CORPORATE DEBT RATINGS
Commercial Paper Ratings
Standard & Poors
. Standard & Poors short-term ratings are generally assigned to those
obligations considered short-term in the relevant market. In the U.S., for example, that means
obligations with an original maturity of no more than 365 days including commercial paper. The
following are excerpts from Standard & Poors short-term issue credit ratings definitions:
A-1 A short-term obligation rated A-1 is rated in the highest category by Standard & Poors.
The obligors capacity to meet its financial commitment on the obligation is strong. Within this
category, certain obligations are designated with a plus sign (+). This indicates that the
obligors capacity to meet its financial commitment on these obligations is extremely strong.
A-2 A short-term obligation rated A-2 is somewhat more susceptible to the adverse effects of
changes in circumstances and economic conditions than obligations in higher rating categories.
However, the obligors capacity to meet its financial commitment on the obligation is satisfactory.
A-3 A short-term obligation rated A-3 exhibits adequate protection parameters. However,
adverse economic conditions or changing circumstances are more likely to lead to a weakened
capacity of the obligor to meet its financial commitment on the obligation.
B A short-term obligation rated B is regarded as having significant speculative
characteristics. Ratings of B-1, B-2, and B-3 may be assigned to indicate finer distinctions
within the B category. The obligor currently has the capacity to meet its financial commitment
on the obligation; however, it faces major ongoing uncertainties which could lead to the obligors
inadequate capacity to meet its financial commitment on the obligation.
B-1 A short-term obligation rated B-1 is regarded as having significant speculative
characteristics, but the obligor has a relatively stronger capacity to meet its financial
commitments over the short-term compared to other speculative-grade obligors.
B-2 A short-term obligation rated B-2 is regarded as having significant speculative
characteristics, and the obligor has an average speculative-grade capacity to meet its financial
commitments over the short-term compared to other speculative-grade obligors.
B-3 A short-term obligation rated B-3 is regarded as having significant speculative
characteristics, and the obligor has a relatively weaker capacity to meet its financial commitments
over the short-term compared to other speculative-grade obligors.
C A short-term obligation rated C is currently vulnerable to nonpayment and is dependent upon
favorable business, financial, and economic conditions for the obligor to meet its financial
commitment on the obligation.
D A short-term obligation rated D is in payment default. The D rating category is used
when payments on an obligation, including a regulatory capital instrument, are not made on the date
due even if the applicable
A-1
Appendix A
grace period has not expired, unless Standard & Poors believes that such payments will be made
during such grace period. The D rating also will be used upon the filing of a bankruptcy
petition or the taking of a similar action if payments on an obligation are jeopardized.
Moodys
.
Moodys short-term ratings are opinions of the ability of issuers to honor short-term
financial obligations. Ratings may be assigned to issuers, short-term programs, or to individual
short-term debt instruments. Such obligations generally have an original maturity not exceeding
thirteen months, unless explicitly noted. The following are excerpts from Moodys short-term
ratings definitions:
P-1 Issuers (or supporting institutions) rated Prime-1 have a superior ability to repay
short-term debt obligations.
P-2 Issuers (or supporting institutions) rated Prime-2 have a strong ability to repay
short-term debt obligations.
P-3 Issuers (or supporting institutions) rated Prime-3 have an acceptable ability to repay
short-term obligations.
NP Issuers (or supporting institutions) rated Not Prime do not fall within any of the Prime
rating categories.
Note: Canadian issuers rated P-1 or P-2 have their short-term ratings enhanced by the senior-most
long-term rating of the issuer, its guarantor or support-provider.
Corporate Debt Ratings
Standard & Poors
. A Standard & Poors issue credit rating is a forward-looking opinion about the
creditworthiness of an obligor with respect to a specific financial obligation, a specific class of
financial obligations, or a specific financial program. The following are excerpts from Standard &
Poors long-term issue credit ratings definitions:
AAA An obligation rated AAA has the highest rating assigned by Standard & Poors. The
obligors capacity to meet its financial commitment on the obligation is extremely strong.
AA An obligation rated AA differs from the highest-rated obligations only to a small degree.
The obligors capacity to meet its financial commitment on the obligation is very strong.
A An obligation rated A is somewhat more susceptible to the adverse effects of changes in
circumstances and economic conditions than obligations in higher-rated categories. However, the
obligors capacity to meet its financial commitment on the obligation is still strong.
BBB An obligation rated BBB exhibits adequate protection parameters. However, adverse
economic conditions or changing circumstances are more likely to lead to a weakened capacity of the
obligor to meet its financial commitment on the obligation.
BB, B, CCC, CC, and C Obligations rated BB, B, CCC, CC, and C are regarded as having
significant speculative characteristics. BB indicates the least degree of speculation and C the
highest. While
A-2
Appendix A
such obligations will likely have some quality and protective characteristics, these may be
outweighed by large uncertainties or major exposures to adverse conditions.
BB An obligation rated BB is less vulnerable to nonpayment than other speculative issues.
However, it faces major ongoing uncertainties or exposure to adverse business, financial, or
economic conditions, which could lead to the obligors inadequate capacity to meet its financial
commitment on the obligation.
B An obligation rated B is more vulnerable to nonpayment than obligations rated BB, but the
obligor currently has the capacity to meet its financial commitment on the obligation. Adverse
business, financial, or economic conditions will likely impair the obligors capacity or
willingness to meet its financial commitment on the obligation.
CCC An obligation rated CCC is currently vulnerable to nonpayment, and is dependent upon
favorable business, financial, and economic conditions for the obligor to meet its financial
commitment on the obligation. In the event of adverse business, financial, or economic conditions,
the obligor is not likely to have the capacity to meet its financial commitment on the obligation.
CC An obligation rated CC is currently highly vulnerable to nonpayment.
C A C rating is assigned to obligations that are currently highly vulnerable to nonpayment,
obligations that have payment arrearages allowed by the terms of the documents, or obligations of
an issuer that is the subject of a bankruptcy petition or similar action which have not experienced
a payment default. Among others, the C rating may be assigned to subordinated debt, preferred
stock or other obligations on which cash payments have been suspended in accordance with the
instruments terms or when preferred stock is the subject of a distressed exchange offer, whereby
some or all of the issue is either repurchased for an amount of cash or replaced by other
instruments having a total value that is less than par.
D An obligation rated D is in payment default. The D rating category is used when payments
on an obligation, including a regulatory capital instrument, are not made on the date due even if
the applicable grace period has not expired, unless Standard & Poors believes that such payments
will be made during such grace period. The D rating also will be used upon the filing of a
bankruptcy petition or the taking of similar action if payments on an obligation are jeopardized.
An obligations rating is lowered to D upon completion of a distressed exchange offer, whereby
some or all of the issue is either repurchased for an amount of cash or replaced by other
instruments having a total value that is less than par.
Plus (+) or Minus (-) The ratings from AA to CCC may be modified by the addition of a plus
(+) or minus (-) sign to show relative standing within the major rating categories.
NR This indicates that no rating has been requested, that there is insufficient information on
which to base a rating, or that Standard & Poors does not rate a particular obligation as a matter
of policy.
Moodys
.
Moodys long-term ratings are opinions of the relative credit risk of financial
obligations with an original maturity of one year or more. They address the possibility that a
financial obligation will not be
A-3
Appendix A
honored as promised. Such ratings use Moodys Global Scale and reflect both the likelihood of
default and any financial loss suffered in the event of default. The following are excerpts from
Moodys long-term obligation ratings definitions:
Aaa Obligations rated Aaa are judged to be of the highest quality, with minimal credit risk.
Aa Obligations rated Aa are judged to be of high quality and are subject to very low credit
risk.
A Obligations rated A are considered upper-medium grade and are subject to low credit risk.
Baa Obligations rated Baa are subject to moderate credit risk. They are considered
medium-grade and as such may possess certain speculative characteristics.
Ba Obligations rated Ba are judged to have speculative elements and are subject to
substantial credit risk.
B Obligations rated B are considered speculative and are subject to high credit risk.
Caa Obligations rated Caa are judged to be of poor standing and are subject to very high
credit risk.
Ca Obligations rated Ca are highly speculative and are likely in, or very near, default, with
some prospect of recovery of principal and interest.
C Obligations rated C are the lowest rated class and are typically in default, with little
prospect for recovery of principal or interest.
Note: Moodys appends numerical modifiers 1, 2, and 3 to each generic rating classification from
Aa through Caa. The modifier 1 indicates that the obligation ranks in the higher end of its generic
rating category; the modifier 2 indicates a mid-range ranking; and the modifier 3 indicates a
ranking in the lower end of that generic rating category.
A-4
Appendix B
Report of Independent Registered Public Accounting Firm
To the Board of Trustees of GMO Series Trust and Shareholder of GMO U.S. Core Equity Series Fund
In our opinion, the accompanying statement of assets and liabilities, presents fairly, in all
material respects, the financial position of GMO U.S. Core Equity Series Fund (the Fund) at
August 24, 2011, in conformity with accounting principles generally accepted in the United States
of America. This financial statement is the responsibility of the Funds management; our
responsibility is to express an opinion on this financial statement based on our audit. We
conducted our audit of this financial statement in accordance with the standards of the Public
Company Accounting Oversight Board (United States). Those standards require that we plan and
perform the audit to obtain reasonable assurance about whether the financial statement is free of
material misstatement. An audit includes examining, on a test basis, evidence supporting the
amounts and disclosures in the financial statement, assessing the accounting principles used and
significant estimates made by management, and evaluating the overall financial statement
presentation. We believe that our audit provides a reasonable basis for our opinion.
/s/ PricewaterhouseCoopers LLP
September 7, 2011
B-1
Appendix B
FINANCIAL STATEMENTS
GMO U.S. Core Equity Series Fund
(A Series of GMO Series Trust)
|
|
|
|
|
Statement of Assets and Liabilities August 24, 2011
|
Assets:
|
|
|
|
|
|
|
|
|
|
Cash
|
|
$
|
100,000
|
|
|
|
|
|
|
Total assets
|
|
|
100,000
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
0
|
|
|
|
|
|
|
Net assets
|
|
$
|
100,000
|
|
|
|
|
|
|
|
|
|
|
Net assets consist of:
|
|
|
|
|
|
|
|
|
|
Paid-in capital
|
|
$
|
100,000
|
|
|
|
|
|
|
Shares outstanding:
|
|
|
5,000
|
|
|
|
|
|
|
Net asset value per share:
|
|
$
|
20.00
|
|
See accompanying notes to financial statement.
B-2
Appendix B
GMO U.S. CORE EQUITY SERIES FUND
(A SERIES OF GMO SERIES TRUST)
NOTES TO FINANCIAL STATEMENTS
August 24, 2011
|
1.
|
|
Organization
|
|
|
|
|
|
GMO Series Trust, a Massachusetts business trust, was formed on May 27, 2011 and is
registered as a diversified, open-end management investment company under the Investment
Company Act of 1940 (the 1940 Act), as amended. The Trust currently consists of one
series, GMO U.S. Core Equity Series Fund (the Fund).
|
|
|
|
|
|
|
|
|
The Fund has had no operations to date other than matters relating to its organization and
the sale and issuance of 5,000 shares of beneficial interest in the Fund to Grantham, Mayo ,
Van Otterloo & Co. LLC (the Manager or GMO), at a net asset value of $20.00 per share on
August 24, 2011.
|
|
|
|
|
|
|
Upon commencement of the Funds investment operations, it will invest substantially all of
its assets in GMO U.S. Core Equity Fund (USCEF), which invests directly in securities and
other instruments. The Funds investment objective and principal investment strategies,
therefore, will be substantially similar to those of USCEF. References to the Fund may
refer to actions undertaken by the Fund or USCEF. The Funds investment advisor, GMO, is
also the investment advisor to USCEF.
|
|
|
|
|
2.
|
|
Summary of Significant Accounting Policies
|
|
|
|
|
|
|
Use of Estimates:
|
|
|
|
|
|
|
The preparation of financial statements in conformity with accounting principles generally
accepted in the United States requires management to make estimates and assumptions that
affect the reported amounts and disclosures in these financial statements. Actual results
could differ from those estimates.
|
|
|
|
|
|
|
Federal Income Tax:
|
|
|
|
|
|
|
The Fund intends to qualify as a regulated investment company under Subchapter M of the
Internal Revenue Code of 1986, as amended. The Fund intends to distribute substantially all
of its net investment income and all of its net realized short-term and long-term capital
gain, if any, after giving effect to any available capital loss carryovers. Therefore, no
U.S. federal income or excise tax provisions are necessary.
|
|
|
|
|
|
|
Organizational Expenses:
|
|
|
|
|
|
|
All organizational and offering expenses of the Trust will be borne by GMO and will not be
subject to future recoupment. As a result, organizational and offering expenses are not
reflected in this financial statement.
|
|
B-3
Appendix B
|
|
|
|
Concentration of Credit Risk:
|
|
|
|
|
|
|
Cash at August 24, 2011, is on deposit at State Street Bank and Trust Company in a
non-interest bearing account.
|
|
|
|
|
3.
|
|
Agreements
|
|
|
|
|
|
|
State Street Bank and Trust Company serves as the Funds custodian, fund accounting agent
and transfer agent.
|
|
|
|
|
4.
|
|
Related Parties
|
|
|
|
|
|
|
Certain officers of the Trust are also employees of the Advisor.
|
|
|
|
|
5.
|
|
Principal Risks of Investing in the Fund
|
|
|
|
|
|
|
The value of the Funds shares changes with the value of the Funds investments, principally
in USCEF shares. Many factors can affect this value, and you may lose money by investing in
the Fund. Because the Fund invests substantially all of its assets in USCEF, the most
significant risks of investing in the Fund are the risks to which the Fund is exposed
through USCEF, which include those outlined in the following brief summary of principal
risks. In addition to the risks the Fund is exposed to through its investment in USCEF, the
Fund is subject to the risk that cash flows in or out of the Fund will cause its performance
to differ from that of USCEF.
|
|
|
|
|
|
Market Risk Equity Securities
The market value of equity investments
may decline due to factors affecting the issuing companies, their industries, or the
economy and equity markets generally. If the Fund purchases equity investments at a
discount from their value as determined by the Manager, the Fund runs the risk that the
market prices of these investments will not increase to that value for a variety of
reasons, one of which may be the Managers overestimation of the value of those
investments. The Fund also may purchase equity investments that typically trade at
higher multiples of current earnings than other securities, and the market values of
these investments often are more sensitive to changes in future earnings expectations
than those other securities. Because the Fund normally does not take temporary
defensive positions, declines in stock market prices generally are likely to reduce the
net asset value of the Funds shares.
|
|
|
|
|
|
|
Management and Operational Risk
The Fund relies on GMOs ability to
achieve its investment objective by effectively implementing its investment approach.
The Fund runs the risk that GMOs proprietary investment techniques will fail to
produce the desired results. The Funds portfolio managers may use quantitative
analyses and/or models and any imperfections or limitations in such analyses and/or
models could affect the ability of the portfolio managers to implement strategies. By
necessity, these analyses and models make simplifying assumptions that limit their
efficacy. Models that appear to explain prior market data can fail to predict future
market events. Further, the data used in models may be inaccurate and/or it may not
include the most recent information about a company or a security. The Fund is also
subject to the risk that deficiencies in the Managers or another service providers
internal systems or controls will cause losses for the Fund or impair operations.
|
|
B-4
Appendix B
|
|
|
|
Derivatives Risk
The use of derivatives involves the risk that their
value may not move as expected relative to the value of the relevant underlying assets,
rates or indices. Derivatives also present other Fund risks, including market risk,
liquidity risk and counterparty risk.
|
|
|
|
|
|
|
Counterparty Risk
The Fund runs the risk that the counterparty to an
OTC derivatives contract or a borrower of the Funds securities will be unable or
unwilling to make timely settlement payments or otherwise honor its obligations.
|
|
|
|
|
|
|
Leveraging Risk
The Funds use of derivatives and securities lending
may cause its portfolio to be leveraged. Leverage increases the Funds portfolio losses
when the value of its investments decline.
|
|
|
|
|
|
|
Smaller Company Risk
Smaller companies may have limited product lines,
markets, or financial resources, may lack the competitive strength of larger companies,
or may lack managers with experience or depend on a few key employees. The securities
of small- and mid-cap companies often are less widely held and trade less frequently
and in lesser quantities, and their market prices often fluctuate more, than the
securities of companies with larger market capitalizations.
|
|
|
|
|
|
|
Focused Investment Risk
Focusing investments in sectors or companies or
in industries with high positive correlations to one another creates additional risk.
|
|
|
|
|
|
|
Market Disruption and Geopolitical Risk
Geopolitical and other events
may disrupt securities markets and adversely affect global economies and markets. Those
events as well as other changes in foreign and domestic economic and political
conditions could adversely affect the value of the Funds investments.
|
|
|
|
|
|
|
Large Shareholder Risk
To the extent that shares of the Fund are held
by large shareholders (e.g., institutional investors, financial intermediaries, asset
allocation funds, or other funds managed by GMO (GMO Funds)), the Fund is subject to
the risk that these shareholders will disrupt operations by purchasing or redeeming
shares in large amounts and/or on a frequent basis.
|
|
|
|
|
|
|
Fund of Funds Risk
The Fund is indirectly exposed to all of the risks
of an investment in USCEF, including the risk that USCEF will not perform as expected.
|
|
|
|
6.
|
|
Guarantees
|
|
|
|
|
|
|
In the normal course of business the Fund enters into contracts with third-party service
providers that contain a variety of representations and warranties that provide general
indemnifications. The Funds maximum exposure under these arrangements is unknown, as it
involves possible future claims that may or may not be made against the Fund. Based on
experience, GMO is of the view that the risk of loss to the Fund in connection with the
Funds indemnification obligations is remote; however, there can be no assurance that such
obligations will not result in material liabilities that adversely affect the Fund.
|
|
B-5
GMO SERIES TRUST
PART C.
OTHER INFORMATION
Item 28.
Exhibits
|
|
(a)
|
|
1.
|
|
Agreement and Declaration of Trust of GMO Series Trust (the Trust or
Registrant), dated May 27, 2011 (the Declaration of Trust) Previously filed
with the SEC as part of the Initial Registration Statement of the Registrant on Form N-1A
on May 31, 2011, and hereby incorporated by reference; and
|
|
|
|
|
|
2.
|
|
Amended and Restated Declaration of Trust, dated September 13, 2011
Exhibit (a)(2).
|
|
|
|
(b)
|
|
None.
|
|
|
|
|
(c)
|
|
Please refer to Article II (Shares) and Article V (Shareholders Voting Powers and
Meetings) of the Amended and Restated Declaration of Trust, which is filed herewith as
Exhibit (a)(2).
|
|
|
|
|
(d)
|
|
Form of Management Contract between the Trust, on behalf of GMO U.S. Core Equity
Series Fund, and Grantham, Mayo, Van Otterloo & Co. LLC (GMO) Exhibit (d).
|
|
|
|
|
(e)
|
|
Conforming Distribution Agreement, dated August 23, 2011, between the Trust and Funds
Distributor, LLC Exhibit (e).
|
|
|
|
(f)
|
|
None.
|
|
|
|
(g)
|
|
Conforming Custodian Agreement, dated August 23, 2011, between the Trust and State
Street Bank and Trust Company (State Street Bank) Exhibit (g).
|
|
|
(h)
|
|
1.
|
|
Conforming Transfer Agency and Service Agreement, dated August 23, 2011, between
the Trust and State Street Bank Exhibit (h)(1).
|
|
|
|
|
2.
|
|
Form of Administration Agreement between the Trust, on behalf of GMO U.S.
Core Equity Series Fund, and GMO Exhibit (h)(2).
|
|
|
|
|
|
|
3.
|
|
Conforming Administration Agreement, dated August 23, 2011, between GMO and
State Street Bank Exhibit (h)(3).
|
|
|
|
|
|
|
4.
|
|
Form of Notification of Undertaking to Reimburse Certain Fund Expenses by GMO
to the Trust Exhibit (h)(4).
|
|
|
|
(i)
|
|
Opinion and Consent of Legal Counsel Exhibit (i).
|
|
1
|
|
(j)
|
|
Consent of Independent Registered Public Accounting Firm Exhibit (j).
|
|
|
|
|
(k)
|
|
Not applicable.
|
|
|
|
|
(l)
|
|
Form of Initial Capital and Subscription Agreement Exhibit (l).
|
|
|
|
(m)
|
|
Not applicable.
|
|
|
(n)
|
|
Not applicable.
|
|
|
(o)
|
|
Reserved.
|
|
|
(p)
|
|
1.
|
|
GMO Code of Ethics, dated May 20, 2011, adopted by GMO, GMO Australasia LLC,
GMO Australia Ltd., GMO Singapore PTE Ltd., GMO Switzerland GMBH, GMO U.K. Ltd., GMO
Woolley Ltd., GMO Renewable Resources LLC, GMO Renewable Resources (in New Zealand), and
GMO Renewable Resources Uruguay, SRL Exhibit (p)(1).
|
|
|
|
|
|
2.
|
|
GMO Series Trust and GMO Trust Code of Ethics, dated September 5, 2008, as
adopted by the Trust on August 23, 2011 Exhibit (p)(2).
|
|
|
|
|
|
|
3.
|
|
Code of Ethics for the Independent Trustee of GMO Series Trust, dated August
23, 2011, adopted by the Board of Trustees of the Trust Exhibit (p)(3).
|
|
Item 29.
Persons Controlled by or Under Common Control with the Fund
None.
Item 30.
Indemnification
Please refer to Article VIII (Indemnification) of the Amended and Restated Declaration of
Trust.
In addition, the Trust will maintain a trustees and officers liability insurance policy under
which the Trust and its trustees and officers will be named insureds. The Trust also has entered
into agreements with each of its trustees pursuant to which each of the Funds has agreed to
indemnify each Trustee to the maximum extent permitted by applicable law against any liability and
expense incurred by the Trustee by reason of the Trustee being or having been a Trustee.
Insofar as indemnification for liability arising under the Securities Act of 1933 (the
Securities Act) may be permitted to trustees, officers and controlling persons of the Registrant
pursuant to the Trusts By-laws, or otherwise, the Registrant has been advised
that in the opinion of the Securities and Exchange Commission such indemnification is
2
against
public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event
that a claim for indemnification against such liabilities (other than the payment by the Registrant
of expenses incurred or paid by a trustee, officer or controlling person of the Registrant in the
successful defense of any action, suit or proceeding) is asserted by such trustee, officer or
controlling person in connection with the securities being registered, the Registrant will, unless
in the opinion of its counsel the matter has been settled by controlling precedent, submit to a
court of appropriate jurisdiction the question whether such indemnification by it is against public
policy as expressed in the Securities Act and will be governed by the final adjudication of such
issue.
Item 31.
Business and Other Connections of Investment Adviser
A description of the business of Grantham, Mayo, Van Otterloo & Co. LLC, the investment
adviser of the Fund (the Investment Adviser), is set forth under the captions Management of the
Trust in the prospectuses and Investment Advisory and Other Services in the statements of
additional information, all forming part of this Registration Statement.
Except as set forth below, the directors, officers, and members of the Investment Adviser,
have been engaged during the past two fiscal years in no business, profession, vocation or
employment of a substantial nature other than as directors, officers, or members of the Investment
Adviser or certain of its affiliates. Certain directors, officers, and members of the Investment
Adviser serve as officers or trustees of the Registrant as set forth under the caption Management
of the Trust in the Registrants statements of additional information, forming part of this
Registration Statement, and/or as officers and/or directors of certain private investment companies
managed by the Investment Adviser or certain of its affiliates. The address of the Investment
Adviser and the Registrant is 40 Rowes Wharf, Boston, Massachusetts 02110.
|
|
|
|
|
|
|
Position with
|
|
|
Name
|
|
Investment Adviser
|
|
Other Connections
|
Arjun Divecha
|
|
Member, Chairman of the
Board of Directors, and
Investment Director
|
|
Board Member, Divecha
Centre for Climate
Change, Indian Institute
of Science, Bengaluru,
India; Director, Frog
Hollow Fresh LLC, P.O.
Box 872, Brentwood, CA
94513
|
|
|
|
|
|
R. Jeremy Grantham
|
|
Founding Member, Member
of the Board of
Directors, and Chief
Investment Strategist
|
|
Board Member, Divecha
Centre for Climate
Change, Indian Institute
of Science, Bengaluru,
India; CFA Institute
Investors Working Group
(IWG) Member, 560 Ray C.
Hunt Drive,
Charlottesville, VA
22903; MSPCC Investment
Committee, 555 Amory
Street, Jamaica Plain,
MA 02130; Board Member,
Imperial College of
London Grantham
Institute for Climate
Change, London SW7 2AZ;
Board Member, London
School of Economics
Grantham Institute for
Climate Change, Houghton
Street, London, WC2A 2AE
|
3
|
|
|
|
|
|
|
Position with
|
|
|
Name
|
|
Investment Adviser
|
|
Other Connections
|
John Rosenblum
|
|
Member and Vice Chairman
of the Board of
Directors
|
|
Trustee,
Jamestown-Yorktown
Foundation, Inc., P.O.
Box 1607, Williamsburg,
VA 23187-1607; American
Civil War Center
Foundation, 200 S. Third
St., Richmond, VA 23219;
Chair of the Board, The
Apprenticeshop (f/k/a
Atlantic Challenge), 643
Main St., Rockland, ME
04841; University
Symphony Society, 112
Old Cabell Hall,
Charlottesville, VA
22903; Treasurer and
Board Member, Farnsworth
Art Museum, 16 Museum
Street, Rockland, Maine
04841; Board Member,
Maine Media Workshops
and Maine Media College,
70 Camden Street,
Rockport, ME 04856
|
|
|
|
|
|
Eyk Van Otterloo
|
|
Founding Member and
Member of the Board of
Directors
|
|
Chairman of the Board,
Chemonics International,
1133 20th Street, NW,
Suite 600, Washington,
D.C. 20036; Board
Member, CliniLabs, 423
W. 55th Street, 4th
Floor, New York, NY
10019; Overseer, Peabody
Essex Museum, East India
Square, Salem, MA 01970;
Member, Board of
Commissioners,
Groothandelsgebouw NV,
45 Stationsplein P.O.
Box 29057, 3001GB
Rotterdam, Netherlands
|
Item 32.
Principal Underwriters
|
|
|
|
Item 32(a).
|
|
Funds Distributor, LLC (FD) serves as principal underwriter for the following
investment companies registered under the Investment Company Act of 1940, as amended:
|
|
|
|
|
GMO Series Trust
GMO Trust
Munder Series Trust II
Munder Series Trust
Mirae Asset Discovery Funds
|
4
Item 32(b). The following are officers and directors of FD, the Registrants principal underwriter.
FDs main business address is Three Canal Plaza, Suite 100, Portland, Maine 04101.
|
|
|
|
|
Director or Officer
|
|
Positions with FD
|
|
Positions with Registrant
|
Mark A. Fairbanks
|
|
President and Manager
|
|
None
|
Richard J. Berthy
|
|
Vice President, Treasurer and Manager
|
|
None
|
Jennifer E. Hoopes
|
|
Secretary
|
|
None
|
Nanette K. Chern
|
|
Vice President and Chief Compliance Officer
|
|
None
|
Lisa S. Clifford
|
|
Vice President and Director of Compliance
|
|
None
|
Item 32(c). None.
Item 33.
Location of Accounts and Records
The accounts, books, and other documents required to be maintained by Section 31(a) and the
rules thereunder will be maintained at the offices of the Registrant, 40 Rowes Wharf, Boston, MA
02110, and at the offices of the Registrants investment adviser, Grantham, Mayo, Van Otterloo &
Co. LLC, 40 Rowes Wharf, Boston, MA 02110; the Registrants distributor, Funds Distributor, LLC, Three Canal Plaza, Suite 100,
Portland, Maine 04101; and the Registrants custodian and transfer agent, State
Street Bank and Trust Company, One Lincoln Street, Boston, MA 02111.
Item 34.
Management Services
Not applicable.
Item 35.
Undertakings
None.
Notice
A copy of the Declaration of Trust, together with all amendments thereto, is on file with the
Secretary of the Commonwealth of Massachusetts and notice is hereby given that this instrument is
executed on behalf of the Trust by an officer of the Trust as an officer and not individually and
that the obligations of this instrument are not binding upon any of the Trustees or officers of the
Trust or shareholders of any series of the Trust individually but are binding only upon the assets
and property of the Trust or the respective series.
5
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933 (the Securities Act)
and the Investment Company Act of 1940, each as amended, the Registrant, GMO Series Trust, has duly
caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Boston and The Commonwealth of Massachusetts, on the 15
th
day of
September, 2011.
|
|
|
|
|
|
GMO Series Trust
|
|
|
By:
|
J.B. KITTREDGE*
|
|
|
|
J.B. Kittredge
|
|
|
Title:
|
President, Chief Executive Officer and
Principal Executive Officer
|
|
Pursuant to the requirements of the Securities Act, this Registration Statement has been
signed below by the following persons in the capacities and on the date indicated.
|
|
|
|
|
Signatures
|
|
Title
|
|
Date
|
|
J.B. KITTREDGE*
J.B. Kittredge
|
|
Trustee; President; Chief
Executive Officer; Principal
Executive Officer
|
|
September 15, 2011
|
SHEPPARD N. BURNETT*
Sheppard N. Burnett
|
|
Treasurer; Chief Financial
Officer; Principal Financial
and Accounting Officer
|
|
September 15, 2011
|
MARIA D. FURMAN*
Maria D. Furman
|
|
Trustee
|
|
September 15, 2011
|
|
|
|
|
|
|
|
|
|
*By:
|
/s/ Jason B. Harrison
|
|
|
|
Jason B. Harrison
|
|
|
|
Attorney-in-Fact**
|
|
|
|
|
|
|
**
|
|
Pursuant to Powers of Attorney for each of J.B. Kittredge and Sheppard N.
Burnett, filed with the SEC as part of the Initial Registration Statement of the
Registrant on May 31, 2011, and pursuant to Power of Attorney for Maria D. Furman
filed herewith as Exhibit 2.
|
|
GMO SERIES TRUST PRE-EFFECTIVE AMENDMENT NO. 2
6
EXHIBIT INDEX
GMO SERIES TRUST
|
|
|
Exhibit Ref.
|
|
Title of Exhibit
|
(a)(2)
|
|
Amended and Restated Declaration of Trust, dated September 13, 2011.
|
|
|
|
(d)
|
|
Form of Management Contract between the Trust, on behalf of GMO
U.S. Core Equity Series Fund, and GMO.
|
|
|
|
(e)
|
|
Conforming Distribution Agreement, dated August 23, 2011, between
the Trust and Funds Distributor, LLC.
|
|
|
|
(g)
|
|
Conforming Custodian Agreement, dated August 23, 2011, between the
Trust and State Street Bank.
|
|
|
|
(h)(1)
|
|
Conforming Transfer Agency and Service Agreement, dated August 23,
2011, between the Trust and State Street Bank.
|
|
|
|
(h)(2)
|
|
Form of Administration Agreement between the Trust, on behalf of
GMO U.S. Core Equity Series Fund, and GMO.
|
|
|
|
(h)(3)
|
|
Conforming Administration Agreement, dated August 23, 2011,
between GMO and State Street Bank.
|
|
|
|
(h)(4)
|
|
Form of Notification of Undertaking to Reimburse Certain Fund
Expenses by GMO to the Trust.
|
|
|
|
(i)
|
|
Opinion and Consent of Legal Counsel.
|
|
|
|
(j)
|
|
Consent of Independent Registered Public Accounting Firm.
|
|
|
|
(l)
|
|
Form of Initial Capital and Subscription Agreement.
|
|
|
|
(p)(1)
|
|
GMO Code of Ethics, dated May 20, 2011.
|
|
|
|
(p)(2)
|
|
GMO Series Trust and GMO Trust Code of Ethics, dated September 5,
2008, as adopted by the Trust on August 23, 2011.
|
|
|
|
(p)(3)
|
|
Code of Ethics for the Independent Trustee of GMO Series Trust,
dated August 23, 2011, adopted by the Board of Trustees of the
Trust.
|
|
|
|
Other.
|
|
|
|
|
|
1
|
|
Certificate of Clerk of the Trust certifying action by written
consent of the sole Trustee of the Trust required pursuant to Rule
483 under the Securities Act of 1933.
|
|
|
|
2
|
|
Power of Attorney for Maria D. Furman.
|
7
Exhibit (a)(2)
AMENDED AND RESTATED
AGREEMENT AND DECLARATION OF TRUST
GMO SERIES TRUST
THIS AMENDED AND RESTATED AGREEMENT AND DECLARATION OF TRUST made at Boston, Massachusetts
this 13th day of September, 2011 hereby amends and restates in its entirety the Agreement and
Declaration of Trust dated May 27, 2011 by the sole initial Trustee hereunder and by the holders of
shares of beneficial interest to be issued hereunder as hereinafter provided.
WITNESSETH that
WHEREAS this Trust has been formed to carry on the business of an investment company;
WHEREAS this Trust has registered as a registered investment company and plans to comply with
the applicable requirements of the 1940 Act; and
WHEREAS the Trustee has agreed to manage all property coming into his hands as a trustee of a
Massachusetts business trust in accordance with the provisions hereinafter set forth.
NOW, THEREFORE, the Trustee does hereby direct that this Amended and Restated Agreement and
Declaration of Trust be filed with the Secretary of The Commonwealth of Massachusetts and with the
City Clerk of the City of Boston and does hereby declare that he will hold all cash, securities and
other assets, which he may from time to time acquire in any manner as a Trustee hereunder IN TRUST
to manage and dispose of the same upon the following terms and conditions for the benefit of the
holders from time to time of Shares in this Trust as hereinafter set forth.
ARTICLE I.
Name and Definitions
Section 1.
This Trust shall be known as GMO Series Trust with its principal place of
business at 40 Rowes Wharf, Boston, Massachusetts 02110, and the Trustees shall conduct the
business of the Trust under that name or any other name as they may from time to time determine.
Section 2.
Definitions
. Whenever used herein, unless otherwise required by the
context or specifically provided:
(a) Trust refers to the Massachusetts business trust established by this Agreement and
Declaration of Trust, as amended from time to time;
(b) Trustees refers to the Trustees of the Trust named in Article IV hereof or elected or
appointed in accordance with such Article;
(c) Independent Trustees refers to the Trustees who are not interested persons of the Trust, as
defined in the 1940 Act.
(d) Interested Trustees refers to the Trustees who are interested persons of the Trust, as
defined in the 1940 Act.
(d) Shares means the equal proportionate transferable units of interest into which the beneficial
interest in the Trust shall be divided from time to time or, if more than one Series or Class of
Shares is authorized by the Trustees, the equal proportionate transferable units into which each
Series or Class of Shares shall be divided from time to time.
(e) Shareholder means a record owner of Shares;
(f) 1940 Act refers to the Investment Company Act of 1940 and the Rules and Regulations
thereunder, all as amended from time to time;
(g) The terms Commission and principal underwriter shall have the meanings given to them in the
1940 Act;
(h) Declaration of Trust shall mean this Agreement and Declaration of Trust, as amended or
restated from time to time;
(i) By-Laws shall mean the By-Laws of the Trust as amended from time to time;
(j) Series or Series of Shares refers to the one or more separate investment portfolios of the
Trust into which the assets and liabilities of the Trust may be divided and the Shares of the Trust
representing the beneficial interest of Shareholders in such respective portfolios; and
(k) Class or Class of Shares refers to the division of Shares representing any Series into two
or more Classes, as provided in Article III, Section 1.
ARTICLE II.
Purpose of Trust
The purpose of the Trust is to provide investors a managed investment directly or indirectly
primarily in securities (including options), debt instruments, commodities, commodity contracts and
options thereon, notional and other over-the-counter contracts, and other investments of any kind.
-2-
ARTICLE III.
Shares
Section 1.
Division of Beneficial Interest
. The Shares of the Trust shall be
issued in one or more Series as the Trustees may authorize. Each Series shall be preferred over
all other Series in respect of the assets allocated to that Series within the meaning of the 1940
Act and shall represent a separate investment portfolio of the Trust. The beneficial interest in
each Series shall at all times be divided into Shares, without par value, each of which shall,
except as provided in the following sentence, represent an equal proportionate interest in the
Series with each other Share of the same Series, none having priority or preference over another.
The Trustees may divide the Shares of any Series into two or more Classes, with Shares of each such
Class having such preferences and special or relative rights and privileges (including conversion
rights, if any) as the Trustees may determine and as shall be set forth herein and/or in such other
document as the Trustees determine. The number of Shares authorized shall be unlimited. The
Trustees may from time to time divide or combine the Shares of any Series or Class into a greater
or lesser number, classify or re-classify any issued or unissued Shares of any Series or Class into
one or more Series or Classes, and take such other actions with respect to the Shares as the
Trustees deem desirable.
Section 2.
Ownership of Shares
. The ownership of Shares shall be recorded on the
books of the Trust or a transfer or similar agent for the Trust, which books shall be maintained
separately for the Shares of each Series and Class. No certificates certifying the ownership of
Shares shall be issued except as the Trustees may otherwise determine from time to time. The
Trustees may make such rules as they consider appropriate for the transfer of Shares of each Series
and Class and similar matters. The record books of the Trust as kept by the Trust or any transfer
or similar agent, as the case may be, shall be conclusive as to who are the Shareholders of each
Series and Class and as to the number of Shares of each Series and Class held from time to time by
each.
Section 3.
Investments in the Trust
. The Trustees shall accept investments in the
Trust from such persons and on such terms and for such consideration, including the payment of any
purchase premium fixed by the Trustees, as they from time to time authorize.
Section 4.
Status of Shares and Limitation of Personal Liability
. Shares shall be
deemed to be personal property giving only the rights provided in this instrument. Every
Shareholder by virtue of having become a Shareholder shall be held to have expressly assented and
agreed to the terms of this Declaration of Trust and the By-Laws (each as amended from time to
time) and to have become a party thereto. The death of a Shareholder during the continuance of the
Trust shall not operate to terminate the same nor entitle the representative of any deceased
Shareholder to an accounting or to take any action in court or elsewhere against the Trust or the
Trustees, but entitles such representative only to the rights of said deceased Shareholder under
this Trust. Ownership of Shares shall not entitle the Shareholder to any title in or to the whole
or any part of the Trust property or right to call for a partition or division of the same or for
an accounting, nor shall the ownership of Shares constitute the Shareholders partners. Neither the
Trust nor the Trustees, nor any officer, employee or agent of the Trust shall have any power to
bind personally any Shareholders, nor except as specifically provided herein, to call upon any
Shareholder for the
-3-
payment of any sum of money or assessment whatsoever other than such as the Shareholder may at any
time personally agree to pay.
Section 5.
Power of Trustees to Change Provisions Relating to Shares
.
Notwithstanding any other provisions of this Declaration of Trust and without limiting the power of
the Trustees to amend the Declaration of Trust as provided elsewhere herein, the Trustees shall
have the power to amend this Declaration of Trust, at any time and from time to time, in such
manner as the Trustees may determine in their sole discretion, without the need for Shareholder
action, so as to add to, delete, replace or otherwise modify any provisions relating to the Shares
contained in this Declaration of Trust. The establishment and designation of any Series or Class
of Shares in addition to the Series and Classes established and designated in Section 6 of this
Article III shall be effective upon the execution by the Trustees of an amendment to this
Declaration of Trust, taking the form of a complete restatement or otherwise, setting forth such
establishment and designation and the relative rights and preferences of such Series or Class, as
the case may be, or as otherwise provided in such instrument, this Declaration of Trust, and/or in
such other document as the Trustees determine.
Without limiting the generality of the foregoing, the Trustees may amend the Declaration of
Trust to:
(a) create one or more Series or Classes of Shares (in addition to any Series or Classes already
existing or otherwise) with such rights and preferences and such eligibility requirements for
investment therein as the Trustees shall determine and reclassify any or all outstanding Shares as
shares of particular Series or Classes in accordance with such eligibility requirements;
(b) combine one or more Series or Classes of Shares into a single Series or Class on such terms and
conditions as the Trustees shall determine;
(c) change or eliminate any eligibility requirements for investment in Shares of any Series or
Class, including without limitation the power to provide for the issue of Shares of any Series or
Class in connection with any merger or consolidation of the Trust with another trust or company or
any acquisition by the Trust of part or all of the assets of another trust or company;
(d) change the designation of any Series or Class of Shares;
(e) change the method of allocating dividends among the various Series and Classes of Shares;
(f) allocate any specific assets or liabilities of the Trust or any specific items of income or
expense of the Trust to one or more Series or Classes of Shares;
(g) specifically allocate assets to any or all Series or Classes of Shares or create one or more
additional Series or Classes of Shares which are preferred over all other Series or Classes of
Shares in respect of assets specifically allocated thereto or any dividends paid by the Trust with
respect to any net income, however determined, earned from the investment and reinvestment of any
assets so allocated or otherwise and provide for any special voting or other rights with respect to
such Series or Classes; and
-4-
(h) amend any of the provisions set forth in paragraphs (a) through (g) of this Section 5.
Section 6.
Establishment and Designation of Series
. Without limiting the authority
of the Trustees set forth in Section 5 of this Article III,
inter
alia
, to
establish and designate any further Series or Classes or to modify the rights and preferences of
any Series, each Series set forth on Schedule 3.6A attached hereto shall be, and are hereby,
established and designated. In addition, with respect to each such Series, the Classes of Shares
set forth on Schedule 3.6B attached hereto shall be, and are hereby, established and designated,
which Classes shall have the respective rights and preferences as set forth herein and/or in such
other document as the Trustees determine.
Section 7.
Rights and Preferences of Series and Classes
. Shares of each Series (or
Class, as the case may be) established in this Article III shall have the following relative rights
and preferences:
(a)
Assets belonging to Series
. All consideration received by the Trust for the issue or
sale of Shares of a particular Series, together with all assets in which such consideration is
invested or reinvested, all income, earnings, profits, and proceeds thereof from whatever source
derived, including, without limitation, any proceeds derived from the sale, exchange or liquidation
of such assets, and any funds or payments derived from any reinvestment of such proceeds in
whatever form the same may be, shall irrevocably belong to that Series for all purposes, subject
only to the rights of creditors, and shall be so recorded upon the books of account of the Trust.
Such consideration, assets, income, earnings, profits and proceeds thereof, from whatever source
derived, including, without limitation, any proceeds derived from the sale, exchange or liquidation
of such assets, and any funds or payments derived from any reinvestment of such proceeds, in
whatever form the same may be, are herein referred to as assets belonging to that Series. In the
event that there are any assets, income, earnings, profits and proceeds thereof, funds or payments
which are not readily identifiable as belonging to any particular Series (collectively, General
Assets), the Trustees shall allocate such General Assets to, between or among any one or more of
the Series established and designated from time to time in such manner and on such basis as they,
in their sole discretion, deem fair and equitable, and any General Asset so allocated to a
particular Series shall belong to that Series. Each such allocation by the Trustees shall be
conclusive and binding upon the Shareholders of all Series for all purposes.
(b)
Liabilities Belonging to Series
. The assets belonging to each particular Series shall
be charged solely with the liabilities of the Trust in respect to that Series, expenses, costs,
charges and reserves attributable to that Series, and any general liabilities of the Trust which
are not readily identifiable as belonging to any particular Series but which are allocated and
charged by the Trustees to and among any one or more of the Series established and designated from
time to time in a manner and on such basis as the Trustees in their sole discretion deem fair and
equitable. The liabilities, expenses, costs, charges, and reserves so charged to a Series are
herein referred to as liabilities belonging to that Series. Each allocation of liabilities,
expenses, costs, charges and reserves by the Trustees shall be conclusive and binding upon the
holders of all Series for all purposes.
-5-
(c)
Dividends, Distributions, Redemptions, and Repurchases
. Notwithstanding any other
provisions of this Declaration, including, without limitation, Article VI, no dividend or
distribution (including, without limitation, any distribution paid upon termination of the Trust or
of any Series or Class) with respect to, nor any redemption or repurchase of, the Shares of any
Series shall be effected by the Trust other than from the assets belonging to such Series, nor
shall any Shareholder of any particular Series otherwise have any right or claim against the assets
belonging to any other Series except to the extent that such Shareholder has such a right or claim
hereunder as a Shareholder of such other Series.
(d)
Voting
. Shareholders of any particular Series or Class shall not be entitled to vote
on any matters as to which such Series or Class is not affected except as otherwise determined by
the Trustees or required by the 1940 Act. On any matter submitted to a vote of Shareholders, all
Shares of the Trust then entitled to vote shall be voted by individual Series, unless otherwise
determined by the Trustees or required by the 1940 Act.
(e)
Equality
. All the Shares of each particular Class of a Series shall represent an equal
proportionate interest in the assets allocable to that Class, and each Share of any particular
Series shall be equal to each other Share of that Series (subject to the liabilities allocated to
each Class of that Series).
(f)
Fractions
. Any fractional Share of a Series or Class shall carry proportionately all
the rights and obligations of a whole share of that Series or Class, including rights with respect
to voting, receipt of dividends and distributions, redemption of Shares and termination of the
Trust.
(g)
Exchange Privilege
. The Trustees shall have the authority to provide that the holders
of Shares of any Series or Class shall have the right to exchange said Shares for Shares of one or
more other Series or Class of Shares in accordance with such requirements and procedures as may be
established by the Trustees.
(h)
Combination of Series or Classes
. The Trustees shall have the authority to combine the
assets and liabilities belonging to any two or more Series (or the assets allocable to any two or
more Classes) into assets and liabilities belonging (or allocable) to a single Series or Class.
(i)
Division of Series or Classes.
The Trustees shall have the authority to divide the
assets and liabilities belonging to any Series (or the assets allocable to any Class) into assets
and liabilities belonging (or allocable) to two or more Series or Classes
(j)
Elimination of Series or Classes
. The Trustees shall have the authority to eliminate
any particular Series or Class previously established and designated.
(k)
Assets and Liabilities Allocable to a Class
. To the extent necessary or appropriate to
give effect to the preferences and special or relative rights and privileges of any Classes, the
Trustees may, allocate assets and liabilities belonging to a Series to a particular Class of that
Series or apportion the same among two or more Classes of that Series.
Section 8.
No Preemptive Rights
. Shareholders shall have no preemptive or other
right to subscribe to any additional Shares or other securities issued by the Trust.
-6-
ARTICLE IV.
The Trustees
Section 1.
Appointment and Tenure
. The number of Trustees shall be fixed from time
to time by the Trustees and may be fixed at one Trustee.
Each Trustee shall serve during the continued lifetime of the Trust for a term of eight years or,
if sooner, until he dies, resigns or is removed, or until the election and qualification of his
successor; provided, however, that the Trustees may extend a Trustees term for one or more
successive eight (or fewer)-year periods. Any Trustee may resign at any time by written instrument
signed by him and delivered to any officer of the Trust or at a meeting of the Trustees. Such
resignation shall be effective upon receipt unless specified to be effective at some other time.
Except to the extent expressly provided in a written agreement with the Trust, no Trustee resigning
and no Trustee removed shall have any right to any compensation for any period following his
resignation or removal, or any right to damages on account of such removal.
Section 2.
Removal
. The Trustees may remove a Trustee with or without cause.
Section 3.
Effect of Death, Resignation, etc. of a Trustee
. The death,
declination, resignation, retirement, removal, or incapacity of the Trustees, or any of them, shall
not operate to annul the Trust or to revoke any existing agency created pursuant to the terms of
this Declaration of Trust. If at any time there is a sole Trustee, such Trustee may designate a
successor Trustee in writing and such successor Trustee shall take office upon the death,
declination, resignation, retirement, removal, or incapacity of the sole Trustee. The Trustees may
fill any vacancies; provided, however, that no person may be appointed to serve as an Interested
Trustee unless he has been nominated by at least one Interested Trustee (or, if there is no
Interested Trustee, then by the most senior officer of the Trust who is an interested person of
the Trust, as defined in the 1940 Act).
Section 4.
Powers
. Subject to the provisions of this Declaration of Trust, the
business of the Trust shall be managed by the Trustees, and they shall have all powers necessary or
convenient to carry out that responsibility (or incidental to the foregoing) including the power to
engage in transactions of all kinds on behalf of the Trust. The exercise by the Trustees of their
powers shall be valid if, but only if, the exercise is approved by a majority of the Trustees then
in office, so long as: (i) at least one Independent Trustee votes for or abstains from such
exercise, and (ii) except in the case of the appointment of or shareholder election of an
Interested Trustee nominated in accordance with Section 3 above, at least one Interested Trustee
votes for or abstains from such exercise; and further provided that if there is only one Trustee,
such Trustee is permitted to exercise any power on his own. The Trustees are permitted to delegate
any or all of their authority to the officers of the Trust. Except as otherwise provided herein,
any action to be taken by the Trustees may be taken at a meeting of the Trustees (a quorum being
present), within or without Massachusetts, including any meeting held by means of a conference
telephone or other communications equipment by means of which all persons participating in the
meeting
-7-
can hear each other at the same time and participation by such means shall constitute presence in
person at a meeting, or by written consents of the Trustees.
Without limiting the foregoing, the Trustees shall have the following powers and authority:
(a) to determine the name under which the Trust shall conduct business and to establish and
designate any Series or Classes (and amend Schedules 3.6A and 3.6B of the Declaration of Trust
accordingly);
(b) to amend this Declaration of Trust, including to add to, delete, replace or otherwise modify
any provisions of this Declaration of Trust relating to the Shares;
(c) to divide the Shares of the Trust into Series and Classes and to divide the Shares of any
Series into two or more Classes, and to divide or combine the Shares of any Series or Class into a
greater or lesser number, classify or re-classify any issued or unissued Shares of any Series or
Class into one or more Series or Classes, and take such other actions with respect to the Shares as
the Trustees deem desirable;
(d) to determine the preferences and special or relative rights and privileges of each Series or
Class of Shares;
(e) to adopt a plan pursuant to Rule 18f-3 under the 1940 Act (and amend such plan from time to
time);
(f) to establish an exchange privilege for holders of Shares of any Series or Class and to
establish any related requirements and procedures;
(g) to combine the assets and liabilities belonging to any two or more Series (or the assets
allocable to any two or more Classes) into assets and liabilities belonging (or allocable) to a
single Series or Class and to cause the Trust or any Series or Class thereof to be merged or
reorganized into or consolidated with another trust or company (including another Series or Class
of the Trust) or its shares exchanged under or pursuant to any state or federal statute, if any, or
otherwise to the extent permitted by law;
(h) to terminate the Trust or any particular Series or Class previously established and designated;
(i) at any time when no Shares of a Series or Class are outstanding, to exercise all rights of
Shareholders of that Series or Class with respect to matters affecting that Series or Class and
take any action required to be taken by the Shareholders;
(j) to allocate assets and liabilities belonging to a Series to a particular Class of that Series
or apportion the same among two or more Classes of that Series, to the extent necessary or
appropriate to give effect to the preferences and special or relative rights and privileges of any
Classes and to allocate General Assets (as defined in Article III, Section 7(a)) to, between or
among any one or more of the Series;
-8-
(k) to select the investment companies, including series of GMO Trust, in which a Series shall
invest;
(l) to adopt, amend or repeal By-Laws not inconsistent with this Declaration of Trust providing for
the regulation and management of the affairs of the Trust;
(m) to elect and remove officers and appoint and terminate agents;
(n) to fix the number of Trustees and, subject to the provisions of Section 1 of this Article IV,
to fill any vacancies on the Board;
(o) to remove a Trustee;
(p) to extend a Trustees term for one or more successive eight (or fewer)-year periods;
(q) to designate one or more committees of the Trustees with such powers and authority as the
Trustees determine;
(r) to employ one or more custodians of the assets of the Trust and to authorize such custodians to
employ subcustodians and to deposit all or any part of such assets in a system or systems for the
central handling of securities or with a Federal Reserve Bank;
(s) to retain a transfer agent or a shareholder servicing agent, or both, to provide for the
distribution of Shares by the Trust, through one or more principal underwriters or otherwise, and
to make rules for the transfer of Shares of each Series and Class and similar matters;
(t) to retain legal counsel for the Trust or any Series;
(u) to call meetings of Shareholders, give notice of such meetings to Shareholders, designate the
location of such meetings, establish a larger quorum for such meetings than the quorum required in
Article V, Section 4, establish or change a record date for determining the Shareholders of any
Series or Class having the right to notice of and to vote at such meeting and any adjournment
thereof, and close the register or transfer books of a Series or Class prior to such meeting.
(v) to cause the Trust to issue certificates certifying ownership of Shares;
(w) to cause each Shareholder to pay expenses of the Trust;
(x) to establish or change a record date for determining Shareholders who are entitled to receive
payment of any dividend or other distribution and close the register or transfer books of a Series
or Class prior to the payment of a distribution;
(y) to determine whether to accept investments in the Trust and to establish the terms and
consideration for such investments in the Trusts, including any purchase premium;
-9-
(z) to exercise the powers set forth in Article VI of this Declaration of Trust;
(aa) to invest and reinvest cash, and to hold cash uninvested;
(bb) to sell, exchange, lend, pledge, mortgage, hypothecate, lease, or write options with respect
to or otherwise deal in any property rights relating to any or all of the assets of the Trust;
(cc) to vote or give assent, or exercise any rights of ownership, with respect to stock or other
securities or property; and to execute and deliver proxies or powers of attorney to such person or
persons as the Trustees shall deem proper, granting to such person or persons such power and
discretion with relation to securities or property as the Trustees shall deem proper;
(dd) to exercise power and rights of subscription or otherwise which may in any manner arise out of
the ownership of securities;
(ee) to hold any security or property in a form not indicating any trust, whether in bearer,
unregistered or other negotiable form, or in its own name or in the name of a custodian or
subcustodian or a nominee or nominees or otherwise;
(ff) to consent to or participate in any plan for the reorganization, consolidation or merger of
any corporation or issuer of any security which is held in the Trust; to consent to any contract,
lease, mortgage, purchase or sale of property by such corporation or issuer; and to pay calls or
subscriptions with respect to any security held in the Trust;
(gg) to contract for advisory and/or management services for the Trust or for any Series;
(hh) to join with other security holders in acting through a committee, depositary, voting trustee
or otherwise, and in that connection to deposit any security with, or transfer any security to, any
such committee, depositary or trustee, and to delegate to them such power and authority with
relation to any security (whether or not so deposited or transferred) as the Trustees shall deem
proper and to agree to pay, and to pay, such portion of the expenses and compensation of such
committee, depositary or trustee as the Trustees shall deem proper;
(ii) to compromise, arbitrate or otherwise adjust claims in favor of or against the Trust or any
matter in controversy, including but not limited to claims for taxes;
(jj) to enter into joint ventures, general or limited partnerships and any other combinations or
associations;
(kk) to borrow funds or other property;
(ll) to make or issue notes, bonds, contracts, instruments, certificates or other undertakings on
behalf of the Trust;
(mm) to endorse or guarantee the payment of any notes or other obligations of any person; to make
contracts of guaranty or suretyship, or otherwise assume liability for payment thereof; and to
mortgage and pledge Trust property or any part thereof to secure any of or all such obligations;
-10-
(nn) to pay or cause to be paid, entirely out of Trust property, all expenses, fees, charges, taxes
and liabilities incurred or arising in connection with the Trust including, but not limited to, the
Trustees compensation;
(oo) to purchase and pay for, entirely out of Trust property, such insurance as they may deem
necessary or appropriate for the conduct of the business, including without limitation, insurance
policies insuring the assets of the Trust and payment of distributions and principal on its
portfolio investments, and insurance policies insuring the Shareholders, Trustees, officers,
employees, agents, investment advisers, principal underwriters, or independent contractors of the
Trust individually against all claims and liabilities of every nature arising by reason of holding
being or having held any such office or position, or by reason of any action alleged to have been
taken or omitted by any such person as Shareholder, Trustee, officer, employee, agent, investment
adviser, principal underwriter, or independent contractor, including any action taken or omitted
that may be determined to constitute negligence, whether or not the Trust would have the power to
indemnify such person against liability; and
(pp) to pay pensions as deemed appropriate by the Trustees and to adopt, establish and carry out
pension, profit-sharing, share bonus, share purchase, savings, thrift and other retirement,
incentive and benefit plans, trusts and provisions, including the purchasing of life insurance and
annuity contracts as a means of providing such retirement and other benefits, for any or all of the
Trustees, officers, employees and agents of the Trust.
The Trustees shall not in any way be bound or limited by any present or future law or custom
in regard to investments by Trustees. The Trustees shall not be required to obtain any court order
to deal with any assets of the Trust or take any other action hereunder.
Section 5.
Payment of Expenses by the Trust
. The Trustees are authorized to pay or
cause to be paid out of the principal or income of the Trust, or partly out of principal and partly
out of income, as they deem fair, all expenses, fees, charges, taxes and liabilities incurred or
arising in connection with the Trust, or in connection with the management thereof, including but
not limited to, the Trustees compensation and such expenses and charges for the services of the
Trusts officers, employees, investment adviser or manager, principal underwriter, auditor,
counsel, custodian, transfer agent, shareholder servicing agent, and such other agents or
independent contractors and such other expenses and charges as the Trustees may deem necessary or
proper to incur.
Section 6.
Payment of Expenses by Shareholders
. The Trustees shall have the power,
as frequently as they may determine, to cause each Shareholder, or each Shareholder of any
particular Series or Class, to pay directly, in advance or arrears, for charges of the Trusts
custodian or transfer, shareholder servicing or similar agent, an amount fixed from time to time by
the Trustees, by setting off such charges due from such Shareholder from declared but unpaid
dividends owed such Shareholder and/or by reducing the number of Shares in the account of such
Shareholder by that number of full and/or fractional Shares which represents the outstanding amount
of such charges due from such Shareholder.
Section 7.
Ownership of Assets of the Trust
. Title to all of the assets of the
Trust shall at all times be considered as vested in the Trustees.
-11-
Section 8.
Advisory, Management and Distribution Contracts; Other Service
Providers
. The Trustees may, at any time and from time to time, contract for exclusive or
nonexclusive advisory and/or management services for the Trust or for any Series with Grantham,
Mayo, Van Otterloo & Co. LLC or any other partnership, corporation, trust, association or other
organization (the Manager); and any such contract may contain such other terms as the Trustees
may determine, including, without limitation, authority for a Manager to determine from time to
time without prior consultation with the Trustees what investments shall be purchased, held, sold
or exchanged and what portion, if any, of the assets of the Trust shall be held uninvested and to
make changes in the Trusts investments. The Trustees may also, at any time and from time to time,
contract with the Manager or any other partnership, corporation, trust, association or other
organization, appointing it exclusive or nonexclusive distributor or principal underwriter for the
Shares; and any such contract may contain such other terms as the Trustees may determine.
The fact that:
(i) any of the Shareholders, Trustees or officers of the Trust is a shareholder, director,
officer, partner, trustee, employee, manager, adviser, principal underwriter, distributor or
affiliate or agent of or for any partnership, corporation, trust, association, or other
organization, or of or for any parent or affiliate of any organization, with which an advisory or
management contract, or principal underwriters or distributors contract, or transfer, shareholder
servicing or other agency contract may have been or may hereafter be made, or that any such
organization, or any parent or affiliate thereof, is a Shareholder or has an interest in the Trust,
or that
(ii) any corporation, trust, association or other organization with which an advisory or
management contract or principal underwriters or distributors contract, or transfer, shareholder
servicing or other agency contract may have been or may hereafter be made also has an advisory or
management contract, or principal underwriters or distributors contract, or transfer, shareholder
servicing or other agency contract with one or more other corporations, trusts, associations, or
other organizations, or has other business or interests,
shall not affect the validity of any such contract or disqualify any Shareholder, Trustee or
officer of the Trust from voting upon or executing the same or create any liability or
accountability to the Trust or its Shareholders.
ARTICLE V.
Shareholders Voting Powers and Meetings
Section 1.
Voting Powers
. The Shareholders shall have power to vote only on
matters that the Trustees consider necessary or desirable. Each whole Share shall be entitled to
one vote as to any matter on which it is entitled to vote and each fractional Share shall be
entitled to a proportionate fractional vote. There shall be no cumulative voting in the election
of Trustees. Shares may be voted in person or by proxy. A proxy with respect to Shares held in
the name of
-12-
two or more persons shall be valid if executed by any one of them unless at or prior to exercise of
the proxy the Trust receives a specific written notice to the contrary from any one of them. A
proxy purporting to be executed by or on behalf of a Shareholder shall be deemed valid unless
challenged at its exercise and the burden of proving invalidity shall rest on the challenger. At
any time when no Shares of a Series or Class are outstanding, the Trustees may exercise all rights
of Shareholders of that Series or Class with respect to matters affecting that Series or Class and
may, with respect to that Series or Class, take any action required to be taken by the
Shareholders.
Section 2.
Meetings
. Meetings of the Shareholders may be called by the Trustees. A
meeting of Shareholders may be held at any place designated by the Trustees.
Section 3.
Derivative Actions
. No Shareholder shall have the right to bring or
maintain any court action, proceeding, or claim on behalf of the Trust. In addition, no
Shareholder shall have the right to bring or maintain any court action, proceeding, or claim on
behalf of the Trust without first making a written demand on the Trustees requesting the Trustees
to bring or maintain such action, proceeding, or claim. Such demand shall be mailed to the
Secretary of the Trust at the Trusts principal office and shall set forth in reasonable detail the
nature of the proposed court action, proceeding, or claim and the essential facts relied upon by
the Shareholder to support the allegations made in the demand. In their sole discretion, the
Trustees may act on any demand or may submit the matter to a vote of the Shareholders of the Trust,
as appropriate.
Section 4.
Quorum and Required Vote
. Except when a larger quorum is established by
the Trustees, 10% of the Shares entitled to vote shall constitute a quorum at a Shareholders
meeting. When any one Series or Class is to vote separately from any other Shares which are to
vote on the same matters as a separate Series or Class, 10% of the Shares of each such Series or
Class entitled to vote shall constitute a quorum at a Shareholders meeting of that Series or
Class. Any meeting of Shareholders may be adjourned from time to time, whether or not a quorum is
present, and the meeting may be held as adjourned after the date set for the original meeting
without further notice. The Trustees shall determine the vote of Shares necessary to decide any
questions at a Shareholders meeting.
Section 5.
Action by Written Consent
. At the discretion of the Trustees, any
action to be taken by Shareholders may be taken by written consent. Such consent shall be treated
for all purposes as a vote taken at a meeting of Shareholders.
Section 6.
Record Dates
. For the purpose of determining the Shareholders of any
Series or Class who are entitled to vote or act at any meeting or any adjournment thereof, the
Trustees may from time to time fix a time as the record date for determining the Shareholders of
such Series or Class having the right to notice of and to vote at such meeting and any adjournment
thereof, and in such case only Shareholders of record on such record date shall have such right,
notwithstanding any transfer of shares on the books of the Trust after the record date. For the
purpose of determining the Shareholders of any Series or Class who are entitled to receive payment
of any dividend or of any other distribution, the Trustees may from time to time fix a date, which
shall be before the date for the payment of such dividend or such other payment, as the record date
for determining the Shareholders of such Series or Class having the right to receive such dividend
or distribution. Without fixing a record date, the Trustees may, for voting
-13-
and/or distribution purposes, close the register or transfer books for one or more Series or
Classes for all or any part of the period between a record date and a meeting of shareholders or
the payment of a distribution. Nothing in this section shall be construed as precluding the
Trustees from setting different record dates for different Series or Classes.
Section 7.
Additional Provisions
. The By-Laws may include further provisions for
Shareholders votes and meetings and related matters.
ARTICLE VI.
Net Income, Distributions, Allocations, and Redemptions and Repurchases
Section 1.
Distributions
. The Trustees shall each year, or more frequently if they
so determine in their sole discretion, distribute to the Shareholders of each Series or Class, in
shares of that Series or Class, cash or otherwise, an amount approximately equal to the net income
attributable to the assets belonging to such Series (or the assets allocable to such Class) and may
from time to time distribute to the Shareholders of each Series or Class, in shares of that Series,
cash or otherwise, such additional amounts from sources including, without limitation, capital
gains and/or paid in surplus, but only from the assets belonging to such Series (or allocable to
that Class), as they may authorize; provided, however, that with respect to any Series for which it
is determined, prior to the time that any Shares of such Series are outstanding, that the Series
will elect to be treated as a partnership for tax purposes, the Trustees shall determine in their
sole discretion the timing and amount of any distributions to Shareholders of such Series. All
dividends and distributions on Shares of a particular Series or Class shall be distributed pro rata
to the holders of that Series or Class in proportion to the number of Shares of that Series or
Class held by such holders and recorded on the books of the Trust at the date and time of record
established for that payment or such dividend or distributions.
The manner of determining net income, income, asset values, capital gains, expenses,
liabilities and reserves of any Series or Class may from time to time be altered as necessary or
desirable in the judgment of the Trustees to conform such manner of determination to any other
method prescribed or permitted by applicable law. Net income shall be determined by the Trustees
or by such person as they may authorize at the times and in the manner provided in the By-Laws.
Determinations of net income of any Series or Class and determination of income, asset value,
capital gains, expenses, and liabilities made by the Trustees, or by such person as they may
authorize, in good faith, shall be binding on all parties concerned. The foregoing sentence shall
not be construed to protect any Trustee, officer or agent of the Trust against any liability to the
Trust or its security holders to which he would otherwise be subject by reason of willful
misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the
conduct of his office.
If, for any reason, the net income of any Series or Class determined at any time is a negative
amount, the pro rata share of such negative amount allocable to each Shareholder of such Series or
Class shall constitute a liability of such Shareholder to that Series or Class which shall be paid
out of such Shareholders account at such times and in such manner as the Trustees
-14-
may from time to time determine (x) out of the accrued dividend account of such Shareholder,
(y) by reducing the number of Shares of that Series or Class in the account of such Shareholder, or
(z) otherwise.
Section 2.
Allocations
. In respect of any Series that is treated as a partnership
for federal income tax purposes, the Trustees (or such other person designated by the Trustees as
having responsibility for making tax determinations on behalf of the Series) shall have authority
to make special allocations of income, gain, loss or deduction among Shareholders upon withdrawals
or transfers of shares as necessary to avoid mandatory basis adjustments in the assets of the
Series as required by Internal Revenue Code of 1986, as amended (the Code), section 743 or 734
that would otherwise apply as a result of amendments to such Code sections under The American Jobs
Creation Act of 2004, enacted on October 22, 2004.
Section 3.
Redemptions and Repurchases
. The Trust shall purchase such Shares as
are offered by any Shareholder for redemption, upon the presentation of a proper instrument of
transfer together with a request directed to the Trust or a person designated by the Trust that the
Trust purchase such Shares or in accordance with such other procedures for redemption as the
Trustees may from time to time authorize; and the Trust will pay therefor the net asset value
thereof, as determined in accordance with the By-Laws, next determined, less any applicable
redemption fee as the Trustees may approve from time to time. The Board may approve a redemption
fee from time to time applicable to Shares whether such Shares were outstanding at the time of the
Boards approval or issued after the time of the Boards approval.
Payment for said Shares shall be made by the Trust to the Shareholder within seven days after
the date on which the request is made. The obligation set forth in this Section 3 is subject to
the provision that in the event that any time the New York Stock Exchange is closed for other than
weekends or holidays, or if permitted by the rules of the Commission during periods when trading on
the Exchange is restricted or during any emergency which makes it impracticable for the Trust to
dispose of the investments of the applicable Series or to determine fairly the value of the net
assets belonging to such Series (or net assets allocable to such Class) or during any other period
permitted by order of the Commission for the protection of investors, such obligations may be
suspended or postponed by the Trustees. The Trust may also purchase or repurchase Shares at a
price not exceeding the net asset value of such Shares in effect when the purchase or repurchase or
any contract to purchase or repurchase is made.
Payment for any redemption, purchase, or repurchase may be made in cash or in other property,
or in any combination thereof. The composition of any such payment shall be determined by the
Trust in its sole discretion, and the Trust shall have no obligation to effect a pro rata division
of cash or other property in making any such payment. In no case shall the Trust be liable for any
delay of any corporation or other person in transferring securities selected for delivery as all or
part of any payment in kind.
Section 4.
Redemptions at the Option of the Trust
. The Trustees shall have the
right, in their sole discretion, to cause the Trust at any time to redeem Shares of any Shareholder
at the net asset value thereof as described in Section 3 of this Article VI, less any redemption
fee as the Board may approve from time to time as applicable to Shares, whether such Shares were
outstanding at the time of the Boards approval or issued after the time of the Boards approval.
-15-
ARTICLE VII.
Compensation and Limitation of Liability of Trustees
Section 1.
Compensation
. The Trustees as such shall be entitled to reasonable
compensation from the Trust, which compensation shall be determined by the Trustees. Nothing
herein shall in any way prevent the employment of any Trustee for advisory, management, legal,
accounting, investment banking or other services and payment for the same by the Trust.
Section 2.
Limitation of Liability
. A Trustee shall be liable for his own willful
misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the
conduct of the office of Trustee, and for nothing else, and shall not be liable for errors of
judgment or mistakes of fact or law. The Trustees may take advice of counsel or other experts with
respect to the meaning and operation of this Declaration of Trust, and shall be under no liability
for any act or omission in accordance with such advice or for failing to follow such advice. The
Trustees shall not be responsible or liable in any event for any neglect or wrong-doing of any
officer, agent, employee, Manager or principal underwriter of the Trust, nor shall any Trustee be
responsible for the act or omission of any other Trustee, but, for so long as the Trust is
registered as an investment company under the 1940 Act and as long required by Section 17(h) of the
1940 Act, nothing herein contained shall protect any Trustee against any liability to which he
would otherwise be subject by reason of willful misfeasance, bad faith, gross negligence or
reckless disregard of the duties involved in the conduct of his office.
Every note, bond, contract, instrument, certificate or undertaking and every other act or thing
whatsoever issued, executed or done by or on behalf of the Trust or the Trustees or any of them in
connection with the Trust shall be conclusively deemed to have been issued, executed or done only
in or with respect to their or his capacity as Trustees or Trustee, and such Trustees or Trustee
shall not be personally liable thereon.
ARTICLE VIII.
Indemnification
Section 1.
Trustees, Officers, etc.
The Trust shall, to the maximum extent
permitted by applicable law, indemnify each of its Trustees and officers (including persons who
serve at the Trusts request as directors, officers or trustees of another organization in which
the Trust has any interest as a shareholder, creditor or otherwise) (hereinafter referred to as a
Covered Person) against all liabilities and expenses, including but not limited to amounts paid
in satisfaction of judgments, in compromise or as fines and penalties, and counsel fees reasonably
incurred by any Covered Person in connection with the defense or disposition of any action, suit or
other proceedings, whether civil or criminal, before any court or administrative or legislative
body, in which such Covered Person may be or may have been involved as a party or otherwise or with
which such person may be or may have been threatened, while in office or thereafter, by reason of
any alleged act or omission as a Trustee or officer or by reason of his being or having been such a
Trustee or officer, except with respect to any matter as to which such Covered
-16-
Person shall have been finally adjudicated in any such action, suit or other proceeding not to have
acted in good faith in the reasonable belief that such Covered Persons action was in or not
opposed to the best interest of the Trust and except that no Covered Person shall be indemnified
against any liability to the Trust or its Shareholders to which such Covered Person would otherwise
be subject by reason of willful misfeasance, bad faith, gross negligence or reckless disregard of
the duties involved in the conduct of such Covered Persons office. Expenses, including counsel
fees so incurred by any such Covered Person (but excluding amounts paid in satisfaction of
judgments, in compromise or as fines or penalties), shall be paid by the Trust in advance of the
final disposition of any such action, suit or proceeding upon receipt of an undertaking by or on
behalf of such Covered Person to repay amounts so paid to the Trust if it is ultimately determined
that indemnification of such expenses is not authorized under this Article, provided, however, that
(a) such Covered Person shall provide security for his or her undertaking, (b) the Trust shall be
insured against losses arising by reason of such Covered Persons failure to fulfill his or her
undertaking, or (c) either a majority of the Trustees who are disinterested persons (as defined in
Section 4 of this Article VIII) and who are not interested persons of the Trust, as defined in
the 1940 Act (provided that a majority of such Trustees then in office act on the matter), or
independent legal counsel in a written opinion, shall determine, based on a review of readily
available facts (but not a full trial-type inquiry), that there is reason to believe such Covered
Person ultimately will be entitled to indemnification.
Section 2.
Compromise Payment
. As to any matter disposed of (whether by a
compromise payment, pursuant to a consent decree or otherwise) without an adjudication in a
decision on the merits by a court, or by any other body before which the proceeding was brought,
that such Covered Person either (a) did not act in good faith in the reasonable belief that such
Covered Persons action was in or not opposed to the best interests of the Trust or (b) is liable
to the Trust or its Shareholders by reason of willful misfeasance, bad faith, gross negligence or
reckless disregard of the duties involved in the conduct of such Covered Persons office,
indemnification shall be provided if (x) approved as in or not opposed to the best interests of the
Trust, after notice that it involves such indemnification, by at least a majority of the Trustees
who are disinterested persons and are not interested persons of the Trust, as defined in the
1940 Act (provided that a majority of such Trustees then in office act on the matter), upon a
determination, based upon a review of readily available facts (but not a full trial-type inquiry)
that such Covered Person is not liable to the Trust or its Shareholders by reason of willful
misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the
conduct of such Covered Persons office, or (y) there has been obtained an opinion in writing of
independent legal counsel, based upon a review of readily available facts (but not a full
trial-type inquiry), to the effect that such indemnification would not protect such Covered Person
against any liability to the Trust or its Shareholders to which such Covered Person would otherwise
be subject by reason of willful misfeasance, bad faith, gross negligence or reckless disregard of
the duties involved in the conduct of his or her office. Any approval pursuant to this Section 2
shall not prevent the recovery from any Covered Person of any amount paid to such Covered Person in
accordance with this Section 2 as indemnification if such Covered Person is subsequently
adjudicated by a court of competent jurisdiction not to have acted in good faith in the reasonable
belief that such Covered Persons action was in or not opposed to the best interests of the Trust
or to have been liable to the Trust or its Shareholders by reason of willful misfeasance, bad
faith, gross negligence or reckless disregard of the duties involved in the conduct of such Covered
Persons office.
-17-
Section 3.
Rebuttable Presumption
. For purposes of the determination or opinion
referred to in clause (c) of Section 1 of this Article VIII or clauses (x) or (y) of Section 2 of
this Article VIII, the disinterested Trustees acting on the matter or independent legal counsel, as
the case may be, shall be entitled to rely upon a rebuttable presumption that the Covered Person
has not engaged in willful misfeasance, bad faith, gross negligence or reckless disregard of the
duties involved in the conduct of such Covered Persons office.
Section 4.
Indemnification Not Exclusive
. The right of indemnification hereby
provided shall not be exclusive of or affect any other rights to which any such Covered Person may
be entitled, whether by contract or otherwise. As used in this Article VIII, the term Covered
Person shall include such persons heirs, executors and administrators; and a disinterested
Trustee or disinterested person is a Trustee or a person against whom none of such actions,
suits or other proceedings or another action, suit or other proceeding on the same or similar
grounds is then or has been pending. Nothing contained in this Article VIII shall affect the power
of the Trust to purchase and maintain liability insurance on behalf of any such person.
Section 5.
Amendment
. Notwithstanding any other provision of this Declaration of
Trust relating to its amendment generally, any repeal or modification of this Article VIII shall
not adversely affect any right or protection of a Trustee or officer of the Trust with respect to
any acts or omissions of such Trustee or officer occurring prior to such repeal or modification.
Section 6
.
Shareholders
. In case any Shareholder or former Shareholder shall be
held to be personally liable solely by reason of his or her being or having been a Shareholder and
not because of his or her acts or omissions or for some other reason, the Shareholder or former
Shareholder (or his or her heirs, executors, administrators or other legal representative or in the
case of a corporation or other entity, its corporate or other general successor) shall be entitled
to be held harmless from and indemnified against all loss and expense arising from such liability,
but only out of the assets of the particular Series or Class of Shares of which he or she is or was
a Shareholder.
ARTICLE IX.
Miscellaneous
Section 1.
Trustees, Shareholders, etc. Not Personally Liable; Notice
. All persons
extending credit to, contracting with or having any claim against the Trust or any Series or Class
of Shares shall look only to the assets of the Trust, or, to the extent that the liability of the
Trust may have been expressly limited by contract to the assets of a particular Series (or the
assets allocable to a particular Class), only to the assets belonging to the relevant Series (or
allocable to the relevant Class), for payment under such credit, contract or claim; and neither the
Shareholders nor the Trustees, nor any of the Trusts officers, employees or agents, whether past,
present or future, shall be personally liable therefor. Nothing in this Declaration of Trust shall
protect any Trustee against any liability to which such Trustee would otherwise be subject by
reason of willful misfeasance, bad faith, gross negligence or reckless disregard of the duties
involved in the conduct of the office of Trustee.
-18-
Every note, bond, contract, instrument, certificate or undertaking made or issued on behalf of
the Trust by the Trustees, by any officers or officer or otherwise shall give notice that this
Declaration of Trust is on file with the Secretary of The Commonwealth of Massachusetts and shall
recite that the same was executed or made by or on behalf of the Trust or by them as Trustee or
Trustees or as officers or officer or otherwise and not individually and that the obligations of
such instrument are not binding upon any of them or the shareholders individually but are binding
only upon the assets and property of the Trust or upon the assets belonging to the Series (or
allocable to the Class) for the benefit of which the Trustees have caused the note, bond, contract,
instrument, certificate or undertaking to be made, or issued, and may contain such further recital
as he or they may deem appropriate, but the omission of any such recital shall not operate to bind
any Trustee or Trustees or officers or officer or Shareholders or any other person individually.
Section 2.
No Bond or Surety
. The exercise by the Trustees of their powers and
discretions hereunder shall be binding upon everyone interested. The Trustees shall not be
required to give any bond as such, nor any surety if a bond is required.
Section 3.
Liability of Third Persons Dealing with Trustees
. No person dealing
with the Trustees shall be bound to make any inquiry concerning the validity of any transaction
made or to be made by the Trustees or to see to the application of any payments made or property
transferred to the Trust or upon its order.
Section 4.
Termination of Trust or Series or Class
. Unless terminated as provided
herein, the Trust shall continue without limitation of time. The Trust may be terminated at any
time by the Trustees. Any Series may be terminated at any time by the Trustees. Any Class may be
separately terminated at any time by the Trustees.
Upon termination of the Trust (or any Series or Class, as the case may be), after paying or
otherwise providing for all charges, taxes, expenses and liabilities belonging, severally, to each
Series or allocable to each Class (or the applicable Series or Classes, as the case may be),
whether due or accrued or anticipated as may be determined by the Trustees, the Trust shall in
accordance with such procedures as the Trustees consider appropriate reduce the remaining assets
belonging, severally, to each Series or allocable to each Class (or the applicable Series or
Classes, as the case may be), to distributable form in cash or shares or other securities, or any
combination thereof, and distribute the proceeds belonging to each Series or allocable to each
Class (or the applicable Series or Classes, as the case may be), to the Shareholders of that Series
or Class, as a Series or Class, ratably according to the number of Shares of that Series or Class
held by the several Shareholders on the date of termination.
Section 5.
Merger and Consolidation
. The Trustees may cause the Trust or any
Series or Class thereof to be merged or reorganized into or consolidated with another trust or
company (including another Series or Class of the Trust) or its shares exchanged under or pursuant
to any state or federal statute, if any, or otherwise to the extent permitted by law; provided that
in all respects not governed by statute or applicable law, the Trustees shall have power to
prescribe the procedure necessary or appropriate to accomplish a sale of assets, merger or
consolidation.
-19-
Section 6.
Initials GMO and the name Grantham, Mayo, Van Otterloo & Co. LLC
.
The Trust acknowledges that the initials GMO and the name Grantham, Mayo, Van Otterloo & Co.
LLC and any derivatives thereof are owned by the Manager and that the Trust may use the initials
GMO, the name GMO Series Trust, or any other name embodying the initials GMO or the name
Grantham, Mayo, Van Otterloo & Co. LLC only with the consent of the Manager and subject to such
conditions as the Manager may impose. The Trust acknowledges and agrees that as between the
Manager and the Trust, the Manager has the exclusive right to use, or authorize others to use, said
initials and name and the Trust agrees to take such action as may reasonably be requested by the
Manager to give full effect to the provisions of this section (including, without limitation,
consenting to use of said initials and name by others). The Trust agrees that if the Manager
terminates its consent to the use by the Trust of the initials GMO or the name Grantham, Mayo,
Van Otterloo & Co. LLC the Trust will, at the request of the Manager, use its best efforts to
promptly change the name of the Trust (and, as applicable, each Series thereof) so as to eliminate
all reference, if any, to the initials GMO or the name Grantham, Mayo, Van Otterloo & Co. LLC
and will not thereafter transact any business in a name containing the initials GMO or the words
Grantham, Mayo, Van Otterloo & Co. LLC in any form or combination whatsoever, or designate itself
as the same entity as or successor to an entity of such name, or otherwise use the initials GMO
or the name Grantham, Mayo, Van Otterloo & Co. LLC or any other reference to the Manager. Such
covenants on the part of the Trust shall be binding upon it, its Trustees, officers, Shareholders,
creditors and all other persons claiming under or through it.
Section 7.
Filing of Copies, References, Headings
. The original or a copy of this
instrument and of each amendment hereto shall be kept at the office of the Trust. A copy of this
instrument and of each amendment hereto shall be filed by the Trust with the Secretary of The
Commonwealth of Massachusetts and with any other governmental office where such filing may from
time to time be required. Anyone dealing with the Trust may rely on a certificate by an officer of
the Trust as to whether or not any such amendments have been made and as to any matters in
connection with the Trust hereunder; and, with the same effect as if it were the original, may rely
on a copy certified by an officer of the Trust to be a copy of this instrument or of any such
amendments. In this instrument and in any such amendment, references to this instrument, and all
expressions like herein, hereof, and hereunder shall be deemed to refer to this instrument as
amended or affected by any such amendments. Headings are placed herein for convenience of
reference only and shall not be taken as a part hereof or control or affect the meaning,
construction or effect of this instrument. This instrument may be executed in any number of
counterparts each of which shall be deemed an original.
Section 8.
Applicable Law
. This Declaration of Trust is made in The Commonwealth
of Massachusetts, and it is created under and is to be governed by and construed and administered
according to the laws of said Commonwealth. The Trust shall be of the type commonly called a
Massachusetts business trust, and without limiting the provisions hereof, the Trust may exercise
all powers which are ordinarily exercised by such a trust. The Massachusetts Business Corporations
Act and the regulations thereunder shall not apply to the operations of the Trust or this
Declaration of Trust. Should any part of this Declaration of Trust be held or made invalid by a
court decision, statute, rule or otherwise, the remainder of this Declaration of Trust shall not be
affected thereby.
-20-
Section 9.
Amendments
. This Declaration of Trust may be amended, without
Shareholder approval, at any time by the Trustees.
-21-
IN WITNESS WHEREOF, the undersigned Trustee as aforesaid does hereto set his hand this 13
th
day of September, 2011.
|
|
|
|
|
|
|
|
/s/ J.B. Kittredge, Jr.
J.B. Kittredge, Jr.
|
|
|
|
|
Trustee
|
|
|
-22-
Schedule 3.6A to Declaration of Trust
Series
GMO U.S. Core Equity Series Fund
GMO Quality Series Fund
GMO U.S. Intrinsic Value Series Fund
GMO U.S. Growth Series Fund
GMO Foreign Series Fund
GMO International Core Equity Series Fund
GMO International Growth Equity Series Fund
GMO International Large/Mid Cap Value Series Fund
GMO Developed World Stock Series Fund
GMO Emerging Countries Series Fund
GMO Core Plus Bond Series Fund
GMO International Bond Series Fund
GMO Global Asset Allocation Series Fund
GMO Global Equity Allocation Series Fund
GMO International Equity Allocation Series Fund
GMO U.S. Equity Allocation Series Fund
GMO Benchmark-Free Allocation Series Fund
GMO Emerging Country Debt Series Fund
Schedule 3.6B to Declaration of Trust
Classes
Class R1
Class R2
Class R3
Class R4
Class R5
Class R6
Exhibit (g)
CONFORMING CUSTODIAN AGREEMENT
Conforming Custodian Agreement (the Conforming Agreement) made as of this 23
rd
day of August, 2011 by and between GMO Series Trust (the Series Trust), a business trust
established under the laws of the Commonwealth of Massachusetts, and State Street Bank and Trust
Company (as successor by merger to Investors Bank Trust Company) (State Street).
WHEREAS, GMO Trust (the Company), Grantham, Mayo, Van Otterloo & Co. LLC (GMO) and State
Street are party to the Custodian Agreement dated August 1, 1991, as amended, supplemented or
otherwise modified from time to time (the Agreement), pursuant to which State Street agrees to
provide certain services to the Company;
WHEREAS, in connection with the creation of the Series Trust, the parties intend to apply the
terms of the Agreement to the Series Trust, without modifying the terms of the Agreement with
respect to the Company;
NOW, THEREFORE, in connection with the foregoing and in consideration of the mutual covenants
herein set forth, the Series Trust and State Street agree as follows:
|
1.
|
|
The terms of the Agreement shall apply,
mutatis mutandis
, to the Series Trust as if
it were the Company and to each series of the Series Trust as if it were a series of the
Company, provided that all obligations of GMO in the Agreement shall be the obligations of
the Series Trust.
|
|
|
2.
|
|
A list of the series of the Series Trust is set forth in Schedule A, which shall be
amended from time to time in writing by mutual agreement of the Series Trust and State
Street.
|
|
|
3.
|
|
For the avoidance of doubt, the Series Trust and State Street shall be liable to the
other to the extent and under the circumstances described in the Agreement.
|
[signature page immediately follows]
1
IN WITNESS WHEREOF; the parties hereto have caused this Conforming Agreement to be duly
executed as of the day and year first written above.
|
|
|
|
|
|
GMO SERIES TRUST*
|
|
|
By:
|
/s/ JB Kittredge
|
|
|
Name:
|
JB Kittredge
|
|
|
Title:
|
President and Chief Executive Officer
|
|
|
|
|
*
|
|
GMO Series Trust is a Massachusetts business trust and a copy of the Agreement and Declaration
of Trust of GMO Series Trust is on file with the Secretary of State of the Commonwealth of
Massachusetts. Notice is hereby given that this Agreement is executed on behalf of the Trustees of
the Series Trust as Trustees and not individually, and that the obligations of or arising out of
this Agreement with respect to each series of the Series Trust are not binding upon any of the
Trustees or shareholders individually or any other series, but are binding only upon the assets and
property of that series.
|
STATE STREET BANK AND TRUST COMPANY
|
|
|
|
|
|
By:
|
/s/ Michael F. Rogers
|
|
|
Name:
|
Michael F. Rogers
|
|
|
Title:
|
Executive Vice President
|
|
2
SCHEDULE A
LIST OF GMO SERIES TRUST FUNDS
1
GMO U.S. Core Equity Series Fund
3
[This page intentionally left blank.]
Custodian Agreement
Among
GMO trust
and
Grantham, Mayo, Van Otterloo & Co.
and
Investors Bank & Trust Company
TABLE OF CONTENTS
|
|
|
|
|
TOPIC
|
|
PAGE
|
|
1. Bank appointed custodian
|
|
|
1
|
|
|
|
|
|
|
2. Definitions
|
|
|
1
|
|
2.1 Authorized Person
|
|
|
1
|
|
2.2 Security
|
|
|
1
|
|
2.3 Portfolio security
|
|
|
2
|
|
2.4 Officers Certificate
|
|
|
2
|
|
2.5 Book-Entry System
|
|
|
2
|
|
2.6 Depository
|
|
|
2
|
|
|
|
|
|
|
3. Proper Instructions
|
|
|
2
|
|
|
|
|
|
|
4. Separate Accounts
|
|
|
2
|
|
|
|
|
|
|
5. Certification as to Authorized Persons
|
|
|
3
|
|
|
|
|
|
|
6. Custody of Cash and Securities
|
|
|
3
|
|
6.1 Cash
|
|
|
3
|
|
(a) Purchase of Securities
|
|
|
3
|
|
(b) Redemptions
|
|
|
3
|
|
(c) Distributions and Expenses or Fund
|
|
|
3
|
|
(d) Payment in respect of Securities
|
|
|
4
|
|
(e) Repayment of loans
|
|
|
4
|
|
(f) Repayment of Cash
|
|
|
4
|
|
(g) Foreign Exchange Transactions
|
|
|
4
|
|
(h) Other Authorized payments
|
|
|
4
|
|
(i) Termination
|
|
|
4
|
|
6.2 Securities
|
|
|
4
|
|
(a) Book-Entry System
|
|
|
5
|
|
(b) Use of a Depository
|
|
|
6
|
|
(c) Use of Book-Entry System for Commercial Paper
|
|
|
8
|
|
(d) Use of Immobilization Programs
|
|
|
8
|
|
6.3 Options and Futures Transactions
|
|
|
9
|
|
(a) Puts and Calls Traded on Securities Exchanges, NASDAQ or
Over-the-Counter
|
|
|
9
|
|
(b) Puts, Calls and Futures Traded on Commodities
|
|
|
9
|
|
(c) Segregated Account
|
|
|
10
|
|
6.4 Segregated Account for when-issued, forward commitment and reverse
repurchase agreement transactions
|
|
|
10
|
|
6.5 Interest Bearing Call or Time Deposits
|
|
|
11
|
|
|
|
|
|
|
7. Transfer of Securities
|
|
|
11
|
|
|
|
|
|
|
8. Redemptions
|
|
|
12
|
|
|
|
|
|
|
TOPIC
|
|
PAGE
|
|
9. Merger, dissolution, etc. of Trust
|
|
|
13
|
|
|
|
|
|
|
10. Actions of Bank without prior Authorization
|
|
|
13
|
|
|
|
|
|
|
11. Maintenance of Records: Fund Evaluation: Accounting Services
|
|
|
14
|
|
|
|
|
|
|
12. Concerning the Bank
|
|
|
15
|
|
12.1 Performance of Duties
|
|
|
15
|
|
12.2 Fees and Expenses of Bank
|
|
|
16
|
|
12.3 Advances by Bank
|
|
|
17
|
|
|
|
|
|
|
13. Termination
|
|
|
17
|
|
|
|
|
|
|
14. Notices
|
|
|
18
|
|
|
|
|
|
|
15. Amendments
|
|
|
19
|
|
|
|
|
|
|
16. Parties
|
|
|
19
|
|
|
|
|
|
|
17. Governing Law
|
|
|
19
|
|
|
|
|
|
|
18. Limitation of Liability
|
|
|
19
|
|
|
|
|
|
|
Schedule A Custody of Foreign Securities
|
|
|
21
|
|
CUSTODIAN AGREEMENT
AGREEMENT made this 1st day of August, 1991 by and among
GMO Trust
, a business trust
established under the laws of the Commonwealth of Massachusetts (the
Trust
) on behalf of the GMO
Core Fund, GMO SAF Core Fund, GMO Value Allocation Fund, GMO Growth Fund, GMO Short-Term Income
Fund and any other series of the Trust, currently existing or hereafter created, as shall be
mutually agreed to by the parties hereto to be subject to this Agreement (each such series referred
to herein as the
Fund
and collectively as the
Funds
),
Grantham, Mayo, Van Otterloo & Co.
, a
Massachusetts general partnership, (the
Manage
r) and Investors Bank & Trust Company, a
Massachusetts trust company (the
Bank
).
The Trust, an open-end management investment company, desires to place and maintain all of its
portfolio securities and cash in the custody of the Bank. The Bank has at least the minimum
qualifications required by Section 17(f)(1) of the Investment Company Act of 1940 to act as
custodian of the portfolio securities and cash of the Trust, and has indicated its willingness to
so act, subject to the terms and conditions of this Agreement.
NOW, THEREFORE, in consideration of the premises and of the mutual agreements contained herein, the
parties hereto agree as follows:
1. Bank appointed custodian
. The Trust hereby appoints the Bank as custodian; of its
portfolio securities and cash delivered to the Bank as hereinafter described and to perform such
duties and provide such services as are set forth on any schedule hereto, and the Bank agrees to
act as such upon the terms and conditions hereinafter set forth.
2. Definitions
. Whenever used herein, the terms listed below will have the following meaning:
2.1
Authorized Person
. Authorized Person will mean any of the persons duly authorized
to give Proper Instructions or otherwise act on behalf of the Trust by appropriate
resolution of the Trustees of the Trust.
2.2
Security
. The term security as used herein will have the same meaning as when such
term is used in the Securities Act of 1933 as amended, including, without limitation, any
note, stock, treasury stock, bond, debenture, evidence of indebtedness, certificate of
interest or participation in any profit sharing agreement, collateral-trust certificate,
preorganization certificate or subscription, transferable share, investment contract,
voting-trust certificate, certificate of deposit for a security, fractional undivided
interest in oil, gas, or other mineral rights, any put, call, straddle, option, or privilege
on any security, certificate of deposit, or group or index of securities (including any
interest therein or based on the value thereof), or any put, call, straddle, option, or
privilege entered into on a national securities exchange relating to a foreign currency, or,
in general, any interest or instrument commonly known as a security, or any certificate of
interest or participation in, temporary or interim certificate for, receipt for, guarantee
of,
or warrant or right to subscribe to, or option contract to purchase or sell any of the
foregoing and futures, forward contracts and options thereon.
Page 1
2.3
Portfolio security
. Portfolio security will mean any security owned by the Trust.
2.4
Officers Certificate
. Officers Certificate will mean unless otherwise indicated,
any request, direction, instruction, or certification in writing signed by any two
Authorized Persons of the Trust.
2.5
Book-Entry System
. Book-Entry System shall mean the Federal Reserve-Treasury
Department Book Entry System for United States government, instrumentality and agency
securities operated by the Federal Reserve Bank, its successor or successors and its nominee
or nominees.
2.6
Depository
. Depository shall mean The Depository Trust Company (
DTC
), a clearing
agency registered with the Securities and Exchange Commission under Section 17A of the
Securities Exchange Act of 1934, its successor or successors and its nominee or nominees.
The term Depository shall further mean and include any other person authorized to act as a
depository under the Investment Company Act of 1940, its successor or successors and its
nominee or nominees, specifically identified in a certified copy of a resolution of the
Trustees of the Trust.
3. Proper Instructions
. Proper Instructions shall mean (i) instructions regarding the
purchase or sale of securities for the portfolio of the Trust, and payments and deliveries in
connection therewith, given by an Authorized Person as shall have been designated in an Officers
Certificate, such instructions to be given in such form and manner as the Bank and the Trust shall
agree upon from time to time, and (ii) instructions (which may be continuing instructions)
regarding other matters signed or initialed by such one or more persons from time to time
designated in an Officers Certificate as having been authorized by the Trustees of the Trust.
Oral instructions will be considered Proper Instructions if the Bank reasonably believes them to
have been given by a person authorized to give such instructions with respect to the transaction
involved. The Trust shall cause all oral instructions to be promptly confirmed in writing. The
Bank shall act upon and comply with any subsequent Proper Instruction which modifies a prior
instruction and the sole obligation of the Bank with respect to any follow-up or confirmatory
instruction shall be to make reasonable efforts to detect any discrepancy between the original
instruction and such confirmation and to report such discrepancy to the Trust. The Trust shall be
responsible, at the Trusts expense, for taking any action, including any reprocessing, necessary
to correct any such discrepancy or error, and to the extent such action requires the Bank to act
the Trust shall give the Bank specific Proper Instructions as to the action required. Upon receipt
of an Officers Certificate as to the authorization by the Trustees of the Trust accompanied by a
detailed description of procedures approved by the Trust, Proper Instructions may include
communication effected directly between electro-mechanical or
electronic devices provided that the Trustees and the Bank are satisfied that such procedures
afford adequate safeguards for the Trusts assets.
4. Separate Accounts
. The Bank will establish a Separate Account for each Fund of the Trust,
and deposit and maintain therein the assets of such Fund (and all investment earnings thereon).
Any references in this Agreement to the Trust shall be deemed to be references to the separate
Funds as appropriate.
Page 2
5. Certification as to Authorized Persons
. The Secretary or Assistant Secretary of the Trust
will at all times maintain on file with the Bank his certification to the Bank, in such form as may
be acceptable to the Bank, of (i) the names and signatures of the Authorized Persons and (ii) the
names of the members of the Trustees of the Trust, it being understood that upon the occurrence of
any change in the information set forth in the most recent certification on file (including without
limitation any person named in the most recent certification who is no longer an Authorized Person
as designated therein), the Secretary or Assistant Secretary of the Trust will sign a new or
amended certification setting forth the change and the new, additional or omitted names or
signatures. The Bank will be entitled to rely and act upon any Officers Certificate given to it
by the Trust which has been signed by officers named in the most recent certification.
6. Custody of Cash and Securities
. Except as set forth on Schedule A hereto with respect to
assets of the Trust held outside of the U.S., as custodian for the Trust, the Bank will keep safely
all of the portfolio securities delivered to the Bank, and will deposit to the account of the Trust
all of the cash of the Trust delivered to the Bank, as set forth below.
6.1
Cash
. The Bank will open and maintain a separate account or accounts in the name
of the Trust or in the name of the Bank, as custodian of the Trust, subject only to draft or
order by the Bank acting pursuant to the terms of this Agreement. The Bank will hold in
such account or accounts as custodian, subject to the provisions hereof, all cash received
by it, including borrowed funds, for the account of the Trust. Upon receipt by the Bank of
Proper Instructions (which may be continuing instructions) or in the case of payments for
redemptions and repurchases of outstanding shares of common stock of the Trust, notification
from the Trusts transfer agent as provided in Section 8, requesting such payment,
designating the payee or the account or accounts to which the Bank will release funds for
deposit, and stating that it is for a purpose permitted under the terms of this Section 6.1,
specifying the applicable subsection, or describing such purpose with sufficient
particularity to permit the Bank to ascertain the applicable subsection, the Bank will make
payments of cash held for the accounts of the Trust, insofar as funds are available for that
purpose, only as permitted in (a)-(i) below.
(a)
Purchase of Securities:
upon the purchase of securities for the Trust, against
contemporaneous receipt of such securities or, where appropriate, satisfactory evidence of
title thereto by the Bank registered in the name of the Trust or in the name of, or properly
endorsed and in form for transfer to, the Bank, or a nominee of the Bank, or
receipt for the account of the Bank through use of (1) the Book-Entry System pursuant
to Section 6.2(a)(3) below, (2) Depository pursuant to 6.2(b) below, or (3) Book Entry Paper
pursuant to Section 62(c) below, each such payment to be made at the purchase price shown in
the Proper Instructions received by the Bank before such payment is made;
(b)
Redemptions:
in such amount as may be necessary for the repurchase or redemption of
shares of beneficial interest of the Trust offered for repurchase or redemption in
accordance with Section 8 of this Agreement;
(c)
Distributions and Expenses or Fund:
for the payment on the account of the Trust of
dividends or other distributions to shareholders as may from time to time be declared by the
Trustees of the Trust, interest, taxes, management or supervisory fees,
Page 3
distribution fees,
fees of the Bank for its services hereunder and reimbursement of the expenses and
liabilities of the Bank as provided hereunder, fees of any transfer agent, fees for legal,
accounting, and auditing services, or other operating expenses of the Trust;
(d)
Payment in respect of Securities:
for payments in connection with the conversion,
exchange or surrender of portfolio securities or securities subscribed to by the Trust held
by or to be delivered to the Bank;
(e)
Repayment of loans:
to repay loans of money made to the Trust, but, in the case of
final payment, only upon redelivery to the Bank of any portfolio securities pledged or
hypothecated therefor and upon surrender of documents evidencing the loan;
(f)
Repayment of Cash:
to repay the cash delivered to the Trust for the purpose of
collateralizing the obligation to return to the Trust certificates borrowed from the Trust
representing portfolio securities, but only upon redelivery to the Bank of such borrowed
certificates;
(g)
Foreign Exchange Transactions:
for payments in connection with foreign exchange
contracts or options to purchase and sell foreign currencies for spot and future delivery
which may be entered into by the Bank on behalf of the Trust upon the receipt of Proper
Instructions, such Proper Instructions to specify the currency broker or banking institution
(which may be the Bank, or any other subcustodian or agent hereunder, acting as principal)
with which the contract or option is made, and the Bank shall have no duty with respect to
the selection of such currency brokers or banking institutions with which the Trust deals or
for their failure to comply with the terms of any contract or option;
(h)
Other Authorized payments:
for other authorized transactions of the Trust, or other
obligations of the Trust incurred for proper Trust
purposes; provided that before making any such payment the Bank will also receive a
certified copy of a resolution of the Trustees signed by an Authorized Person of the Trust
(other than the Person certifying such resolution) and certified by its Secretary or
Assistant Secretary, naming the person or persons to whom such payment is to be made, and
either describing the transaction for which payment is to be made and declaring it to be an
authorized transaction of the Trust, or specifying the amount of the obligation for which
payment is to be made, setting forth the purpose for which such obligation was incurred and
declaring such purpose to be a proper corporate purpose; and
(i)
Termination:
upon the termination of this Agreement as hereinafter set forth
pursuant to Section 9 and Section 13 of this Agreement.
The Bank is hereby authorized to endorse for collection and collect on behalf of and in
the name of the Trust all checks, drafts, or other negotiable or transferable instruments or
other orders for the payment of money received by it for the account of the Trust.
6.2
Securities
. Except as otherwise provided herein, the Bank as custodian, will
receive and hold pursuant to the provisions hereof, in a separate account or accounts and
physically segregated at all times from those of other persons, any and all portfolio
securities which may now or hereafter be delivered to it by or for the account of the
Page 4
Trust.
All such portfolio securities will be held or disposed of by the Bank for, and subject at
all times to, the instructions of the Trust pursuant to the terms of this Agreement.
Subject to the specific provisions herein relating to securities that are not physically
held by the Bank, the Bank will register all portfolio securities (unless otherwise directed
by Proper Instructions or an Officers Certificate), in the name of a registered nominee of
the Bank as defined in the Internal Revenue Code and any Regulations of the Treasury
Department issued thereunder, and will execute and deliver all such certificates in
connection therewith as may be required by such laws or regulations or under the laws of any
State. The Bank will use its best efforts to the end that the specific securities held by
it hereunder will be at all times identifiable.
The Bank will use the same care with respect to the safekeeping of portfolio securities
and cash of the Trust held by it as it uses in respect of its own similar property but it
need not maintain any special insurance for the benefit of the Trust.
The Trust will from time to time furnish to the Bank appropriate instruments to enable
it to hold or deliver in proper form for transfer, or to register in the name of its
registered nominee, any securities which it may hold for the account of the Trust and which
may from time to time be registered in the name of the Trust.
Neither the Bank nor any nominee of the Bank will vote any of the portfolio securities
held hereunder by or for the account of the Trust, except in accordance with Proper
Instructions or an Officers Certificate.
The Bank will execute and deliver, or cause to be executed and delivered, to the Trust
all notices, proxies and proxy soliciting materials with respect to such securities, such
proxies to be executed by the registered holder of such securities (if registered
otherwise than in the name of the Trust), but without indicating the manner in which
such proxies are to be voted.
(a)
Book-Entry System.
Provided (i) the Bank has received a certified copy of a
resolution of the Trustees of the Trust specifically approving deposits of Trust assets in
the Book-Entry System, and (ii) for each year following such approval, the Trustees of the
Trust have reviewed and approved the arrangement and have not delivered an Officers
Certificate to the Bank indicating that the Trustees have withdrawn their approval:
1. The Bank may keep Securities of the Trust in the Book-Entry System provided that
such securities are represented in an account (
Account
) of the Bank (or its agent) in such
System which shall not include any assets of the Bank (or such agent) other than assets held
as a fiduciary, custodian, or otherwise for customers.
2. The records of the Bank (and any such agent) with respect to the Trusts
participation in the Book-Entry System through the Bank (or any such agent) will identify by
book entry securities belonging to the Trust which are included with other securities
deposited in the Account and shall at all times during the regular business hours of the
Bank (or such agent) be open for inspection by duly authorized officers, employees or agents
of the Trust. Where securities are transferred to the Trusts account, the Bank shall also,
by book entry or otherwise, identify as belonging to the Trust a quantity of
Page 5
securities in
fusible bulk of securities (i) registered in the name of the Bank or its nominee, or (ii)
shown on the Banks account on the books of the Federal Reserve Bank
3. The Bank (or its agent) shall pay for securities purchased for the account of the
Trust or shall pay cash collateral against the return of securities loaned by the Trust upon
(i) receipt of advice from the Book-Entry System that such Securities have been transferred
to the Account, and (ii) the making of an entry on the records of the Bank (or its agent) to
reflect such payment and transfer for the account of the Trust. The Bank (or its agent)
shall transfer securities sold or loaned for the account of the Trust upon
(i) receipt of advice from the Book-Entry System that payment for
Securities sold or payment of the initial cash collateral against the delivery
of securities loaned by the Trust has been transferred to the Account, and
(ii) the making of an entry on the records of the Bank (or its agent) to
reflect such transfer and payment for the account of the Trust. Copies of all
advices from the Book-Entry System of transfers of Securities for the account of
the Trust shall identify the Trust, be maintained for the Trust by the Bank and
shall be provided to the Trust at its request. The Bank shall send the Trust a
confirmation, as defined by Rule 17f-4, under the Investment Company Act of
1940, of any transfers to or from the account of the Trust.
4. The Bank will promptly provide the Trust with any report obtained by the Bank or its
agent on the Book-Entry Systems accounting system, internal accounting control and
procedures for safeguarding securities deposited in the Book-Entry System. The Bank will
provide the Trust and cause any such agent to provide, at such times as the
Trust may reasonably require, with reports by independent public accountants on the
accounting system, internal accounting control and procedures for safeguarding securities,
including Securities deposited in the Book-Entry System, relating to the services provided
by the Bank or such agent under the Agreement.
5. Anything to the contrary in the Agreement notwithstanding, the Bank shall be liable
to the Trust for any loss or damage to the Trust resulting from use of the Book-Entry System
by reason of any negligence, willful misfeasance or bad faith of the Bank or any of its
agents or of any of its or their employees or from any reckless disregard by the Bank or any
such agent of its duty to enforce effectively such rights as it may have against the
Book-Entry System; at the election of the Trust, it shall be entitled to be subrogated for
the Bank in any claim against the Book-Entry System or any other person which the Bank or
its agent may have as a consequence of any such loss or damage if and to the extent that the
Trust has not been made whole for any loss or damage.
(b)
Use of a Depository.
Provided (i) the Bank has received a certified copy of a
resolution of the Trustees of the Trust specifically approving deposits in DTC or other such
Depository and (ii) for each year following such approval, the Trustees of the Trust have
reviewed and approved the arrangement and have not delivered an Officers Certificate to the
Bank indicating that the Trustees have withdrawn their approval:
Page 6
1. The Bank may use a Depository to hold, receive, exchange, release, lend, deliver
and otherwise deal with the securities owned by the Trust, including stock dividends,
rights and other items of like nature, and to receive and remit to the Bank on behalf of
the Trust all income and other payments thereon and to take all steps necessary and
proper in connection with the collection thereof.
2. Registration of the Trusts securities may be made in the name of any nominee or
nominees used by such Depository.
3. Payment for securities purchased and sold may be made through the clearing
medium employed by such Depository for transactions of participants acting through it.
Upon any purchase of securities for the account of the Trust, payment will be made only
upon delivery of the securities to or for the account of the Trust and the Trust shall
pay cash collateral against the return of securities loaned by the Trust only upon
delivery of the securities to or for the account of the Trust; and upon any sale of
securities for the account of the Trust, delivery of the securities will be made only
against payment thereof or, in the event securities are loaned, delivery of securities
will be made only against receipt of the initial cash collateral to or for the account
of the Trust.
4. The Bank shall be subject to the same liability and duty to the Trust and its
shareholders with respect to all securities of the Trust, and all cash, stock dividends,
rights and items of like nature to which the Trust is entitled, held or received by a
central securities system as agent for the Bank, pursuant to the foregoing
authorization, as if the same were held or received by the Bank at its own offices. In
this connection, with respect to the use of the Depository by the Bank but
without limiting the foregoing duty or liability, the Bank, without cost to the
Trust, shall ensure that:
(i) The Depository obtains replacement of any certificated security
deposited with it in the event such security is lost, destroyed, wrongfully
taken or otherwise not available to be returned to the Bank upon its request;
(ii) Any proxy materials received by Depository with respect to securities
of the Trust deposited with such Depository are forwarded immediately to the
Bank for prompt transmittal to the Trust;
(iii) Such Depository immediately forwards to the Bank confirmation of any
purchase or sale of securities for the account of the Trust and of the
appropriate book entry made by such Depository to the Trusts account;
(iv) Such Depository prepares and delivers to the Bank such records with
respect to the performance of the Banks obligations and duties hereunder as may
be necessary for the Trust to comply with the recordkeeping requirements of
Section 31(a) of the Investment Company Act of 1940 and Rules 31a-1 and 31a-2
thereunder; and
(v) Such Depository delivers to the Bank and the Trust all internal
accounting control reports, whether or not audited by an independent public
Page 7
accountant, as well as such other reports as the Trust may reasonably request in
order to verify the Trusts securities held by such Depository.
(c)
Use of Book-Entry System for Commercial Paper.
Provided (i) the Bank has received
a certified copy of a resolution of the Trustees of the Trust specifically approving
participation in a system maintained by the Bank for the holding of commercial paper in
book-entry form (
Book Entry Paper
) and (ii) for each year following such approval the
Trustees of the Trust have received and approved the arrangements, upon receipt of Proper
Instructions and upon receipt of confirmation from an Issuer (as defined below) that the
Trust has purchased such Issuers Book Entry Paper, the Bank shall issue and hold in
book-entry form, on behalf of the Trust, commercial paper issued by issuers with whom the
Bank has entered into a book-entry agreement (the
Issuers
). In maintaining its Book Entry
Paper System, the Bank agrees that:
1. the Bank will maintain all Book Entry Paper held by the Trust in an account
of the Bank that includes only assets held by it for customers;
2. the records of the Bank with respect to the Trusts purchase of Book Entry
Paper through the Bank will identify, by book entry, Commercial Paper belonging to
the Trust which is included in the Book Entry Paper System and shall at all times
during the regular business hours of the Bank be open for inspection by duly
authorized officers, employees or agents of the Trust.
3. (a) The Bank shall pay for Book Entry Paper purchased for the account of the
Trust upon contemporaneous (i) receipt of advice from the Issuer that such sale of
Book Entry Paper has been effected, and (ii) the making of an entry on the records
of the Bank to reflect such payment and transfer for the account of the Trust.
(b) The Bank shall cancel such Book Entry Paper obligation upon the maturity
thereof upon contemporaneous (i) receipt of advice that payment for such Book Entry
Paper has been transferred to the Trust, and (ii) the making of an entry on the
records of the Bank to reflect such payment for the account of the Trust;
4. the Bank shall transmit to the Trust a transaction journal confirming each
transaction in Book Entry Paper for the account of the Trust on the next business
day following the transactions; and
5. the Bank will send to the Trust such reports on its system of internal
accounting control as the Trust may reasonably request from time to time.
(d)
Use of Immobilization Programs.
Provided (i) the Bank has received a certified
copy of a resolution of the Trustees of the Trust specifically approving the maintenance of
portfolio securities in an immobilization program operated by a bank which meets the
requirements of Section 26(a)(1) of the Investment Company Act of 1940, and (ii) for each
year following such approval the Trustees of the Trust have reviewed and approved the
arrangement and have not delivered an Officers Certificate to the Bank indicating that the
Trustees have withdrawn their approval, the Bank shall enter into such immobilization
program with such bank acting as a subcustodian hereunder.
Page 8
6.3
Options and Futures Transactions
.
(a)
Puts and Calls Traded on Securities Exchanges, NASDAQ or Over-the-Counter
.
1. The Bank shall take action as to put options (
puts
) and call
options (
calls
) purchased or sold (written) by the Trust regarding escrow
or other arrangements (i) in accordance with the provisions of any agreement
entered into upon receipt of Proper Instructions between the Bank, any
broker-dealer registered under the Securities Exchange Act of 1934 and a
member of the National Association of Securities Dealers, Inc., and, if
necessary, the Trust relating to the compliance with the rules of the
Options Clearing Corporation and of any registered national securities
exchange, or of any similar organization or organizations.
2. Unless another agreement requires it to do so, the Bank shall be
under no duly or obligation to see that the Trust has deposited or
is maintaining adequate margin, if required, with any broker in
connection with any option, nor shall the Bank be under duty or obligation
to present such option to the broker for exercise unless it receives Proper
Instructions from the Trust. The Bank shall have no responsibility for the
legality of any put or call purchased or sold on behalf of the Trust, the
property of any such purchase or sale, or the adequacy of any collateral
delivered to a broker in connection with an option or deposited to or
withdrawn from a Segregated Account as described in subparagraph c of this
Section 6.3. The Bank specifically, but not by way of limitation, shall not
be under any duty or obligation to: (i) periodically check or notify the
Trust that the amount of such collateral held by a broker or held in a
Segregated Account as described in subparagraph (c) of this Section 6.3 is
sufficient to protect such broker of the Trust against any loss; (ii) effect
the return of any collateral delivered to a broker, or (iii) advise the
Trust that any option it holds, has or is about to expire. Such duties or
obligations shall be the sole responsibility of the Trust.
(b)
Puts, Calls and Futures Traded on Commodities
.
1. The Bank shall take action as to puts, calls and futures contracts
(
Futures
) purchased or sold by the Trust in accordance with the provisions
of any agreement among the Trust, the Bank and a Futures Commission Merchant
registered under the Commodity Exchange Act, relating to compliance with the
rules of the Commodity Futures Trading Commission and/or any Contract
Market, or any similar organization or organizations, regarding account
deposits in connection with transactions by the Trust.
2. The responsibilities and liabilities of the Bank as to Futures, puts
and calls traded on commodities exchanges, any Futures Commission Merchant
account and the Segregated Amount shall be limited as set forth in
subparagraph (a)(2) of this Section 6.3 as if such
Page 9
subparagraph referred to
Futures Commission Merchants rather than brokers, and Futures and puts and
calls thereon instead of options.
(c)
Segregated Account
. The Bank shall upon receipt of Proper Instructions
establish and maintain a Segregated Account or Accounts for and on behalf of the
Trust, into which Account or Accounts may be transferred cash and/or securities
including securities maintained in an Account by the Bank pursuant to Section 6.2
hereof, (i) in accordance with the provisions of any agreement among the Trust, the
Bank and a broker/dealer registered under the Exchange Act and a member of the NASD
or any Futures Commission Merchant registered under the Commodity Exchange Act,
relating to compliance with the rules of the Options Clearing Corporation and of any
registered national securities exchange or the Commodity Futures Trading Commission
or any registered Contract Market, or of any similar organization or organizations
regarding escrow
or other arrangements in connection with transactions by the Trust, and (ii)
for the purpose of segregating cash or securities in connection with options
purchased, or written by the Trust or commodity futures purchased or written by the
Trust, and (iii) for the purposes of compliance by the Trust with the procedures
required by Investment Company Act Release No. 10666, or any subsequent release or
releases of the Securities and Exchange Commission relating to the maintenance of
Segregated Accounts by registered investment companies and (iv) for other proper
corporate purposes, but only, in the case of clause (iv), upon receipt of, in
addition to Proper Instructions, a certified copy of a resolution of the Trustees of
the Trust, or of the Executive Committee signed by an officer of the Trust and
certified by the Secretary or an Assistant Secretary, setting forth the purpose or
purposes of such Segregated Account and declaring such purposes to be proper
corporate purposes.
6.4
Segregated Account for when-issued, forward commitment and reverse repurchase
agreement transactions
. Notwithstanding any other provisions hereof, the Bank will maintain
a segregated account (the
Segregated Account
) in the name of the Trust (i) for the deposit
of liquid assets, such as cash, U.S. Government securities or other high grade debt
obligations, having a market value (marked to the market on a daily basis) at all times
equal to not less than the aggregate purchase price due on the settlement dates of all the
Trusts then outstanding forward commitment or when-issued agreements relating to the
purchase of portfolio securities and all the Trusts then outstanding commitments under
reverse repurchase agreements entered into with broker-dealer firms, and (ii) for the
deposit of any portfolio securities which the Trust has agreed to sell on a forward
commitment basis, all in accordance with Investment Company Act Release No. 10666. No
assets shall be deposited in the Segregated Account except pursuant to Proper Instructions.
Assets may be withdrawn from the Segregated Account pursuant to Proper Instructions
only (a) for sale or delivery to meet the Trusts obligations under outstanding firm
commitment or when-issued agreements for the purchase of portfolio securities and under
reverse repurchase agreements, (b) for exchange for other liquid assets of equal or greater
value deposited in the Segregated Account, (c) to the extent that the Trusts outstanding
forward commitment or when-issued agreements for the purchase of portfolio securities or
reverse repurchase agreements are sold to other parties or the
Page 10
Trusts obligations
thereunder are met from assets of the Trust other than those in the Segregated Account, or
(d) for delivery upon settlement of a forward commitment agreement for the sale of portfolio
securities.
6.5
Interest Bearing Call or Time Deposits
. The Bank shall, upon receipt of Proper
Instructions relating to the purchase by the Trust of interest bearing fixed term and call
deposits, transfer cash, by wire or otherwise, in such amounts and to such bank or banks as
shall be indicated in such Proper Instructions. The Bank shall include in its records with
respect to the assets of the Trust appropriate notation as to the amount of each such
deposit, the banking institution with which such deposit is made (the
Deposit Bank
), and
shall retain such forms of advice
or receipt evidencing the deposit, if any, as may be forwarded to the Bank by the
Deposit Bank. Such deposits shall be deemed portfolio securities of the Trust and the
responsibility of the Bank therefore shall be the same as and no greater than the Banks
responsibility in respect of other portfolio securities of the Trust.
7. Transfer of Securities
. The Bank will transfer, exchange, deliver or release portfolio
securities held by it hereunder, insofar as such securities are available for such purpose,
provided that before making any transfer, exchange, delivery or release under this Section the Bank
will receive Proper Instructions requesting such transfer, exchange or delivery stating that it is
for a purpose permitted under the terms of this Section 7, specifying the applicable subsection, or
describing the purpose of the transaction with sufficient particularity to permit the Bank to
ascertain the applicable subsection, only
(a) upon sales of portfolio securities for the account of the Trust, against
contemporaneous receipt by the Bank of payment therefor in full, each such payment to be in
the amount of the sale price set forth in the Proper Instructions received by the Bank
before such payment is made;
(b) in exchange for or upon conversion into other securities alone or other securities
and cash pursuant to any plan of merger, consolidation, reorganization, share split-up,
change in par value, recapitalization or readjustment or otherwise, upon exercise of
subscription, purchase or sale or other similar rights represented by such portfolio
securities, or for the purpose of tendering shares in the event of a tender offer therefor,
provided however that in the event of an offer of exchange, tender offer, or other exercise
of rights requiring the physical tender or delivery of portfolio securities, the Bank shall
have no liability for failure to so tender in a timely manner unless such Proper
Instructions are received by the Bank at least two business days prior to the date required
for tender, and unless the Bank (or its agent or subcustodian hereunder) has actual
possession of such security at least two business days prior to the date of tender;
(c) upon conversion of portfolio securities pursuant to their terms into other
securities;
(d) for the purpose of redeeming in kind shares of the trust upon authorization from
the Trust;
(e) in the case of option contracts owned by the Trust, for presentation to the
endorsing broker;
Page 11
(f) when such portfolio securities are called, redeemed or retired or otherwise become
payable;
(g) for the purpose of effectuating the pledge of portfolio securities held by the Bank
pursuant to this Agreement in order to collateralize loans made to the Trust by any bank,
including the Bank; provided, however, that such portfolio securities will be released only
upon payment to the Bank for the account of the Trust of the monies borrowed, except that in
cases where additional collateral is required to secure a borrowing already made, and such
fact is made to appear in the Proper Instructions, further portfolio securities may be
released for that purpose without any such payment.
In the event that any such pledged portfolio securities are held by the Bank, they will
be so held for the account of the lender, and after notice to the Trust from the lender in
accordance with the normal procedures of the lender, that an event of deficiency or default
on the loan has occurred, the Bank may deliver such pledged portfolio securities to or for
the account of the lender;
(h) for the purpose of releasing certificates representing portfolio securities of the
Trust, against contemporaneous receipt by the Bank of the fair market value of such
security, as set forth in Proper Instructions received by the Bank before such payment is
made;
(i) for the purpose of delivering securities lent by the Trust to a bank or broker
dealer, but only against receipt in accordance with street delivery custom except as
otherwise provided in Subsections 6.2(a) and (b) hereof, of adequate collateral as agreed
upon from time to time by the Trust and the Bank, and upon receipt of payment in connection
with any repurchase agreement relating to such securities entered into by the Trust;
(j) for other authorized transactions of the Trust or for other proper corporate
purposes; provided that before making such transfer, the Bank will also receive a certified
copy of resolutions of the Trustees of the Trust, signed by an authorized officer of the
Trust (other than the officer certifying such resolution) and certified by its Secretary or
Assistant Secretary, specifying the portfolio securities to be delivered, setting forth the
transaction in or purpose for which such delivery is to be made, declaring such transaction
to be an authorized transaction of the Trust or such purpose to be a proper corporate
purpose, and naming the person or persons to whom delivery of such securities shall be made;
and
(k) upon termination of this Agreement as hereinafter set forth pursuant to Section 9
and Section 13 of this Agreement.
As to any deliveries made by the Bank pursuant to subsections (a), (b), (c), (e), (f),
(g), (h) and (i) securities or cash receivable in exchange therefor shall be delivered to
the Bank.
8. Redemptions
. In the case of payment of assets of the Trust held by the Bank in connection
with redemptions and repurchases by the Trust of outstanding shares of beneficial interest, the
Bank will rely on notification by the Trusts transfer agent of receipt of a request for redemption
and certificates, if issued, in proper form for redemption before such payment is
Page 12
made. Payment
shall be made in accordance with the Declaration of Trust of the Trust, from assets available for
said purpose.
9. Merger, dissolution, etc. of Trust
. In the case of the following transactions, not in the
ordinary course of business, namely, the merger of the Trust into or the consolidation of the Trust
with another investment company, the sale by the Trust of all, or substantially all, of its assets
to another investment company, or the liquidation or dissolution of the Trust and distribution of
its assets, the Bank will deliver the portfolio securities held by it under this Agreement and
disburse cash only upon the order of the Trust set forth in an Officers
Certificate, accompanied by a certified copy of a resolution of the Trustees of the Trust
authorizing any of the foregoing transactions. Upon completion of such delivery and disbursement
and the payment of the fees, disbursements and expenses of the Bank, this Agreement will terminate.
10. Actions of Bank without prior Authorization
. Notwithstanding anything herein to the
contrary, unless and until the Bank receives an Officers Certificate to the contrary, it will
without prior authorization or instruction of the Trust or the transfer agent:
10.1 Receive and hold for the account of the Trust hereunder and deposit in the account
or accounts referred to in Section 6 hereof, all income, dividends, interest and other
payments or distribution of cash with respect to the portfolio securities held thereunder;
10.2 Present for payment all coupons and other income items held by it for the account
of the Trust which call for payment upon presentation and hold the cash received by it upon
such payment for the account of the Trust account or accounts referred to in Section 6
hereof;
10.3 Receive and hold for the account of the Trust hereunder and deposit in the account
or accounts referred to in Section 6 hereof all securities received as a distribution on
portfolio securities as a result of a stock dividend, share split-up, reorganization,
recapitalization, merger, consolidation, readjustment, distribution of rights and similar
securities issued with respect to any portfolio securities held by it hereunder;
10.4 Execute as agent on behalf of the Trust all necessary ownership and other
certificates and affidavits required by the Internal Revenue Code or the regulations of the
Treasury Department issued thereunder, or by the laws of any state, now or hereafter in
effect, inserting the Trusts name on such certificates as the owner of the securities
covered thereby, to the extent it may lawfully do so and as may be required to obtain
payment in respect thereof. The Bank will execute and deliver such certificates in
connection with portfolio securities delivered to it or by it under this Agreement as may be
required under the provisions of the Internal Revenue Code and any Regulations of the
Treasury Department issued thereunder, or under the laws of any State;
10.5 Present for payment all portfolio securities which are called, redeemed, retired
or otherwise become payable, and hold cash received by it upon payment for the account of
the Trust in the account or accounts referred to in Section 6 hereof; and
10.6 Exchange interim receipts or temporary securities for definitive securities.
Page 13
The Bank will use all reasonable effort to collect any funds which may to its knowledge become
collectible arising from such securities, including dividends, interest and other income, and to
transmit to the Trust notice actually received by it of any call for redemption, offer of exchange,
right of subscription, reorganization or other proceedings affecting such securities.
If portfolio securities upon which such income is payable are in default or payment is refused
after due demand or presentation, the Bank will notify the Trust in writing of any default
or refusal to pay within two business days from the day on which it receives knowledge of such
default or refusal. In addition, the Bank will send the Trust a written report once each month
showing any income on any portfolio security held by it which is more than ten days overdue on the
date of such report and which has not previously been reported.
11. Maintenance of Records: Fund Evaluation: Accounting Services
. The Bank will maintain
records with respect to transactions for which the Bank is responsible pursuant to the terms and
conditions of this Agreement, and in compliance with the applicable rules and regulations of the
Investment Company Act of 1940, as amended, or any other applicable laws or rules, and will furnish
the Trust daily with a statement of condition of the Trust. The Bank will furnish to the Trust at
the end of every month, the close of each quarter of the Trusts fiscal year, and at any other time
upon receipt of reasonable notice, a list of the portfolio securities and the aggregate amount of
cash held by it for the Trust. The books and records of the Bank pertaining to its actions under
this Agreement and reports by the Bank or its independent accountants concerning its accounting
system, procedures for safeguarding securities and internal amounting controls will be open to
inspection and audit at reasonable times by officers of or auditors employed by the Trust and will
be preserved by the Bank in the manner and in accordance With the applicable rules and regulations
under the Investment Company Act of 1940 and any other applicable laws or rules.
As custodian the Bank shall have and perform the following powers and duties:
11.1 To keep the books of account and render statements or copies from time to time as
reasonably requested by the Treasurer or any executive officer of the Trust.
11.2 To compute and, unless otherwise directed by the Trustees of the Trust, determine
as of the close of business on the New York Stock Exchange on each day on which said
Exchange is open for unrestricted trading and as of such other hours, if any, as may be
authorized by said Trustees the net asset value and the public offering price of a share of
capital stock of the Trust, such determination to be made in accordance with the provisions
of the Declaration of Trust of the Trust and Prospectus and Statement of Additional
Information relating to the Trust, as they may from time to time be amended, and any
applicable resolutions of the Trustees of the Trust at the time in force and applicable; and
promptly to notify the Trust, or such other persons as the Trust may request of the results
of such computation and determination. In computing the net asset value hereunder, the Bank
may rely in good faith upon information furnished to it by any Authorized Person in respect
of (i) the manner of accrual of the liabilities of the Trust and in respect of liabilities
of the Trust not appearing on its books of account kept by the Bank, (ii) reserves, if any,
authorized by the Trustees or that no such reserves have been authorized, (iii) the source
of the quotations to be used in computing the net asset value, (iv) the value to be assigned
to any security for which no price quotations are available, and (v) the method of
computation of the public offering price on the basis of the net
Page 14
asset value of the shares,
and the Bank shall not be responsible for any loss occasioned by such reliance or for any
good faith reliance on any quotations received from a source pursuant to (iii) above.
11.3 To assist generally in the preparation of reports to shareholders and others,
audits of accounts, and other ministerial matters of like nature.
12. Concerning the Bank
.
12.1
Performance of Duties
. In performing its duties hereunder and any other duties
listed on any Schedule hereto, if any, the Bank will be entitled to receive and act upon the
advice of independent counsel of its own selection, which may be counsel for the Trust, and
will be without liability for any action taken or thing done or omitted to be done in
accordance with this Agreement in good faith in conformity with such advice. In the
performance of its duties hereunder, the Bank will be protected and not be liable, and will
be indemnified and saved harmless, by the Manager, for any action taken or omitted to be
taken by it in good faith reliance upon the terms of this Agreement, any Officers
Certificate, Proper Instructions, resolution of the Trustees, telegram, notice, request,
certificate or other instrument reasonably believed by the Bank to be genuine and for any
other loss to the Bank or the Trust except in the case of the Banks negligence, willful
misfeasance or bad faith in the performance of its duties or reckless disregard of its
obligations and duties hereunder. Notwithstanding anything herein to the contrary, in the
event that the Bank is entitled to indemnification from the Manager pursuant to the terms
hereof and the Bank is not promptly or fully indemnified, the Trust agrees that the Trust
shall indemnify the Bank in accordance with the provisions hereof, and all references to the
Manager in this Section 12.1 shall be deemed to refer to the Trust.
The Bank may employ agents in the performance of its duties hereunder, including, upon receipt
of Proper Instructions, subcustodians, provided that any such subcustodian meets at least the
minimum qualifications required by Section 17(f)(1) of the Investment Company Act of 1940 to act as
a custodian of the Trusts assets; and provided further that the Bank shall have no more or less
responsibility or liability to the Trust on account of any actions or omissions of any subcustodian
so employed than any such subcustodian has to the Bank, and the Bank shall indemnify the Trust for
any loss to the Trust resulting from the acts or omissions of any subcustodian to the extent that
the Bank is so indemnified by the subcustodian.
In order that the indemnification provision contained in this section 12.1 shall apply,
however, it is understood that if in any case the Manager or the Trust may be asked to indemnify or
save the Bank harmless, the Manager and Trust shall be fully and promptly advised of all pertinent
facts concerning the situation in question, and it is further understood that the Bank will use all
reasonable care to identify and notify the Manager and Trust promptly concerning any situation
which presents or appears likely to present the probability of such claim for indemnification. The
Manager or the Trust, as the case may be, shall have the option to defend the Bank against any
claim which may be the subject of this indemnification, and in the event that the Manager or the
Trust so elects it will so notify the Bank and thereupon the Manager or the Trust, as the case may
be, shall take over the complete defense of the claim, and the Bank shall in such situations incur
no further legal or other expenses in connection with such claim, provided however, if the
defendants in any such action include both (i) the Manager or the Trust and (ii) the Bank, and the
Bank shall have reasonably concluded that there may be legal defenses
Page 15
available to it which are
different from or additional to those available to the Manager or the Trust, as the case may be,
the Bank shall have the right to select separate counsel to assert such legal defenses and to
otherwise participate in the defense of such action on behalf of the Bank with such cost to be
borne by the party hereto ultimately liable with respect to such claim. The Bank shall in no case
confess any claim or make any compromise in any case in which the
Manager or the Trust will be asked to indemnify the Bank except with the prior written consent
of the Manager or the Trust, as the case may be, which consent shall not be unreasonably withheld.
The Manager or the Trust, as the case may be, shall not settle any claim without the Banks prior
written consent, provided however that the Bank shall not unreasonably withhold its consent.
The Trust shall pay all fees and expenses of any subcustodian.
The Bank will be under no duty or obligation to inquire into and will not be liable for:
(a) the validity of the issue of any portfolio securities purchased by or for the
Trust, the legality of the purchases thereof or the propriety of the price incurred
therefor;
(b) the legality of any sale of any portfolio securities by or for the Trust or the
propriety of the amount for which the same are sold;
(c) the legality of an issue or sale of any shares of beneficial interest of the Trust
or the sufficiency of the amount to be received therefor;
(d) the legality of the repurchase of any shares of beneficial interest of the Trust or
the propriety of the amount to be paid therefore except as specifically set forth on any
Schedule hereto;
(e) the legality of the declaration of any dividend by the Trust or the legality of the
distribution of any portfolio securities as payment in kind of such dividend; or
(f) any property or moneys of the Trust unless and until received by it, and any such
property or moneys delivered or paid by it pursuant to the terms hereof.
Moreover, the Bank will not be under any duty or obligation to ascertain whether any portfolio
securities at any time delivered to or held by it for the account of the Trust are such as may
properly be held by the Trust under the provisions of its Declaration of Trust, any federal or
state statutes or any rule or regulation of any governmental agency.
12.2
Fees and Expenses of Bank
. The Manager will pay or reimburse the Bank from time
to time for any transfer taxes payable upon transfer of portfolio securities made hereunder,
and for all necessary proper disbursements, expenses and charges made or incurred by the
Bank in the performance of this Agreement (including any duties listed on any Schedule
hereto, if any) including any indemnities for any loss, liabilities or expense to the Bank
as provided above. For the services rendered by the Bank hereunder, the Manager will pay to
the Bank such compensation or fees at such rate and at such times as shall be agreed upon in
writing by the parties from time to time. The Bank will also be entitled to reimbursement
by the Manager for all reasonable expenses incurred in conjunction with termination of this
Agreement by the Trust. To the extent the Manager is not obligated pursuant to an agreement
with the Trust to pay the fees and
Page 16
expenses of the Bank hereunder, the Trust shall be
responsible for such obligations of the Manager set forth in this section 12.2.
12.3
Advances by Bank
. The Bank may, in its sole discretion, advance funds on behalf
of any Fund to make any payment permitted by this Agreement upon receipt of any proper
authorization required by this Agreement for such payments by the Fund. Should such a
payment or payments, with advanced funds, result in an overdraft (due to insufficiencies of
the Funds account with the Bank, or for any other reason) this Agreement deems any such or
related indebtedness, a loan made by the Bank to such Fund payable on demand and bearing
interest at the current rate charged by the Bank for such loans unless the Trust shall
provide the Bank with agreed upon compensating balances. Provided, however, that any such
payment or payments by the Bank shall only be deemed a loan made by the Bank to a Fund to
the extent such payment or payments do not exceed 10% of the value (taken at the lower of
cost or current value) of such Funds total assets (not including the amount borrowed) at
the time such payment or payments are made, and are made to facilitate the meeting of
redemption requests which might otherwise require the untimely disposition of portfolio
investments or for extraordinary or emergency purposes. To secure any such payments deemed
to be loans in accordance with the foregoing, the Trust hereby grants to the Bank a security
interest in and pledges to the Bank securities held by the Bank on behalf of the Fund on
whose behalf such payments were made, in an amount not to exceed the lesser of the dollar
amount deemed to constitute a loan or ten percent of such Funds total assets (taken at
cost), the specific securities to be designated in writing from time to time by the Trust or
the Manager; and provided, further, that (1) if from time to time neither the Trust nor the
Manager shall have designated in writing specific securities in an amount at least equal to
the lesser of the dollar amount deemed to constitute a loan or ten percent of the particular
Funds total assets, or (2) if as a result of the delivery by the Bank out of its custody,
pursuant to Proper Instructions, of any securities previously so designated, the remaining
amount of securities so designated shall be less than the lesser of the dollar amount deemed
to constitute a loan or ten percent of such Funds total assets, then the Bank shall have a
security interest in the securities of such Fund, in an amount that, taken together with
amounts of securities from time to time designated in writing by the Trust or the Manager
that have not been delivered out of the custody of the Bank pursuant to Proper Instructions,
does not exceed the lesser of the dollar amount deemed to constitute a loan or ten percent
of such Funds total assets. Should the Trust fail to repay promptly any such advances, the
Bank shall be entitled to use available cash and to dispose of pledged securities and
property as is necessary to repay any such advances.
13. Termination
.
13.1 This Agreement may be terminated at any time without penalty upon sixty days
written notice delivered by either party to the other by means of registered mail, and upon
the expiration of such sixty days this Agreement will terminate; provided, however, that the
effective date of such termination may be postponed to a date not more than ninety days from
the date of delivery of such notice (i) by the Bank in order to prepare for the transfer by
the Bank of all of the assets of the Trust held hereunder, and (ii) by the Trust in order to
give the Trust an opportunity to make suitable arrangements for a successor custodian. At
any time after the termination of this Agreement, the Trust will,
Page 17
at its request, have
access to the records of the Bank relating to the performance of its duties as custodian.
13.2 In the event of the termination of this Agreement, the Bank will immediately upon
receipt or transmittal, as the case may be, of notice of termination, commence and prosecute
diligently to completion the transfer of all cash and the delivery of all portfolio
securities duly endorsed and all records maintained under Section 11 to the successor
custodian when appointed by the Trust. The obligation of the Bank to deliver and transfer
over the assets of the Trust held by it directly to such successor custodian will commence
as soon as such successor is appointed and will continue until completed as aforesaid. If
the Trust does not select a successor custodian within ninety (90) days from the date of
delivery of notice of termination the Bank may, subject to the provisions of subsection 13.3
of this Section, deliver the portfolio securities and cash of the Trust held by the Bank to
a bank or trust company of its own selection which meets the requirements of Section
17(f)(1) of the Investment Company Act of 1940 and has a reported capital, surplus and
undivided profits aggregating not less than $25,000,000, to be held as the property of the
Trust under terms similar to those on which they were held by the Bank, whereupon such bank
or trust company so selected by the Bank will become the successor custodian of such assets
of the Trust with the same effect as though selected by the Trustees of the Trust.
13.3 Prior to the expiration of ninety (90) days after notice of termination has been
given, the Trust may furnish the Bank with an order of the Trust advising that a successor
custodian cannot be found willing and able to act upon reasonable and customary terms and
that there has been submitted to the shareholders of the Trust the question of whether the
Trust will be liquidated or will function without a custodian for the assets of the Trust
held by the Bank. In that event the Bank will deliver the portfolio securities and cash of
the Trust held by it, subject as aforesaid, in accordance with one of such alternatives
which may be approved by the requisite vote of shareholders, upon receipt by the Bank of a
copy of the minutes of the meeting of shareholders at which action was taken, certified by
the Trusts Secretary.
14. Notices
. Any notice or other instrument in writing authorized or required by this
Agreement to be given to either party hereto will be sufficiently given if addressed to such party
and mailed or delivered to it at its office at the address set forth below; namely:
|
(a)
|
|
In the case of notices sent to the Trust to:
|
|
|
|
|
GMO Trust
c/o Grantham, Mayo, Van Otterloo & Co.
40 Rowes Wharf
4th Floor
Boston, MA 02110
Attn: David A. Salem
|
|
|
(b)
|
|
In the case of notices sent to the Bank to:
|
|
|
|
|
Investors Bank & Trust Company
Financial Product Services
One Lincoln Plaza P.O. Box 1537
|
Page 18
|
|
|
Boston, Massachusetts 02205-1537
|
|
|
|
|
or at such other place as such party may from time to time designate in
writing.
|
15. Amendments
. This Agreement may not be altered or amended, except by an instrument in
writing, executed by both parties, and in the case of the Trust, such alteration or amendment will
be authorized and approved by its Trustees.
16. Parties
. This Agreement will be binding upon and shall inure to the benefit of the
parties hereto and their respective successors and assigns; provided, however, that this Agreement
will not be assignable by the Trust without the written consent of the Bank or by the Bank without
the written consent of the Trust, authorized and approved by its Trustees; and provided further
that termination proceedings pursuant to Section 13 hereof will not be deemed to be an assignment
within the meaning of this provision.
17. Governing Law
. This Agreement and all performance hereunder will be governed by the laws
of the Commonwealth of Massachusetts.
18. Limitation of Liability
. The term GMO Trust means and refers to the Trustees from time to
time serving under the Agreement and Declaration of Trust of the Trust dated June 24, 1985, as the
same may subsequently thereto have been, or subsequently hereto be, amended. It is expressly
agreed that the obligations of the Trust hereunder shall not be binding upon any of the Trustees,
shareholders, nominees, officers, agents or employees of the Trust, personally, but shall bind only
the trust property of the Trust as provided in the Agreement and Declaration of Trust of the Trust.
The execution and delivery of this Agreement have been authorized by the Trustees of the Trust and
this Agreement has been signed by an authorized officer of the Trust, acting as such, and neither
such authorization by such Trustees nor such execution and delivery by such officer shall be deemed
to have been made by any of them, but shall bind only the trust property of the Trust as provided
in the Agreement and Declaration of Trust.
Page 19
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed in duplicate and
their respective corporate seals to be affixed hereto as of the date first above written by their
respective officers thereunto duly authorized.
|
|
|
|
|
|
|
GMO Trust
|
|
|
|
|
|
|
|
By:
|
|
/s/ R. Jeremy Grantham
|
|
|
|
|
|
ATTEST:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Grantham, Mayo, Van Otterloo & Co.
|
|
|
|
|
|
|
|
By:
|
|
/s/ David A. Salem
|
|
|
|
|
|
|
|
|
|
|
ATTEST:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investors Bank & Trust Company
|
|
|
|
|
|
|
|
By:
|
|
/s/ [signature]
|
|
|
|
|
|
|
|
|
|
|
ATTEST:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Page 20
Schedule A
Custody of Foreign Securities
The following provisions govern the maintenance of the Funds foreign securities, and cash
incidental to transactions in such securities, which pursuant to this Schedule A shall be held in
the custody of certain foreign banking institutions and foreign securities depositories acting as
sub-custodians in conformity with the requirements of Rule 17f-5 under the Investment Company Act
of 1940 (the
Act
):
I. EUROCLEAR
1.
Appointment of Euroclear as Sub-Custodian
. The Fund hereby authorizes and
instructs the Bank to employ the securities clearance and depository facilities operated by Morgan
Guaranty Trust Company of New York in Brussels, Belgium (
Euroclear
), to act as sub-custodian of
the Fund pursuant to and governed by the Terms and Conditions Governing the Euroclear System (the
Terms and Conditions
).
2.
Assets to be Held
. The Bank shall limit the securities and other assets
maintained in Euroclear to those Euroclear eligible securities which are foreign securities, as
defined in paragraph (c)(l) of Rule 17f-5 of the Act, and to cash and cash equivalents in such
amounts as the Bank or the Fund may determine to be reasonably necessary to effect the Funds
foreign securities transactions through Euroclear.
3.
Use of Euroclear
. Except as may other wise be agreed upon in writing by the Bank
and the Fund, the Fund authorizes the deposit in Euroclear of all foreign securities of the Fund
eligible for deposit therein and to utilize such securities depository to the extent possible in
connection with settlements of purchases and sales of securities and deliveries and returns of
securities, until notified to the contrary pursuant to Section 9 hereunder.
4.
Segregation of Securities
. The Bank shall identify on its books as belonging to
the Fund the foreign securities of the Fund held in Euroclear and shall hold all securities of the
Fund in an Unencumbered Securities Account with Euroclear.
5.
Reports by Bank
. The Bank shall supply the Fund from time to time, as mutually
agreed upon, statements in respect of the securities and other assets of the Fund held in Euroclear
as shall be made available to the Bank by Euroclear.
6.
Transactions in Foreign Custody Account
. Transactions with respect to the
securities and other assets of the Fund held in Euroclear shall be effected pursuant to Proper
Instructions from the Fund to the Bank in accordance with the Terms and Conditions.
7.
Terms and Conditions
. The Fund acknowledges that the Bank, as a participant in
Euroclear, is subject to the Terms and Conditions, a copy of which has been made available to the
Fund. The Fund acknowledges that pursuant to such Terms and Conditions, Morgan Guaranty Brussels
shall have the sole right to exercise or assert any and all rights or claims in respect of actions
or omissions of, or the bankruptcy or insolvency of, any other depository, clearance system or
custodian utilized by Euroclear in connection with the Funds securities and other assets.
Page 21
8.
Monitoring Responsibilities
. The Bank shall furnish to the Fund information made
available to it by Euroclear concerning the Euroclear system for use by the Fund in evaluating such
system to ensure compliance with the requirements of Rule l7f-5 of the Act. The Bank shall
promptly inform the Fund of any material changes in the circumstances surrounding the foreign
custody arrangements provided by Euroclear as such information shall be made available to the Bank
by Euroclear or otherwise.
9.
Termination of Euroclear
. Upon receipt of Proper Instructions, the Fund may
instruct the Bank to cease the employment of Euroclear for maintaining custody of the Funds
assets, and the Bank shall so cease to employ Euroclear as soon as alternate custodial arrangements
have been implemented.
II. CITIBANK.
1.
Appointment of Citibank as Sub-Custodian
. The Fund hereby authorizes and
instructs the Bank to employ Citibank, NA, a national bank organized and existing under the laws of
the United States, having its principal office and place of business at 399 Park Avenue, New York,
New York (
Citibank
) which has established a global custody network for the custody of foreign
securities (the
Citibank Network
) as sub-custodian for the Funds securities and other assets
maintained outside the United States pursuant to the Sub-Custodial Agreement by and between
Citibank and the Bank (the
Citibank Agreement
) a copy of which has been provided to the Fund.
2.
Appointment of Foreign Sub-Custodians
. The Fund hereby authorizes the Bank and
Citibank to employ as sub-custodians for the Funds securities and other assets maintained outside
the United States those eligible foreign custodians as such term is defined in Rule 17f-S of the
Act (an
Eligible Foreign Custodian
) or the foreign branch offices of Citibank (a
Branch
) which
are listed on Annex A hereto (the
Selected Foreign Sub-Custodians
) pursuant to agreements between
Citibank and each of such Selected Foreign Sub-Custodians (the
Sub-Custodial Agreement
) as shall
have been previously furnished to the Fund by the Bank. Upon receipt of certified resolutions of
the Funds Board of Directors, the Bank and the Fund may agree to amend Annex A hereto from time to
time to designate additional Eligible Foreign Sub-Custodians or Branches which are part of the
Citibank Network to act as sub-custodians.
3.
Assets to be Held
. The Bank shall limit the securities and other assets
maintained through Citibank in the custody of the foreign sub-custodians to: (a) foreign
securities, as defined in paragraph (c)(1) of Rule 17f-5 under the Act, and (b) cash and cash
equivalents in such amounts as the Bank or the Fund may determine to be reasonably necessary to
effect the Funds foreign securities transactions, subject to the provisions of Part I of this
Schedule A, relating to Euroclear eligible securities, and Part III of this Schedule A, relating to
securities to be held in Australia.
4.
Foreign Securities Depositories
. Except as may other wise be agreed upon in
writing by the Bank and the Fund, the Fund authorizes the deposit in a securities depository which
is a Selected Foreign Sub-Custodian, all securities of the Fund held in the Citibank Network
eligible for deposit therein and to utilize such securities depository to the extent possible in
connection with settlements of purchases and sales of securities and deliveries and returns of
securities.
Page 22
5.
Segregation of Securities
. The Bank shall identify on its books as belonging to
the Fund the foreign securities of the Fund held in the Citibank Network, and Citibank shall
identify in a separate account, pursuant to the Citibank Agreement, all securities and moneys of
the Fund.
6.
Agreements with Selected Foreign Sub-Custodians
. Upon receiving notification
from Citibank, the Bank shall promptly notify the Fund of any changes in the terms of the
Sub-Custodial Agreements in effect with Citibank with respect to Selected Foreign Sub-Custodians.
7.
Reports by Bank
. The Bank shall supply the Fund from time to time, as mutually
agreed upon, statements in respect of the securities and other assets of the Fund held in the
Citibank Network, including but not limited to the identification of entities having possession of
the Funds securities and other assets and advices or notifications of any transfers of securities
to or from each account maintained on behalf of the Fund, as shall be made available to the Bank by
Citibank.
8.
Transactions in Foreign Custody Account
. Transactions with respect to the
securities and other assets of the Fund held in the Citibank Network shall be effected pursuant to
Proper Instructions from the Fund to the Bank in accordance with the Citibank Agreement If at any
time, at the request of the Fund, any securities of the Fund shall be registered in the name of the
nominee-of the Selected Foreign Sub-Custodian, the Fund agrees to reimburse the Bank for any
expenses to which it may become liable pursuant to the Citibank Agreement by reason of the
registration of such securities in the name of such nominee.
9.
Liability of Citibank
. The standard of care and the liability of Citibank for
its actions and the actions of Selected Foreign Sub-Custodians in connection with the securities
and other assets of the Fund held in the . Citibank Network is set forth in the Citibank
Agreement.
10.
Monitoring Responsibilities
. The Bank shall furnish to the Fund information
made available to it by Citibank concerning the Selected Foreign Sub-Custodians for use by the Fund
in evaluating such Selected Foreign Sub-Custodians to ensure compliance with the requirements of
Rule 17f-5 of the Act. The Bank shall promptly inform the Fund of any material changes in the
circumstances surrounding the foreign custody arrangements provided by Citibank as such information
shall be made available to the Bank by Citibank.
11. Upon receipt of Proper Instructions, the Fund may instruct the Bank to cease the
employment of any one or more of such Selected Foreign Sub-Custodians for maintaining custody of
the Funds assets, or to terminate Citibank as Sub-Custodian of the Fund, and the Bank shall so
cease to employ such sub-custodian as soon as alternate custodial arrangements have been
implemented.
III. NATIONAL AUSTRALIA BANK LIMITED.
1.
Appointment of National Australia Bank Limited as Sub-Custodian
. The Fund hereby
authorizes and instructs the Bank to employ National Australia Bank Limited, a banking institution
organized under the laws of Australia N.A., meeting the requirements of an eligible foreign
custodian as that term is defined in Rule 171-5 of the Act, having its principal office and place
of business in Melbourne, Victoria, Australia (
NAB
) as sub-custodian for the Funds securities
and other assets maintained in Australia and New Zealand pursuant to the
Page 23
Master Sub-custodian Agreement by and between NAB and the Bank (the
NAB Agreement
), a copy
of which has been made available to the Fund.
2.
Assets to be Held
. The Bank shall limit the securities and other assets
maintained at NAB to: (a) foreign securities, as defined in paragraph (c)(1) of Rule 17f-5 under
the Act, the principal trading market for which is in Australia or New Zealand and (b) cash and
cash equivalents in such amounts as the Bank or the Fund may determine to be reasonably necessary
to effect the Funds foreign securities transactions, subject to the provisions of Part I of this
Schedule A, relating to Euroclear eligible securities.
3.
National Nominees Limited
. All securities of the Fund held by NAB shall be
registered in the name of its wholly-owned subsidiary, National Nominees Limited.
4.
Segregation of Securities
. The Bank shall identify on its books as belonging to
the Fund the foreign securities of the Fund held by NAB, and NAB shall identify in a separate
account, pursuant to the NAB Agreement, all securities and moneys of the Fund.
5.
Reports by Bank
. The Bank shall supply the Fund from time to time, as mutually
agreed upon, statements in respect of the securities and other assets of the Fund held by NAB,
including but not limited to advices or notifications of any transfers of securities to or from
each account maintained on behalf of the Fund, as shall be made available to the Bank by NAB.
6.
Transactions in Foreign Custody Account
. Transactions with respect to the
securities and other assets of the Fund held by NAB shall be effected pursuant to Proper
Instructions from the Fund to the Bank in accordance with the NAB Agreement
7.
Use of Austraclear
. Upon receipt of certified resolutions of the Funds Board of
Directors authorizing the use of Austraclear, a securities depository, all securities of the Fund
held by NAB and eligible for deposit therein may be so deposited and held therein.
8.
Liability of NAB
. The standard of care and the liability of NAB for its actions
in connection with the securities and other assets of the Fund held by NAB is set forth in the NAB
Agreement.
9.
Monitoring Responsibilities
. The Bank shall furnish to the Fund information made
available to it by NAB concerning NAB for use by the Fund in evaluating NAB and to ensure
compliance with the requirements of Rule 17f-5 of the Act. The Bank shall promptly inform the Fund
of any material changes in the circumstances surrounding the foreign custody arrangements provided
by NAB as such information shall be made available to the Bank by NAB.
10.
Termination
. Upon receipt of Proper Instructions, the Fund may instruct the
Bank to cease the employment of NAB for maintaining custody of the Funds assets, and the Bank
shall so cease to employ NAB as soon as alternate custodial arrangements have been implemented.
Page 24
[This page is intentionally left blank.]
[IBT LETTERHEAD]
May 30, 2003
GMO Trust
40 Rowes Wharf
Boston, MA 02110
Grantham, Mayo, Van Otterloo & Co. LLC
40 Rowes Wharf
Boston, MA 02110
Re: Amendment to the Custodian Agreement (the Agreement), dated August 1, 1991, by and among GMO
Trust (the Trust), on behalf of certain series of the Trust (the Funds), Grantham, Mayo, Van
Otterloo & Co. LLC (GMO) and Investors Bank & Trust Co. (the Bank), as amended.
Ladies and Gentlemen:
Pursuant to Section 15 of the Agreement, this letter amends the Agreement as required by
recently adopted amendments to Rule 17f-4 under the Investment Company Act of 1940, as amended
(Rule 17-4), governing investment companies use of securities depositories. Capitalized terms
used, but not otherwise defined herein, shall have the meanings ascribed to them in the Agreement.
The terms financial assets, securities entitlements, securities intermediary, securities
depository, and intermediary custodian, as used herein, shall have the same meaning as when such
terms are used in Rule 17f-4 for purposes of Rule 17f-4.
The Bank hereby agrees to the following as of the date hereof:
|
(1)
|
|
In addition to, and not in lieu of, any standard of care
set forth in the Agreement, the Bank shall be obligated to exercise due care
in accordance with reasonable commercial standards when placing and
maintaining financial assets corresponding to the Trusts securities
entitlements with a securities depository or an intermediary custodian;
|
|
|
(2)
|
|
In addition to the Banks obligations under Section 11 of
the Agreement, the Bank shall provide, promptly upon request by
|
1
|
|
|
the Trust, such reports as are available regarding its internal accounting
controls and financial strength;
|
|
|
(3)
|
|
In addition to, and not in lieu of, any standard of care
set forth in the Agreement that is applicable to an intermediary custodian
appointed by the Bank pursuant to the terms of the Agreement, any such
intermediary custodian shall be obligated, pursuant to the terms of its
agreement or other arrangement with the Bank, at a minimum to exercise due
care in accordance with reasonable commercial standards in discharging its
duty as a securities intermediary to obtain and thereafter maintain financial
assets, corresponding to the security entitlements of its entitlement holders
(as defined in U.C.C. Sections 8-102(a)(7) (2002));
|
|
|
(4)
|
|
Notwithstanding requirements to the contrary in Sections
6.2(a) through (c) of the Agreement, the Trustees of the Trust shall not be
required to provide prior approval or annual reapproval of the Banks use of
the Book-Entry System, a Depository, or a system maintained by the Bank for
the holding of Book-Entry Paper, and the Trust hereby agrees that the Bank
may so use such systems or depositories; and
|
|
|
(5)
|
|
The clause , specifically identified in a certified copy
of a resolution of the Trustees of the Trust in the last sentence of Section
2.6 of the Agreement is hereby deleted.
|
This letter agreement shall constitute an amendment to the Agreement and, as such, a binding
agreement among the Trust, on behalf of the Funds, the Manager, and the Bank in accordance with its
terms. The terms of this letter agreement shall be effective as of March 28, 2003.
2
|
|
|
|
|
|
Sincerely,
INVESTORS BANK & TRUST
COMPANY
|
|
|
By:
|
/S/ Andrew M. Nesvet
|
|
|
|
Name:
|
Andrew M. Nesvet
|
|
|
|
Title:
|
Managing Director
|
|
|
The foregoing is hereby
accepted and agreed.
GMO TRUST, on behalf of the Funds
|
|
|
|
|
|
|
|
By:
|
/S/ Elaine M. Hartnett
|
|
|
|
Name:
|
Elaine M. Hartnett
|
|
|
|
Title:
|
Vice President and Secretary
|
|
|
|
GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC
|
|
|
By:
|
/S/ Elaine M. Hartnett
|
|
|
|
Name:
|
Elaine M. Hartnett
|
|
|
|
Title:
|
Associate General Counsel
|
|
|
|
3
Exhibit (h)(1)
Execution Copy
CONFORMING TRANSFER AGENCY
AND SERVICE AGREEMENT
Conforming Transfer Agency and Service Agreement (Conforming Agreement) made as of this
23
rd
day of August, 2011 by and between GMO Series Trust, (the Series Trust), a
business trust established under the laws of the Commonwealth of Massachusetts, and State Street
Bank and Trust Company (as successor by merger to Investors Bank & Trust Company)(State Street).
WHEREAS, GMO Trust (the Company), Grantham, Mayo, Van Otterloo & Co. LLC (GMO) and State
Street are party to the Transfer Agency and Service Agreement dated August 1, 1991, as amended,
supplemented or otherwise modified from time to time (the Agreement) pursuant to which State
Street agrees to provide certain services to the Company;
WHEREAS, in connection with the creation of the Series Trust, the parties intend to apply the
terms of the Agreement to the Series Trust without modifying the terms of the Agreement with
respect to the Company;
NOW, THEREFORE, in connection with the foregoing and in consideration of the mutual covenants
herein set forth, the Series Trust and State Street agree as follows:
|
1.
|
|
The terms of the Agreement shall apply,
mutatis mutandis
, to the Series Trust as if
it were the Company and to each series of the Series Trust as if it were a series of the
Company, provided that all obligations of GMO in the Agreement shall be the obligations of
the Series Trust.
|
|
|
2.
|
|
A list of the series of the Series Trust is set forth in Schedule A, which shall be
amended from time to time in writing by mutual agreement of the Series Trust and State
Street.
|
|
|
3.
|
|
For the avoidance of doubt, the Series Trust and State Street shall be liable to the
other to the extent and under the circumstances described in the Agreement. Further, with
respect to Section 14, references to the Manager shall be replaced by the Series
Trust; provided, however that the obligations of each series of the Series Trust are
binding solely upon the assets and liability of the relevant series. Section 14.06 of the
Agreement shall not apply with respect to the Series Trust.
|
[signature page immediately follows]
1
IN WITNESS WHEREOF; the parties hereto have caused this Conforming Agreement to be duly
executed as of the day and year first written above.
|
|
|
|
|
GMO SERIES TRUST*
|
|
|
|
|
|
|
|
By:
|
|
/s/ JB Kittredge
|
|
|
Name:
|
|
JB Kittredge
|
|
|
Title:
|
|
President and Chief Executive Officer
|
|
|
|
|
|
*
|
|
GMO Series Trust is a Massachusetts business trust and a copy of the Agreement and Declaration
of Trust of GMO Series Trust is on file with the Secretary of State of the Commonwealth of
Massachusetts. Notice is hereby given that this Agreement is executed on behalf of the Trustees of
the Series Trust as Trustees and not individually, and that the obligations of or arising out of
this Agreement with respect to each series of the Series Trust are not binding upon any of the
Trustees or shareholders individually or any other series, but are binding only upon the assets and
property of that series.
|
|
|
|
|
|
STATE STREET BANK AND TRUST COMPANY
|
|
|
|
|
|
|
|
By:
|
|
/s/ Michael F. Rogers
|
|
|
|
|
|
|
|
Name:
|
|
Michael F. Rogers
|
|
|
Title:
|
|
Executive Vice President
|
|
|
2
SCHEDULE A
LIST OF GMO SERIES TRUST FUNDS
1
GMO U.S. Core Equity Series Fund
3
[This page intentionally left blank.]
EXECUTION COPY
TRANSFER AGENCY AND SERVICE AGREEMENT
AGREEMENT made as of this 1st day of August, 1991 by and among GMO TRUST, a business trust
established under the laws of the Commonwealth of Massachusetts (the Company) on behalf of the
GMO Core Fund, GMO SAF Core Fund, GMO Value Allocation Fund, GMO Growth Fund, GMO Short-Term Income
Fund, GMO International Core Fund, GMO Japan Fund and any other series of the Trust currently
existing or hereafter created, as shall be mutually agreed to by the parties hereto to be subject
to this Agreement in accordance with Article 17 (each such series referred to herein as the Fund
and collectively as the Funds), GRANTHAM, MAYO, VAN OTTERLOO & CO., a Massachusetts General
Partnership, (the Manager) and INVESTORS BANK & TRUST COMPANY, a Massachusetts trust company (the
Bank).
WITNESSETH:
WHEREAS, the Company desires to appoint the Bank as its transfer agent, dividend disbursing
agent and agent in connection with certain other activities, and the Bank desires to accept such
appointment;
WHEREAS, the Bank is duly registered as a transfer agent as provided in Section 17A(c) of the
Securities Exchange Act of 1934, as amended;
NOW, THEREFORE, in consideration of the mutual covenants herein set forth, the Company and the
Bank agree as follows:
|
|
ARTICLE
1.
Terms of Appointment; Duties of the Bank
.
|
1.01 Subject to the terms and conditions set forth in this Agreement, the Company hereby,
employs and appoints the Bank to act as, and the Bank agrees to act as transfer agent for the
Companys authorized and issued shares of beneficial interest (Shares), dividend disbursing agent
and agent in connection with any accumulation, open-account or similar plans provided to the
shareholders of the Company (Shareholders) and set out in the currently effective prospectus and
statement of additional information of the Company (the Prospectus), including without limitation
any periodic investment plan or periodic withdrawal program.
Page 2
1.02 The Bank agrees that it will perform the following services:
(a) In accordance with procedures established from time to time by agreement between the
Company and the Bank, the Bank shall:
(i) Receive for acceptance, orders for the purchase of Shares, and promptly deliver
payment and appropriate documentation therefor to the Custodian of the Company appointed by
the Trustees (the Trustees) of the Company (the Custodian);
(ii) Pursuant to purchase orders, issue the appropriate number of Shares and hold such
Shares in the appropriate Shareholder account;
(iii) Receive for acceptance, redemption requests and redemption directions and deliver
the appropriate documentation therefor to the Custodian;
(iv) At the appropriate time as and when it receives monies paid to it by the Custodian
with respect to any redemption, pay over or cause to be paid over in the appropriate manner
such monies as instructed by the redeeming Shareholders;
(v) Effect transfers of Shares by the registered owners thereof upon receipt of
appropriate instructions;
(vi) Prepare and transmit payments for dividends and distributions declared by a Fund;
and
(vii) Create and maintain all necessary records including those specified in Article 10
hereof, in accordance with all applicable laws, rules and regulations, including but not
limited to records required by Section 31(a) of the Investment Company Act of 1940 (the
1940 Act), and those records pertaining to the various functions performed by it
hereunder. All records shall be available for inspection and use by the Company. Where
applicable, such records shall be maintained by the Bank for the periods and in the places
required by Rule 31a-2 under the 1940 Act.
(viii) Make available during regular business hours all records and other data created
and maintained pursuant to this Agreement for reasonable audit and inspection by
Page 3
the Company, or any person retained by the Company. Upon reasonable notice by the
Company, the Bank shall make available during regular business hours its facilities and
premises employed in connection with its performance of this Agreement for reasonable
visitation by the Company, or any person retained by the Company;
(ix) At the expense of the Company, the Bank shall maintain an adequate supply of blank
share certificates for each Fund providing for the issuance of certificates to meet the
Banks requirements therefor. Such share certificates shall be properly signed by
facsimile. The Company agrees that, notwithstanding the death, resignation, or removal of
any officer of the Company whose signature appears on such certificates, the Bank may
continue to countersign certificates which bear such signatures until otherwise directed by
the Company. Share certificates may be issued and accounted for entirely by the Bank and do
not require any third party registrar or other endorsing party;
(x) Issue replacement share certificates in lieu of certificates which have been lost,
stolen or destroyed, without any further action by the Trustees or any officer of the
Company, upon receipt by the Bank of properly executed affidavits and lost certificate
bonds, in form satisfactory to the Bank, with the Company and the Bank as obligees under the
bond. At the discretion of the Bank, and at its sole risk, the Bank may issue replacement
certificates without requiring the affidavits and lost certificate bonds described above and
the Bank agrees to indemnify the Company against any and all losses or claims which may
arise by reason of the issuance of such new certificates in the place of the ones allegedly
lost, stolen or destroyed;
(xi) Record the issuance of Shares of the Company and maintain pursuant to SEC Rule
17Ad-10(e) a record of the total number of Shares of the Company which are authorized, based
upon data provided to it by the Company, and issued and outstanding. The Bank shall also
provide the Company on a regular basis with the total number of Shares which are authorized
and issued and outstanding and shall have no obligation, when recording the issuance of
Shares, to monitor the issuance of such Shares or to take cognizance of any laws relating to
the issue or sale of such Shares, which functions shall be the sole responsibility of the
Company.
(b) In addition to and not in lieu of the services set forth in the above paragraph (a) or in
Schedule A hereto, if any, the Bank shall: (i) perform all of the customary services of a transfer
agent, dividend disbursing agent and, as relevant, agent in connection with accumulation,
open-account or similar plans (including without limitation any periodic investment plan or
periodic withdrawal program); including but not limited to: maintaining all Shareholder accounts,
preparing Shareholder meeting lists, mailing proxies, receiving and tabulating proxies, mailing
Shareholder reports and prospectuses to current Shareholders, withholding taxes on all accounts,
including non-resident alien accounts, preparing and filing U.S. Treasury Department Forms 1099 and
other appropriate forms required with respect to dividends and distributions by federal authorities
for all Shareholders, preparing and mailing confirmations forms and statements of account to
Shareholders for all purchases and redemptions of Shares and other confirmable transactions in
Shareholder accounts, responding to Shareholder telephone calls and Shareholder correspondence,
preparing and mailing activity statements for Shareholders, and providing Shareholder account
information and (ii) provide a system which will enable the Company to monitor the total number of
Shares sold in each State. The Company shall (i) identify to the Bank in writing those
transactions and assets to be treated as exempt from the blue sky reporting for each State and (ii)
verify the establishment of transactions for each state on the system prior to activation and
thereafter monitor the daily activity for each State. The responsibility of the Bank for a Funds
blue sky State registration status is solely limited to the initial establishment of transactions
subject to blue sky compliance by such Fund(s) and the reporting of such transactions to the
Fund(s) as provided above.
(c) Additionally, the Bank shall:
(i) Utilize a system to identify all share transactions which involve purchase and
redemption orders that are processed at a time other than the time of the computation of net
asset value per share next computed after receipt of such orders, and shall compute the net
effect upon the Fund(s) of such transactions so identified on a daily and cumulative basis.
(ii) If upon any day the cumulative net effect of such transactions upon the Fund(s) is
negative and exceed a dollar amount equivalent to 1/2 of 1 cent per share due to an error of
the Bank, the Bank shall promptly make a payment to the Fund(s) in cash or through the use
of a
Page 5
credit, in the manner described in paragraph (iv) below, in such amount as may be
necessary to reduce the negative cumulative net effect to less than 1/2 of 1 cent per share.
(iii) If on the last business day of any month the cumulative net effect upon the
Fund(s) (adjusted by the amount of all prior payments and credits by the Bank and the
Fund(s)) is negative, the Fund(s) shall be entitled to a reduction in the fee next payable
under the Agreement by an equivalent amount, except as provided in paragraph (iv) below. If
on the last business day in any month the cumulative net effect upon the Fund(s) (adjusted
by the amount of all prior payments and credits by the Bank and the Fund(s)) is positive,
the Bank shall be entitled to recover certain past payments and reductions in fees, and to
credit against all future payments and fee reductions that may be required under the
Agreement as herein described in paragraph (iv) below.
(iv) At the end of each month, any positive cumulative net effect upon the Fund(s)
shall be deemed to be a credit to the Bank which shall first be applied to permit the Bank
to recover any prior cash payments and fee reductions made by it to the Fund(s) under
paragraphs (ii) and (iii) above during the calendar year, by increasing the amount of the
monthly fee under the Agreement next payable in an amount equal to prior payments and fee
reductions made by the Bank during such calendar year, but not exceeding the sum of that
months credit and credits arising in prior months during such calendar year to the extent
such prior credits have not previously been utilized as contemplated by this paragraph. Any
portion of a credit to the Bank not so used by it shall remain as a credit to be used as
payment against the amount of any future negative cumulative net effects that would
otherwise require a cash payment or fee reduction to be made to the Fund(s) pursuant to
paragraphs (ii) or (iii) above (regardless of whether or not the credit or any portion
thereof arose in the same calendar year as that in which the negative cumulative net effects
or any portion thereof arose).
(v) The Bank shall supply to the Fund(s) from time to time, as mutually agreed upon,
reports summarizing the transactions identified pursuant to paragraph (i) above, and the
daily and cumulative net effects of such transactions, and shall advise the Fund(s) at the
end of each month of the net cumulative effect at such time. The
Page 6
Bank shall promptly advise the Fund(s) if at any time the cumulative net effects
exceeds a dollar amount equivalent to 1/2 of 1 cent per share.
(vi) In the event that this Agreement is terminated for whatever cause, or this
provision 1.02(c) is terminated pursuant to paragraph (vii) below, the Fund shall promptly
pay to the Bank an amount in cash equal to the amount by which the cumulative net effect
upon the Fund(s) is positive or, if the cumulative net effect upon the Fund(s) is negative,
the Bank shall promptly pay to the Fund(s) an amount in cash equal to the amount of such
cumulative net effect.
(vii) This provision 1.02(c) of the Agreement may be terminated by the Bank at any time
without cause, effective as of the close of business on the date written notice (which may
be by telex) is received by the Fund(s).
ARTICLE
2.
Sale of Company Shares
.
2.01 Whenever the Company shall sell or cause to be sold any Shares of a Fund, the Company
shall deliver or cause to be delivered to the Bank a document duly specifying: (i) the name of the
Fund whose Shares were sold; (ii) the number of Shares sold, trade date, and price; (iii) the
amount of money to be delivered to the Custodian for the sale of such Shares and specifically
allocated to such Fund; and (iv) in the case of a new account, a new account application or
sufficient information to establish an account.
2.02 The Bank will, upon receipt by it of a check or other payment identified by it as an
investment in Shares of one of the Funds and drawn or endorsed to the Bank as agent for, or
identified as being for the account of, one of the Funds, promptly deposit such check or other
payment to the appropriate account postings necessary to reflect the investment. The Bank will
notify the Company, or its designee, and the Custodian of all purchases and related account
adjustments.
2.03 Under procedures as established by mutual agreement between the Company and the Bank, the
Bank shall issue to the purchaser or his authorized agent such Shares, computed to the nearest
three decimal points, as he is entitled to receive, based on the appropriate net asset value of the
Funds Shares, determined in accordance with applicable Federal law or regulation. In issuing
Shares to a purchaser or his authorized agent, the Bank shall be entitled to rely upon the latest
Page 7
directions, if any, previously received by the Bank from the purchaser or his authorized agent
concerning the delivery of such Shares.
2.04 The Bank shall not be required to issue any Shares of the Company where it has received a
written instruction from the Company or written notification from any appropriate Federal or state
authority that the sale of the Shares of the Fund(s) in question has been suspended or
discontinued, and the Bank shall be entitled to rely upon such written instructions or written
notification, provided however that this provision shall not imply any duty or obligation on the
part of the Bank to monitor federal or state laws with regard to the sale of Shares.
2.05 Upon the issuance of any Shares of any Fund(s) in accordance with the foregoing
provisions of this Section, the Bank shall not be responsible for the payment of any original issue
or other taxes required to be paid by the Company in connection with such issuance.
2.06 The Bank may establish such additional rules and regulations governing the transfer or
registration of Shares as it may deem advisable and consistent with such rules and regulations
generally adopted by transfer agents.
ARTICLE
3.
3.01
Returned Checks
. In the event that any check or other order for the transfer of
money is returned unpaid for any reason, the Bank will take such steps as the Bank may, in its
discretion, deem appropriate to protect the Company from financial loss or as the Company or its
designee may instruct. Provided that the standard procedures, as agreed upon from time to time,
between the Company and the Bank, regarding purchases and redemptions of Shares, are adhered to by
the Bank, the Bank shall not be liable for any loss suffered by a Fund as a result of returned or
unpaid purchase or redemption transactions. Legal or other expenses incurred to collect amounts
owed to a Fund as a consequence of returned or unpaid purchase or redemption transactions shall be
paid by the Manager or, if not so paid promptly, then by the relevant Fund.
ARTICLE
4.
4.01
Redemptions
. Shares of any Fund may be redeemed in accordance with the
procedures set forth in the Prospectus and the Bank will duly process all redemption requests.
Page 8
ARTICLE
5.
5.01
Transfers and Exchanges
. The Bank is authorized to review and process transfers
of Shares of each Fund, exchanges between Funds on the records of the Funds maintained by the Bank,
and exchanges between the Company and any other entity, in each case as may be permitted by the
Prospectus. If Shares to be transferred are represented by outstanding certificates, the Bank
will, upon surrender to it of the certificates in proper form for transfer, and upon cancellation
thereof, countersign and issue new certificates for a like number of Shares and deliver the same.
If the Shares to be transferred are not represented by outstanding certificates, the Bank will,
upon an order therefor by or on behalf of the registered holder thereof in proper form, credit the
same to the transferee on its books. If Shares are to be exchanged for Shares of another Fund, the
Bank will process such exchange in the same manner as a redemption and sale of Shares, except that
it may in its discretion waive requirements for information and documentation.
ARTICLE
6.
6.01
Right to Seek Assurances
. The Bank reserves the right to refuse to transfer or
redeem Shares until it is satisfied that the requested transfer or redemption is legally
authorized, and it shall incur no liability for the refusal, in good faith, to make transfer or
redemptions which the Bank, in its judgment, deems improper or unauthorized, or until it is
satisfied that there is no basis for any claims adverse to such transfer or redemption. The Bank
may, in effecting transfers, rely upon the provisions of the Uniform Act for the Simplification of
Fiduciary Security Transfers or the Uniform Commercial Code, as the same may be amended from time
to time, which in the opinion of legal counsel for the Company or of its own legal counsel protect
it in not requiring certain documents in connection with the transfer or redemption of Shares of
any Fund, and the Bank shall be entitled to indemnification in accordance with Article 14 hereof
for any act done or omitted by it in reliance upon such laws or opinions of counsel of the Company
or of its own counsel.
ARTICLE
7.
Distributions
.
7.01 The Company will promptly notify the Bank of the declaration of any dividend or
distribution. The Company shall furnish to the Bank a resolution of the Trustees of the Company
certified by the Secretary: (i) authorizing the declaration of dividends on a specified periodic
basis and authorizing the Bank
Page 9
to rely on oral instructions or a Certificate specifying the date of the declaration of such
dividend or distribution, the date of payment thereof, the record date as of which Shareholders
entitled to payment shall be determined and the amount payable per share to Shareholders of record
as of the date and the total amount payable to the Bank on the payment date; or (ii) setting forth
the date of the declaration of any dividend or distribution by a Fund, the date of payment thereof,
the record date as of which Shareholders entitled to payment shall be determined, and the amount
payable per share to the Shareholders of record as of that date and the total amount payable to the
Bank on the payment date.
7.02 The Bank, on behalf of the Company, shall instruct the Custodian to place in a dividend
disbursing account funds equal to the cash amount of any dividend or distribution to be paid out.
The Bank will calculate, prepare and mail checks to (at the address as it appears on the records of
the Bank), or (where appropriate) credit such dividend or distribution to the account of, Fund
Shareholders, and maintain and safeguard all underlying records.
7.03 The Bank will replace lost checks at its discretion and in conformity with regular
business practices.
7.04 The Bank will maintain all records necessary to reflect the crediting of dividends which
are reinvested in Shares of the Company, including without limitation daily dividends.
7.05 The Bank shall not be liable for any improper payments made in accordance with a
resolution of the Trustees of the Company.
7.06 If the Bank shall not receive from the Custodian sufficient cash to make payment to all
Shareholders of the Company as of the record date, the Bank shall, upon notifying the Company,
withhold payment to all Shareholders of record as of the record date until such sufficient cash is
provided to the Bank.
ARTICLE
8.
8.01
Other Duties
. In addition to the duties expressly provided for herein, the Bank
shall perform such other duties and functions and shall be paid such amounts therefore as may from
time to time be agreed in writing.
Page 10
ARTICLE
9.
9.01
Taxes
. It is understood that the Bank shall file such appropriate information
returns concerning the payment of dividends and capital gain distributions and tax withholding with
the proper Federal, State and local authorities as are required by law to be filed by the Company
and shall withhold such sums as are required to be withheld by applicable law.
ARTICLE
10.
Books and Records
.
10.01 The Bank shall maintain records showing for each Shareholders account the following:
(i) names, addresses and tax identification numbers; (ii) numbers of Shares held; (iii) historical
information regarding the account of each Shareholder, including dividends paid and date and price
of all transactions on a Shareholders account; (iv) any stop or restraining order placed against a
Shareholders account; (v) information with respect to withholdings; (vi) any capital gain or
dividend reinvestment order, plan application, dividend address and correspondence relating to the
current maintenance of a Shareholders account; (vii) certificate numbers and denominations for any
Shareholders holding certificates; (viii) any information required in order for the Bank to perform
the calculations contemplated or required by this Agreement; and (ix) such other information and
data as may be required by applicable law.
10.02 Any records required to be maintained by Rule 31a-1 under the 1940 Act will be preserved
for the periods prescribed in Rule 31a-2 under the 1940 Act. Such records may be inspected by the
Company at reasonable times. The Bank may, at its option at any time, and shall forthwith upon the
Companys demand, turn over to the Company and cease to retain in the Banks files, records and
documents created and maintained by the Bank in performance of its service or for its protection.
At the end of the six-year retention period, such periods and documents will either be turned over
to the Company, or destroyed in accordance with the Companys authorization.
10.03 Procedures applicable to the services to be performed hereunder may be established from
time to time by agreement between the Fund(s) and the Bank. The Bank shall have the right to
utilize any shareholder accounting and recordkeeping systems which, in its opinion, qualifies to
perform any services to be performed hereunder.
Page 11
ARTICLE
11.
Fees and Expenses
.
11.01 For performance by the Bank pursuant to this Agreement, the Manager agrees to pay the
Bank an annual maintenance fee for each Shareholder account as set out in the initial fee schedule
attached hereto. Such fees and out-of-pocket expenses and advances identified under Section 11.02
below may be changed from time to time subject to mutual written agreement between the Manager and
the Bank.
11.02 In addition to the fee paid under Section 11.01 above, the Manager agrees to reimburse
the Bank for out-of-pocket expenses or advances incurred by the Bank for the items set out in the
fee schedule attached hereto. In addition, any other expenses incurred by the Bank at the request
or with the consent of the Fund(s) including, without limitation, any equipment or supplies
specifically ordered by the Company or required to be purchased by the Company, will be reimbursed
by the Manager.
11.03 The Manager agrees to pay all fees and reimbursable expenses within five days following
the mailing of the respective billing notice. Postage for mailing of dividends, proxies, Fund
reports and other mailings to all shareholder accounts shall be advanced to the Bank by the Manager
at least seven (7) days prior to the mailing date of such materials.
11.04 Notwithstanding the foregoing, to the extent the Manager is not obligated pursuant to an
agreement with the Company to pay the fees and expenses of the Bank hereunder, the Company shall be
responsible for such obligations of the Manager set forth in this Article 11.
ARTICLE
12.
Representations and Warranties of the Bank
.
The Bank represents and warrants to the Company that:
12.01 It is a banking association duly organized and existing and in good standing under the
laws of the United States of America.
12.02 It is empowered under applicable laws and by its charter and By-laws to enter into and
perform this Agreement.
12.03 All requisite corporate proceedings have been taken to authorize it to enter into and
perform this Agreement.
Page 12
12.04 It has and will continue to have access to the necessary facilities, equipment and
personnel to perform its duties and obligations under this Agreement.
ARTICLE
13.
Representations and Warranties of the Company and the Manager
.
The Company represents and warrants to the Bank that:
13.01 It is a business trust duly organized and existing and in good standing under the laws
of the state of its organization as set forth in the preamble hereto.
13.02 It is empowered under applicable laws and by its charter documents and By-Laws to enter
into and perform this Agreement.
13.03 All proceedings required by said charter documents and By-Laws have been taken to
authorize it to enter into and perform this Agreement.
13.04 It is an open-end, management investment company registered under the Investment Company
Act of 1940.
13.05 A registration statement on Form N-1A (including a prospectus and statement of
additional information) under the Investment Company Act of 1940 is currently effective and will
remain effective, and appropriate state securities law filings have been made and will continue to
be made, with respect to all Shares of the Company being offered for sale.
13.06 When Shares are hereafter issued in accordance with the terms of the Prospectus, such
Shares shall be validly issued, fully paid and nonassessable by the Company.
The Manager represents and warrants to the Bank that:
13.07 It is a Massachusetts general partnership, empowered under applicable laws and by its
agreement of partnership to enter into and perform this Agreement.
13.08 All proceedings required by said agreement have been taken to authorize it to enter into
and perform this Agreement, and the partner executing this Agreement on behalf of the partnership
has full authority to do so on behalf of the partnership.
Page 13
ARTICLE
14.
Indemnification
.
14.01 The Bank shall not be responsible for, and the Manager shall indemnify and hold the Bank
harmless from and against, any and all losses, damages, costs, charges, counsel fees, payments,
expenses and liability arising out of or attributable to:
(a) All actions taken or omitted to be taken by the Bank or its agent or subcontractors in
good faith in reliance on, or, use by the Bank or its agents or subcontractors of information,
records and documents which (i) are received by the Bank or its agents or subcontractors and
furnished to it by or on behalf of the Fund(s), (ii) have been prepared and/or maintained by the
Fund(s) or any other person or firm on behalf of the Fund(s), or (iii) were received by the Bank or
its agents or subcontractors from a prior transfer agent.
(b) Any action taken or omitted to be taken in good faith by the Bank in connection with its
appointment hereunder, in reliance upon any law, act, regulation or interpretation of the same even
though the same may thereafter have been altered, changed, amended or repealed.
(c) The Funds refusal or failure to comply with the terms of this Agreement, or which arise
out of the Funds lack of good faith, negligence or willful misconduct or which arise out of the
breach of any representation or warranty of the Fund(s) hereunder.
(d) The reliance on, or the carrying out by the Bank or its agents or subcontractors of any
instructions or requests, whether written or oral, of the Fund(s).
(e) The offer or sale of Shares in violation of any requirement under the federal securities
laws or regulations or the securities laws or regulations of any state that such Shares be
registered in such state or in violation of any stop order or other determination or ruling by any
federal agency or any state with respect to the offer or sale of such Shares in such state.
(f) Indemnification under this Agreement shall not apply to actions or omissions of the Bank
or its directors, officers, employees, agents or subcontractors in cases of its own negligence,
willful misconduct, bad faith, or reckless disregard of its duties or their own duties hereunder.
Page 14
14.02 The Bank shall indemnify and hold the Fund(s) harmless from and against any and all
losses, damages, costs, charges, counsel fees, payments, expenses and liability arising out of or
attributed to any action or failure, or omission to act by the Bank as a result of the Banks lack
of good faith, negligence or willful misconduct.
14.03 At any time the Bank may apply to any officer of the Company for instructions, and may
consult with legal counsel with respect to any matter arising in connection with the services to be
performed by the Bank under this Agreement, and the Bank and its agents or subcontractors shall not
be liable and shall be indemnified by the Manager for any action taken or omitted by it in reliance
upon such instructions or upon the opinion of such counsel. The Bank, its agents and
subcontractors shall be protected and indemnified in acting upon any paper or document furnished by
or on behalf of the Fund(s), reasonably believed to be genuine and to have been signed by the
proper person or persons, or upon any instruction, information, data, records or documents provided
the Bank or its agents or subcontractors by machine readable input, telex, CRT data entry or other
similar means authorized by the Fund(s), and shall not be held to have notice of any change of
authority of any person, until receipt of written notice thereof from the Fund(s). The Bank, its
agents and subcontractors shall also be protected and indemnified in recognizing stock certificates
which are reasonably believed to bear the proper manual or facsimile signatures of the officer of
the Company, and one proper countersignature of any former transfer agent or registrar, or of a
co-transfer agent or co-registrar.
14.04 In the event either party is unable to perform its obligations under the terms of this
Agreement because of acts of God, strikes, interruption of electrical power or other utilities,
equipment or transmission failure or damage reasonably beyond its control, or other causes
reasonably beyond its control, such party shall not be liable to the other for any damages
resulting from such failure to perform or otherwise from such causes.
14.05 No party to this Agreement shall be liable to any other party for consequential damages
under any provision of this Agreement or for any act or failure to act hereunder.
14.06 Notwithstanding anything herein to the contrary, in the event that the Bank is entitled
to indemnification from the Manager pursuant to the terms hereof and the Bank is not promptly or
fully indemnified, the Company agrees that the
Page 15
Company shall indemnify the Bank in accordance with the provisions hereof, and all references
to the Manager in this Article 14 shall be deemed to refer to the Company.
14.07 In order that the indemnification provision contained in this Article 14 shall apply,
however, it is understood that if in any case the Manager or the Company may be asked to indemnify
or save the Bank harmless, the Manager and the Company shall be fully and promptly advised of all
pertinent facts concerning the situation in question, and it is further understood that the Bank
will use all reasonable care to identify and notify the Manager and the Company promptly concerning
any situation which presents or appears likely to present the probability of such claim for
indemnification. The Manager or the Company, as the case may be, shall have the option to defend
the Bank against any claim which may be the subject of this indemnification, and in the event that
the Manager or the Company so elects it will so notify the Bank and thereupon the Manager or the
Company as the case may be, shall take over the complete defense of the claim, and the Bank shall
in such situations incur no further legal or other expenses in connection with such claim, provided
however, if the defendants in any such action include both (i) the Manager or the Company and (ii)
the Bank, and the Bank shall have reasonably concluded that there may be legal defenses available
to it which are different from or additional to those available to the Manager or the Company, as
the case may be, the Bank shall have the right to select separate counsel to assert such legal
defenses and to otherwise participate in the defense of such action on behalf of the Bank with such
cost to be borne by the party hereto ultimately liable with respect to such claim. The Bank shall
in no case confess any claim or make any compromise in any case in which the Manager or the Company
will be asked to indemnify the Bank except with the prior written consent of the Manager or the
Company, as the case may be, which consent shall not be unreasonably withheld. The Manager or the
Company, as the case may be, shall not settle any claim without the Banks prior written consent,
provided however that the Bank shall not unreasonably withhold its consent.
ARTICLE
15.
Covenants of the Company and the Bank
.
15.01 The Company shall promptly furnish to the Bank the following:
(a) A certified copy of the resolution of the Trustees of the Company authorizing the
appointment of the Bank and the execution and delivery of this Agreement.
Page 16
(b) A copy of the charter documents and By-Laws of the Company and all amendments thereto.
(c) Copies of each vote of the Trustees designating authorized persons to give instructions to
the Bank.
(d) Certificates as to any change in any officer or Trustee of the Company.
(e) If applicable, a specimen of the certificate of Shares of each Fund of the Company in the
form approved by the Trustees, with a certificate of the Secretary of the Company as to such
approval.
(f) Specimens of all new certificates for Shares, accompanied by the Trustees resolutions
approving such forms.
(g) All account application forms and other documents relating to shareholder accounts or
relating to any plan, program or service offered by the Company.
(h) A list of Shareholders of the Fund(s) with the name, address and tax identification number
of each Shareholder, and the number of Shares of the Fund(s) held by each, certificate numbers and
denominations (if any certificates have been issued), lists of any account against which stops have
been placed, together with the reasons for said stops, and the number of Shares redeemed by the
Fund(s).
(i) An opinion of counsel for the Company with respect to the validity of the currently
authorized Shares and the status of such Shares under the Securities Act of 1933, which may be
copies of previously issued opinions, and an opinion of counsel for the Company with respect to
newly authorized Shares with respect to the validity of such Shares and the status of such Shares
under the Securities Act of 1933.
(j) Copies of the Fund(s) registration statement on Form N-1A as currently in effect as of the
date hereof and all post-effective amendments thereto filed subsequent to the date hereof.
(k) Such other certificates, documents or opinions as may mutually be deemed necessary or
appropriate for the Bank in the proper performance of its duties.
15.02 The Bank hereby agrees to establish and maintain facilities and procedures reasonably
acceptable to the Company
Page 17
for safekeeping of stock certificates, check forms and facsimile signature imprinting devices,
if any; and for the preparation or use, and for keeping account of, such certificates, forms and
devices.
15.03 The Bank shall keep records relating to the services to be performed hereunder, in the
form and manner as it may deem advisable. To the extent required by Section 31 of the Investment
Company Act of 1940, as amended, and the Rules thereunder, the Bank agrees that all such records
prepared or maintained by the Bank relating to the services to be performed by the Bank hereunder
are the property of the Company and will be preserved, maintained and made available in accordance
with such Section and Rules, and will be surrendered to the Company on and in accordance with its
request.
15.04 The Bank and the Company agree that all books, records, information and data pertaining
to the business of the other party which are exchanged or received pursuant to the negotiation or
the carrying out of this Agreement shall remain confidential, and shall not be voluntarily
disclosed to any other person, except as may be required by law.
15.05 In case of any requests or demands for the inspection of the Shareholder records of the
Company, the Bank will endeavor to notify the Company and to secure instructions from an authorized
officer of the Company as to such instruction. The Bank reserves the right, however, to exhibit
the Shareholder records to any person whenever it is advised by its counsel that it may be held
liable for the failure to exhibit the Shareholder records to such person.
ARTICLE
16.
Term of Agreement
.
16.01 This Agreement shall become effective on the date hereof (the Effective Date) and
shall continue in effect for twelve months from the Effective Date (the Initial Term) and from
year to year thereafter with respect to each Fund, provided that subsequent to the Initial Term,
this Agreement may be terminated by either the Company or the Bank at any time without payment of
any penalty upon ninety (90) days written notice to the other. In the event such notice is given
by the Company, it shall be accompanied by a resolution of the Trustees, certified by the
Secretary, electing to terminate this Agreement and designating a successor transfer agent.
16.02 Should the Company exercise its right to terminate, all out-of-pocket expenses
associated with the
Page 18
movement of records and material will be borne by the Manager, except as set forth in Article
11.04 hereof. Additionally, the Bank reserves the right to charge for any other reasonable
expenses associated with such termination.
ARTICLE
17.
Additional Funds
.
17.01 In the event that the Company establishes one or more series of Shares in addition to
the initial series listed by name in the preamble to this Agreement with respect to which it
desires to have the Bank render services as transfer agent under the terms hereof, it shall so
notify the Bank in writing, and if the Bank agrees in writing to provide such services, such series
of Shares shall become a Fund hereunder.
ARTICLE
18.
Assignment
.
18.01 Except as provided in Section 18.03 below, neither this Agreement nor any rights or
obligations hereunder may be assigned by any party without the written consent of the other
parties.
18.02 This Agreement shall inure to the benefit of and be binding upon the parties and their
respective permitted successors and assigns.
18.03 The Bank, may without further consent on the part of the Company, subcontract for the
performance of services to be provided hereunder to third parties, including any affiliate of the
Bank, provided that the Bank shall remain liable hereunder for any acts or omissions of any
subcontractor as if performed by the Bank.
ARTICLE
19.
Amendment
.
19.01 This Agreement may be amended or modified by a written agreement executed by each of the
parties.
ARTICLE
20.
Massachusetts Law to Apply
.
20.01 This Agreement shall be construed and the provisions thereof interpreted under and in
accordance with the laws of The Commonwealth of Massachusetts.
ARTICLE
21.
Merger of Agreement
.
21.01 This Agreement constitutes the entire agreement between the parties hereto and
supersedes any prior agreement with respect to the subject hereof whether oral or written.
Page 19
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed in their
names and on their behalf under their seals by and through their duly authorized officers, as of
the day and year first above written.
|
|
|
|
|
|
|
|
|
|
|
|
|
GMO TRUST
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ R. Jeremy Grantham
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ATTEST:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Esther Cash
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GRANTHAM, MAYO, VAN OTTERLOO & CO.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ David A. Salem
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ATTEST:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Esther Cash
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INVESTORS BANK & TRUST COMPANY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ [signature]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ATTEST:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ [signature]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
[This page intentionally left blank.]
|
|
|
|
|
Grantham, Mayo, Van Otterloo & Co. LLC
40 Rowes Wharf
o
Boston, MA 02110
T: (617) 330-7500
o
F: (617) 261-0134
o
www.gmo.com
|
June 1, 2010
State Street Bank and Trust Company
Attn: Transfer Agent
200 Clarendon Street
16th Floor
Boston, MA 02116
Re:
Fund of Funds Procedures
Ladies and Gentlemen:
Pursuant to the Transfer Agency and Service Agreement, dated August 1, 1991, by and among GMO
Trust (the Trust), on behalf of certain of its series of the Trust, Grantham, Mayo, Van Otterloo
& Co. LLC (GMO) and State Street Bank and Trust Company (as successor by merger to Investors Bank
& Trust Co.), as amended (the Agreement), State Street Bank and Trust Company (State Street)
serves as transfer agent, dividend disbursing agent and agent for certain other activities for the
Trust. The purpose of this letter is to instruct State Street to follow the procedures set forth
below (the Procedures) so that certain conditions set forth by the staff of the Securities and
Exchange Commission in a line of no action letters
2
may be met in connection with the
investment by certain series of the Trust (each, a Fund of Funds) in shares issued by other
series of the Trust (each, an Underlying Fund), and which shares are maintained in the name of
the relevant Fund of Funds in the book-entry system of State Street pursuant to the Agreement.
Procedures
1. Upon ceasing to act as transfer agent for the Trust, State Street will deliver all shares of
Underlying Funds owned by each Fund of Funds to the successor transfer agent, clearing agency,
custodian, or safekeeper designated by the Trust.
2. In its capacity as transfer agent for each Underlying Fund, State Street will maintain a
segregated account, that is, an account of record on State Streets shareholder record keeping
system, representing only shares held for each Fund of Funds.
|
|
|
2
|
|
See
,
e.g.
, Franklin Investors Securities Trust (pub. avail. September 24, 1992).
|
Page 2
3. With respect to each Fund of Funds investments in shares of an Underlying Fund, State Street
will send to the address of record for each Fund of Funds copies of all confirmations of any
purchases, redemptions, or other transfers to or from the segregated account of the Fund of Funds.
4. Upon the reasonable request of GMO or the Trust, State Street will send to the Trust a copy of
State Streets most recent SAS 70 report (or equivalent assurance report) regarding State Streets
transfer agency system of internal accounting control and such other documentation on State
Streets system of internal accounting control as may be mutually agreed between State Street and
GMO or the Trust.
5. Transaction orders submitted to State Street by GMO on behalf of any Fund of Funds in accordance
with the Agreement and the following procedures will constitute valid, authorized, and appropriate
instructions under the Agreement, upon which State Street may rely:
|
(a)
|
|
Each business day, GMO shall aggregate all orders received by GMO Shareholder
Services (SHS) in good order in accordance with the relevant Fund of Funds
prospectus.
|
|
|
(b)
|
|
A SHS representative previously identified by GMO to State Street in accordance
with the Agreement as an authorized person of the Trust shall transmit an electronic
file or fax containing all such orders.
|
|
|
(c)
|
|
Each business day, State Street shall confirm to GMO in writing receipt of the
file containing the orders and that the file is readable and complete.
|
Notice
A copy of the Declaration of Trust, together with all amendments thereto, is on file with the
Secretary of the Commonwealth of Massachusetts and notice is hereby given that this instrument is
executed on behalf of the Trust by an officer of the Trust as an officer and not individually and
that the obligations of this instrument are not binding upon any of the Trustees or officers of the
Trust or shareholders of any series of the Trust individually but are binding only upon the assets
and property of the Trust or the respective series.
* * * *
The signature of a duly authorized officer of State Street at the end of this letter will
constitute State Streets acknowledgement that GMO provided the Procedures to State Street for
State Streets review and State Streets willingness to treat the Procedures as mutually agreed
upon procedures under the Agreement. These Procedures may be amended by the parties from time to
time in a writing signed by both parties. The parties also agree that in the event any clause of
the Agreement contradicts any provision of this letter, the provisions of the Agreement shall
control.
Page 3
This letter may be executed in one or more counterparts, each of which will be deemed an
original, but all of which together shall constitute one and the same instrument.
|
|
|
|
|
|
|
|
|
Sincerely,
|
|
|
|
|
|
|
|
|
|
|
|
GMO TRUST
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Jason Harrison
|
|
|
|
|
|
|
|
|
|
|
|
Name:
|
|
Jason Harrison
|
|
|
|
|
Title:
|
|
Clerk
|
|
|
|
|
|
|
|
|
|
|
|
GRANTHAM, MAYO
|
|
|
|
|
VAN OTTERLOO & Co. LLC
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ JB Kittredge
|
|
|
|
|
|
|
|
|
|
|
|
Name:
|
|
JB Kittredge
|
|
|
|
|
Title:
|
|
General Counsel
|
|
|
|
|
|
|
|
The foregoing is hereby
accepted and agreed to as of
the date written below.
|
|
|
|
|
|
|
|
STATE STREET BANK AND TRUST COMPANY
|
|
|
|
|
|
|
|
By:
|
|
/s/ Joshua Lovell
|
|
|
|
|
|
|
|
Name:
|
|
Joshua Lovell
|
|
|
Title:
|
|
Senior Vice President
|
|
|
|
|
|
|
|
Date:
|
|
6/9/2010
|
|
|
This Agreement is executed on behalf of Grantham, Mayo, Van Otterloo & Co. LLC (GMO) by a duly
authorized officer or other agent solely in his or her capacity as an authorized signatory,
pursuant to delegated authority from GMO, and not individually. The obligations of or arising out
of this Agreement are not binding upon any officer or other agent, partner, member or director of
GMO individually, but are binding only upon GMO and its assets. GMOs certificate of organization
is on file with the Secretary of State of The Commonwealth of Massachusetts.
Exhibit (p)(1)
GMO
CODE OF ETHICS
GMO AUSTRALASIA LLC
GMO AUSTRALIA LTD.
GMO SINGAPORE PTE LTD.
GMO SWITZERLAND GMBH
GMO U.K. LIMITED
GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC
GMO RENEWABLE RESOURCES, LLC
GMO RENEWABLE RESOURCES (in New Zealand)
GMO RENEWABLE RESOURCES URUGUAY, SRL
Dated May 20, 2011
Table of Contents
|
|
|
|
|
Overview and Summary Charts
|
|
|
1
|
|
Overview Chart/Basic Rules and Exceptions
|
|
|
1
|
|
Overview ChartBy Instrument
|
|
|
2
|
|
|
|
|
|
|
1. PROHIBITED TRANSACTIONS
|
|
|
3
|
|
1.1 Securities Being Considered for Purchase or Sale
|
|
|
3
|
|
1.2 Options on Securities
|
|
|
4
|
|
1.3 Short Selling of Securities
|
|
|
4
|
|
1.4 Short-Term Trading
|
|
|
5
|
|
1.5 Short-Term Trading Strategies in GMO Long-Term Funds
|
|
|
5
|
|
1.6 Trading on Inside Information
|
|
|
6
|
|
1.7 Market Manipulation
|
|
|
6
|
|
1.8 Other Illegal and/or Impermissible Transactions
|
|
|
6
|
|
|
|
|
|
|
2. PRE-CLEARANCE REQUIREMENTS
|
|
|
6
|
|
2.1 Transactions in Certain Securities
|
|
|
6
|
|
2.2 Dividend Reinvestment, etc.
|
|
|
7
|
|
2.3 Discretionary Accounts
|
|
|
7
|
|
2.4 De Minimis Purchases and Sales of Certain Large Cap Securities
|
|
|
7
|
|
2.5 Transactions Pursuant to Limit Orders Previously Approved by Compliance Department
|
|
|
8
|
|
2.6 Transactions by Brokers to Satisfy Margin Calls
|
|
|
8
|
|
2.7 Non-GMO Employee Stock Investment Options
|
|
|
8
|
|
2.8 Donation of Securities to a Charity
|
|
|
8
|
|
2.9 GMO Hedge Funds
|
|
|
8
|
|
|
|
|
|
|
3. REPORTING REQUIREMENTS
|
|
|
9
|
|
3.1 Initial and Annual Disclosure of Personal Holdings
|
|
|
9
|
|
3.2 Quarterly Reporting Requirements
|
|
|
9
|
|
3.3 Exemptions for Transactions in Certain Securities
|
|
|
10
|
|
3.4 Additional Exemption From Quarterly Reports
|
|
|
10
|
|
3.5 Brokerage Confirmations
|
|
|
10
|
|
3.6 Procedures for Filing Reports
|
|
|
11
|
|
3.7 Reporting Violations
|
|
|
11
|
|
i
|
|
|
|
|
4. ADMINISTRATION AND ENFORCEMENT OF CODE OF ETHICS
|
|
|
11
|
|
4.1 General Principles
|
|
|
11
|
|
4.2 Role of COIC; Delegation
|
|
|
11
|
|
4.3 CCO Role, Investigations
|
|
|
12
|
|
4.4 Sanctions
|
|
|
12
|
|
4.5 Administration of Pre-clearance
|
|
|
12
|
|
4.6 No Explanation Required for Refusals
|
|
|
13
|
|
4.7 Review of Denied Pre-Clearance Requests
|
|
|
13
|
|
|
|
|
|
|
5. MISCELLANEOUS
|
|
|
13
|
|
5.1 Copies of Code; Annual Affirmation
|
|
|
13
|
|
5.2 Review of Reports
|
|
|
13
|
|
5.3 Availability of Reports
|
|
|
13
|
|
5.4 Exceptions to the Code
|
|
|
14
|
|
5.5 Inquiries Regarding the Code
|
|
|
14
|
|
5.6 Amendments to Code
|
|
|
14
|
|
|
|
|
|
|
Exhibit A: Definitions
|
|
|
15
|
|
Appendix A-1 List of Restricted Exchange Traded Funds
|
|
|
20
|
|
Appendix A-2 List of Reportable 529 Plans
|
|
|
21
|
|
GMO UK Limited Code of Ethics Supplement
|
|
|
22
|
|
GMO Australia Ltd. Code of Ethics Supplement
|
|
|
25
|
|
GMO Renewable Resources (in New Zealand) Code of Ethics Supplement
|
|
|
27
|
|
GMO Non-Access Director Code of Ethics Supplement
|
|
|
28
|
|
ii
GMO CODE OF ETHICS
as revised May 20, 2011
OVERVIEW AND SUMMARY CHARTS
GMO and its affiliates have adopted this Code of Ethics in order to reflect the values of the firm
and to fulfill the firms regulatory obligations. Because the regulations are complex and
technical, a number of terms are defined in Exhibit A and appear in the Code in
bold
.
The following chart provides an overview of some key rules under the Code and some common
exceptions. This is only an overview and there are other rules and exceptions.
Each
Access
Person
is still responsible for reading and understanding this Code in its entirety.
|
|
|
Five Basic Rules
|
|
Common Exceptions
|
Basic Rule #1:
|
|
Mutual Funds
|
Do not trade in advance of clients
|
|
Most Exchange Traded Funds
|
|
|
U.S. Government Securities
|
|
|
Money Market Instruments
|
|
|
Financial Futures
|
|
|
|
Basic Rule #2:
|
|
Mutual Funds
|
Pre-Clear all trades
|
|
Most Exchange Traded Funds
|
|
|
529 Plans
|
|
|
U.S. Government Securities
|
|
|
Money Market Instruments
|
|
|
Municipal Bonds
|
|
|
Financial Futures
|
|
|
|
Basic Rule #3:
|
|
Mutual Funds not advised/sub-advised by GMO (but not Exchange Traded
Funds)
|
Report all trades
|
|
Most 529 Plans
|
|
|
U.S. Government Securities
|
|
|
Money Market Instruments
|
|
|
Currencies/Currency forwards/Non-exchange traded options on currencies
|
|
|
Futures on interest rates/currencies
|
|
|
|
Basic Rule # 4:
|
|
Mutual Funds not advised/sub-advised by GMO
|
Dont churn your account
|
|
U.S. Government Securities
|
|
|
Money Market Instruments
|
|
|
Currencies/Currency forwards/Non-exchange traded options on currencies
|
|
|
Municipal Bonds
|
|
|
Financial Futures
|
|
|
|
Basic Rule #5:
|
|
None
|
No violation of laws, for example:
No Transactions on inside information;
No market manipulation.
The following chart provides a different overview of the Codes operation, organized by the type of
security. As with the previous chart, this is, however, only an overview of some of the rules
applicable to different kinds of securities.
Every
Access Person
is still responsible for
reading and understanding this Code in its entirety.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prohibited if
|
|
|
|
|
|
|
|
|
|
|
Purchase or
|
|
Subject to
|
|
|
|
|
|
|
|
|
Sale Being
|
|
Quarterly and
|
|
Disgorge Short-
|
|
|
|
|
|
|
Considered for
|
|
Annual
|
|
Term Profit
|
|
Short Sales
|
|
|
Preclearance
|
|
a GMO Client
|
|
Reporting
|
|
(<60 day
|
|
Generally
|
Type of Security
|
|
Required
|
|
Account
|
|
Requirements
|
|
Round Trip)
|
|
Prohibited
1
|
GMO Mutual Funds and GMO
Sub-Advised Funds
|
|
No
|
|
No
|
|
Yes
2
|
|
Yes, except SDCF,
SDC Share, SDIF,
Domestic Bond and
WOOF
|
|
Yes
|
Non-GMO Mutual Funds
|
|
No
|
|
No
|
|
No
|
|
No
|
|
Yes
|
Closed-End Funds
|
|
Yes
|
|
Yes
|
|
Yes
|
|
Yes
|
|
Yes
|
Most Exchange Traded
Funds
3
(does not
include Closed-End Funds)
|
|
No
|
|
No
|
|
Yes
|
|
No
|
|
No
|
Exempted Government Securities
|
|
No
|
|
No
|
|
No
|
|
No
|
|
Yes
|
Money Market Instruments
|
|
No
|
|
No
|
|
No
|
|
No
|
|
Yes
|
Currencies and related
forward contracts
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
Financial Futures (including
physical commodities)
|
|
No
|
|
No
|
|
Generally Yes
4
|
|
No
|
|
No
|
|
|
|
1
|
|
Subject to limited exceptions (see Section 1.3), short selling is prohibited with respect
to any investment held in any GMO Client Account.
|
|
2
|
|
Please note that Access Persons do not need to enter reporting details in StarCompliance
for GMO Mutual Fund investments only. However, investments in GMO Sub-Advised Funds will
need to be entered in StarCompliance.
|
|
3
|
|
See Appendix A-1 for a list of exceptions.
|
|
4
|
|
Futures on interest rates and currencies are exempt from the Codes reporting requirements.
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prohibited if
|
|
|
|
|
|
|
|
|
|
|
Purchase or
|
|
Subject to
|
|
|
|
|
|
|
|
|
Sale Being
|
|
Quarterly and
|
|
Disgorge Short-
|
|
|
|
|
|
|
Considered for
|
|
Annual
|
|
Term Profit
|
|
Short Sales
|
|
|
Preclearance
|
|
a GMO Client
|
|
Reporting
|
|
(<60 day
|
|
Generally
|
Type of Security
|
|
Required
|
|
Account
|
|
Requirements
|
|
Round Trip)
|
|
Prohibited
1
|
Put or Call Options (buying or writing)
|
|
Generally Yes
|
|
Yes
|
|
Generally Yes
|
|
Generally Yes
|
|
N/A
|
Municipal Bonds
|
|
No
|
|
Yes
|
|
Yes
|
|
No
|
|
Yes
|
IPOs
|
|
Yes
|
|
Yes
|
|
Yes
|
|
Yes
|
|
Yes
|
Private Placements (including third
party private funds)
|
|
Yes
|
|
Yes
|
|
Yes
|
|
Yes
|
|
Yes
|
Most 529 Plans
5
|
|
No
|
|
Not Applicable
|
|
Generally No
|
|
N/A
|
|
N/A
|
MOST OTHER INVESTMENTS
|
|
Yes
|
|
Yes
|
|
Yes
|
|
Yes
|
|
Yes
|
Gift Policy:
GMO also has a Gift Policy which is a separate, stand-alone document.
Special Rules for Access Persons of Subsidiaries; Non-Access Directors
. Employees,
partners, consultants and all other
Access Persons
are subject to
all
provisions of this
Code unless you are an
Independent Trustee
of GMO Trust or a
Non-Access Director
of GMO. If you are
one of the following, you should also look at the related Code Supplement
:
|
4
|
|
Officers and Employees of GMO UK Limited;
|
|
|
4
|
|
Officers and Employees of GMO Australia Limited;
|
|
|
4
|
|
Officers and Employees of GMO Renewable Resources (in New Zealand); and
|
|
|
4
|
|
Non-Access Directors
of GMO;
|
1.
|
|
PROHIBITED TRANSACTIONS
|
Access Persons
and members of their
Immediate Family
are prohibited from engaging in the following
transactions:
|
1.1
|
|
Securities Being Considered for Purchase or Sale
.
|
Except as provided below, any transaction in a
Security
being considered for purchase or sale
by a
GMO Client Account
is prohibited. For this purpose, a
Security
is being considered for
purchase or sale when a recommendation to purchase or sell the
Security
has been communicated or,
with respect to the person making the recommendation, when such person seriously considers making
the recommendation. The following
Securities
are
not
subject to this prohibition:
|
|
|
5
|
|
See Section 3.3 (Exemptions for Transactions in Certain Securities) and the definition of
Reportable 529 Plan
.
|
3
|
|
|
Registered open-end investment companies (but not
Restricted Exchange Traded Funds)
;
|
|
|
|
|
Unrestricted Exchange Traded Funds
(including short sales thereof);
|
|
|
|
|
Financial Futures
; options on
Financial Futures
; and short sales of
Financial Futures
.
|
|
|
|
|
U.S. Government Securities and other Exempted Government Securities
;
|
|
|
|
|
Money Market Investments
;
|
|
|
|
|
Securities
held or to be acquired by a
Discretionary Account
; and
|
|
|
|
|
Currencies, options on currencies, and forward contracts on currencies.
|
Note: The formulation of purchases and sale orders generally begins
before
the relevant
trading desk is asked to execute the trade. GMO reserves the right to require the unwinding of
personal trades that occur on or about the same time as client trades without proving that the
Access Person or member or his or her Immediate Family had actual knowledge of the pending client
trade.
1.2
Options on Securities
.
Purchasing or selling options on a
Security
held (or being considered for purchase or sale) by
any
GMO Client Account
is prohibited (other than options on
Financial Futures
or on foreign
currencies). The following
Securities
are
not
subject to this prohibition:
|
|
|
Securities
held or to be acquired by a
Discretionary Account
.
|
1.3
Short Selling of
Securities
.
Short selling
Securities
held (or being considered for purchase or sale) in any
GMO Client
Account
is prohibited. The following
Securities
are
not
subject to this prohibition:
|
|
|
Short sales of
Unrestricted Exchange Traded Funds
; and
|
|
|
|
|
Short sales of
Financial Futures
and options on
Financial Futures
.
|
|
|
|
|
Securities
held or to be acquired by a
Discretionary Account
.
|
Note: Forward contracts on currencies are not considered a short sale of either currency for
purposes of this Code.
4
1.4
Short-Term Trading
.
Except as provided below, purchasing and selling the same or equivalent
Securities
within 60
calendar days is prohibited. (For the sake of clarity, except as otherwise noted, this prohibition
applies to short-term profiting through the use of derivatives, either alone (e.g., exercising an
option within 60 days of purchasing the option) or in combination with other
Securities
Transactions
(e.g., selling the underlying
Security
within 60 days of purchasing a call on such
Security)
). The following
Securities
are
not
subject to this prohibition:
|
|
|
Registered open-end investment companies (other than
GMO Long-Term Funds
and
GMO Sub-Advised Funds
)
|
|
|
|
|
U.S. Government Securities and other Exempted Government Securities
;
|
|
|
|
|
Exchange Traded Funds
(whether or not they are registered open-end investment companies)
|
|
|
|
|
Money Market Instruments
;
|
|
|
|
|
Currencies and related forward contracts;
|
|
|
|
|
Financial Futures
and short sales of
Financial Futures
;
|
|
|
|
|
Physical commodity contracts and options on physical commodity contracts;
|
|
|
|
|
Securities
acquired through the exercise of rights issued by an issuer to all holders of a class
of its
Securities
, to the extent the rights were acquired in the issue;
|
|
|
|
|
Securities acquired through
Non-GMO Employee Stock Investment Options
;
|
|
|
|
|
Transactions resulting from stop-loss orders (note that this does not apply to limit orders).
|
|
|
|
|
Municipal bonds; and
|
|
|
|
|
Securities held in a
Discretionary Account
.
|
1.5
Short-Term Trading Strategies in
GMO Long-Term Funds
.
Transactions in any
GMO Long-Term Fund
that, when taken together, constitute a short-term
trading strategy that is inconsistent with the interests of the Funds long-term investors, are
prohibited. In addition (and in addition to the prohibition in Section 1.4), making three
round-trip transactions (purchase and
5
subsequent redemption) over a 12-month period in the same
GMO Long-Term Fund
is prohibited.
1.6
Trading on Inside Information
.
Any transaction in a
Security
while in possession of material nonpublic information regarding
the
Security
or the issuer of the
Security
is prohibited.
1.7
Market Manipulation
.
Transactions intended to raise, lower, or maintain the price of any
Security
or to create a
false appearance of active trading are prohibited.
1.8
Other Illegal and/or Impermissible Transactions
.
All
Access Persons
and all members of their
Immediate Family
are required to comply with all
applicable
Federal Securities Laws
. In addition to the prohibitions in Sections 1.6 (Trading on
Inside Information) and 1.7 (Market Manipulation),
Securities Transactions
not in compliance with
applicable
Federal Securities Laws
, or any other transactions deemed by the
CCO
to involve a
conflict of interest, possible diversion of corporate opportunity, or an appearance of impropriety,
are prohibited.
2. PRE-CLEARANCE REQUIREMENTS
Access Persons
and members of their
Immediate Family
are prohibited from engaging in any
Securities
Transaction
without prior approval of the
Compliance Department
unless otherwise provided below.
Once obtained, pre-clearance is valid only for the day on which it is granted and the following
three business days (or the following 30 calendar days in the case of a
Private Placement
). Limit
orders and stop-loss orders relating to
Securities
must be pre-cleared prior to establishment and
prior to any modifications, including cancellations.
There is no exemption from pre-clearance for IPOs or Private Placements
,
even where such
transactions are effected through Discretionary Accounts
.
See Sections 4.5.1 and 4.5.2 on how
to process a request for pre-clearance.
Please refer to the StarCompliance User Guide found within StarCompliance for information
regarding how to request pre-clearance or how to appeal denied pre-clearance requests.
The following
Securities Transactions
are exempt from the pre-clearance requirement:
2.1
Transactions in Certain Securities
.
Securities Transactions
involving the following instruments may be subject to the substantive
prohibitions in Section 1, but they are exempt from the pre-clearance requirement:
6
|
|
|
Securities issued by any registered open-end investment company (including
GMO
Affiliated Funds
, but excluding
Restricted Exchange Traded Funds
).
|
|
|
|
|
Unrestricted Exchange Traded Funds
(including short sales thereof);
|
|
|
|
|
U.S. Government Securities and other Exempted Government Securities
.
|
|
|
|
|
Money Market Instruments
.
|
|
|
|
|
Currencies and related forward contracts.
|
|
|
|
|
Options on currencies.
|
|
|
|
|
Financial Futures
; options on
Financial Futures
; and short sales of
Financial Futures
.
|
|
|
|
|
Physical commodities (e.g., gold).
|
|
|
|
|
Municipal bonds.
|
|
|
|
|
529 Plans.
|
|
|
|
|
Any transaction in other
Securities
as may from time to time be designated in writing
by the CCO (as directed by the
COIC)
on the ground that the risk of abuse is minimal
or non-existent.
|
2.2
Dividend Reinvestment, etc
.
Securities Transactions
involving acquisition of
Securities
acquired through stock dividends,
dividend reinvestments, stock splits, reverse stock splits, mergers, consolidations, spin-offs, the
exercise of rights issued by an issuer to all holders of the same class of
Securities
, or other
similar corporate reorganizations or distributions generally applicable to all holders of the same
class of
Securities.
2.3
Discretionary Accounts
.
Securities Transactions
through
Discretionary Accounts
in
Securities
other than
IPOs
and
Private Placements.
2.4
De Minimis Purchases and Sales of Certain Large Cap Securities
.
Purchases or sales of less than $25,000 of common stock, depository receipts, or preferred
stock where the size of the relevant issue is greater than $5 billion as of the date of such
purchases or sales are exempt from pre-clearance. This exemption from pre-clearance may be utilized
once per security within multiple accounts during a 4-day pre-clearance period (i.e., the day
pre-clearance
7
is granted and the following three business days) so long as the total across all accounts is less
than $25,000.
2.5
Transactions Pursuant to Limit Orders or Stop-Loss Orders Previously Approved by
Compliance Department
.
Transactions effected pursuant to limit orders or stop-loss orders already approved by the
Compliance Department
are exempt from pre-clearance, provided that the
Access Person
provides the
Compliance Department
with an attestation from the relevant broker stating that the broker will act
solely in accordance with that limit order or stop-loss order, with no influence exercised or
information supplied by the
Access Person
or anyone else acting on his or her behalf.
2.6
Transactions by Brokers to Satisfy Margin Calls
.
Liquidations of
Securities
by a broker to satisfy margin calls are not subject to
pre-clearance, provided that the
Access Person
provides to the
Compliance Department
a letter or
other documentation from the brokerage firm confirming that the liquidation was effected to satisfy
applicable margin requirements, and was not requested by the
Access Person
.
2.7
Non-GMO Employee Stock Investment Options
.
The receipt of stock or options in connection with an
Immediate Family
members
employment
are exempt from pre-clearance provided that the
Compliance Department
receives an
initial attestation from the
Immediate Family
members employer confirming that the securities were
acquired through a non-GMO compensation program. This attestation can be documentation detailing
the program, such as terms and entitlements, or, to the extent such documentation is not available,
an attestation from the employer. This exemption is inclusive of
exercising a cash-settled
option or the acquisition of stock by exercising an option acquired in connection with an
Immediate
Family
members employment.
The receipt of stock and options is still subject to reporting
requirements under the Code.
2.8
Donation of
Securities
to a Charity
.
Donations of
Securities
to charities are not subject to pre-clearance.
2.9
GMO Hedge Funds
Investments in GMO hedge funds, while subject to pre-clearance, are automatically pre-cleared
when the subscription is accepted by GMO.
8
3.
REPORTING REQUIREMENTS
3.1
Initial and Annual Disclosure of Personal Holdings
.
No later than 10 calendar days after initial designation as an
Access Person
and thereafter on
an annual basis (currently expected of all
Access Persons
by January 30 of each year), each
Access
Person
must report to the
Compliance Department
all of the following (subject to the exceptions in
Section 3.3):
3.1.1. The title, type, number of shares and principal amount of each
Security
(including as
applicable any exchange ticker symbol or CUSIP number) in which that
Access Person
has any
Beneficial Interest
(including
Securities
held in
Discretionary Accounts
);
3.1.2. The name of any broker, dealer or bank with whom the
Access Person
maintains a
Reportable
Account
; and
3.1.3. The date that the report is submitted by the
Access Person
.
Both initial reports and annual reports must be based on information current as of a date not
more than 30 days before the report is submitted.
3.2
Quarterly Reporting Requirements
.
Each
Access Person
must file a quarterly report with the
Compliance Department
no later than
30 calendar days following the end of each calendar quarter. The quarterly report shall include the
following information regarding each transaction during the quarter in any
Security
in which the
Access Person
had any
Beneficial Interest
(subject to the exceptions in Sections 3.3 and 3.4):
3.2.1. The date of the transaction, the title, the interest rate and maturity date (if applicable),
the number of shares and the principal amount of each
Security
(including as applicable any
exchange ticker symbol or CUSIP number) involved;
3.2.2. The nature of the transaction (i.e., purchase, sale or any other type of acquisition or
disposition);
3.2.3. The price of the
Security
at which the transaction was effected;
3.2.4. The name of the broker, dealer or bank with or through which the transaction was effected;
3.2.5. A certification that, with respect to each transaction effected during the quarter, the
Access Person neither had confidential information nor was aware of any pending consideration of
possible transactions or pending transactions in the relevant security by GMO on behalf of a GMO
client; and
3.2.6. The date that the report is submitted by the
Access Person
.
9
In addition, with respect to any
Reportable Account
established during such quarter by the
Access Person
, the quarterly report must also include the name of the broker, dealer or bank with
whom the
Access Person
established the account.
No quarterly report is required to list transactions that are automatic dividend
reinvestments.
3.3
Exemptions for Transactions in Certain Securities
.
Transactions in the following instruments may be subject to the substantive prohibitions in
Section 1 and/or the pre-clearance requirements in Section 2, but are exempt from the Reporting
Requirements in Sections 3.1 (Initial/Annual Report) and 3.2 (Quarterly Reports):
|
|
|
Securities issued by any registered open-end investment company
(other than a
GMO Affiliated Fund
or an
Exchange Traded Fund
.)
|
|
|
|
|
U.S. Government Securities and other Exempted Government Securities
.
|
|
|
|
|
Money Market Instruments
.
|
|
|
|
|
Futures on interest rates, futures on currencies, and
non-exchange-traded options on currencies and currency futures
(including short sales of any of the foregoing). (NOTE: Not all
Financial Futures
are covered by this exemption.)
|
|
|
|
|
Currencies and related forward contracts.
|
|
|
|
|
529 Plans (other than
Reportable 529 Plans
)
|
3.4
Additional Exemption From Quarterly Reports
.
Transactions in the following are exempt from the quarterly transaction reporting requirement
in Section 3.2 (but the results of these transactions must still be included in the annual report
required by Section 3.1):
|
|
|
Securities
acquired through stock dividends, dividend reinvestments,
stock splits, reverse stock splits, mergers, consolidations,
spin-offs, the exercise of rights issued by an issuer to all holders
of the same class of
Securities
, or other similar corporate
reorganizations or distributions generally applicable to all holders
of the same class of
Securities
.
|
3.5
Brokerage Confirmations
.
With respect to each
Reportable Account
, each
Access Person
must require the applicable
broker, dealer or bank to forward to the
Compliance Department
copies of
10
confirmations of account transactions. The Compliance Department has forms that can be used for
this purpose.
3.6
Procedures for Filing Reports
.
Please refer to the StarCompliance User Guide found within StarCompliance for information
regarding how to submit the reports and other information required by this Code.
3.7
Reporting Violations
.
Any violations of the Code shall be reported promptly to the
CCO
.
4. ADMINISTRATION AND ENFORCEMENT OF CODE OF ETHICS
4.1
General Principles
.
The administration of this Code shall be guided by the general principle that, as an
investment adviser, all
GMO Advisory Entities
(and all
Access Persons
) are fiduciaries with respect
to the assets managed on behalf of various clients. Consequently, GMO holds all
Access Persons
responsible for:
Honest and ethical conduct, including the ethical handling of actual or apparent conflicts of
interest between personal and professional relationships; and
Compliance with applicable laws and governmental rules and regulations, including the requirement
in Section 206(4) of the Advisers Act that GMO shall not engage in any act, practice, or course of
business that is fraudulent, deceptive or manipulative.
4.2
Role of COIC; Delegation
.
The
COIC
is responsible for overseeing the application of this Code, and has the authority to
interpret this Code in the event of any ambiguities. The COIC may also recommend changes to the
Code to the board of managing directors of GMO or a designated committee thereof (the GMO Board)
and may authorize any changes in procedures recommended by the CCO. No member of the
COIC
or the
CCO
may review his or her own transactions. The
COIC
may delegate some or all of its authority to
the
CCO
, whether as explicitly set forth in this Code or by specific resolution of the
COIC
. The
CCO
may, in turn, delegate any or all of his or her responsibilities hereunder to members of the
Compliance Department
; provided, however, that in the event that the
Compliance Department
is
notified of any violation of this Code, the
Compliance Department
shall promptly notify the
CCO
.
The
COIC
will consider appropriate actions, if any, as described in Section 4.4 of this Code.
The
COIC
may determine to delay the imposition of any sanctions pending review by the GMO Board
and/or the Board of Trustees of GMO Trust.
11
4.3
CCO
Role, Investigations
.
The
CCO
shall recommend to the
COIC
such changes to procedures, if any, as the
CCO
may
determine in his or her reasonable judgment may be necessary or appropriate to enable the detection
of violations of this Code. The
CCO
is hereby delegated the authority to use those procedures and
the reports made under this Code to investigate and detect any violations and/or potential
violations of the Code
.
The
CCO
will report all violations to the
COIC
and shall also report such
potential violations as the
CCO
may deem appropriate.
4.4
Sanctions
.
If an
Access Person
(or a member of his or her
Immediate Family
) has committed a violation of
the Code, the
COIC
or
CCO
may take such actions against the
Access Person
as the
COIC
or
CCO
deems
appropriate, including a letter of caution or warning, reversal of relevant trade(s) in question,
forfeiture of any profit derived thereon, suspension of personal trading rights, suspension of
employment (with or without compensation), fine, civil referral to the
SEC
, criminal referral,
and/or termination of the employment of the violator for cause. All findings and actions taken by
the
COIC
or
CCO
with respect to violations of this Code will be reported by the
CCO
to the Trustees
of GMO Trust and by the
COIC
to GMOs Board.
The
COIC
may delegate to the
CCO
the authority to assess monetary penalties in amounts
determined by the
COIC
from time to time (such amounts not to exceed $10,000).
4.5
Administration of Pre-clearance
Requests for pre-clearance will be handled in the first instance by the
CCO
, who shall operate
in accordance with the following:
4.5.1.
Blackout Policy
. In general, pre-clearance requests to buy or sell a
Security
(or to
sell the Security short) will be denied if the
Security
(a) was purchased or sold by any
GMO Client
Account
within 3 calendar days prior to the date of the request or (b) in the reasonable judgment
of the CCO is being considered for purchase or sale by any
GMO Client Account
within 7 calendar
days after the date of the request. Pre-clearance requests to sell a
Security
short or to buy or
write an option will be denied if the underlying
Security
is owned by any
GMO Client Account
. The
CCO
will consult with appropriate representatives of the
Investment Division(s)
for purposes of
determining whether a
Security
is being considered for purchase or sale.
4.5.2.
IPOs.
Pre-clearance requests to purchase
Securities
in an IPO will generally be
denied by the
CCO
, subject to the following exceptions: (i) new offerings of a registered open-end
investment company or (ii) any initial offering that an
Access Person
can demonstrate in the
pre-clearance process is available and accessible to the general investing public through on-line
or other means.
12
4.5.3.
Private Placements
. Pre-clearance requests to purchase
Securities
in a
Private
Placement
will be processed in a manner prescribed from time to time by the
CCO
. At the date of
adoption of this Code of Ethics, those procedures require the
Access Person
to complete and submit
a questionnaire at least 10 calendar days before the date of requested approval.
4.6
No Explanation Required for Refusals
.
The
COIC
and/or the
CCO
may refuse to authorize a pre-clearance request for a reason that is
confidential. Neither the
COIC
nor the
CCO
is required to provide an explanation for refusing to
authorize any transaction.
4.7
Review of Denied Pre-Clearance Requests
.
Upon written request by any
Access Person
, the
COIC
shall review any request for pre-clearance
that is denied by the
Compliance Department
. The
COIC
may override a pre-clearance denial if, in
its absolute discretion, it believes the proposed activity is not fraudulent or manipulative, and
not inconsistent with GMOs fiduciary standards.
5. MISCELLANEOUS.
5.1
Copies of Code; Annual Affirmation
.
Each
Access Person
will be provided with a copy of the Code and any amendments to the Code.
Each
Access Person
will be required to acknowledge in writing receipt of the Code and any
amendments to the Code.
At least once annually, each
Access Person
must affirm in writing (which may be by electronic
means) that the
Access Person
has received, has read, understands, and has complied with the Code
and any amendments thereto.
5.2
Review of Reports
.
The
CCO
shall review and maintain each
Access Persons
reports filed pursuant to Section 3.
5.3
Availability of Reports
.
All information supplied pursuant to this Code will generally be maintained in a secure and
confidential manner, but may, without notice to the relevant
Access Person
, be made available for
inspection by the directors, trustees or equivalent persons of each
GMO Entity
employing the
Access
Person
, the directors, trustees or senior management of the GMO Trust or other GMO
Client
, the
COIC
, the
Compliance Department,
the
CCO
, GMO Trusts Chief Compliance Officer, the
Access Persons
department manager (or designee), any party to which any investigation is referred by any of the
foregoing, the
SEC
, any state securities commission, any attorney or agent of the foregoing or of
the GMO Trust, and any other person as may be approved by the
COIC
.
13
5.4
Exceptions to the Code
.
The
COIC
may in unusual or unforeseen circumstances grant exceptions to the requirements of
the Code if the
COIC
finds that the proposed conduct involves negligible opportunity and/or motive
for abuse. All such exceptions must be in writing and must be reported by the
CCO
to the Boards of
Trustees of the GMO Trust at their next regularly scheduled meeting after the exception is granted.
Exceptions granted prior to the date of this Code and identified by the CCO as being of continued
relevance and validity are grandfathered.
5.5
Inquiries Regarding the Code
.
Access Persons
should direct all inquiries regarding this Code (or any other
compliance-related matter) to the
CCO
.
However, it is the personal responsibility of every
Access Person
to understand this Code and to comply with it (and for his or her Immediate Family to
understand and comply with it).
5.6
Amendments to Code
.
The Boards of Trustees of GMO Trust, including a majority of the Trustees who are not
interested persons under the 1940 Act, and the board of directors of every
GMO Sub-Advised Fund
must approve any material amendment to the Code within six months of such change.
* * * * * * * * * *
Special Note for Certain Officers of GMO Trust:
In addition to the requirements set forth in this
Code, the Principal Executive Officer and Principal Financial Officer of GMO Trust are also subject
to the GMO Trust Code of Ethics for Principal Executive Officer and Principal Financial Officer.
Special Note for Independent Trustees
:
Independent Trustees
of GMO Trust are subject to a separate
code of ethics, and are exempt from all requirements under this Code.
Adopted by the GMO Board of Directors on
May 19, 2011
.
To be effective May 20, 2011 or such later date as may be determined by the
CCO
.
14
Exhibit A: Definitions
Access Person
means, except as specifically noted otherwise:
(1)
|
|
every employee or on-site consultant of any
GMO Advisory Entity
;
every partner, member (excluding Class I-A, Special Class I-As,
and Capital Members of GMO), trustee, director or officer (or
other person occupying a similar status or performing similar
functions) of GMO Trust or any
GMO Advisory Entity
; and every
other person who provides investment advice on behalf of a
GMO
Advisory Entity
and that is subject to the supervision and
control of a
GMO Advisory Entity
;
|
|
(2)
|
|
every general partner, member (excluding Class I-A, Special Class
I-As, and Capital Members of GMO), trustee, director, officer,
employee or on-site consultant of GMO Trust or any
GMO Advisory
Entity
(or any company in a control relationship to any
GMO
Mutual Fund
or
GMO Advisory Entity
) who, in connection with his
or her regular functions or duties, makes, participates in, or
obtains information regarding, the purchase or sale of a
Security
by a
GMO Mutual Fund
, or whose functions relate to the making of
any recommendations with respect to such purchases or sales;
|
|
(3)
|
|
every natural person in a control relationship to a
GMO Mutual
Fund
or
GMO Advisory Entity
who obtains information concerning
recommendations made to a
GMO Mutual Fund
with regard to the
purchase or sale of Securities by the
GMO Mutual Fund
; and
|
|
(4)
|
|
such other persons as the
Compliance Department
shall designate;
|
provided
,
however
, that
Independent Trustees
are
not
Access Persons
for
purposes of this Code and provided further that the
Compliance Department
may except certain
persons who are on-site consultants based on various factors, which may include length of contract,
physical location, and computer system access.
Beneficial Interest
means the opportunity, directly or indirectly, through any contract,
arrangement, understanding, relationship or otherwise, to profit, or share in any profit derived
from, a transaction in the subject
Securities
. An
Access Person
is deemed to have a
Beneficial
Interest
in
Securities
owned by members of his or her
Immediate Family
. Common examples of
Beneficial Interest
include joint accounts, spousal accounts (including
Non-GMO Employee Stock
Investment Options
), UTMA accounts, partnerships, trusts and controlling interests in corporations.
Any uncertainty as to whether an
Access Person
has a
Beneficial Interest
in a
Security
should be
brought to the attention of the
Compliance Department
. Such questions will be resolved in
accordance with, and this definition shall be interpreted in a manner consistent with, the
definition of beneficial owner set forth in Rules 16a-1(a)(2) and (5) promulgated under the
Securities Exchange Act of 1934.
Client
means any
GMO Client Account
.
Closed-End Funds
means any fund with a fixed number of shares and which does not issue
and redeem shares on a continuous basis. While Closed-End Funds are often listed and trade on stock
exchanges, they are not
Exchange Traded Funds
as defined below.
15
Compliance Department
means the Compliance Department of Grantham, Mayo, Van Otterloo &
Co. LLC. Communications required under this Code to be directed to the
Compliance Department
should
in the first instance be directed to the
CCO
.
CCO
means the Chief Compliance Officer of Grantham, Mayo, Van Otterloo & Co. LLC
(currently, John McGinty).
COIC
means the GMO Conflicts of Interest Committee (currently, Bevis Longstreth
(Chairman), Domenic Esposito and J.B. Kittredge).
Discretionary Account
is an account that satisfies
all
of the following criteria:
(1) the
Access Person
has no authority to make investment decisions with respect to the assets in
the account
and
(2) the
Access Person
has arranged for quarterly certification from the
third party manager stating that the relevant owner (
Access Person
or
Immediate Family Member
) has
not influenced the discretionary managers decisions during the period in question
and
(3)
the account is confirmed in advance by the
Compliance Department
to be a
Discretionary Account
.
Exchange Traded Funds
are registered open-end investment companies, unit investment
trusts or depository receipts that trade on a national securities exchange and that hold portfolios
of
Securities
that closely track the performance and dividend yield of specific indexes, either
broad market, sector or international. Examples of ETFs include iShares, NASDAQ 100 Index Shares
(QQQQ), HOLDRs Trusts, and S&P Depository Receipts (SPY). For avoidance of doubt, Exchange Traded
Funds do not include Closed-End Funds, even if the Closed-End Funds are traded on a national
securities exchange.
Exempted Government Securities
means direct obligations of the governments of the United
States, New Zealand, Australia, and the United Kingdom.
Federal Securities Laws
means the Securities Act of 1933, Securities Act of 1934,
Sarbanes-Oxley Act of 2002, 1940 Act, Investment Advisers Act of 1940, Title V of
Gramm-Leach-Bliley Act, any rules adopted by the SEC under any of these statutes, the Bank Secrecy
Act as it applies to investment companies and investment advisers, and any rules adopted thereunder
by the SEC or the Department of the Treasury.
Financial Futures
means futures contracts on any of the following: (i) indexes of stocks,
bonds or currencies (but excluding single stock futures); (ii) interest rates; (iii) currencies; or
(iv) commodities.
GMO Advisory Entity
means Grantham, Mayo, Van Otterloo & Co. LLC, GMO Australasia LLC,
GMO Australia Ltd., GMO Singapore PTE Ltd., GMO Switzerland GMBH, GMO U.K. Limited, GMO Renewable
Resources, LLC, GMO Renewable Resources (in New Zealand) or GMO Renewable Resources Uruguay, SRL.
GMO Affiliated Fund
means any
GMO Mutual Fund
or
GMO Sub-Advised Fund
or Wells Fargo
Advantage Asset Allocation Fund.
16
GMO Client Account
means any investments managed for a client by a
GMO Advisory Entity
,
including
GMO Affiliated Funds
, private investment accounts, ERISA pools and unregistered pooled
investment vehicles.
GMO Entity
means
GMO Trust
and each
GMO Advisory Entity
.
GMO Long-Term Fund
means a
GMO Affiliated Fund
that seeks to limit frequent trading of
its shares, as disclosed in its prospectus as amended from time to time. As of December 16, 2009,
the
GMO Long-Term Funds
are all
GMO Affiliated Funds
other than the following:
|
§
|
|
GMO Asset Allocation Bond Fund
|
|
|
§
|
|
GMO Asset Allocation International Bond Fund
|
|
|
§
|
|
GMO Debt Opportunities Fund
|
|
|
§
|
|
GMO Domestic Bond Fund
|
|
|
§
|
|
GMO Flexible Equities Fund
|
|
|
§
|
|
GMO High Quality Short-Duration Bond Fund
|
|
|
§
|
|
GMO Short-Duration Collateral Fund
|
|
|
§
|
|
GMO Short-Duration Collateral Share Fund
|
|
|
§
|
|
GMO Short-Duration Investment Fund
|
|
|
§
|
|
GMO Special Situations Fund
|
|
|
§
|
|
GMO U.S. Treasury Fund
|
|
|
§
|
|
GMO World Opportunity Overlay Fund
|
|
|
§
|
|
GMO World Opportunity Overlay Share Fund
|
GMO Mutual Fund
means any series of GMO Trust.
GMO Sub-Advised Fund
means a registered investment company for which a
GMO Advisory
Entity
serves as a sub-adviser.
Immediate Family
of an
Access Person
means any spouse, domestic partner, child,
stepchild, grandchild, parent, stepparent, grandparent, sibling, mother-in-law, father-in-law,
son-in-law, daughter-in-law, brother-in-law, or sister-in-law of an
Access Person
who resides in
the same household.
Immediate Family
includes adoptive relationships and any other relationship
(whether or not recognized by law) which the
Compliance Department
determines could lead to the
possible conflicts of interest or appearances of impropriety which this Code is intended to
prevent. The
Compliance Department
may from time to time circulate such expanded definitions of
this term as it deems appropriate.
Independent Trustee
means any trustee of GMO Trust who is not an interested person (as
defined in Section 2(a)(19) of the 1940 Act) of GMO Trust.
Investment Division
means any of the following functional investment divisions of GMO:
International Active, U.S. Quantitative, International Quantitative, Emerging Quantitative, Fixed
Income, Forestry, Asset Allocation, U.K. Equities, Australian Equities, Global Tactical and any
other discrete investment division dedicated to a discrete asset class and/or style of investing.
17
IPO
means an offering of securities registered under the Securities Act of 1933, the
issuer of which, immediately before the registration, was not subject to the reporting requirements
of Section 13 or 15(d) of the Securities Exchange Act of 1934.
Money Market Instruments
means money market instruments or their equivalents, including
bankers acceptances, bank certificates of deposit, commercial paper and high quality short-term
debt instruments, including repurchase agreements.
Mutual Funds
means registered open-end investment companies (and does not include
closed-end investment companies).
Non-Access Director
means any person who is a director of GMO who (1) is not an officer
or employee of a
GMO Entity
; (2) has been designated as a
Non-Access Director
by the
CCO
(or a
designee); (3) is subject to any requirements of GMOs Procedures Regarding Certain Outside
Directors; and (4) meets each of the following conditions:
|
(1)
|
|
he or she does not have access to nonpublic information
regarding any
Client
s purchase or sale of securities
(other than shares of
GMO Affiliated Funds
), or nonpublic
information regarding the portfolio holdings of any
GMO
Affiliated Fund
;
|
|
|
(2)
|
|
he or she is not involved in making securities
recommendations to
Clients
, and does not have access to
such recommendations that are nonpublic; and
|
|
|
(3)
|
|
he or she, in connection with his or her regular functions
or duties, does not make, participate in, or obtain
information regarding the purchase or sale of a
Security
by
a
GMO Affiliated Fund
, and his or her functions do not
relate to the making of any recommendations with respect to
such purchases or sales.
|
A list of Non-Access Directors may be found on Appendix A of the Procedures Regarding Certain
Outside Directors.
Non-GMO Employee Stock Investment Options
means a compensation program offered through
the employer of an
Access Person
s spouse.
Private Placement
means an offering that is exempt from registration under the Securities
Act of 1933 pursuant to Section 4(2) or Section 4(6) of such Act or pursuant to Rule 504, Rule 505
or Rule 506 under such Act.
Reportable 529 Plan
means any 529 Plan for which GMO (or a control affiliate) manages the
investments or strategies underlying the 529 Plan or for which GMO (or a control affiliate)
manages, distributes, markets or underwrites the 529 Plan. While not an exclusive list and while
Access Persons are ultimately responsible for determining whether a 529 Plan is a
Reportable 529
Plan
, Appendix A-2 to this Code includes a list of
Reportable 529 Plans
as of the date of this
Code.
Reportable Account
means, with respect to any
Access Person
, an account in which the
Access Person
has a
Beneficial Interest
and in which any
Securities
are held.
18
Restricted Exchange Traded Fund
means any
Exchange Traded Fund
determined by the
CCO
, in
consultation with GMOs trading desks, to: (i) be likely to be used by a trading desk;
and
(ii) possess attributes (e.g., limited liquidity or limited number of underlying securities)
suggesting that contemporaneous trading by
Access Persons
could result in a benefit to an
Access
Person
or a detriment to any GMO client. A complete list of
Restricted Exchange Traded Funds
is set
forth in Appendix A-1 to this Code.
SEC
means the Securities and Exchange Commission.
Security
means any security (as defined in Section 2(a)(36) of the 1940 Act) as well as
any derivative instrument (including swaps), financial commodity or other investment instrument
that is traded in any public or private market. The definition in the 1940 Act is very broad and
includes notes, bonds, debentures, participations in any profit sharing agreement, collateral-trust
certificates, investment contracts, undivided interests in oil, gas or other mineral rights, any
put, call, straddle, option or privilege on any security or on any group or index of securities,
any put, call, straddle, option, or privilege entered into on a national securities exchange
relating to a foreign currency or, in general, any interest or instrument commonly known as a
security.
Securities Transaction
means a transaction (including both purchases and sales) in a
Security
in which the
Access Person
or a member of his or her
Immediate Family
has or acquires a
Beneficial Interest
. For avoidance of doubt, a donation of
Securities
to a charity is considered a
Securities Transaction
. In addition, certain investments may involve multiple
Securities
Transactions
for purposes of this Code (e.g., purchase of option, followed by exercise of option).
StarCompliance
means a web-based, automated, fully managed personal trading solution,
accessible from GMO computer terminals via http://starcompliance.
Unrestricted Exchange Traded Fund
means any
Exchange Traded Fund
not designated as a
Restricted Exchange Traded Fund
.
U.S. Government Securities
means direct obligations of the Government of the United
States.
19
Appendix A-1
This Appendix A-1 is maintained on the GMO Legal Department intranet website. Please consult the
website for the most current list of Restricted Exchange Traded Funds.
20
Appendix A-2
This Appendix A-2 is maintained on the GMO Legal Department intranet website. Please consult the
website for the most current list of Reportable 529 Plans.
21
GMO U.K. Limited Code of Ethics Supplement
(Last Amended February 23, 2011)
In order to comply with the FSAs personal account dealing rules and to allow for certain UK
specific investment practices, this supplement (the UK Supplement) has been issued to all GMO UK
staff as a supplement to the GMO Code of Ethics (Code). In the event of a conflict between the
Code and the UK Supplement, the UK Supplement shall govern.
1.
|
|
Application of the Code to Covered Accounts
|
|
|
|
The Code and the UK Supplement apply to all GMO UK employees,
on-site consultants and Covered Accounts. A Covered Account
includes the employees spouse and minor children and any person
to whom the employee, in his or her personal capacity, gives share
recommendations including, a relative, co-habitee, business
partner or friend. GMO presumes that an employee exercises control
or influence over a spouses or minor childs personal account
transactions and therefore any such transactions must comply with
the Code. All transactions by a Covered Account must be reported
by the employee concerned.
|
|
2.
|
|
Special Rules for Certain Investments and Investment Practices
|
|
|
|
UK Gilts: Transactions in UK Gilts are not subject to pre-clearance but must be reported quarterly.
|
|
|
|
|
PEPs and ISAs: Any proposed transaction for a PEP or ISA account must be pre-cleared unless an
available exemption exists.
|
|
|
|
|
De Minimis Purchases and Sales of FTSE 100 stocks: Employees may purchase or sell up to a maximum
of £15,000 of any FTSE 100 stock once, within a three business day period without obtaining
pre-clearance. All such transactions are subject to quarterly reporting.
|
|
|
|
|
Investment Trusts: Purchases and sales of investment trusts which hold predominantly UK equities
are not subject to pre-clearance but are subject to quarterly reporting. Pre-clearance will be
required for transactions in investment trusts holding non-UK stocks as such trusts may be
purchased for client accounts from time to time.
|
|
|
|
|
Contracts for Differences (CFDs) and Spread Bets: CFDs and spread bets are not subject to the
short-term trading prohibition set forth in Section 1.4 of the Code, PROVIDED that the security
underlying the CFD or spread bet would itself be exempted from the prohibition.
|
3.
|
|
Exemptions for Unit Trusts, etc.
The prohibitions in Section 1 of the
Code and the pre-clearance requirements in Section 2 of the Code do
not extend to any transaction by you in an authorised unit trust, a
regulated collective investment scheme or a life assurance policy
(including a pension).
|
22
4. Counseling and procuring
If the Code precludes you from entering into any transaction, you cannot:
|
(a)
|
|
advise or cause any other person to enter into such a transaction; or
|
|
|
(b)
|
|
communicate any information or opinion to any other person,
|
|
|
if you know, or have reason to believe, that the other person will
as a result enter into such a transaction or cause or advise
someone else to do so.
|
|
|
|
This does not apply to actions that you take in the course of your
employment with us. For example, the fact that you are yourself
prohibited from dealing in a certain stock as a result of one of
the provisions above does not necessarily mean that you are
precluded from dealing for the clients account, subject to the
insider dealing legislation summarised in 8 below.
|
|
5.
|
|
Summary of insider dealing legislation
|
|
|
|
The UK insider dealing provisions contained in part V of the
Criminal Justice Act 1993 (the Act) are complex, and if you
would like fuller details or are in any doubt whether a particular
transaction would be prohibited, you should consult the
Compliance
Department
.
|
|
|
|
The Act applies to all securities traded on a regulated market
(which currently includes all EC stock exchanges, LIFFE, OMLX and
NASDAQ) and to warrants and derivatives (including index options
and futures) relating to these securities even if these warrants
and derivatives are only over the counter or otherwise not
publicly traded.
|
|
|
|
In broad terms, and subject to the exemptions provided by the Act,
the Act makes it a criminal offence, with a maximum penalty of
seven years imprisonment and an unlimited fine, for an individual
who has non-public information to deal in price-affected
securities (including warrants or derivatives relating to them) on
a regulated market; or deal with or through a professional
intermediary; or by acting himself as a professional intermediary.
Securities are price-affected if the inside information, if made
public, would be likely to have a significant effect on the price
of the securities. This applies to all companies securities
affected by the information, whether directly or indirectly (for
example, competitors of a company about to bring out a new
product).
|
|
|
|
The Act applies whether you deal as part of your employment or on
your own account. It also applies to information which you obtain
directly or indirectly from an insider whether or not in the
course of your employment (for example, by social contacts).
|
|
(1)
|
|
If you are precluded from dealing, normally you are also prohibited
from dealing on behalf of the firm or a client (except perhaps on an
unsolicited basis);
|
23
|
(2)
|
|
Procuring or encouraging another person to deal in the price-affected securities (whether or not the
other person knows they are price affected); and
|
|
|
(3)
|
|
Passing the inside information to another person other than in the proper performance of your employment.
|
|
|
It is possible for a transaction which involves insider dealing to constitute an offence
otherwise than under the insider dealing provisions of the Criminal Justice Act. In
particular, under section 118 of the Financial Services and Markets Act 2000 a person who
dishonestly conceals any material facts is guilty of an offence if he does so for the
purpose of inducing, or is reckless as to whether it may induce, another person (whether
or not the person from whom the facts are concealed) to buy or sell an investment, or to
refrain from buying or selling and investment. This offence could well be committed by a
person who conceals price sensitive information from a counterparty to induce him to deal,
if the concealment is dishonest.
|
|
6.
|
|
Compliance Contacts
|
|
|
|
For queries in relation to this GMO U.K. Limited Code of Ethics Supplement please refer to:
|
|
|
|
Rishika Jay Prakash, Compliance Officer
|
24
GMO Australia Limited Code of Ethics Supplement
(Last Amended October 1, 2010)
The following policies and procedures are in addition to, and where relevant supersede the policies
and procedures detailed in the GMO Code of Ethics (the Code).
Authorisation
Authorisation must be sought by all staff members prior to trading via the
StarCompliance
system.
Exemption from Authorisation Requirement
Authorisation for purchasing securities in an unrestricted public offer is not required.
GMOA Trading
Securities that are held in the GMOA trusts or individually managed portfolios:
|
|
may not be traded by staff during the 3 working days before and after re-balancing* by GMOA.
|
|
|
and are not being traded as part of the re-balancing* by GMOA may be
traded during this 6 working day period subject to pre-authorisation.
|
Staff may trade securities at any other time subject to the pre-authorisation.
*
|
|
Re-balancing includes normal monthly trading and any other trading as a result of cash flows.
|
Special Rules for Certain Investments
Australian Registered Managed Investment Schemes and Superannuation Funds: Australian Registered
Managed Investment Schemes are publicly offered pooled investment products registered and regulated
by the Australian Securities and Investment Commission (ASIC). Superannuation Funds are pooled
superannuation investment products registered and regulated by the Australian Prudential Regulation
authority (APRA). Purchases and Sales of these publicly offered products are not subject to
pre-clearance or reporting requirements under the Code.
Exception for those Australian Registered Managed Investment Schemes and Superannuation Funds
sub-advised or managed by GMOA: Purchases and sales of these schemes are not subject to
pre-clearance but are subject to the reporting requirement of the Code. As of February 2, 2010,
such schemes include but are not limited to:
|
|
|
BT Investments Australia Value Shares Value 1 and Multi-Manager Options
|
|
|
|
|
Colonial First State First Choice Investment Options (Australian Small Companies Option)
|
|
|
|
|
ipac investment management limited: Diversified Investment Strategies
|
25
|
|
|
International Share Strategy No.s 3 & 4
|
|
|
|
|
Diversified Investment Strategies Australia Share Stategy No 1
|
Exception for other types of pooled investments sub-advised or managed by GMOA: Purchases and sales
of these schemes are not subject to pre-clearance but are subject to the reporting requirement of
the Code. As of February 2, 2010, such schemes include but are not limited to:
|
|
|
Partners Group Alternative Strategies PCC Limited Red Epsilon Cell: An open-ended protected cell investment company
established under the laws of Guernsey.
|
|
|
|
|
Global Funds Trust Company GMO Global Tactical Fund F: a unit trust esablished under the laws of the Cayman Islands.
|
The above list may change regularly. It is best in all circumstances to confer with Legal &
Compliance Asia-Pacific prior to making any investments in order to ensure the above list is
current.
26
GMO Renewable Resources (in New Zealand) Code of Ethics Supplement
(Last Amended September 8, 2009)
The following policies and procedures are in addition to, and where relevant supersede the policies
and procedures detailed in the GMO Code of Ethics (the Code).
De Minimis Purchases and Sales of Certain Securities of Issuers in the NZSX 50 Index
Purchases or sales by
Access Persons
of less than NZ$40,000 of common stock, depository receipts,
or preferred stock of issuers who are not timber or timber-related and are listed in the New
Zealand Stock Exchange Top 50 Companies (NZSX 50 Index) as of the date of such purchases or sales
are not subject to pre-clearance requirement. This exemption from pre-clearance may be utilized
once per security within multiple accounts during a pre-clearance period so long as the total
across all accounts is less than NZ$40,000;
The NZSX 50 index contains the top fifty securities ranked by tradable equity quoted on the New
Zealand Stock Exchange.
27
GMO Non-Access Directors Code of Ethics Supplement
Non-Access Directors
of GMO are exempt from all requirements under the GMO Code except for the
following:
Non-Access Directors
are subject to the Codes restrictions relating to Inside Information
(see Section 1.6), Market Manipulation (see Section 1.7), and Short-Term Trading Strategies in
GMO
Long-Term Funds
(see Section 1.5);
Non-Access Directors
are subject to any personal trading restrictions and periodic reporting
requirements set forth in GMOs Procedures for Certain Outside Directors, as may be in effect
from time to time; and
Non-Access Directors
are subject to the GMO Gift Policy (which is set forth in a separate
stand-alone policy), except that
Non-Access Directors
shall not be restricted from receiving, nor
required to report, gifts received from current or former clients or business associates,
notwithstanding that such persons may also be clients or prospective clients of GMO.
28